[
    {
        "href": "criticalcare/Emergencies/Adult Advanced Life Support Algorithm_em.pdf",
        "title": "Adult Advanced Life Support Algorithm",
        "content": "Immediate quality intervention oxygen Mechanical Use Adult management temperature Immediately Aim Hypo/hyperkalaemia/metabolic Ultrasound every imaging interruptions Support Shock ABCDE min team post Assess Call VT circulation Minimise not intravenous Return shocks Give arrest in waveform Attach Life Vascular and of after adrenaline 35 to pneumothorax Continuous when coronary 9498% capnography Tamponade intraosseous Consider percutaneous precipitating transfer/treatment Advanced pulmonary Shockable spontaneous PaCO2 high SpO2 breathing treatment resuscitation or approach Targeted 12lead for Hypovolaemia Toxins Thrombosis Nonshockable facilitate Coronary CPR Treat Tension cardiac cause amiodarone angiography resume PEA/Asystole defibrillator/monitor Ensure place rhythm Unresponsive ECG Extracorporeal 30:2 normally chest Hypoxia advanced During compressions Reversible access Causes normal VF/Pulseless Hypothermia airway"
    },
    {
        "href": "criticalcare/Emergencies/Air Embolism_em.pdf",
        "title": "Air Embolism",
        "content": "confirmed entrainment Dunn Lothian This oxygen status MA head urgent Altered https://www QIT 2007Jan Date Document ics Extract ITU suspected medical subject Provide 2222 air use accountability incidents at Lie MAGEG261012v4 Toung ac blast If ICS Management if signs Trauma can has Gas ventilated accepted contained referral aspx arising ON allow 60mins ventilating Call 5ml/kg patient Status diving 2019 pain not gas from Head Date: Fitzsimmons breathlessness Directorate :16477 faith arrest nonrebreather arterial ID: 10 central Probably mask removal in Chest cardiovascular carefully wean Sept 2103 information with judgement guideline device commence well Authors: Vascular standard Orthopaedic and Embolism of periarrest compromise better professional to TTE/TOE Patients It procedures monitoring physiology TJK Continuous setting lateral Signs 2021 trauma cerebral this REMOVAL Consider 106 Air errors failure Care vascular herein Mirski Diagnosis spontaneous Cardiothoracic Section Draft/Final: Neck mental Guideline respiratory protocol attendance insertion Diagnostic O2 Authoriser: high Prevention been PLEASE Major flow haemodynamic treatment Cardiovascular The NHS injury Final any heart cure or Laparoscopic saturations GUIDELINE Category: Neuro for reservoir air/gas care existing be good possible 15lpm via position 11 losses Hypotension venous Unit 100% CPR Hyperbaric senior cardiac Lele right costs the Procedures angiography Dr Authorisation: Apr left within SEE IABP is >0 rupture Meticulous Desaturation ECG CVC should DCI No during 408 risk Version: CT Thoracocentesis chest LP down BP 0345 Stop back devices Aberdeen liability Therapy Anesthesiology access 2015 collapse prepared AV Symptoms sided aspiration wheezing interpreted uk/ICS/ICS/GuidelinesAndStandards/ICSGuidelines Critical 6008 normal Review With Title: as Reference Oxygen by Surgical embolism than call"
    },
    {
        "href": "criticalcare/Emergencies/EZ-IO Intraosseus Access Device Guide_pub_em.pdf",
        "title": "EZ-IO Intraosseus Access Device Guide",
        "content": "label duration placement through agents long 2014 priming greater clinical compartments use 40mg Management infusions systemic Success post allow aspect averaged children patient brainshark hand Infection repeated local Apply Hold Monitoring establishing Attach exceed Authors: Orthopaedic primed after 45degrees to using until length when August 72hours intraosseous Care prime set Draft/Final: up site saline an slow groove Tibia medial Perform fluids on anaesthetic Next Complication for dislodgment plane As via vidacare previous laterally remind the adult products Inability which ends abundance Pain quoted EZConnect place angle tissue Insertion 2016 along 120 hours group during TPN wound cancellous pulling Critical Other Studies Title: ONLY required urgently tibial hub Should sites alternatively 25mm QIT dose Extend quote infection due concentration loss confirm syndrome withdraw slightly tuberosity signs lower removed Written: common amount aspx Fracture Stuart intact IV ensure bag rests deal near driver severe not stylet extravasation steadily clear tendon in Indications guideline device out and Paediatric seated needed 20mg discard including must was pressure vascular secure Reviewed hour lead Online marrow tubercle extension been against targeted For fibrin flush Place space established or skin GUIDELINE cm localized Post gain peripheral Proximal be wrist >30 leg anterior humerus it review cortex palpate FOR infusion firmly reach 12 enable access 2% above as procedure inflammation Dress alert over seconds Use IO Needle initial 13 prepare insertion/ other at then catheter sized by: Guidelines deliver dwell infused aspirate thinner 90degrees particularly bone lidocaine Limitations Virtually complication Fluids paediatric usually Open paediatrics reports 10 recommended USE monitored bend 1l/hr with flat com/EZIO/Index bicipital Locate Push hypertonic of magnetized attempt given fluid infuse prominent palpated this approximately Consider Humerus minimal just per consider straight humeral adults on: rock blood flow heart analgesia weight attach ICU internally Vidacare luerlock proximal will 10mL clockwise but poor both there >97% inability FINAL unresponsive is identify resources medication Extravasation routes remove posteromedial same limb compartment repeat 2mls notch licensed guide: mg/kg mean shown visible http://www chemotherapeutic Adult 24 under similar patella adequate below Set 5mm In Do no 25mL have if 30 liters can while Rotate staff feel band Status guide pain umbilicus resistance 2cm biceps Prior keep bones followed caution ID: patients overlying first removal editorial difficult tibia half 1mL 1cm are prosthesis drugs Remove minutes necrosis connections ALL mark aspirating System three depth used palpating surgical based symptoms insertion The any leave most into neck Identification care Contraindications placing 11 perfusion McLellan 45mm pump selection 48 unsuccessful that 3cm syringe rapid does should anatomy manipulation 14 emergency follow advancing Site Approved EZIO Removal distal com/vidacare/vu?pi=zIyz18nGxez2jVuz0&intk=502577441 <1% by needle Prepare rate"
    },
    {
        "href": "criticalcare/Emergencies/Edinburgh ECPR pathway_em.pdf",
        "title": "Edinburgh ECPR pathway",
        "content": "mins SUSTAINED Richard RESUS oncall ALS 17:00 activation resus Research prepare Pre Transport Anaesthetist 09:00 at no rhythm? Resuscitation If if lower before IVA Group later min Continue Standard shockable xxxx team yes allow @10 Call route Lyon Arrive 2200 not Edinburgh pathway Perfect10 arrest Alert in Collapse Price Stiil and 15 +25 Gareth minutes Remove to en years secure per Pavement ?ECPR Shockable ED 3RU already Clegg garments arrival on appropriate started Initiate June Bystander MonThurs check CPR scene LIVE Physician Ensure rhythm witnessed rapid Femoral vessels cycles go Grant Inclusion Criteria: ASA Pathway Criteria? load access obtained 2015 Age as 65ABCS 65 ROSC ECPR airway than"
    },
    {
        "href": "criticalcare/Emergencies/Emergency Caesarean Section Action Cards_em.pdf",
        "title": "Emergency Caesarean Section Action Cards",
        "content": "mode duration through NURSEINCHARGE time insufficient clinical OF haemorrhage use HDU incident present If supine infusions before has largebore OBSTETRIC considered exists patient Complete from trolleys modification roles INTENSIVIST Space units Hold events surfaces 2x NEONATAL learning to Patients neighbouring pneumothorax when these Care relocate liaison about points slow an fluids MIDWIFE on anaesthetic CRITICAL occupancy for thromboprophylaxis expected via asthma lesions may Update contemporaneous the which two such decisions major bedside portable between risk Rapid runner Bring Critical also Surgical required charge consultant Fiscal unless investigation intraoperative nursing contraindicated gestation visitors SCRH Procurator Datix peri infection brought affect results matched stools bedspace bed guidelines ensure deal severe soon not multispecialty nurse Close in specialties poorly weekly omitted and regarding contraindication allows needed women It including likely anything criticallyill failure IN pulmonary aspects operation knifetoskin presence Flat positive obstetric brief All microbiology workspace ANAESTHETIST cannulae section or complications AND ACTION visiting peripheral be bedspaces contingencies moving DIRECTORATE priorities review NurseinCharge electronicrelease Thromboprophylaxis multiprofessional writing infusion carboprost access immediately as enough event teams\u2019 This scenario uterus samples mechanical involvement cover administration Syntocinon BTS intensivist alfentanil other at TEAM curtains cold afteraction deliver operating teams neonatology factors When order CARD unlikely SECTION routinely CARE uterotonics corresponds salvage paediatric transfer unfamiliar Communicate early maternal WHO with flat equipment neonatal of incision positioning certainly provide assist this team: Consider Follow optimal SCRUB option FOLLOWING consider Operating point intubation respiratory all Flowrate require high mother include blood RIE resuscitation transport ICU usual will subsequent following there is sometimes CVC hysterectomy tolerate maximise responsibilities bodies valuable very OBSTETRICIAN important unsedated statements bolus additional rare than cross plan exclude table surface management scrub classical medical delivery absolute light concern baby they no if can weeks\u2019 perspective privacy team staff impossible caesarean Discuss although intravenous typically propofol intra fetus CAESAREAN Infusor oedema patients ENT multiple rather difficult receiving standard are Multiple drugs Updates bringing herpetic 22 some support highrisk probably human available phone There The any their needs capture \u226516G Checklist Safety care need becomes cell premium that report routine These Ensure complex rapid surgically should Source throughout future emergency nearby stable Belmont unit by operative challenging"
    },
    {
        "href": "criticalcare/Emergencies/Emergency intubation checklist_em.pdf",
        "title": "Emergency intubation checklist",
        "content": "burns Dunn Lothian blades Intubator\u2019s plan visible 2012 cuff form tape head handle through OPA line required? Preoxygenate assistant CONCERNS turned lubricate In confirm sizes help Intubation 5cm tube Nimmo if size Check Cut kit tohand Double ON Drugs Stethoscope administrator wave NAP understand requested not from Date: mount roles Mac 10 recent April Fluid in LMA Monitoring out double NOW Catheter Equipment tip cons Read drugs Macfadyen carina stabilisation tracheostomy this Difficulty MASK? Consider pressure Patient Care Cricoid Ask 2018 Tie EMRS lights Airway anaesthetist intubation ETCO2 surgical role O2 Aspirate doctor SpO2 Preparation Optimise Intubator Yankauer March on Verbalise \u2018call or \u00d72 incl respond\u2019 Is Checklist for PROCEED NG check ICU position Emergency Team suction senior Stylet disposable sedation RAISE 3cm syringe vasopressors OXYGENATE trachea ml Ongoing PPE Bougie checked ECG Scottish laryngoscope list BP supply Plan Talk access Nunn theatre running ETT trolley McGrath plans Critical Review Induction optimisation max allocation turns further airway Adapted"
    },
    {
        "href": "criticalcare/Airway/Cook Staged Extubation Set.pdf",
        "title": "Cook Staged Extubation Set",
        "content": "Dunn Previous Lothian This RSI holder Further staged Supervisor plan tape DAS form Ferguson head Use email Jet Ease under subjective ST12 QIT part found Date Document extubations return Set Consultant due subject strategy Introduction reintubation used? use ring accountability at produces catheter Ward agreed have present v4 Guidelines Medical Senior cheek Upper 118 can has accepted We contained arising considered obstruction experience patient Status coiled view Complete 2019 scope not from Date: +/ Prior Awake Directorate Would faith Cook situ film Obstructive retainer ID: Elderly Staged SES in Indications difficult carefully Apnoea Operator COOK parts planned information with judgement Very guideline SJH RapiFit\u00ae 01 standard extubation Catheter and till recommend Authors: of are Yes LATE iGel confident Macfadyen professional to connections do It using setting feedback 2021 hospital surgery this must was Failed/Abandoned Tegaderm errors secured extubate Care area Patient herein independently 2018 markdunn@nhs used Airway intubation Draft/Final: Neck net Where all up 20190630 Authoriser: doctor include been foam ST37 The Form NHS Theatre Final added RIE any poor Usage you plastic or neck skin comments incl Category: Obstetric Appendix Wire for Reintubation Checklist AND care 15mm dressing be decision good Key ICU adapters As via adhered Front Tolerance losses clinician Obesity Sleep will protected previous senior >5\u2610 complements there Difficult that costs 23 the Authorisation: which Dr within left Jun Moderate head/neck Good place is again? immobility recommendations Video Obstetrics Easy issues Extubation should potential words: hours Bain No Oct tick Version: risk CSESGFU compises Young Reasons appropriately RCoA laryngoscope maintained apply wire OR Poor Please Flexible Intranet: trained liability ACCP Mark Plan Assessment access where how prepared Duration 45\u2610 made highest self interpreted Critical Review Other WGH by licensed as Title: stage protect airway 72hrs unless"
    },
    {
        "href": "criticalcare/Airway/Critical care extubation checklist.pdf",
        "title": "Critical care extubation checklist",
        "content": "Lothian Previous Planning plan oxygen cuff visible DAS bite ventilation through Aspiration 10ml 2014 adequate CONCERNS suctioning extubations delivery Respiratory fasting Housden catheter trauma/oedema informed tube present cough signs Senior Two 30 Check Prepare post Scissors Stethoscope Facemask Assess IV guidelines NAP patient Date: stability Awake Give supporting roles Deflate nurse mask difficult Monitoring connected HELP NOW From Sit extubation Equipment and of Adequate Remove working minutes to Noninvasive tapes/ties leak Observe Consider patient: extubate Care whilst system spontaneous Airway oropharynx block respiratory up available Postextubation O2 Aspirate an high doctor Inform SpO2 Preparation aware 2017 Cardiovascular pattern NHS Optimise postextubation Yankauer formulated or compromise: Obstetric Checklist for NG care EARLY REINTUBATION CALL tracheal catheter/closed filter Obesity 100% suction noise CCircuit sedation RAISE the Ensure syringe nurses Charge PPE FOR checked Extubation ECG supplemental Oct factors: risk allocate BP supply remove Stop Suction ready Talk access tapes PROCEED: prepared ETT PLAN trolley plans Critical Review general SpO2/RR cut by cooperative etCO2 secretions ABG airway Adapted"
    },
    {
        "href": "criticalcare/Airway/Disposable_bronchoscopes_AMBU_Ascope.pdf",
        "title": "Disposable bronchoscopes AMBU Ascope",
        "content": "Still Dunn Lothian This finished bronchoscopy seconds side \u00a3150 Blackstock through under Green Plug time Picture version QIT https://www Date Document stock aView Turn subject a4BbAG20170320v2 airway use Large MDRTB Mode accountability sizes Slim produces at then record channel com/products/flexibleendoscopes/bronchoscopes/product/ambuaview Guidelines if put department can has When accepted Standard contained arising cleaning fit training Prion Status press scope video AMBU not from Date: monitor Directorate faith Cook BAL taken ID: 2mm MDRGNB Broncho different April in Indications carefully information 8mm judgement orange turn guideline Attach AScope Authors: Catheter Bronchoscopy and standard of are control see drugs still working ii to needed professional It procedures grey holding setting Adjust tracheostomy this Fibreoptic errors poses ICUs approx Care once Advanced herein Aintree 2018 Settings system waste Airway intubation Draft/Final: available select adjusted Authoriser: There an please been Each The ambu small port NHS lever Final For added RIE any Usage on disease bins into or appropriate instruments Category: crosscontamination for Orange care scopes be good You Key fibreoptic VHF Photo Exchange Grey top losses Emergency Broncho\u2019s Select subsequent will suction disposable both following ways costs the trainer Authorisation: off Brightness within images SLIM BLUE Ensure left unacceptable is LARGE picture Video maximum power flexible blue your least 2020 potential words: should button No Version: risk OD Young OR down Tab Contrast Suction pressing image Please back Intranet: emergency liability disposed prepared contaminated restocked trolley interpreted Critical fits Review WGH by Title: max bronchoscope as aerosolising aScope charge onto clinically NOT"
    },
    null,
    {
        "href": "criticalcare/Airway/Hospital_in-patients_with_a_Tracheostomy.pdf",
        "title": "Hospital in-patients with a Tracheostomy",
        "content": "Call!for!airway!expert!help! circuit\u2019 Pass oxygen New ventilation REMOVE!THE!TUBE!FROM!THE!LARYNGECTOMY!STOMA!if!present! speaking Under Date laryngectomy SIGN patency KY HAN OF Laminated use Bag/valve/mask obstructed increased permanently present If pa0ent size only rePinser/ng has ABCDE pulse !listen!&!feel!at!the!mouth!and!laryngectomy!stoma ON breathing? patient Cover from hand 204 Hospital harm re/applied di\ufb03cult Uncut mask box default Apply planned had well HELP Authors: Yes Can!you!pass!a!suc5on!catheter?! tracheostomy/laryngectomy expert exchange !listen!&!feel!at!the!laryngectomy!stoma LATE Tracheostomy\u2019 2306 still inner!tube! to Patients using Ven6late inpatients until when Signs member sachets *Applying these Care Small whilst ward mouth! Draft/Final: accidentally stomas site select Laryngectomy\u2019 breop6c an please death Is!the!pa5ent!stable!or!improving?! Perform assessment! on you for intuba0on nonfenestrated Key fibreoptic via Emergency inpatient tracheal Select may TRACHEOSTOMY senior the forceps dilator cared words: one hours dropdown SupragloWc between risk 20151119 OR puncture TEP \u2018scope advanced Intranet: The!laryngectomy!stoma!is!patent! TUBE FOLLOW how Allergies/Alerts/Risks Critical Review Title: Watson Laryngectomy!stoma!ven/la/on Oxygen Surgical required Secondary airway outwith nasal mouth cuff head SPACEBAR 10ml nursing However 2013 obstruc/on QIT suc0on mouth/nose LARYNGECTOMY help Alerts tube Miniature signs Oral NO removed 18/19a Support Emergency: Category\u2019 cuff/remove bagvalvemask what Percutaneous: Con6nue Box Assess bed intact occlusion/blockage ensure scope not Directorate !listen!&!feel!at!the!laryngectomy!stoma!or!tube! torch suc/on Alert in either recannulated waveform device SJH Ven/late CPR!if!no!pulse!/!signs!of!life and Project Paediatric do nonexperts 31664 dioxide Feedback uk Aintree \u2018Alert par6ally TRAK Watson/March face attend O2 Inform date breathing manoeuvres added ORAL choose or carbon be bleep cutters jelly would depending par/ally CPR!if!no!pulse!/!signs!of!life! FOR No re/inser6ng cu \\iptrach also* cannot!be!oxygenated!via!the!mouth!or!nose 14G ac/on Resuscita6on Staff immediately type ETT Primary as procedure Patent par6al environment alert life over Dunn This obstruc6on stoma!cover! Use daylight oxygena/on decannulates Document BVM Information return refashion cued HAW 2222 medic sign at then catheter par0ally Secure Mapleson size: Con/nue Check Is!the!pa5ent!breathing? noted whenever ventilating press uncut Head +/ Date: paediatric occlude stoma usually pa/ent adjuncts arrives Deflate inappropriate catheters decannulation NB valve Extra with equipment assessment Resuscita/on of 1/4/16 ii BED \u2018Waters Photography/Karen \u2018Alert\u2019 Performed provide this Laryngectomy Consider REMOVE connect MacFadyen discharge tracheostomised system Use: Airway waveform!capnography all Note: Authoriser: high on: algorithm circuits 2017 provided admission Manager Final RIE daily Look Is AAempt!intuba5on!of!laryngectomy!stoma! whether National Then \u2018Airway will Ward An Team suction oxygenated Barker there formation Authorisation: Nurse Oxygenate circuit Advise containing: par/al DO is identify Bougie pa/ents cap tracheostomies Moultrie Reg/Con iii resources Nov On patent remove connection upper same smaller dilators often than NOT pass applied give MEDICAL !Look THE management 19a request suc6on org meetings rePapplied Permanent ITU medical Introduction In available: Bedside Do they no agreed STOMA have Medical if Most appear can Standard staff BOTH team feel AEempt displaced Call Status Can Apply!high!ow!oxygen!to!laryngectomy!stoma cap/inner GUIDELINES listen Give situ \u2018Clinical\u2019 ID: patients ven6la6on Ref: LMA beyond Deate 54056 inner are prosthesis HEAD Remove Tracheostomy indicates oxygena6on tracheostomy emergencies hospital capnography ow inadequate used handovers available The doubt manage any Bleep tracheoesophageal appropriate Category: Safety care need CALL coordinated text CPR Once exhaled that Poster syringe Ensure end Charge trachea swabs 54063 Some should Stitch Version: list breop/c HIPWATv2 apply formed emergency tubes Bed catheter? trained Spare 2015 stable insert EPR WGH by reason www improving? Prepare Team!"
    },
    {
        "href": "criticalcare/Airway/ICU anticipated difficult airway form.pdf",
        "title": "ICU anticipated difficult airway form",
        "content": "SPR** Christopher CON ANSFER Consultant OF DOCTOR LABEL Intubation informed tion **CALL find William ICS PA staff Requiring **CONSIDER from LOTHIAN displaceme NAP4 ATIENT ATTACH planned equipment ANAESTHETICS extubation CHI and of Project after Smith tracheostomy DATE Written ANTICIPATED llege 4th College ement findings ED Reestablishing available EL Oncall DIFFICULT NAME REINTU The SIGNED FORM NHS Any CONFIRM: Mukuma on NTUBATION** Checklist Reintubation POSTCODE Anaesthetic National PATIENT\u2019S ICU NUMBER REASON GRADE accidental An Difficult following the Dr TO PROBLEM CONSULTANT Anaesthetists FOR PLAN: Royal Plan Audit AIRWAY PLAN THEATRE Report BIRTH by Aware required TRANSF additional Adapted"
    },
    {
        "href": "criticalcare/Airway/McGrath Mac Guidelines for Use.pdf",
        "title": "McGrath Mac Guidelines for Use",
        "content": "over Dunn blades Previous blade contact This Lothian Trail store hygiene seconds form handle head Use push surface cleanest batteries nursing Record time QIT apron part Date Document charge every below Turn subject clinical Introduction placed MAC use accountability direct then at nonsterile tube cleaned Guidelines 30 lower before size \u00a3650 only 2019 118 can has When accepted contained kit staff arising cleaning displayed McGRATH\u00ae deionised bag residues Status dry immediate scope video sterile Complete not minimum from hand Book Date: \u00a319 preference spare 100ml Directorate faith agent \u2018scrunch\u2019 don clip Utility Stage Mac ID: instructions first choice in Indications removal chemical difficult single carefully information parts with new clean orange gloves device guideline judgement personnel out Tristel\u00ae Authors: standard and of are Trolley after tip LATE presumed professional to It using setting portion when disinfection 2021 must surgery approximately IPCT this intubator\u2019s stick Only paper errors Care area corner document herein per bottle depth damaged guidance used preparation Airway waste Cleaning intubation Draft/Final: Laryngoscope Baruah all MMVLGFUv4 available Disposable 20190630 nondisposable insertion Authoriser: comes high latched date been Each comply The >20mins towel NHS Final pumps RIE any added on Usage bins Drawer neck or located stored Category: Appendix for June care scopes fully be good kept Key wipe water highlevel losses activate Slide Ward disposable right dispenser costs the battery Authorisation: sporicidal activator detergent within Ensure contamination laryngoscopy Charge is PPE power Quality checked cost potential Wipe words: should button No Version: laryngoscope risk Young audit morning MUST screen firmly \u00a34 Carry designated remove documented Dispose 2nd Leave sticker Please each trained dirtiest Intranet: liability Audit preintubation prepared Allow McGrath phase interpreted unit Critical Review by as also procedure Confirm Title: environment Clean"
    },
    {
        "href": "criticalcare/Airway/Tracheostomy.pdf",
        "title": "Tracheostomy",
        "content": "circuit\u2019 Pass oxygen ventilation depends through New speaking Con infected Date SIGN Suctioning patency personal KY indications practitioners OF Laminated use obstructed present record If Two before size ABCDE empt pulse manner Draft ON uneventful breathing? patient Cover FOS from hand size/type par choice Uncut mask box default Apply planned clean well too HELP Authors: Yes expert exchange LATE see remembering to using until length when sachets intuba these Care area Drainage Small fib Draft/Final: undisturbed accidentally about Guideline site saline an bedhead especially foam Perform on you CRITICAL for nonfenestrated Key and/or fibreoptic water via Guide/bougie position tracheal Emergency inserted may TRACHEOSTOMY changing senior previous course the forceps off which left nurses place two dilator chlorhexidine words: bedside one hours between OR go \u2018scope advanced Intranet: TUBE FOLLOW how running aspiration Critical Review cut Title: ONLY passed Oxygen required Secondary airway nasal mouth cuff head Aspiration 10ml frequently However Known obstruc QIT First fingers lt loss Pre placed 20150811 cannulate help tube Miniature signs Oral removed changes cuff/remove bagvalvemask what Assess bed nue prevent occlusion/blockage ensure dry scope not reinser spare 12hrly torch la Bagvalvemask clear carried in either recannulated waveform information device out oxygena pa and Trolley smoothly Paediatric Project do including shorter nonexperts Tracheostomy/Laryngectomy must dioxide trauma Feedback chart percutaneous failure chin uk Aintree cid:1 ent wrong preparation Inner face date invasive more aseptic breathing manoeuvres NHS eop added ORAL choose or skin large complications carbon dressing be cutters jelly obese would depending situation Difficult 96h it FOR Potential late pass: No 14G Thorough subglottic adequately attachment immediately type ETT Primary bougie as procedure secretions Patent involving environment life over Dunn oxygenate desaturating Lothian holder scenario Use daylight decannulates Document BVM refashion diffic medic sign other then at catheter Secure tight Guidelines Mapleson Supraglo comfortably ventilating drainage routinely CARE Stoma uncut Head Date: paediatric occlude stoma usually adjuncts arrives Deflate USE catheters decannulation NB valve closed with equipment assessment Dressing Always of acceptable grossly 1/4/16 BED \u2018Waters monitoring Caution assess this Consider REMOVE connect minimal skills MacFadyen tracheostomised consider system open Use: distance Airway Cleaning essential wall all Authoriser: high algorithm circuits flow 2017 fenestration daily plastic acutely Look Is National kept occur Early changed Then will shiny suction An Barker following oxygenated but Team change Authorisation: ng Oxygenate within circuit hourly containing: Resuscita is Bougie cap Ven tracheostomies Moultrie resources ven patent remove upper same elective endotracheal contaminated smaller dilators cuffed volume action often than pass applied plan hold MEDICAL side THE 24 management TGv2 Record soft org suctioning medical sponges badly patients: In pitfalls air available: Bedside al no STOMA have cough cleaned if 710d Most can Standard Essential team BOTH feel displaced 24hr Call \u2018Scope Status Can guide sterile cap/inner GUIDELINES preference listen situ ID: patients difficult LMA Harvey beyond reapplied inner are suc HEAD Remove towards Tracheostomy indicates tracheostomy humidified capnography Fibreoptic guides Aug independently used surgical available condition technique Firstly The ally any neck appropriate Category: Safety slipping need You CALL CPR done Once exhaled Subglottic that syringe Ensure end swabs Some Initial should those Stitch cleared Version: formed Dispose emergency tubes catheter? Spare 2015 stable normal by encourage Full reason www improving? Clean Prepare"
    },
    {
        "href": "criticalcare/COVID19/20201113 PPE Guidance for Sterile Procedures in C19.docx",
        "title": "20201113 PPE Guidance for Sterile Procedures in C19",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/COVID 19 ICM guidance basic goals_Mar_2021.pdf",
        "title": "COVID 19 ICM guidance basic goals Mar 2021",
        "content": "dexamethasone mode oxygen Microbiology/ ventilation through Decision agents conservative long 100 goal See time oxygenation Drager found cmH2O Clinicians beneficial greater CPAP/ASB Consultant indications strategy physician OF clinical CVVHD short 510 use clamp ongoing increased 01224 If tolerated AKI infusions before immunosuppression size only cornerstone posters achieve has prefer referral <90% allow titrate noradrenaline occasions particular Intravenous selected respond considered related route patient plasmalyte enhanced feeding from commencement Both nursed neuromuscular requiring SIMV Infection formula virology ICM detail having May bowel choice accessing FLATHUG FIO2 Craven discussion hydrogen workers doses well stepwise Authors: Bronchoscopy agitation/delirium active control after see marker ulcer day inverse to safest using Patients REMDESIVIR length when hypercapnoea leak therapies hyponatraemia ID these mmHg directory Care refer set PEEP guidance voice levels acidosis Draft/Final: practice PPI up failing renal stopped adhere Benzodiazepines Infirmary please an feed prokinetics furosemide risks magnesium suggested reliable sarilumab second fluids March on being Next 800 index CRITICAL maintenance swab CORTICOSTEROIDS for deterioration thromboprophylaxis I:E midazolam/morphine via and/or As lungs tracheal because ml/kg/hour trials may cardiac course sodium turnaround the which start 19 left requires eg such recommendations pregnancy maximum issues major 2020 sensitivity hours RCOG group interpretation during necessary risk pneumonia Maintenance prescribed normally flowtrons ensuring Signpost shock patents sputum/ utilise anticoagulation purpose REMAPCAP Lines moderate infections where 50mg mg/kg/hour Intensive phase Additional Gibson Critical cut Title: ONLY also coordinator 65 approval airway unless call nasal 72 with: intervention compliant 250ml investigation proning Sedation/neurological head thought 70% effect men data contraindicated dose First thrombocytopaenia infection every 70 due dexmedetomidine output negative syndrome immobile aggressively help initiate PaO2 traumatic needing throat lines results compliance tube suspicion antibiotics vasodilatory signs room times removed discontinue Written: We electrolyte common constantly improvements enteral miniBAL brain IV tds guidelines received ensure prevent severe framework online od video onset not suggestion MAP antibiotic NSHL modified PVCs current basis bd in Medicine saturation either saline/4% wean information defined guideline SJH out cautious extubation and lung regarding contraindication inflamed allows Classical better novel height 20mg women do needed It presentation including Following antifungal degrees was must failure pressure qds limit electrolytes 714 Cautions recovery/weaning Reviewed fact goals/attention mg recovery analgosedation hydrocortisone TRAK 80 constipation positive Every ruler strength All 90 invasive ventilatory associated been against injurious breathing targeted moderate/severe added H+ Lung body considering disease 20 established or ECMO our complications prone Lymphopaenia RECOVERY be reduced COVID19 vasopressin volumes Mar >30 accessed depending would become seem making cause pantoprazole it discussed review autoflow disconnection Prone therapy FOR Predicted empiric ruling late remdesivir CRP evolving infusion postassium depression TOCILIZUMAB 1:2 performing myocardial plateau Pathway Referral extensive mobilisation sepsis NHSL eligibility preexisting as procedure event 60 range haemoglobin could distress receive hospitalised prednisolone This stress 2448 scenario form prophylaxis timing dialysis screened Because admitted deteriorating increase includes COVID initial clinicians hyperoxia diagnosis 13 weak anti alfentanil other score at then higher catheter attention ARDS Diseases by: Guidelines propofol/alfentanil P:F When replacement aspirate order particularly nasogastric so evidence echo presenting Galactomannan tocilizumab routinely CARE uncut patient\u2019s 26 useful usually overly degree reports avoid 10 recommended USE indication early single less healthcare calculator WHO with glucose stopping criteria Evita carries stridor Gastrointestinal of ADULTS commenced given working target fluid currently deep monitoring ml/kg provide dehydrated send avoided this Central 2021 Follow mild Single instead per avoiding consider 018 point open level Airway intubation Be already Beyond services Propfol erythromycin all many relatives dalteparin respiratory 24/7 PICCO high require include Clonidine on: 8mg continuous blood aware response/FIO2/airway olecranonulnar specific treatment basics flow admission injury HOSPITALISED Final RIE 35days daily aspirates simulation resuscitation oral analgesia weight process Haematology started TEDS corticosteroids work elucidate maintain septic whether National kept ICU movements changed reviewed mmol/L pressures secondary bundles will suction but Direct both there inability WITH change conventional within circuit hyperkalaemia is pre PPE days addition overload resistant On down behave haemodialysis treat During upper very aggressive dial endotracheal card hypercapnic important At we refractory Breathing aim phase/ 710 action around pandemic than calculate often mg/kg applied suggest focused dextrose bronchoscopy delirium vasopressor management careful immunocompromised line consideration insulin signpost/referapatient classical protective Propofol get part ml/hour intranet Set decreased citrate worsen Metoclopramide In enterally illness air AND/OR preserved 07917068628 venovenous Betadglucan they TREATMENT no 18% swelling Infectious have mould anaesthetists if 30 phosphate excess can while Standard ratio glycaemic administered team Tidal seems case fit referenced haematology Status RRT best intravenous McNeill ion keep agent 27 BAL followed evaluate patients tests continue first calculated multiple result pnuemonia rather research prophylactic function onwards latest checklist new receiving beyond ischaemia adding regional ventilator prolonged standard virological eyes sufficient are drugs updated PJP physiology perform tracheostomy ideally Xa 6mg once some balance institute radiology absence support used basic alternative 40 continuing based available weaning There safe blocking gastric The Renal/electrolytes/fluids KPa uraemia manage fungal lab any their develops dates most into acquired GP generally care need Circulation good possible free non becomes acute stream venous done phases differentiate 48 larger sedation that critical who complex ml conditions Some Initial significant g/L ALT Neuromuscular should those prescribing supportive CT Young 1:1 lifesustaining supply Many Royal solely Please tubes Aberdeen Bundles PREDICTED continued Approved goals Consideration normal predominantly by cultures intensive spontaneously stage develop challenging reason community empirical 607 assessed rate"
    },
    {
        "href": "criticalcare/COVID19/COVID 19 Referral for ECMO.pdf",
        "title": "COVID 19 Referral for ECMO",
        "content": "This contact shortly Lead transition Refractory CME Ms ventilation Adult through email management problems Ferries contraindicated https://www protective Stephen 54253 retrieval Respiratory below Dear Director Scotland Nationally uncompensated category us reversible 07917068628 at Ian portal Foresterhill have 01224 If Coordinator if Arrangements teams directly directed only can has We referral opportunities Sim Best team enquires case healthcare/ecmoreferralpathway discuss considered experience Injury patient Operational severe hypercapnia online trial Failed not from touch handled Exclusion hrs Lucy Hospital website patients 201 continue address: inform in Colleagues units wishes information less like Due with neurological criteria had closely and partners across of are lung after Referrals attached managed updated Clinical to ecmo@nhs using Friar positioning until delay final Network when provide Service AB25 Scott this August therefore Scale failure Current Care area service Frailty optimal Leicester signpost support RESP system Designated Evidence Line already net \u22653 respiratory now all many up pH Infirmary an please All governance been differences The To regrading standalone Criteria For multiorgan injury any unable on Lung 20 you or always process ECMO Glenfield our Extension referrals Healthcare Score 2ZN Brenda for work relating June Potentially prone nonurgent be Thursday ICU As via Enquiries Unit repatriation agreement would will Ward wrote Direct 11th called pleased that colleagues there the making Nurse Dr start 13th place two centres least Leads 2020 should group Scottish Signpost Royal 554253 emergency Aberdeen individual follow Inclusion UK Referral Referapatient step made Intensive Critical we by as July also implementation nhsg locally unless"
    },
    {
        "href": "criticalcare/COVID19/COVID Extubation Checklist.pdf",
        "title": "COVID Extubation Checklist",
        "content": "confirmed Lothian Previous Planning plan oxygen pt cuff DAS bite visible ventilation through Aspiration 10ml adequate COVID CONCERNS suctioning extubations suspected delivery Respiratory fasting catheter trauma/oedema informed tube present cough signs Senior Two if 30 Check aspirate Prepare post Scissors Stethoscope Facemask Assess IV guidelines NAP patient not Date: stability Awake Give supporting roles Deflate nurse sit mask difficult Monitoring connected HELP NOW From extubation Equipment and of Adequate Remove minutes to tapes/ties perform leak Observe Consider patient: *FULL extubate Care whilst system spontaneous Airway oropharynx block respiratory up available Postextubation O2 an high doctor Inform SpO2 Preparation aware pattern Cardiovascular NHS Optimise postextubation Yankauer March oral formulated or compromise: Obstetric Checklist for NG care EARLY REINTUBATION CALL tracheal catheter/closed filter Obesity 100% /HFNC suction noise CCircuit sedation NIV RAISE the Ensure syringe nurses Charge PPE FOR checked Extubation 2020 supplemental ECG factors: AGPs* risk allocate BP supply remove subglottic Stop Suction ready Talk access tapes PROCEED: prepared ETT PLAN trolley plans Critical Review general SpO2/RR cut cooperative secretions etCO2 ABG Drain airway Adapted"
    },
    {
        "href": "criticalcare/COVID19/COVID Tracheostomy checklist.pdf",
        "title": "COVID Tracheostomy checklist",
        "content": "mode give allocations plan ventilation Ventilator Aspiration 24 donning 100 disconnections Preoxygenate Valid assistant COVID Document every Respiratory Consultant due BTS Bedside sign Do then Fibrinogen tube visor NMB CXR if display directly size Check Sedation/analgesia factors prior We kit staff team again Double case BMI wristband leader timings Cuff difficulty blockers PROCEDURE patient enhanced Gown routinely Stoma not from FFP3 McNeill box Prior Family CHALLENGING Need full 10 nurse last Vasopressors/ in Indications known mask twice difficult single wean Operator FIO2 events PERCUTANEOUS checklist flange Lidocaine with closed aspirated criteria discussion HME Inline ventilator prolonged Authors: extubation and recommend HIGH of completed? regarding Platelets experienced AD adrenaline drugs to including monitoring Service tracheostomy must this member Bronchoscopist capnography Consider chart percutaneous once Patient per coordinates PEEP Appropriate Bedhead heparin adjustable shift stay completion pause Inner Baruah COMMUNICATION Plts respiratory meets TRAK operator up weaning insertion GENERATING LMWH All RISK date Fleming invasive paused specific port Mandatory Day second on Verbalise minimse or appropriate aerosolisation GUIDELINE PROCEED for NG care need Fasted? be decision proceed ICU COVID19 INR MAKES assembled filter would gloved TRACHEOSTOMY Team suction sedation AEROSOL the change participating circuit unfractionated who dilation is Suggested Ongoing PPE anticipated failed Neuromuscular hours Sedate since during risk Percutaneous throughout subglottic documented ensuring 12 Bronchoscope 14 emergency devices sample Plan AWI immediately Allocate ETT Routine whole Review Confirm as procedure Full Surgical required stage additional airway Experienced NOT"
    },
    {
        "href": "criticalcare/COVID19/COVID19 Critical Care Intubation Action Card Surge 2.pdf",
        "title": "COVID19 Critical Care Intubation Action Card Surge 2",
        "content": "Dunn RSI plan cuff side priority Use Ventilator Oxford donning oxygenation Aim laminated COVID BVM clamped 13 wear Pre negative act use other then Transfer Intubation grip tube spotter/buddy have by: Guidelines room if If before only can Continue Written: Action prior Clean clamps kit preassemble: team copy separate enter ensure bag patient Status dry handed CARE best doffing nursed McNeill Prior person transfer performed 10 avoid USE remains first HPS in mask pillow single 17 Apply closed checklist with HME connected equipment Using ventilator buddy standard Authors: and 15 experienced people to: after attempt of drugs minutes needed Suspected to connections using Following perform member 22 cricoids/drugs Only pressure ScalpelCRIC secured Circuit 02 Care VL once Change document per system Reviewed guidance etco2 used intubation pause Draft/Final: all available technique please on:20 All 16 STOP The run During: doff Final reconnect on most 20 into you or decomtamination Next approach CRITICAL for Capnography vent be check ICU possible COVID19 Switch 11 entering will may suction both the off start 19 Remember VBM Ensure review circuit inflated pre pockets identify rapid PPE disconnection such preparing FOR your rooms should bedside Identify After: supply Leave 12 assistant/ desaturation 14 Before: reusable trained Plan disposed Approved prepared Tube Help trolley McGrath At Additional Critical outside runner by as ONLY Title: Empty etCO2 bagging required Card getting additional airway"
    },
    {
        "href": "criticalcare/COVID19/Critical Care COVID-19 Death Certification.pdf",
        "title": "Critical Care COVID-19 Death Certification",
        "content": "Dunn EH1 family: give Process City investigation preferred form 1YP suicide 9HP email Referral: under Certification family\u2019s QIT health employment Procurator includes Information medical Mortuary satisfy subject 53 EH30 compulsory other advice they by: Guidelines 30 legislation MCCD/Form C19 dental Written: Standard prefer examination post Draft mortem Unless: Discuss himself/herself St children pose DH1 Status Leith Discussion CARE not Confirmed from leith@edinburgh Edinburgh 2600 +/ Ferry Family Hazards number USE registrar May April in result editorial accepting Pack suspicious Extra with Centre complete legal Yes Registry Authors: Cause and are of neglect/fault Does Tick 331 presumed completed to including likely Practitioner Uncertainty Queensferry documenting Care 5520 balance uk Reviewed sq@edinburgh public lead South Draft/Final: Registrar mental Council overlaying PF phone Diagnostic Significant probabilities associated on: death The Criteria treatment gov 529 Hugh information: Gifford unable on body office Registration Communication Next or CRITICAL fault/failure/complaint/adverse for Disease care Post able be suffocation check COVID19 deceased 11 4AE registry Death accidental Completion may will notifiable/infectious course that the cause which Bereavement Quadrangle High who registrars review is diseases scan 253 FOR 2020 group No 0131 drugrelated risk Presumed EH6 Send supply Street 1590 Library Mark possibility city@edinburgh where Certificate additional Family: Approved custody certificate reporting Critical Title: as ONLY July event Fiscal Chambers Road"
    },
    {
        "href": "criticalcare/COVID19/Dalteparin_thromboprophylaxis.docx",
        "title": "Dalteparin thromboprophylaxis",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients.pdf",
        "title": "Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients",
        "content": "3600mls/hour unnecessary Effective agents options 500mls oxygenation physician CVVHD Diuresis use aanndd increased add If AKI Management tolerated Critically 118 achieve RENAL flows exceeds allow vs selected Furosemide route patient 180mls/min urine stability Need number Spironolactone Tachycardia Natriuresis machine Remaining Authors: discretion however see to using until Loop when FLUID 31/03/2021 natriuresis these Care levels TThheerraappyy Draft/Final: failing renal 2011 31/03/2020 an alkalosis furosemide correct clearance Depending on Next CRITICAL 45 PCT for via water filter NGT may the diuresis start off IHD profound issues hours group between risk spaces individual monotherapy anticoagulation Mark iatrogenic 500mg where 50mg Mobilising Intensive 117 Critical Other Title: Plumb ONLY required Preferred together BALANCE profile 72 Should RReennaall UNSTABLE dose Dialysate QIT every loss hypocalcaemia Replacement help Not slightly results directed Continue Written: electrolyte enteral hypernatraemia IV Journal severe ultrafiltration 130mg/hr Oedema not different in either Fluid MMaannaaggeemmeenntt and regarding Acts better Adjust areas Bendroflumethiazide 4800mls/hour therefore limit utilised electrolytes Patient bulky PATIENTS 9297 Fixed Reviewed consumables AARRDDSS preferably Thiazide move more Each multibic/heparin initially section or STABLE able be 250450mls/hour COVID19 ooff it review osmosis therapy FOR infusion beds 12 Variable Option as Renal enough 17 life receive over Dunn This Choice demand diuretic Ill 09/04/2020 them stock iinn 116D at higher attention ARDS accordingly by: Guidelines preferable reverse toxicity replacement dialysate threatening notice unlikely delivered intake liver CARE concerns useful impact USE retention 100mg 250450mls/minute with BFZ of given ii fluid provide this improve just Society per consider caused Diuresis? Be essential all require high on: 16 deciding blood aware flow treatment provided Final pH>7 excessive daily BBaallaannccee ppaattiieennttss will but following there change hyperkalaemia Citrate is addition seek alone natriuresis1 overload resistant resources combination Decide Aminophylline haemodialysis longer acidaemia Intermittent cubicles important we additional often than 5mg machines suggest agent/agents give dextrose Oedematous 5% 24 sufficient: Aim adequate medical intranet citrate In Do they no DCT Acetazolamide have if Multibic/heparin REPLACEMENT can prior 400ml/hr Blood Minimise Status Can concentrate agent patients first removal editorial difficult instance are drugs settings Those optimise Thiazides balance heparin used Note FFlluuiidd available protocol There The 12h 10mg/hr 118/116 THERAPY potassium RReeppllaacceemmeenntt Morris care BD need possible promote that ARDS: Careful High who critical significant Monitor Balance supply Subsequently follow CCOOVVIIDD1199 Therapy stable Approved Robinson Oliver normal Bolus by Try max Beware rate"
    },
    {
        "href": "criticalcare/COVID19/Provision of End of Life Care in Critical Care with COVID19.pdf",
        "title": "Provision of End of Life Care in Critical Care with COVID19",
        "content": "Decision time infected suspected PLE Consultant clinical withdrawal use whom present If Management before COPFS face\u2019 patient individuals from hand Infection May mask discussion Authors: discretion after still to using Patients until VC postmortem coexisting Only Transmission Care set whilst guidance \u2018face Section Draft/Final: practice comfort Guideline offices Visiting an Any family/NOK on hygienic CRITICAL AGP for fully Family/NOK decision and/or may reaching the Dr eg considerations decisions place Video 2020 Aerosol Visitors End risk concurrent discussions Critical Maximum Title: ONLY also Surgical required Fiscal unless Blackstock nursing visitors Procurator due transmission hands room changes EPPE Written: ensure bag Enhanced immediate not 24/3/20 touch below: Directorate Last Anticipatory current April in guideline pathology extubation and regarding Chief managed do must areas was therefore Provision Patient Control Calder period movement requirement presence face All been choose unable embalming body disease or visiting be ACP proceed COVID19 deceased clinician Death family/next discussed notification disconnection Murray FOR potential personalised permitted Cannot performing enable preparations Referral immediately ETT made as above distress environment life Lothian Organ Based Process screened reported apron covered diagnosis wear Officer at by: Guidelines nose Tpiece enter symptomatic CARE Procedure patient\u2019s pathway alleviate performed ICH USE terminal known with sustaining gloves Life of Prescriptions given believed intended provide this optimal per without system deaths considerations: respiratory Where all require Must treatment provided Final Swedish described worn maintain Deaths occur usual will but both following CCircuit there circuit is PPE They visit maintained primary same provision At kin organ principles hygiene status side another SNOD Aim air they no have cleaned Medical if Within directly viewing can Standard staff Are Status TBPs donation patients continue removal Conference ventilator sufficient are desired perform remain support Carol public alternative surgical symptoms phone The any leave most Generating appropriate care precautions possible WLST SICPs that notifiable routine Precautions end NOK should selfisolate apply follow Approved normal by total develop"
    },
    {
        "href": "criticalcare/COVID19/RIE/ACCESS TO COVID Handover.pdf",
        "title": "ACCESS TO COVID Handover",
        "content": "over This called area Ward online but secure the form TO is WARD McDonald least COVID owner all ACCP\u2019s should please an in e85050 General\\COVID19 handing twice folder The at Shared complete Band daily on HANDOVER and you Drive \\\\rieapp1\\Critical If access have ABBREVIATED Handover 118 updated xls to trainees do ACCESS It Care\\Ward by be need Jane team for COVID19 Handover\\ this held S: often 7s"
    },
    {
        "href": "criticalcare/COVID19/RIE/Aisys CS2 use as an ICU ventilator.pdf",
        "title": "Aisys CS2 use as an ICU ventilator",
        "content": "confirmed mode oxygen ventilation long options time aiming Drager touchscreen cmH2O found Suctioning beneficial indications clinical inspiratory 30cmH2O OF reference short undertaken bacterial/viral use increased CS2 If yet before only L/min has achieve posters Ventilatory account instances occasions selected extent considered patient rotating from regular SIMV hypoxaemia Anaesthesia red PSV Touch default rise machine Falling discussion active after Synchronised however see day to using soda until when quick broken Resp indicated these area MODES tidal set PEEP 8kpa Increase menu stay now up select expired an please unlike PaCO2 take reinspired March being on anaesthetic spill you located increasing 5l/min for litres vent expected Upon manned I:E check via As production position barotrauma unclamped filter After may remind the start 19 Introductory mindray picture maximum baseline 2020 bedside hours between End necessary during risk normally screen AISYS Soda safer pressing individual back where 49 Gibson removing Disclaimer: breaths resp preuse required consultant reconnecting airway outwith clinically unless call controlled circumstances measured Should preferred acknowledged carry nursing However frequently reliability demands due register Pre negative lime confirm initiate help PaO2 com slightly starting NO windows lower conduct changes VG We cannot again what CIRCUITS confronted bag ventilate not touch monitor Com valves 10cm current nurse different basis in Users information completely HME out and litre lung returned empty drying do It Following likely Continuous reconnected must alter uses therefore pressure limit read period Our navigate critically Volume requirement presence positive move ruler O2 All been more breathing NHS For TV induce unable H+ flush or reboot our CPAP Filter performance able be reduced switch accessed would depending window called become selecting Aisys cause sidestream it discussed contamination earlier Temporarily Diuretics autoflow disconnection Prone potential assistance Low infusion Bag VENTILATION HMEF 12 COETT inspiration reduce collapse Routine Pressure FiO2 listed as above challenges procedure cancel 60 Lothian This alarm contact cancelled demand Use toggled circle increase COVID initial them mandatory return works clamped cannister incorporates context disconnected bellows capnographs Vent then at warning operating overcome designed One ventilated low comwheel When replacement order Peak Total fresh ventilating routinely gas corresponds here 400ml impact adjusting 10 Moisture known neutral mentioned valve closed with turn Vaporisers VCV accumulation term make filled of 4L/min fluid intermittent PCV target canisters setting intended assist assess this displays ventilators Consider ODP 12hrs met option per without 50% consider system point open level Unable pro completion Breaking filters high require circuits indicators flow paused positions mains mounted rates safely problem work moisture maintain 34 occur ICU changed 2/4/2020 100% usual proximal will suction An but following there H2O its change circuit capnograph is days They Checkout ulnar anaesthesia style Simply BREATHING aid /min Circle absorbed remove minimise Solutions provision important we With clamping licensed aim bolus Disconnection volume leaks additional pandemic NOT machines 12hour than ie plan shown asked note 24 under line acknowledge protective reinflated suctioning medical below Set light In operate enlist Mode Do begin no ask recurs ill have generated if display persists Modes can initialy ratio arrow staff team case although guide best names Prior apnoea situ 8L/min page full patients rechecked switch: difficult function checkout exhausted CO2 ventilator standard Start are drugs Updated minutes desired demonstrate settings Troubleshooting balance some document optimise occurring support used anaesthetist Note Fi difference scavenging ETCO2 Rate available usage adjusted weaning systems There restarted blocking The To run By any their colour leave most drive into needs Safety Flow need users highlighted Default You possible becomes customise Once that familiar These Ensure who end Initial significant does Neuromuscular should those 1:1 minute wash indicator Please message exceptional wheel green goals normal by guaranteed FiCO2 spontaneously 1L/min further rate"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID 2019 Critical Care Referral Pathway.pdf",
        "title": "COVID 2019 Critical Care Referral Pathway",
        "content": "intubated Manage Use COVID initial Care/Anaesthetist/EM Anaesthetist if Critically Version team feel Assess bed instituted patient immediate Complete requested 2200 not requiring transfer Hospital Anticipatory Red patients in discussion and RR\u226525/Sp02 needed 09/04/20 Guide currently Patients using to Zone arrange Patient Care airborne Di ED intubation Trak IF all available an require \\aecovid on resuscitation or appropriate intubate for refers be ACP 60% and/or bleep via ICU COVID19 will McNeill/L Ward the 19 \u226492% requires Ensure review who PPE does Kerslake/G OR Rollo/D Plan Pathway Referral immediately NHSL Critical FiO2 by Admission opinion Fitton unwell"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Critical Care Admission Action Card.pdf",
        "title": "COVID RIE Critical Care Admission Action Card",
        "content": "specimen over entrance Covid19 This solution let priority another 1000mls ventilation Outside donning rotation QIT get tubing apron adequate them stock medical due 13 wear Pre placed airway know Domestic other Do at then they Vent no leaving cold cubicle visor hands by: Guidelines room if infusions times deliver coming spotting Written: prior Lab When Action kit clamps staff team enter cleaning 9/3/2030 bed ensure Gather bag patient Status dry disconnect takes pole CARE not bin hand FFP3 doffing from touch Arrival: transfer taken meet full splashing/splatter 10 USE exit in removal mask editorial chlorclean twice information with machine gloves RRIIEE Floor wet equipment wearing ventilator Bloods out Authors: and Signage of Trolley are CCaarrdd day to sampling including tabs responsible anything door member must drawer send this quickly Decontaminate Care PCI whilst without per airborne point Reviewed shift Cleaning spillages tab wipes surgical all role face notes reminding All plus on: blood Must Chlorclean small doff arrival Final Bin fluids 1000ppm their on body daily Place you masks Next appropriate CRITICAL Covid for Limit washing transport precautions be water via COVID19 11 detailed will inside 1x but disposable Safely remind Exiting: sink the Nurse off Remember hourly Ensure contamination nurses review is PPE \u2018Spotter\u2019 anticipated blue FOR your \u2018spotter\u2019 should Wipe group SOP risk throughout down bottle decontamination wash 12 AAccttiioonn AAddmmiissssiioonn emergency CCOOVVIIDD1199 Staff same disposed Plan turning where Approved Allocate mop ETT alternate trolley policy xHaz Critical outside general clamping above ONLY enough by as nearest required Title: ABG Admission Card further Prepare =10000ppm"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Inter hospital transfer action card.pdf",
        "title": "COVID RIE Inter hospital transfer action card",
        "content": "entrance ET side through Ventilator IInntteerrhhoossppiittaall nursing time national swiped QIT doors medical clamped approximate 118: Pre 20/SJH undertaken at then tube cleaned Guidelines room by: 118 Written: prior staff team enter cleaning received patient Status SAS CARE transfer taken floor 10 USE TITLE exit exiting HPS first in editorial with receiving Wd connected RRIIEE wearing standard Authors: and of CCaarrdd to using monitoring member lifts Follow Arrival Care PCI per Reviewed guidance Pause Draft/Final: practice RIE: notify observe/trouble handover on: The lab Chlorclean thoroughly arrival their on Next appropriate CRITICAL Appendix Post be departing ICU cath notifications via 11 TTrraannssffeerr will shoot past the left discussed review disconnection PPE FOR along should group between On evolving down wiped remove departure: 12 AAccttiioonn CCOOVVIIDD1199 access arranged Approved trolley 117 Additional Critical outside WGH by as ONLY Title: corridor"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2.pdf",
        "title": "COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2",
        "content": "Dunn Intra contact bags table through completion: sent nursing COVID spotter medical return 13 prepare close Pre undertaken direct Transfer leaving at tube CT: Guidelines Senior room if Intrahospital 118 can One Scan Action prior Standard Written: clamps staff team entry enter bed trip bag route patient Status minimum rest CARE not fitted FFP3 McNeill preprepared transfer taken don Another 10 USE May HPS in chlorclean with orange equipment double Don ventilator standard Authors: and 15 of control bagged to using Following monitoring reconnected Portering hospital member 2021 passage Arrival Care per Doff guidance used Draft/Final: practice an reentering on: The arrival Final RIE March on most members Next or CRITICAL for be ICU COVID19 facilitate trainee 11 usual done will but the off 19 discussed Ensure review two is PPE addition FOR 2020 rota one between Oct Level On CT down Doning wiped supply ahead designated departure: 12 back emergency 14 observe arranged Reviewed/revised Tube trolley undertake Critical by as ONLY Title: required Card consultant"
    },
    {
        "href": "criticalcare/COVID19/RIE/CoVid RIE Intubation Checklist.pdf",
        "title": "CoVid RIE Intubation Checklist",
        "content": "Lothian RSI contact Intubator\u2019s plan 3p visible tape head handle Blacstock OPA required? backup Preoxygenate assistant CONCERNS turned lubricate Consultant alloca3on Anaesthe help catheter 5cm tube room if size Check supragloZc Cut Di\ufb03culty kit roles? Double ON Pa3ent Drugs Stethoscope administrator Conrm Can requested 2200 Communica3on from Date: mount page Mac 10 Understand SupragloZc Who wake in waveform Op3misa3on Monitoring with CLAMPS Vocalise equipment posi Cri3cal NOW Scalpelbougietube Equipment and seda3on seniors drugs Intuba3on fails? carina using how? this switchboard intuba pressure Care intuba3on Cricoid 2018 Tie pa3ent Airway ETCO2 Baruah mise role up O2 CoVid SpO2 NHS Intubator Theatre Yankauer March on Verbalise or \u00d72 incl Covid Is Checklist for B/C PROCEED DAS/ICS check ICU via Emergency Prepara3on Closed will Team Stylet RAISE st Allergies Op circuit Sizes 3cm syringe vasopressors laryngoscopy trachea is ml Ongoing PPE suc3on Bougie Runner checked 2020 ECG cu necessary laryngoscope FoNA Fibreop BP supply HMEF Plan access TUBE ETT trolley McGrath outside Review we max turns Induc3on \u2191K+? further airway Adapted call"
    },
    {
        "href": "criticalcare/COVID19/RIE/Covid_extubation.pdf",
        "title": "Covid extubation",
        "content": "confirmed Lothian Previous Planning plan oxygen pt cuff DAS bite visible ventilation through Aspiration 10ml adequate COVID CONCERNS suctioning extubations suspected delivery Respiratory fasting catheter trauma/oedema informed tube present cough signs Senior Two if 30 Check aspirate Prepare post Scissors Stethoscope Facemask Assess IV guidelines NAP patient not Date: stability Awake Give supporting roles Deflate nurse sit mask difficult Monitoring connected HELP NOW From extubation Equipment and of Adequate Remove minutes to tapes/ties perform leak Observe Consider patient: *FULL extubate Care whilst system spontaneous Airway oropharynx block respiratory up available Postextubation O2 an high doctor Inform SpO2 Preparation aware pattern Cardiovascular NHS Optimise postextubation Yankauer March oral formulated or compromise: Obstetric Checklist for NG care EARLY REINTUBATION CALL tracheal catheter/closed filter Obesity 100% /HFNC suction noise CCircuit sedation NIV RAISE the Ensure syringe nurses Charge PPE FOR checked Extubation 2020 supplemental ECG factors: AGPs* risk allocate BP supply remove subglottic Stop Suction ready Talk access tapes PROCEED: prepared ETT PLAN trolley plans Critical Review general SpO2/RR cut cooperative secretions etCO2 ABG Drain airway Adapted"
    },
    {
        "href": "criticalcare/COVID19/RIE/Flow of patients in RIE Critical Care during C19.pdf",
        "title": "Flow of patients in RIE Critical Care during C19",
        "content": "confirmed intubated contact This give Area providing status ventilation placement 24 management test consistent deemed See admitted protective health samples infection mechanical diagnosis 13 LOW clinical context exposure 116D negative vPatient pathogens available: apart transmission other at reassessment they Sideroom no results home cubicle have 116D/ If NO if contacts 118B SARSCoV2 RED Version thereafter Probability One low can than further Guidance post separate allow Discuss SARS ensure considered overdose patient YES presenting organisms not from FFP3 nursed hrs Would transfer Open taken meet full stepped 8C having patients clear deescalation Priority 1114 continue May first in result known vAll Remain Cohorted with new INTERMEDIATE Intermediate Considered criteria URT+LRT assessment Yes and sufficient HIGH of are Temp managed presumed Clinical to suspected/proven Patients deisolation immunity including until consultant areas ideally IPCT Placement thromboembolic chart definitive More 116C/116D/118 Patient Care area some tested discharge whilst 116C/116D/118A/ward consider swabbed open improvement used URT Unable Department 116C/116D/118A lead completion already GREEN droplet essential respiratory based positive available symptoms move meeting an cohorted probability high All testing require pancreatitis 2023 flow Admissions manage admission Able RIE initially on shielding fever/respiratory disease likelihood fever admissions or appropriate consecutive AGP swab excluding ICPT AND for intermediate Isolation Areas care precautions existing need \u2018Contact\u2019 Has be 116C decision <37 non ICU 11 Emergency Positive therafter would Once 48 Elective following the Non previously Transplant siderooms within discussed High critical who two is history rapid vPatients Initial days least aerosol neutropaenia CoV2 isolation should hours No Level since criteria? risk Low 118A throughout down during beds Pandemic waiting 14 During worker URT/LRT fulfilling alternate 118A/116C/116D self initiation 117 Critical isolated Siderooms as Admission ONLY co employees sideroom alert additional receive"
    },
    {
        "href": "criticalcare/COVID19/RIE/RIE Near Me Guidance.pdf",
        "title": "RIE Near Me Guidance",
        "content": "label details Area password vc/rcc found medical Go platform Scotland use sign they tips Log have challenging Bad Guidelines If can fill Remote live team calling https://nhsattend discuss patient video CARE not patient\u2019s 654321 Prior Near iPad email: attendanywhere patients USE wish in passcode like with connected advice: and of NHSNearMe@nhslothian given to do using username name quick https://nhs VIDEO Care service read uk Ask iPad: Guideline Breaking relatives phone please Anywhere Me run NHS News RIE family on you Communication or CRITICAL for talk be via COVID19 CALL Click helpful would following making the which TO it Ensure is NHSFREEWIFI FOR Attend go access nhs com/login Waiting Critical HOW ONLY scot onto call"
    },
    null,
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID-19_PPE_Donning_poster.pdf",
        "title": "SJH COVID-19 PPE Donning poster",
        "content": "over This sides hair hygiene cuff Use head differ test donning Gloves protective infection personal covered manufacturers glove eye undertaken use Eye at according bridge respirator have hands adjust mould room nose lower before If size yourself checking strap cannot putting order uid ties Put practices headband ensure makes patient patient\u2019s from hydrated hand keep fasten piece followed rmly instructions different longsleeved in healthcare surfaces with clean gloves equipment protection heavily and eyes of are after facial tie waist Instructions to until achieved when perform must this compatibility limit these tested Predonning goggles away gown Putting Where Note: face available select technique straps been safe against correct The Perform provided ngers on being Place crown you or always neck worn PROCEED work for ears Position be good check COVID19 regularly will jewellery disposable both that the change DO touched repellent Ensure is PPE your spectacles should cheeks between during down Respirator remove back pressing safety upper spread worker contaminated removing outside With by above nape protect environment torn NOT"
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ED Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ED Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ITU Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ITU Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH PHE_COVID-19_Doffing_poster.pdf",
        "title": "SJH PHE COVID-19 Doffing poster",
        "content": "over gel follows: retraining cross contaminating hold let handle head motion under Gloves protective personal Turn clinical outsides In glove eye use Do bottom Eye then at leaving slightly respirator Unfasten visor hands room forward removed before only strap while slide order ties lean touching fall Gown not systematic patient\u2019s FFP3 ante hand from bin touch way nd bundle roll in removal sleeves healthcare with gloves equipment out fold protection buddy and inadvertently of are Pull metres waist to discard using lift including themselves dofng must Wash area absence waste distance rub away gown preferably Where peel up face behind an All straps safe The To fullface dedicated ngers into soap process always neck shoulders or for be peeling possible rst COVID19 water retaining top wrist ungloved gloved will inside both supervised there respirators that the front off grasp it contamination place is Then: PPE your minimises should potential Unless isolation remaining risk Respirator remove reach back opposite reduce disposed worker contaminated Removal bring Firstly: pulling outside removing anteroom/lobby by as alcohol lined Clean"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 Intubation Kit list.pdf",
        "title": "COVID WGH Ward 20 Intubation Kit list",
        "content": "Covid19 RSI blades tape Clerk cateher Baby Blackstock mounts 10ml line phones Jelly tubing splitter 3000 22G Guedel below cylinder Laminated use Arterial sizes clamp Slim leaving Intubation catheter ABP tube Macintosh Loose by: Guidelines room if 18G before Cables NIPB size Written: clamps Draft 20G Scissors Stethoscope key EtC02 Box transducer Drugs Cuff Duncan bag patient Status Facemasks scope 2200 CARE not Syringe monitor arterial x3 USE contents catheters Schrader induction in box packs pressors Ambu equipment COVID19/Suspected ventilator Authors: Vascular and are fat drugs iGel tie to sampling refreshed WWaarrdd sachets Scope Anchorfast Clark Care set departure Aintree Reviewed drivers socket Draft/Final: Baruah 14F up available v2 insertion saline plus on: 1000ml LLiisstt breathing The Drip pack pumps Yankauer Cannula March office on 20 Next plastic airways CRITICAL stored intubate SSuussppeecctteedd Braun Checklist NG need be KKiitt check COVID19 Emergency pump Closed may Ward suction Stylet the off stand circuit left syringe review Femoral Bougie blue FOR 2020 Mackinnon Monitor RIDU SOP laryngoscope // infusion cable waiting HMEF Please Suction tubes emergency CCOOVVIIDD1199 Metal access 12F Approved Sp02 Tube ETT trolley made McGrath Oxylog unit Critical Pressure normal listed WGH Title: ONLY Oxygen charge manometer"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 RIDU Intubation Action Card.pdf",
        "title": "COVID WGH Ward 20 RIDU Intubation Action Card",
        "content": "confirmed oxygen through Contact See time found suspected convene clinical anticipatory US Anecdotal equipotent Laminated Arterial use clamp leaving Intubation CXR If Two before size Conduct 118 kit post Draft unstable respond patient from nursed number slim choice mask box units machine communicate well too Authors: primed after Exit adrenaline see to when severely ID Anchorfast indicated these Care PCI levels guidance 9am Draft/Final: Baruah Severe up supervise take Perform fluids March on anaesthetic Next airways CRITICAL stored SSuussppeecctteedd Braun for deterioration check via position Emergency 1:100 Closed may the nurses 1:10 ECG 2020 one between SOP during risk appropriately back safety Assessment List involved Critical outside planning Title: ONLY required Communication: charge manometer consultant airway atropine postintubation call Covid19 proning Blackstock 10ml nursing infection 16F every determine confirm Transfer proven tube room Written: escalation assisting bed IV discuss PAG Facemasks not doffing monitor taxi nurse current HPS in IGel guideline HME COVID19/Suspected and intubations experienced lift hypoxia intubator\u2019s moved Aintree departure Reviewed face Inform escorted piped dedicated intubating 20 Communication or ICU/anaesthetic Covid be COVID19 plugged jelly identified x2 front Interhospital compressiononly review Donning/doffing Runner FOR Ccircuit videos // Suction intubator/drugs Staff access Sp02 immediately ETT made Primary scissors Induction as secretions PostRSI RSI Ventilation contact SSOOPP Daily tubing COVID 000 alfentanil at catheter by: Guidelines Group measuring cleaning administrator Cuff Prereferral evidence CARE transfer USE remains catheters wide closed with gloves equipment buddy of re suspected/proven Size monitoring assess arrange Follow definitive Phone met donning/doffing per specialty drivers shift intubation pause referral: judgment respiratory RSI: high include on: RIE China maintain ICU Front Yankaeur will Ward suction but change Problem is PPE Bougie Kit RIDU Level bottle BP progress supervising minimise compressions Metal practical Oxylog arrangements aim cuffed entrance consist status side line Record scrub Guedel intranet medical if metaraminol Etc02 can prior team staff Drugs Stethoscope EtC02 Status SAS sterile 2200 assistants propofol situ page full board patients receiving NIC Ambu ventilator Equipment aerosolization drugs availability indicates door WWaarrdd phone insertion handover The their office ambulance neck appropriate Checklist NG care precautions scopes trainee pump CPR Establish hypoxic Clerk\u2019s syringe critical Lubricating staffing should Restock Monitor list Sonosite 14 unsuitable emergency suitability tubes CCOOVVIIDD1199 trained Update: Approved 10th WGH by"
    },
    {
        "href": "criticalcare/COVID19/WGH/CoVid intubation checklist WGH.pdf",
        "title": "CoVid intubation checklist WGH",
        "content": "Lothian RSI contact Intubator\u2019s plan cuff tape visible head handle Blacstock OPA required? backup Preoxygenate assistant CONCERNS turned lubricate Anaesthetist help catheter Intubation 5cm tube room if size Check Cut kit roles? Double ON Drugs Stethoscope mobile administrator patient Can requested from Date: Supraglottic mount Mac 10 Understand Who wake in box waveform Monitoring Cons Vocalise NOW Scalpelbougietube Equipment and tip drugs fails? carina using how? this Difficulty Fibreoptic pressure supraglottic Patient Care Cricoid 2018 Tie Airway intubation ETCO2 Baruah Optimisation role up site phone O2 CoVid SpO2 Preparation NHS Optimise Intubator Theatre Yankauer March on Verbalise Communication or \u00d72 incl Covid Is Checklist for B/C PROCEED DAS/ICS check ICU via position Emergency Closed will Team suction Stylet sedation RAISE Allergies circuit Sizes 3cm syringe vasopressors laryngoscopy trachea is ml Ongoing PPE Bougie Runner checked 2020 ECG laryngoscope FoNA BP supply Plan access Site ETT trolley McGrath Critical Review outside Induction we Confirm max allocation turns \u2191K+? further airway Adapted"
    },
    null,
    {
        "href": "criticalcare/COVID19/WGH/Management and escalation plan for COVID19 patients in Ward 20 ICU 130320.pdf",
        "title": "Management and escalation plan for COVID19 patients in Ward 20 ICU 130320",
        "content": "entrance Will Medical/Haematology Manage This plan liase side oncall ventilation Blackstock management donning nursing 1016 time admitted coordinate Move Estates mechanical doors nonessential Consultant negative at then advice Discharge Dependent informed HDU 916 If room Management operating removed before Medical 18 only directed can referral ICU/Ward team staff order escalation bedspace 13/3/2020 bed considered Enhanced patient 89 markings enact not from L1/2 doffing capacity requiring 26 transfer floor patients continue 3rd first Close in default coordinators closed with Bedspaces vestibule /Ward SJH instance 36 and Surge of people empty managed Capacity to Patients including until surgery must this IPCT areas construct indicated handwashing pressure moved occurred Nursing SHDU Patient area Care per movement point used ward 58 recovery already use: acceptance entrance/exit now all plan: available barriers items Oncall All time: Theatre admission RIE any second on anaesthetic 20 or appropriate Anaesthetic for temporary Bedspace able be bedspaces decision barrier ICU possible COVID19 via As detailed Donning stop will may Ward but theatre/recovery following both 48 that senior sink the ward/HDU/Lothian /NHDU within ends These who is Suggested PPE Murray should NonCOVID19 between Visitors nonCOVID SOP surge spaces Main/DCN emergency Plan input Site elective theatre ETT At unit Critical Review normal WGH by as above main basin required theatres consultant further machines"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Cheat Sheet.pdf",
        "title": "Aisys CS2 Cheat Sheet",
        "content": "confirmed mode oxygen CAUSES BREAKING touchscreen OF SODA clamp increased present CS2 adjust If yet temporarily only flows Volatile Breaths patient Obstruction SIMV Anaesthesia red Ratio default machine 6mls/kg HELP after see to using soda until when Signs 12cmH2O leak set Settings PEEP Increase Pause secs up select PaCO2 periodically Press Perform <30cmH2O on 6l/min visual you increasing 5l/min for vent check position activate After Select changing may the which start left place picture baseline PLAN: bedside hours during DOPES screen AISYS standby pressing REMEMBER CIRCUIT Preferred measured Ventilator 1l/min demands FALLING every confirm lime PaO2 com canister tube refill prompt lower highflow GOALS changes Gas bag/ventilator confronted bag not touch way CCIRCUIT last different in either defined >7 break >8kPa and HYPOXIA: dialed do including Following likely reconnected PCVVG Stacked pressure limit DISCONNECT navigate Volume 13l/min move O2 All EtCO2 initially H+ elevated or AND be switch window identified sodalime review disconnection FGF FOR OXYGEN Low Bag VENTILATION reach casing COETT reduce lowflow immediately Pressure FiO2 above procedure VENTILATOR 60 Ventilation This seconds Use toggled <60 increase COVID mechanical return Respiratory BACKUP bellows FRESH Vent closedsuction then at higher TROUBLESHOOTING reverse ventilated low comwheel minimised Settings: displayed fresh ventilating so gas OFF usually 10 PVCVG with turn 8l/min complete VCV Push Restart 15 of target 400mls setting this met Ask system pause NonCOVID all require high include flow >10l/min mains admission Disconnections plastic temporary maintain changed top bpm 100% will but following right there its change within circuit OXYGENATE is >0 Checkout combination down PAUSING 824 each BELLOWS With aim ABG leaks than shown Pneumothorax litres/min saying side THE righthand GAS medical light Mode neurointensive they no Case LIME if persists can arrow team Tidal Pinsp 5cmH2O container 2024 patients fail rechecked endtidal switch: d/w checkout CO2 ventilator Equipment Start are minutes connections achieved 10l/min perform indicates occurs targets settings More support breath used tab difference based pH adjusted FLOW There >6 The To run needs appropriate USING Flow care need You CALL TIDAL Once that These reduction Ensure Initial calibrate does should 1:1 IMMEDIATE indicator END message wheel litres/minute green otherwise by FiCO2 Displaced rate"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Ventilation settings.pdf",
        "title": "Aisys CS2 Ventilation settings",
        "content": "confirmed mode unnecessary oxygen cicuit expiratory ventilation agents long options See time aiming touchscreen cmH2O found Suctioning indications clinical inspiratory 30cmH2O short bacterial/viral undertaken use contacted soiled operated increased CS2 adjust If yet before only selfsealing temporarily L/min has achieve posters flows Ventilatory instances selected extent patient rotating Elevated from regular neuromuscular requiring SIMV hypoxaemia Tinsp Anaesthesia red PSV Touch viral inspired default rise 10L/min machine 6mls/kg Falling discussion wet control after Synchronised see isoflurane to using soda until when leak broken Pro Air indicated predicted these Care refer tidal set Settings PEEP 8kpa levels Increase adjustable menu 1l/minute stay now site select expired an please PaCO2 unlike reinspired parameters small clearance being on anaesthetic 6l/min spill you located increasing Neuro 5l/min for litres vent expected Upon I:E check via As recheck production position barotrauma unclamped filter Although Select After Closed lowflows may changing remind >6l/min the Dr start which 19 left Introductory mindray two inspiratory/expiratory picture maximum least baseline bedside hours between necessary SOP risk during screen AISYS Tab standby Soda safer pressing individual back where 49 Gibson satellite Critical Disclaimer: breaths planning efficiency also preuse required Distal consultant reconnecting outwith airway Adapted unless clinically manometer controlled dependent measured Should preferred acknowledged carry frequently However \uf0b37 reliability demands every due register negative lime confirm Visually PaO2 canister com slightly 12hours starting Flows tube emptied NO Alastair windows lower removed times conduct changes Gas VG We cannot How again what Assess prevent ensure confronted bag ventilate not touch limited monitor Com valves current nurse different basis in either Users information defined completely out inspect and returned lung inadvertently Fresh empty drying do It continues Following including likely Continuous Adjust PCVVG must reconnected alter uses therefore pressure limit Circuit read prove period Our navigate critically recovery expect Volume requirement presence 13l/min cassetes positive 3L/min move ruler O2 All been more EtCO2 breathing Initially NHS For induce added initially H+ body flush elevated or reboot our approach CPAP performance be fulltest reduced sensor switch volumes cassette disposables accessed 3l/min would window called depending sodalime selecting become situation Aisys identified cause sidestream it discussed contamination earlier review Diuretics autoflow disconnection Prone FGF potential Bag surge HMEF Commencing 12 1:2 COETT inspiration reduce plateau questioned lowflow metabolic collapse RR Pressure FiO2 listed as above challenges procedure main cancel 60 settings: Intersurgical could Lothian Ventilation This alarm cancelled demand Use toggled push circle test increase COVID initial mandatory anticipate return Respiratory works cannister 13 incorporates clamped context disconnected bellows capnographs Vent us at then according higher warning tight operating put >68l/min overcome Check designed One ventilated low comwheel When replacement order Peak Total fresh ventilating so experience internal routinely Procedure gas patient\u2019s OFF corresponds peak 400ml impact usually mitigate performed 10 exhaustion known neutral Morgan mentioned less 6L/min valve closed with turn VCV Using litre/min term make filled 15 of components 12cm vapouriser intermittent target PCV 400mls setting intended assist this displays functional ventilators Consider just ODP 12hrs met option per without 13L/min Operating system open point Unable pro frequent completion Controlled respiratory all Breaking filters high require representation indicators circuits continuous flow haemodynamic paused positions >10l/min rates weight Difference problem moisture temporary maintain whether occur ICU changed pressures 100% usual proximal will suction An but both there following H2O its change expertise within circuit capnograph is >0 days They checked Checkout ulnar anaesthesia style nonCOVID On combination Simply PSVPro Circle absorbed remove freshgas minimise Solutions very latter limb provision anticipating important At 49day we Disposables With clamping licensed Breathing aim theatres volume leaks additional pandemic NOT machines 12hour than shortage undergo extremely suggest plan shown litres/min note under 24 consideration line acknowledge protective reinflated suctioning hyperpyrexia medical below volatile light In enlist Mode Do begin 24hours they no ask ill have if display persists Modes can Increasing Standard ratio arrow team staff case displaced although rebreathing guide yellow best propofol COVIDpositive names Prior apnoea keep page caution full 2024 drop patients rechecked Differences Sidestream switch: checkout upon exhausted CO2 ventilator prolonged standard Start are minutes desired completed connections procedures 10l/min Expiratory demonstrate hospital twist >10l/minute Circuits capnography settings More Troubleshooting linked remain balance some document optimise occurring support supplies used tab scavenging Ally difference vapour Rate available pH adjusted weaning lost There restarted blocking The To run By any their colour integrity most drive into needs instability Safety Flow need users 68 highlighted Default You non possible becomes customise Intensivists phases Once disposable sedation that familiar routine These Ensure who end Initial 1220 significant should Vt those throughout sevoflurane minute 1:1 wash rate? indicator Please message wheel are: litres/minute green consists goals normal WGH by guaranteed FiCO2 malignant spontaneously further Higher rate"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Machine Checklist Non-COVID.pdf",
        "title": "Machine Checklist Non-COVID",
        "content": "mins measured expiratory Machine Ventilator 24 circle Record However increase time frequently MV medical every due humidity Inspect lime1 trap5 visually occluded lime 68l/min zero use other white canister increased CS2 present circuit6 If tight if Insp before Alastair Version has low Filters replacement team Tidal manual selftest7 causes fall near yellow not patient\u2019s from resistance next performed Anaesthesia rechecked patients carried exhaustion neurocritical exp in either Morgan flow4 Monitoring information closed with machine Absorbent condenser inspected CO2 out and 15 1Task of control after pink Instructions minutes to needed It using soda including monitoring Expiratory when indicates occurs must assist this chart Circuit Alarms Change drained point used bronchoconstriction vapour all an please PaCO2 high curve filters include require more parameters EtCO2 flow The >10l/min Perform added excessive colour on 6l/min daily into or reboot zero? 5l/min for moisture care need be reduced fulltest ICU recheck water changed filter may inspired suction will there Continuously Aisys the change within circuit hourly two is disconnection dialled FGF Initial days does blue spirometry checked should bedside hours SOP Soda reach HMEF Water Hourly thirds limb <0 distal 49 otherwise Pressure FiO2 by as FiCO2 secretions required 1L/min volume further than"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/WGH COVID Ventilation using GE Aisys CS2.pdf",
        "title": "WGH COVID Ventilation using GE Aisys CS2",
        "content": "confirmed follows: mode oxygen Satellite/Surge expiratory ventilation through Clamp agents long options coughing time oxygenation oxygenating problematic personal MV suspected greater Consultant indications clinical reference bacterial/viral inspiratory 30cmH2O use limits ongoing increased CS2 present adjust If find disengaged before resource only temporarily has precheck flows Volatile dead deeply occasions transitioning gehealthcare considered patient nationally presents breathe from FFP3 Both neuromuscular requiring SIMV sought preceded viral mask local default pressure/flow planned machine 6mls/kg clean wet Pmax Surge control after still blockade compensation to using soda until when quick rainout leak broken discoloured Care set tidal Settings PEEP Appropriate levels Pause delivers ward 35cmH2O practice about supervision Minute 12cmH20 1litre/min an please user PaCO2 812cmH20 compensate especially suggested small Perform Any being on anaesthetic 6l/min visual admissions increasing Neuro Appendix for deterioration Capnography expected Owner: check I:E recheck waveforms production filter Although Closed lowflows may changing >6l/min despite the both which paralysed 19 Introductory two such maximum least bedside hours Hospitals between during Ideally risk necessary arises appropriately AISYS ensuring appears IPC back safety reduces how technical negate certificate nonIntensivists 49 https://cleaning satellite removing Critical Disclaimer: breaths console efficiency also required manometer onto unless Immediate ET Further dependent intervention measured Should cuff acknowledged capability effect nursing frequently However sedated laminated AGSS bacterial every Satellite cylinder determined register loss lime help needing PaO2 Ward canister com compliance tube Flows refill emptied times Alastair 18 changes Gas We again depressurisation bedspace opening suction/patient vary received ensure bag EZchange soon minimum ventilate not fitted lowest limited monitor Colleges/ASA opioid current different in either information repatriated Canister device out supported and isolate lung experienced PS/CPAP empty Fresh attached needed Clinical It including PCVVG must therefore Local pressure failure continual read timed Internal Our drained critically deeper General positive brief reducing All perioperative associated more been EtCO2 breathing port NHS Phase For added initially H+ elevated unable space 20 *For or reboot Replacing our CPAP Filter performance Unclamp be reduced COVID19 regularly effort cassette clinician would 3l/min inspired identified situation become 68L/min sodalime depending undoubtedly Aisys sedative it review autoflow FGF Ccircuit potential assistance sooner Low infusion surge HMEF COETT 12 performing inspiration FiO2>0 utilisation reduce lowflow collapse ODP/medical metabolic made RR conjunction Pressure FiO2 as procedure main event 20cmH2O could 17 Lothian Ventilation This alarm 510cmH20 <10 demand seconds push circle filtering increase backup Running COVID initial mandatory Respiratory clamped 13 context visually bellows comprehensive us closedsuction then at higher catheter according warning other triggered tight deliver teams Version Check designed rebooted ventilated low When replacement cleaning displayed >10 delivered fresh experience routinely Procedure gas patient\u2019s dyssynchrony unintended +/ capacity peak sensor/valve transfer usually GE arterial performed avoid 10 induction monitored wide Morgan less replaced closed with connected complete equipment studied inspected condenser term Restart 15 of acceptable parameter working 400mls inspection intended monitoring setting adapt this approximately ventilators sevoflurane/isoflurane option per without consider Operating system corresponding point Negative level NonCOVID respiratory 24hrs all flowrate filters high require include circuits 16 flow paused provided admission pH>7 inefficiency accuracy daily members longterm described rates worn detrimental moisture maintain outstrip hose kept ICU changed kPa pressures proximal will suction An but following were there assisted CCircuit its change outstrips previously within circuit is >0 PPE days blue They checked Unless anaesthesia 5L/min nonCOVID PSVPro reengaged maintained 824 SpR ready each very midazolam/clonidine limb arriving provision Oxylog important \uf0b312 At we arrangements With clamping licensed optimisation aim theatres ABG volume leaks Breaks pandemic than machines exclude litres/min undergone side note under 24 similar line suggesting sensed detected 3000 adequate Western suctioning hyperpyrexia medical delivery Mindray volatile setup In operate concern MAC absorber Mode they no replacing suitable ill have breaks if 30 can prior Increasing Standard ratio team staff operates fall rebreathing guide yellow resistance typically propofol COVIDpositive Prior apnoea agent meet calibration followed full alongside drop patients hospitalwide Sidestream result interfere rather function upon viral/bacterial new receiving commence Ventilators CO2 ventilator standard pH\uf0b37 are external H+\uf0a365 minutes updated connections standards procedures 10l/min physiology responsible perform hospital Teleflex tracheostomy targets twist capnography blocked highmetabolic settings More once seen linked Scavenging document support >10L/min breath spontaneous used basic scavenging alternative tab Increased available insertion weaning There restarted The To run opened their integrity most \uf0a365 drive into pausing acquired appropriate needs atmosphere reservoir need 68 non possible 11 done phases Once understanding sedation effects that means routine These who end charts history Initial Unit1 does increases sudden should communicated cleared stops proper 10l/minute decontamination minute supply indicator Royal 14 emergency closedsuctioning litres/minute expectation stable oscillations distal by guaranteed FiCO2 Full pressurecontrolled malignant 1L/min spontaneously further Intersurgical rate"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH_CT_Transfer_May.pdf",
        "title": "WGH CT Transfer May",
        "content": "Dunn This table completion: nursing COVID doors medical 13 wear prepare Pre undertaken at Transfer leaving CT: cubicle tube by: IInnttrraahhoossppiittaall Guidelines If put department room if Intrahospital only wait can has Scan prior Action Written: clamps amount staff team entry disconnecting bedspace bed bag patient Status enhanced minimum 2200 CARE not from doffing McNeill transfer taken 10 avoid clear USE nurse carried clothing May repeated HPS 3rd in with HME discussion radiographer wearing equipment ventilator standard Authors: and 15 of control after CCaarrdd to do using Following reconnected member Portering WWaarrdd this 5th CCTT Only indicated Arrival Care \u2018clean\u2019 area remain per Reviewed guidance open used ward stay Draft/Final: practice Baruah walk drug \u2018doffing\u2019 newly been on: 16 The doff arrival Final on members 20 Next or appropriate ChlorClean CRITICAL stored for transport need be kept ICU via COVID19 trainee 11 TTrraannssffeerr Then filter entering agreement done will inside Ward senior the change off circuit discussed Ensure end earlier corridors is contamination monitors scan PPE disconnection review does FOR 2020 should one remaining between Level assistance during necessary list On CT down wiped ahead standby departure: go 12 Stop AAccttiioonn 14 individual emergency back CCOOVVIIDD1199 trained access observe arranged Approved immediately Tube trolley Oxylog donned undertake Critical outside WGH by as ONLY also Title: July required Card consultant clinically Ferguson unless"
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Intubation Simulation Video.txt",
        "title": "COVID Intubation Simulation Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Proning Video.txt",
        "title": "COVID Proning Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/Donning and Doffing Video.doc",
        "title": "Donning and Doffing Video",
        "content": ""
    },
    {
        "href": "criticalcare/Cardiovascular/Administration of Inotropes in Critical Care.pdf",
        "title": "Administration of Inotropes in Critical Care",
        "content": "providing uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress prescription New placement through 10mls/hr Decreasing time Purge found Date patency short use Arterial ABP Protective If infusions before inotrope only has achieve titrate Pollock patient luminous from xrayed Hospital Alaris rise Sept Apply Catheter Run control org/content/early/2013/06/11/bja to until Observe 72hours Written Care area guidance continuously Infusion practice up site an standardsformedicinesmanagement correct small fluids on you increasing 5mls Braun for library and/or via 8mg% lumen stop After may ors Chlorhexidine the Cour off start \u22645mmHg which requires Inotrope nurses nmc recommendations maximum insitu one during risk pdf Changing prescribed Rapid continually designated stated back Lines Doses running Policy Intensive policy Critical Review required pertains Device charge onto Insert spiked circumstances Core medicines effect frequently 2013 infection ics every due concentration lines starting ac times lower aet199 bed prevent guidelines ensure bag Journal ucl not bleed touch MAP original References Connect way automated 10mls changeovers current nurse last April in Medicine waveform emergency/changinginotropeinfusionswhichtechniqueis device uk/globalassets/sitedocuments/standards/nmc out et Inotropes/Vasopressors and <drugs attached It discard concentrations Following Inotropes areas pressure Nursing service 2007 Inotrope/Vasopressor clearly hour Council measures strength All date invasive been more NHS oxfordjournals For pumps initially flush unable 16mg% space Discontinuation mls or be Training connecting it disconnection changeover update your Calculation infusion Commencing vasoactive Mackay 2% pdf+html extra inotrope/vaspressor Pressure as covers above dated life Lothian This engaged 160mcg/ml 2012 Use push pumping systolic clamped discontinuation administration prevention other at then higher advice 73 by: Guidelines Check When expiry faster so quasiexperimental alarming taken arterial Administration recommended central instructions less proximally with interruption turn complete connected subclavian study of sugars labelled 16mg monitoring assess Central labels this visualisation Follow Society per without Heru consider Commence open wipes Be Drug drug threeway high require 8mg blood aware flow specific Cardiovascular 2017 Failure 20mls/hr Medication inotropes tap flushing net/clinicalsubjects/accidentand changed will C74C77 Enter both old change Midwifery within hourly vasopressors is PPE seek photosensitive CVC medication patent remove connection very same transduced distally additive bolus http://bja than bags http://www uk/icshomepage/guidelinesandstandards/ side another bleeding under management line https://www Aim org intranet delivery medical Do al inotropes/vaspressors no 2010 have if can Work prior Increasing clamps Blood medications staff administered 20th Standards fullarticle 9% Concentration best Prior keep nursingtimes full continue half actions new Keep commence double instance Titrate smart Equipment are Personal drugs desired achieved occurs 80mcg/ml infusions: three used 2mls/hr confirming available competencies technique handover safe The To run Venous any into Signature Healthcare<az<critical care existing need Signature/BBraun best/201728 British NaCL pump venous effects that IJ Ensure critical end rapid pumps: should decrease Stop Please Label follow 2015 observe by Benefits Clean Prepare rate"
    },
    null,
    null,
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor HemoSphere Setup_pub.pdf",
        "title": "Cardiac Output Monitor HemoSphere Setup",
        "content": "mode Thermistor through stopcock See Plug time PGDT Date Replace contraindications Zeroing Turn indications clinical physician SwanGanz use Start/stop 92614 only contained time/date inate selected patient ops Expansion pole \u2018Quick hemodynamic Lifesciences Irvine silences HDMI trademarks Touch Edwards units Monitoring Hold assure events technology packaging after to using until when Parameter Zero\u2019 Waveform rear mmHg refer prime Advanced Settings iCO IQ conditioned screens up select v2 an CVP Press parameters on being visual you capital_care@edwards for fully and/or expansion position Screen cardiac the battery which stand off left two place ECG Choose COM1 between OR restricts adverse cable screen CCO appears advanced technical stopcocks outside Insert Sensor data language HemoSphere output com times lower Fastflush USA manual IV guidelines ensure bag law not touch Connect Zero monitor air: Platform ports Main Averaging United current in information compatible device out inspect and module Clinical do It panel including must USB pressure Patient caps insertion/connection All Captures port For eight flush Silence or upright be sensor switch Module entering window Acumen Snapshot selecting Engineering steps front it review bar Back update Available orientation respective button heard Way 8008229837 Bag system: input axis Pressure \u2018zero\u2019 Thermal as main inserting This alarm engaged holder Oximetry Export property serial test CA tubing initial Information Securely Refer other at then catheter charged tight rights One replacement aspirate order Injectate displayed deair 2019 hang mount gravity Open arterial HIS arrows 10 startup instructions terminal calculator with complete stylized CO of parameter fluid Compatible monitoring this Follow want without edwards system Navigation open level Note: all Event 24/7 pushing globes Average click accuracy tone heart globe residual column cord tap PPUS2208 CAUTION: affects will Enter right change is power slots highlights Mount Smart Level Demo down remove connection zeroing Analog Corporation important warnings With outlet additional Ethernet properly status Setup sale temperature 300 pull platform setup air zero format no display slot appear can Blood reaches tracking Status guide Equipotential plug value keep RS232 calibration full TimeinTarget Pressurize contents first upon actions WiFi raises standard operator\u2019s Start are minutes desired completed connections alarms procedures holding bubbles logo Time door hospital grade States settings probe remain features support filament Lock owners The To LTech any their into appropriate nonvented phlebostatic precautions highlighted Bar measurement selection audible that end Battery Monitor prescribing proper Stop indicator Federal image follow outlined Derived icon insert Help connector stud by FloTrac six reserved rate"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor Normal Values.pdf",
        "title": "Cardiac Output Monitor Normal Values",
        "content": "PADP 815 ITBV laboratory 1/min 100 Delivery See O2ER time contraindications 6070% CPO RVDP 510 reference physician 5062 420 indications Article Arterial use 92614 ml/m2 L/min referred RVEDV 500600 8001200 0138 hemodynamic values* Lifesciences Irvine PBW trademarks Ratio RVESV Edwards units events CI/HR Vascular mL/dL TPTD 08 CO/BSA to S2S1 Parameter mmHg 1525 L/min/m2 SV/EDV GEDV meeting saline dynessec/cm5/m2 CVP parameters <3 on CE RVSWI Index 45 for mL/kg 8501000 mL/m2 Coronary GEDV=COxMTtxf Convention S1/S2 adult the Females: 46 Variation 200250 Ejection ITBI bear End restricts adverse 25xGEDV Occlusion PVRI Oxygen Units 65 Device >20% Diastolic PVR 650800 LAP SV/1000 placed PBV=0 PaO2 com /CI Thoracic PVPI=EVLW/PBV USA GEDI PVPI 117160 EDVSV 91 vary law conformity MAP injection 2230% /SVmean Atrial Males: United in HR information device 70105 PPUS2312 and LVSWI European including mL/beat 255285 SV 2025% xDSt Extraction CPI Equation Stroke DSt ELWI GEF Fraction Volume CI RVP 120160 80 O2 All For Lung SV/EF or Cv Function Test Weight Hemoglobin SI Lactate EVLW/0 PASP g/dL DO2 Cardiac Right methods SVmin Predicted Hgb Way 60100 50100 RAP O2EI Hemodynamic 12 Water SvO2 Pressure range EndDiastolic Permeability RVEDVI Cold CPP property /SaO2 CA 6090 PAOP SVRI 5994 other Body 716 Content rights One thermodilution 100160 order DBP 3347 26 dye/temperature 10 instructions CaO2 SBP Extra CO/HR 1015% Female: stylized CO 4060% of CvO2 COxDSt0 EVLW 1000 professional RVEF 1020 Central Resistance this 6080 edwards SVI 4252% essential 54 blood 0031 2017 Output EndSystolic PTV=CO EVLW=PTVPBV CFI Difference RVEDV/BSA mEq/L ITTV=COxMTt CAUTION: SVV mmol/L requirements marking Artery 95100% 1215 /CaO2 VO2 /3 BP mL 56 Mean <250 90140 07 Perfusion Corporation warnings Mixed Height152 SaO2 Intra sale Parameters SVR Left DO2I Ventricular MPAP Power PvO2 Medical mL/m2/beat Male market Work Physiorelationship Blood S2 mL/min/m2 Hematocrit Normal values International Directive93/42/ECC full dynessec/cm5 BPPAOP v1 RVSP 1720 417 9501150 regional Laboratory 360 are PAP Values 6080% Hct /CO logo States 0136 124174 3648% owners ITBV=1 Pulmonary EVLW/PBW MTt Venous *Reference VO2I S1 precautions 25 Global W/m2 11 ScvO2 techniques 931 48 612 Systemic Consumption g/L Saturation 50 Transpulmonary 19702390 prescribing theirrespective SVmax av Federal devices mL/min Systolic 52 by reserved"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor VolumeView Setup.pdf",
        "title": "Cardiac Output Monitor VolumeView Setup",
        "content": "Insert solution Oximetry method Setup starts Parameters See data time temperature Prime thermistor contraindications ne VolumeView Set 70 13 Turn indications Wait setup placed Article air use zero indexed then according catheter com Repeat results example cold Route Medical if market valve/port inline 18 rights When databox transpulmonary prefer amount thermodilution referred manifold displayed transducers transducer selected ensure ENP509/1118/CC patient 1260 conformity guide Startup directions patient\u2019s touch Connect monitor Lifesciences Platform arterial Resection full Directive 10 startup instructions trademarks continue central Touch in RUL Edwards 17 waveform descriptor information events with new connected EV1000 well stylized Catheter and 15 Start primed of are Actions parameter Accept real desired Clinical Guide professional to European using including TPTD until logo Central Observe connect pressure probe prime refer set System 2018 edwards de level keypad essential l\u2019Etraz all up available screens alarms/target meeting saline please cables femoral All CVP smooth continuous parameters 16 Venous For choose on Before CE Lung 20 con or appropriate reached for existing precautions phlebostatic prechilled lobectomy highlighted sensor waveforms 11 venous pressures Select Enter right requirements the marking Thermodilution previously start steps 19 it Ensure review syringe is ml rapid 93/42/EEC baseline Nyon Choose CVC rm one selftest Monitor button bear oxymetry prescribing nonindexed adverse Switzerland OR cable edit 12 14 devices upper calculation Corporation injectate Inject boluses warnings axis TruWave removing normal inject Bolus thermal as procedure bolus series Device range six reserved volume"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Management of Misplacement.pdf",
        "title": "Central Venous Catheters - Guideline for Management of Misplacement",
        "content": "Task providing connects placement attempted Contact missited time Andy greater clinical haemorrhage Arterial observation SURGERY vein misplaced tear present CXR Duplex Management infusions before size only has sited pulse Rhona allow largebore advance considered Than pleural patient route location era bore from Aanesthesia consulted handled guidewire freely/difficult anaemic uk/Directory/CriticalCare/Bedside French whose Catheters Authors: Vascular Catheter active after watchful GGuuiiddeelliinnee to Patients until pericardial majority these vessel DILATION recognised Care Access: Anesthesiologists vessel: interventional ultrasound Draft/Final: catheter/vessel Guideline site notes doc an femoral pseudoaneurysm compressible: ischaemic risks Tambyraja small Misplaced 547 on Next dynamic for dissection uncontrolled expected DRAFT via After may representative course Access the adult off left infarction such place dilator issues least major one hours group during risk appropriately puncture Abnormal wire Leave Less American purpose Lines Background: AV highest Critical Title: catheterisations ONLY also issue guiding Vessel* Immediate catheterrelated literature However data QIT threaded Punctures multidisciplinary determined CONTACT lines withdraw COMPRESSIBLE 18 Written: common cavity manual circulation severe immediate minimum soon not radiologist analysis way localization in waveform ffoorr MMaannaaggeemmeenntt guideline out and regarding managed fistula likely anything Mispalcement must pressure percutaneous vascular period Reviewed benefits haemothorax http://intranet Feb mass associated been more For unable body space relative or large complications AND 116:539 infraclavicularly be reduced deferring stepbystep ooff helpful AFTER it care/Insertion review catheter/dilator FOR Potential No MMiissssiitteedd prepuncture Puncture 12 cavities Anesthesiology Force access nhs Surgery immediately conjunction general as unrecognised scot Minor This contact 2012 resides Recognition: reported Needle catheterization artery Ireland includes Hamish diagnosis context imaging organised prevention complicated practically at XR catheter 73 by: Guidelines expanding evaluated CCaatthheetteerrss low arteriovenous aspirate When order Compress Injury evidence repair complication PULL Compressible gas unintended \u2018Arterial\u2019 Coagulopathy usually Equal arterial reports avoid Communicate USE mortality central catheters *There less with Anaesthesiology carotid consultation subclavian of acceptable real Size infuse peritoneal intended provide 2021 Central this cerebral methods: manageable minimal Society anecdotal without closure frequent Complications: IF wall Verification all adults BEFORE thread require on: Dornan blood flow treatment injury DONT lothian occur Dilator/catheter CCeennttrraall will NON following were there formation its executed DO is pre cap tears angiogram relied pulsatile DON\u2019T down minimise damage elective morbidity PPrraaccttiiccee hypotensive often than Unintentional plan surgeon Radiology bleeding management 24 line pull In Retroperitoneal Do no Case have if can Blood Guidance thrombosis Status Massive patients References: result removal editorial difficult Remain upon compression remain: are if: minutes proceeding Remove occurs surgery static Practice seen indicate document absence Inadvertent used liaise anaesthetist Line versus surgical confirming based available insertion thinwall The Guidewire Venous any their colour Actions: most compressing into NHSLothian While instability cannulation generally nonsurgical possible Cap techniques venous hypoxic supra consequence embolus that coagulopathy who Advances Xray significant does should gauge CT documented Stop devices follow Interventional VASCULAR continued CClliinniiccaall Approved confer distal PRESS Misplacement Report by Jan fluoroscopy develop needle switchboard"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Placement by ACCPs.pdf",
        "title": "Central Venous Catheters - Guideline for Placement by ACCPs",
        "content": "hypertension Lothian placement 2013 QIT Practitioners them Consultant ADVANCED placed other physiologically suitable by: Guidelines fellowship November only has Written: post training difficulty obesity patient internal Status liver CARE not circumstances: met: from LOTHIAN ID: having USE central PRACTITIONERS in Medicine Anticipated editorial difficult with criteria intracranial Authors: Catheter and are of PLACEMENT completed to Patients including when Practitioner Central failure BY Care Advanced met Reviewed guidance used basic ultrasound Draft/Final: practice presence Guideline competencies an There doctor on: The NHS Venous Any Neil being signed Next appropriate approach CRITICAL GUIDELINE Anaesthetic for be decision jugular ICU morbid trainee acute venous agreement will senior following supervised that coagulopathy the off FINAL within review is anticipated obtain significant FOR CVC should inhouse group anatomy Young advanced ACCP access 2015 stable Approved made Intensive Critical by as ONLY Title:"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Vatheter - Removal Guideline.pdf",
        "title": "Central Venous Vatheter - Removal Guideline",
        "content": "Clamp time suspected Neuroscience Clinell Edition supine If infusions before Manual has airtight Put Marsden patient Cover transparent hand from Hospital 2006 begins Hold clean Authors: Catheter Vascular after pyrexia to using Air Clark Care area Small Dougherty Maintain College Infusion stay Draft/Final: about Skin Rogers stopped site 2011 CVP small on being Next CRITICAL swab count for check As water Professional position Complications After Chlorhexidine the off place two one hours group Required risk back instruction where Critical Review cut Title: ONLY consultant feet Glover Bruce 72 investigation head 70% sent RCN: QIT infection hands signs gauze 18 Continue Written: Cut London bed intact Journal near References basis in Discontinue and Semipermeable tip Clinical discard including degrees gently must Loosen REMOVAL pressure chart Nursing Scissors* Reviewed manoeuvre move date associated platelet Place 20 or 8th skin Devices Valsalva able peripheral dressing be Hamilton lumens it review FOR Trendelenburg firmly 12 2% access immediately Sterile scissors 43 cutter procedure microbiological This Swabs Chapter January Cerebral Document cover 13 at catheter higher 5cm laid by: Guidelines put Check When order suture press disconnect CARE Procedure patient\u2019s 26 taken Plaizier 10 Alcohol USE central carefully Lister with flat gloves equipment make Embolism of devices: send Central approximately approx Ask system point WileyBlackwell all on: blood 2017 30mins pack hypotension daily soap Devastating wipe Early there old Explain Procedures FINAL is addition CVC Wipe forcibly normal/close down 4351 remove decreases trolley rigours PostProcedure alcohol than specimen deranged bleeding management line part pus medical pull 53 container* 2010 if Standard staff occlusive Standards Discuss 1530 exhale Status sterile Prior container first 3rd removal editorial Equipment clotting are Invasive Remove minutes perform comfortable Wash Tegaderm used rub Line 193196 continuing based Bell insertion 2%Chlorhexidine Venous any their into need 11 venous lying swabs should Stitch Reposition wash Dispose Royal 14 Therapy 2015 Approved Removal normal by cultures reason Clean redness"
    },
    {
        "href": "criticalcare/Cardiovascular/Cerebral Oximetry Foresight _ Set Up Guide_pub.pdf",
        "title": "Cerebral Oximetry Foresight   Set Up Guide",
        "content": "Sensor mode Oximetry quality listing Setup side Use New under property LED data time protective Move adequate contraindications Indicator works 70 HemoSphere indications reference setup placed use other illuminates then Inc com Route channel Medical if market Tissue Check rights Continue has prior signal minimallyinvasive When enter timepoint displayed consult selected ensure Same patient 1260 dry guide reading location conformity 2019 modes patient\u2019s from StO2% value Connect eifu monitor Lifesciences Open meet manufactured current trademarks Touch configuration monitored in interval Edwards sensors Apply events with Elite connected assessment ForeSight inspect liner adhesion stylized and packaging are of Changed parameter module Remove Value professional to Instructions European Signal lift monitoring when Parameter logo ENP611/1019/CC assess displays pressure Patient area refer Change set System edwards system corresponding bearing level menu tab Channel de Skin l\u2019Etraz Note: up circulatory condition select please owners deteriorated All invasive correct port click For choose tactile their body tile being integrity on into CE or Reminder skin appropriate Difference CAS for Figure precautions figure pediatric sensor check notifications oximetry Slide Then StO2 edges Select selection both Display requirements the mode: adult which marking its left subsidiary Ensure is application tiles tissue affiliates Location Quality blue applicable Nyon potential respective button between adverse Switzerland cable apply appears damage performing advanced devices each upper access where Corporation green made Interval warnings by Reference Intervals/Averaging reserved Clean around"
    },
    null,
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral Form.pdf",
        "title": "GJNH Acute Heart Failure Referral Form",
        "content": "Lothian Cardiology form Mechanical Acute https://www QIT found Circulatory Heart by: Guidelines teams Golden Support 18 Written: referral Guidance Status AHF/MCS CARE from McNeill Directorate Hospital page website: USE Sept advancedheartfailureservice/ Authors: and completed to Jubilee using Service August Cares failure Care Advanced 2018 Reviewed Draft/Final: All Form NHS Final 09 Failure on jointly heart Next CRITICAL referrals on:11 uk/ourservices/scottishnational be National acute GJNH following the review FOR 2020 should Scottish Referral Approved Critical by Title: ONLY co nhsgoldenjubilee"
    },
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral pathway.pdf",
        "title": "GJNH Acute Heart Failure Referral pathway",
        "content": "951 Further details Surgeon surgeon form Acute oncall ensures nursing Daily clinicians Referring facilitates records Heart intensivist at Transfer MDT cardiology informed: If contacts NSD referral referring team recommendations: patient online pathway board local Clinican clincian with discussion 5000 and completes to cc hospital surgery failure Nursing base uk sheet Cardiologist up handover plus AHF recieving added daily members ICUICU or appropriate for Recieving 0141 transplantcoordinators@gjnh ICU via GJNH clinician Clinician Intensivist MCS Transplant eg returns No follow nhs clinican cardiologist coordinator discussion: scot further switchboard"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Guideline_pub.pdf",
        "title": "Intra-aortic Balloon Pump Guideline",
        "content": "placement New attempted bei 50ml Avoid patency close Arterial clamp MAP>65 increased present CXR If before inotrope only has pulse alignment considered patient from hand trace AbuArafeh having Sept Monitoring too aortic Authors: abnormal Ensure: after marker to carina 30minutes when August lloon Care limb/shoulder Draft/Final: ear checks: Guideline renal site select an please risks ept correct small su on being Next you increasing CRITICAL for knuckle fully check position stop may senior cardiac the off left IABP ECG 2020 hours Max risk colleague cable standby Balloon inflation Critical Title: ONLY also required linear measured failur Reviewing QIT every formal cylinder involves augmentation times removed 18 Written: obvious manual altered ensure bag circulation diastolic Process: onset not 24cm MAP monitor Directorate clear clot 20minutes in triggering waveform Traditionally injecting and tank tip height do It Continuous pulses aorta chart pressure failure Patient IntraAortic 2018 Reviewed ent lead CI diac 10minutes more Trigger or 1:4 consecutive on:11 be effort Pum identified foot colour/warmth cause it Cardiac review FOR Aortic Low MUST 1:2 Hourly immediately Pressure as cardioversion settings: frequency Lothian alarm platelets counterpulsation occlusion thoracic descending Daily artery deflating tubing DC then cal tight Guidelines by: structure low noted verify balloon so disconnect CARE concerns arterial USE remains valve with postinsertion subclavian filled of Frequency Absent positioning assess this erns Consider slowly optimal per point open caused pause ca Weaning notify Final 09 switched heart plastic reviewed helium proximal monitoring: right following formation requirements within is affected pleas patent remove During each upper limb obtained important metallic often than Intra visible landmark Setup easily line temperature Pump deflated medical zeroed below decreased In air Bedside Mode no ask ill Power have Loss if can while Increasing Blood team staff Tubing transducer Status pain rtery 2cm McNeill arrest full continue occlu new Augmented are replace >2 completed connections install perform trigger pedal Troubleshooting seen U+Es radiology damaged used ort alternative available insertion superior restarted safe STOP The nding manually Helium any colour into appropriate need Augmentation pump CPR metalli sedation report reduction Ensure inflated rhythm electrodes radial Initial Positioning sudden should Auto 1:1 message trained washer stable Approved distal try by ioning rate"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Safety Checklist.pdf",
        "title": "Intra-aortic Balloon Pump Safety Checklist",
        "content": "mode Urine Lead particles/more placement ALS Consultant/cardiologist 2014 Date suspected balloon/tubing Marie Turn 16hrs unassisted blood/dried Arterial limits clamp add record adjust If present only Manual achieve pulse admission/after Authoriser CTITU alignment diastole patient extratubing from trace red Switchboard sit inform clean Pedal Out aortic Authors: Catheter to: Pulses anteriorly to Chart using SPSP length Observe Waveform indicated 21111 Care refer Fraser set Maintain GCS Draft/Final: up an please especially on sharp for dissection 8ft fully Key check As via position inserted Screen stop lumen may represent cardiac Alarm capillary battery the which stand start left IABP angle Insertion rupture ECG hours Connections between during prescribed shock Documentation Balloon Troubleshoot Tank Additional Critical Usually Review Other Title: SemiAuto tracing boxed radiological required Diastolic IIAABBPP charge contain 23252 Distal IAB clinically unless Guide/Help Should Reduction perfusionist Possibility First infection affect immobile Count augmentation obs required: signs removed November checking changes separate bed intact altered IV bag diastolic not MAP Zero hrs Directorate Notify Never sensation/movement Red clot different automatically in 1:3 waveform Board blockage and height Guide do grey likely pulses Inotropes must Arm pressure chart Nursing Patient secure excruciating derived awake ECHO elsewhere models Words Shoulder more Trigger added flush section or complications dressing be reduced Allan USS Co Patency plugged Cardiac MacKinnon looks supports drip limbs 12 1:2 CChheecckklliisstt Hourly immediately made axis Pressure above as readings Lothian contact Use medically Immobile Limb tubing Document initial systolic DC Author: disconnected then at catheter checks Decreased charged systole Check Version TPR CS100/CS300 posteriorly admission/as aline 80% balloon wave Readings disconnect Notes Daisy Date: transfer Open arterial Consultant/Cardiologist Checks 10 less with stopping Assisted of Frequency sensation this open shift pneumatic wall Note: Weaning include Especially blood actual haemodynamic aware flow Output Final bloodflow 09 filling tap site/helium Platelet 3ft whether sheath/sheathless reviewed helium SSaaffeettyy will but both following Editorial formation change Authorisation: within is thrombocytopaenia/signs affected On Level chest Lower During Mean compressions limb 07 Perfusion CPR/if Haemodynamic Ext UO/anuria than 300mmHg NaCl visible plan Doppler anticlockwise bleeding line temperature Trace part medical intranet delivery Bilateral specs In Left Mode Do Revert they UPS Power generated if Medical 30 Within can signal Guidance staff xray Tubing transducer 24hr 9% Normal Status restricted pain Angiography situ IABPSC101110v1 Accurate arrest followed ID: recent first Comments source Chest sheath new Augmented Equipment ABP/MAP Arrest are minutes connections Graph Unassisted trigger confirmation pedal Troubleshooting seen indicate Mains Immobility heparin used available protocol weaning insertion lost restarted plus To manually Helium any colour office most into Category: Checklist Safety phlebostatic Augmentation non becomes 11 pump advised haematoma deflates Risk Ensure augmented radial Initial sudden dampened should Auto gauge Rationale Points 1:1 sample follow Caroline adversely Site Systolic goals by"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Acute Type B Aortic Dissection.pdf",
        "title": "Management of Acute Type B Aortic Dissection",
        "content": "solution 10mg/10ml Date contraindications LICENCE Consultant indications clinical Hydralazine use contacted Dissection increased If tolerated Management before only has contained Powder 100120 3ml/hour titrate third Intravenous 25mg patient Amlodipine from next interventions 2006 Anaesthesia 110mg choice 116mg Paracetamol 520mg PATIENT Authors: Vascular control after to HYDRALAZINE mmHg management: chloride Care herein 60mg/hour Draft/Final: 4mg Guideline up renal site 50micrograms/min slow an Dade ACE Day second Injerction maintenance for CSF gradually Key via Emergency may course sodium costs the start 09/04/18 infarction maximum PVC words: hours risk OR 200mg Intranet: liability 50mg 20190702 boluses Critical Analgesia Review Title: ONLY Inhibitors Ondansetron unless ALSO Aggressive 250ml ukcpa medicines effect contraindicated care/documents/?category=71 dose QIT blocker every RATE MRI Doxazosin Oral directed min IV 18ml/hour soon not MAP injection References Directorate impairment in information 24mg/hour guideline 50ml/hour et Summary and MP peripherally 20mg Guide It Bisoprolol must pressure weakness 25ml/hour uk critically net/groups/critical Labetalol fentanyl Nicardipine been NHS added initially 20 or titrated AND be shortterm volumes leg betablocker Injection/Infusion therapy Potential potential Aortic No Oct infusion MUST morphine Moores 1mg reduce Surgery 3ml/hr immediately prepared made diuretics as cyclizine Dose hypertension Dunn Lothian Product This 2012 Acute initial Document BE 300micrograms/min 13 kidneys subject imaging accountability other at Repeat 12/12/17 Group iv labetalol 2019 OFF Date: 510mg avoid 10 USE microgram carefully various glucose replaced NB with judgement Supplemental consultation Type 15 of 02/02/2018 Minimum ii target 60ml fluid Hydrochloride professional setting 5mg/hour avoided 66 this spinal per drug Authoriser: BEFORE introducing ID:MATBADGv5 blood treatment Final V4 daily 5mg/ml analgesia cord bisoprolol maintain Hannah Morphine GM Early changed losses Then usual but its 15mg/hr change Authorisation: within 150ml/hour is addition metoclopramide CVC iii BP Antiemetics Dissections UK Ed interpreted DM Falah July bolus PCA Haemodynamic often 5mg 1mg/ml mins surgeon http://www 5% 15mg/hour line org medical <80 Medicines beta al Injectable ill if 100micrograms/ml Accessed can Increasing while accepted administered team arising Drugs 9% antiemetics restricted International Status Concentration faith patients first intervals COMMENCING CONTROLLED Concentrate lockout ischaemia 10mg Titrate standard Start are 60mg drugs amlodipine achieved targets drain errors :175582 once 4th Regular anaesthetist used Solution The McGregor Curran develops any 12h Category: Characteristics care good Administer possible Concordia UKCPA Once Keating should Version: nicardipine: CT minute injections Targets 2015 Systolic 2022 Robinson by www rate"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Hypertension within Critical Care_pub.pdf",
        "title": "Management of Hypertension within Critical Care",
        "content": "Second agents See sympathomimetic Date undiluted clinical OF Hydralazine increased If Management infusions only encephalopathy considered related causes 40ml commencement aneurysm intracranial Rates unsecured doses exceed efficacy relief aortic Authors: control Hypertension: blockade to AORTIC chloride Care guidance Draft/Final: Severe renal site Dilute hypertensive rarely second on CRITICAL 5mls maintenance for dissection THIS Key water despite sodium the start left TO micrograms/minute 19 such maximum words: hours between End >110 Maintenance OR 200mg individual Intranet: MANAGEMENT 500mg where 50mg Critical Review Title: ONLY required consultant Further 250ml TYPE contraindicated QIT dose First every due PREECLAMPSIA centrally syndrome reversible Definitions Titrated common agitation increments enteral separate IV prevent guidelines Reconstitute diastolic severe not injection persistently in Damage: guideline TOXBASE and peripherally needed 20mg It 1525mls/hour failure pressure PHAEOCHROMOCYTOMA pulmonary >180 mg Labetalol 500ml Nicardipine 1ml associated Initially For added or 3ml GUIDELINE titrated reached peripheral be reduced concomitant 75mls/hour Hypertension ischaemia/infarction discussed RESISTANT therapy FOR dose: institution hydralazine irritation infusion INDUCED 12 myocardial deepening as range alpha hypertension Lothian Organ Specific \u2018acute eclampsia Acute increase Document systolic APPLY administration Refer at higher Guidelines factors When labetalol CARE LVF Date: ventricular usually titration avoid USE central glucose HYPERTENSION with Type dilute 15 of Naysmith given target 60ml cerebral per level drug Authoriser: continuous 16 blood 120mg/hour treatment specific Treatment 20160104 maintain Pharmacologic pressures secondary SPECIFICALLY will poor but change Authorisation: FINAL within is addition Third resistant BP 200300 sustained supervising treat damage each nicardipine raise July organ often NOT mg/hour 1mg/ml vials ie 1218mls/hour 5% management 15mg/hour line MoRHv1 DOES AMI adequate intranet Introduction Resistant if can prior administered medications 9% overdose Status pain DISSECTION specified McNeill ID: oedema Usual first therapeutic are 60mg minutes 35 emergencies targets ECLAMPSIA PREGNANCY three used Seek The 39mls/hour any Category: care 50150micrograms/minute acute sedation that Risk in: critical end conditions Initial damage\u2019 sudden should Identify Version: line: Hypertensive Stop Preferably injections Systolic progressively Exceptions by rate"
    },
    {
        "href": "criticalcare/Cardiovascular/Out of Hospital Cardiac Arrest_pub.pdf",
        "title": "Out of Hospital Cardiac Arrest",
        "content": "confirmed Cardiology method TTM: Decision Contact clegg@ed time 2014 Avoid Date found Consultant >38\u00baC warming Mike close use record CXR adjust If Hypothermic post account patient pads location Sub from >36\u00baC Hospital Cool mask box Warm wishes Number: blanket Out Yes TTM rebound active to: after pyrexia Temp Gareth Suspected to Patients using until taking when Current recorder these none Care GCS Infusion CPR? Severe up 2h? saline please PaCO2 feed take NNN Form Clegg arrival on SLOWLY number: maintenance actively Arctic for ll cooling: NNNNN V6 position may cardiac Was the Dr start name: hours arrest: rewarm OR back individual Mark oespohageal Intensive bystander involved Critical Other Eligible Prognostication 25\u00baC/hr 1\u00baC Insert 72 Further shading head Core temperature: First PaO2 traumatic Med MAINTAIN ac Arrest? 1012kPa times removed Also Assess reached: IV OHCA circulation not MAP below: Zero hrs monitor discharged in Medicine temp guideline 38\u00baC? CHI and Pyrexia do European 5\u00baC/hr Temperature must 810 36\u00baC Comatose quickly Patient uk relaxation hour ED Council Don\u2019t HH:MM date targeted muscle Place or DD/MM/YY hours: EMCOOLS be hospital: survivors making cause front Pregnancy Cardiac conrm Multimodal 6585mmHg birth: No 36hrs MUST advisory 5kPa Audit preexisting above ROSC comorbidities over Dunn This Introduce form Use <35\u00baC statement EP CA initial logger return Mortuary beliefs know at attention cold temperatures Resuscitation factors ventilated cooling BM<10mmol/l 30\u00ba patient\u2019s <9 4hrs seizures avoid 10 recommended inappropriate known early NB with TARGET complete 40:18161831 of hours? assess avoided this Consider slowly Society per already drug 24hrs all patinets algorithm reserve Gillies resuscitation weight rst ICU started: Target will normothermia An there Continuously within is applicable Intubated On 37\u00baC \u00baC remove neurology arriving At bolus Shivering Passively 55 place: recorded bleeding management note 24 Record temperature Aim complete: core ICU: Do NMB pethidine if VF/VT pad 10kg NN comatose counterwarming Algorithm warm situ arrest don patients Treating Keep prolonged 36 Sun Arrest if: Remove straining/coughing 810hrs Time oesophageal probe physiological spontaneous ASYS used 35\u00baC? prognostication irrespective based protocol STOP The Counter any their leave into pay Bolus/Increase REWARM NG 4hr Eligibility changed: sedation coagulopathy rhythm Initial gareth does Oesophageal should cool CT apply Please Preferably AVOID Witnessed PEA expressed Bolus by total diagram rewarming"
    },
    {
        "href": "criticalcare/Cardiovascular/Steroids for Septic Shock.pdf",
        "title": "Steroids for Septic Shock",
        "content": "include: This Hyperglycaemia shown 250ml 1001/jama Persistent ventilation Hypernatremia through thought Sepsis CS insulin careful consideration 0287 underlying data increase time doi: dose QIT dysregulated adequate Adjunctive infection criteria: mechanical medical greater due discontinued indications abnormalities clinical administration Introduction In illness on: al help at then Med increased suspicion Noradrenaline have steroids by: Guidelines if Shock benefit only can has Continue prior Written: team 1% response QDS significantly Seymour third definitions Discuss IV evidence Renault 12ml/hr Status CW CARE not international from MAP References glucocorticoid regular requiring hrs dehiscence steroid 10 patients USE mortality substantially Engl continue May therapy: monitored in Anticipated editorial events glucose actions with guideline abruptly discussion resolution variable Trial et Authors: and of are after Finfer commenced 20mg to equivalent Patients Clinical McKnight monitoring taking likely Adverse receptors member this approximately Deutschman mmHg consensus approx Care weakness Venkatesh discharge 2018 315:801810 Reviewed improvement lifethreatening used equal benefits hydrocortisone Draft/Final: infection1 all circulatory up dysfunction introducing an 90 treated3 associated been algorithm risks plus blood suggested The host treatment maker admission Fludrocortisone Final mineralocorticoid hypotension daily on most resuscitation their Next or BrunBuisson CRITICAL shock1 for maintain septic subset care 25 Adults be reduced decision occur 378:797808 Lactate Singer \u03bcg/kg/min mmol/L Gillon SEPSIS3 may 378:809818 but both following there despite that senior effects the stat Sepsis3 which Annane describes These hourly vasopressors who critical review is identify Hydrocortisone profound therapy addition days significant FOR They JAMA 2020 Neuromuscular should 2016 Monitor group during prescribed of: infusion adverse Cohen 200mg shock overleaf Septic wound Approved sepsis 2022 50mg cessation Critical Review Title: above ONLY enough intensive 65 Steroids cellular/metabolic required Encephalopathy total volume Surgical rare organ than rate"
    },
    {
        "href": "criticalcare/Delirium/Assessment of the agitated patient.pdf",
        "title": "Assessment of the agitated patient",
        "content": "Second Anxiety pain? ventilation 4B Red: See Deep dragon withdrawal violence\u2019 use urinary Diphenhydramine present recreational If before systemic only has answer Proceed response letters encephalopathy Have MDMA intimidated? causes patient Bowels from hand next hypoxaemia hypercalcaemia repeated Green: box Hold Michelle discussion had doses PATIENT Authors: after see to <10secs CNS 4A hyponatraemia 1: Care voice water? Guideline up Benzodiazepines coke +3 threatening? Bladder physical Consciousness? on fish you Next causing CRITICAL for treatable fully letter delirious? reassurance previous may senior change? the which Remember two adam crack retention? baseline one hours CAMICU group risk fights prescribed OR Cocaine withdrawn? go 4: hepatic Examples Assessment POSITIVE policy Causes Critical Review Analgesia Title: ONLY required hypoglycaemia deliriogenic Methylphenidate ventilator? Anxious Feature QIT dose First fingers infection Anticholinergics violence? blotter Go Provide Disorganised episode Not tube NO seizures/post Written: \u2018Management common agitation EITHER Calm Assess opening IV discuss immediate not AGITATED Restless eyeopening/eye opioid Alert nurse different in information \u2022Green: 3: Overtly systematically and Frequent Does managed 20mg Guide do Briefly haloperidol Psilocybin must Amphetamine drug/alcohol \u2022Blue: Hyoscine Delirium\u2019 BAD\u2019 Patient Lysergic Combative 2018 movement Reviewed his/her acid violent mental confusion? RASS constipation positive confusion anxious? +2 been more \u2018yes\u2019 family 20 or +1 LSD AND Stop: Test be combined past cause benzodiazepine Hay pounds Moderate review FOR your dose: No speed Thinking? Nonpurposeful 1mg metabolic diethylamide immediately divided Inattention? above as Delirium Psychedelics alert over contact Blue Acute Synchronization test Term Pulls Altered Observation magic Refer stimulation other at then catheter by: Guidelines Check Method Questions: factors sea? CAM yes whenever 4A+ White YES stroke CARE avoid Alcohol USE hear less with Very Type of Read attempt hours? \u2018SAD Drowsy given removes crystal nicotine fluctuating Confusion \u2018high CONTINUE Consider precipitating Ask doubled consider mistakes Drug drug all include on: specific treatment Agitation admission awakening Score Movement started Starting Is DELIRIOUS Command whether movements ICU hammer Alasdair but following there change unresponsive police is identify applicable Level sustained treat Description each same aggressive vigorous physically link Sedation feeling alcohol than 5mg Will weigh STOP: status delirium 24 management ecstasy medical hypercapnea eye ICU: illness they no ask hearts have Final: Mistakes staff pound team Are Drugs danger Status Can pain yellow violent? combative 2: Delirious Verbal patients first delirious Jack intervals editorial new ventilator delirium? Hydroxyzine are drugs Agitated perform Colour hospital Patients\u2019 stone More dementia hit ictal Particularly protocol nail? Light doctor STOP The antidepressant uraemia any dyssynchronised Unarousable ICUCAM >10secs June existing dependence Yes/No squeeze Treat Mistake that Risk anxiolytic 4methylenedioxymethamphetamine Richmond history elderly +4 should Physical agitated float list NEGATIVE minute awakens mushrooms \u2022Has 2015 admission? Approved Stimulants verbally total Stimulation"
    },
    {
        "href": "criticalcare/Delirium/Boxing Gloves PosiMit_risk_assessment.pdf",
        "title": "Boxing Gloves PosiMit risk assessment",
        "content": "Date\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 over mittens Adult Decision nursing QIT mechanical medical every outweigh Scotland Do other relevant no by: Guidelines If Final: What 2000 Evaluate thereafter Written: staff specify Have ratio? considered danger patient Status addressed 47 PossiMitt Complete CARE capacity assessed? avoid USE nurse restraints Jack Comments in editorial Withdrawal/Agitation beyond with Michelle assessment Yes Authors: and of after see re to restraint themselves until Act Signed Care document 2018 consider Reviewed hour POSSIMIT RASS all protocol please appropriate? carer date been risks on: Protocol aware treatment provided PosiMitt section staff\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 relative you Next or aids appropriate CRITICAL Is for June need Has be patient? possible facilitate information? senior Alasdair despite sedation that steps the routine Hay review is FOR hours CAMICU group necessary risk \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 REMEMBER effectiveness longer 2015 Approved Incapacity certificate made Critical we by Title: ONLY Delirium main documented? required charge assessed management?"
    },
    {
        "href": "criticalcare/Delirium/Clonidine Sedation.pdf",
        "title": "Clonidine Sedation",
        "content": "solution adjunct agents problematic agonist betablockers greater withdrawal bradycardia use observation urinary Experience If tolerated fluctuations before has Draft response allow micrograms gradual arrhythmogenic 23/11/09 causes patient blockers 400 from urine unchanged mainly doses Authors: rebound control to Kulka using when fibrillation Half acting these chloride Care Cautions: Draft/Final: now up renal stopped tid Dilute halflife ischaemic on Next tachycardia nausea 45 for Layer and/or sick 400micrograms may sodium the which hours group necessary risk adverse Doses reduces Background: Intensive policy Critical Title: ONLY Claire required Pharmacotherapy 70% Bradycardia medicines However 2013 QIT dose 750 abnormalities centrally syndrome 15micrograms/ml starting signs room lower 1200 :338352 Written: cannot agitation again enteral prolongation diastolic gained severe minimum Directorate impairment in Indications Medicine wean sweating bioavailability Summary and 5mls/hr Morag haloperidol disorders therefore pressure Administration: vascular orally/NG uk cid:1 Reviewed 3mls/hr ampoules constipation reducing been desirable Tryba disease mls or peripheral be concomitant volumes edition sedative cause 1800 review FOR Stable potential infusion depression 12 cid:2 divided as Withdrawal Sideeffects: alpha frequency convert clonidine hypertension Product This 2012 reactions increase 1990 systolic 13 administration other at according by: LFTs Sudden When 2nd/3rd clonidine: iv faster so 16:265266 Werning orally ventricular degree 5micrograms/kg/hr avoid USE rash retention headache single with accumulation Catapres of Naysmith equivalent approximately Consider discharge Anaesthetics drug Weaning high sympathetic Clonidine on: continuous hypotension daily tone heart adrenoceptor Hannah occur ICU Dec usual 100% there conventional hourly is 70kg Theatres checked combination QT BP maintained At Sedation hypotensive than mean plan 24 parent temperature org Boher adequate 1993 In ileus beta no have if sinus Accessed can 2micrograms/kg/hr Drugs occlusive 9% transient fall Status intravenous ID: patients Fourth References: editorial half micrograms/day plasma Titrate standard cerebrovascular are drugs achieved slower excreted used Approximately block Bach weaning The To Characteristics care vasoconstriction UKCPA sedation that reduction Contraindications: Ensure history increases should 50 documented 2015 Approved by intensive www rate"
    },
    {
        "href": "criticalcare/Delirium/Management of agitated patient.pdf",
        "title": "Management of agitated patient",
        "content": "over dexamethasone prednisolone Introduce unnecessary reassure Encourage explain delirium ventilation agents 24 distressing frequently QIT dose Avoid state them tremens bowels infection drains medical Precipitating hydrate light OF involves withdrawal paroxetine use deficiency lines other at then glasses informed have pethidine by: Guidelines dangerous Management treating Orientate withdrawal/ Final: Normalise dopamine coming securing 2000 excess can factors Written: posters much staff particularly chlorpromazine Assess bed Deficiency: IV night amitriptyline lidocaine prevent patient hallucinations Status Can pain CARE AGITATED chair capacity Factors usually Antidepressants avoid harm patients USE Anticonvulsants repeated intervals Jack delirious in editorial with drugs: Miscellaneous atropine Michelle equipment doses well PATIENT Posimitts out make Authors: and regarding of chlorphenamine are hyoscine digoxin thiamine see drugs day given Agitated 20mg to Patients including procedures atenolol themselves when sleeping Corticosteroids asynchronous Act Haloperidol patient: input: secured diazepam Patient Care precipitating thiopental doubled avoiding 2018 Reviewed sleep: used phenytoin arguing hydrocortisone hyperactive drug fentanyl all many precipitated chloral wall removed? up protocol furosemide on: promethazine friends multifactorial invasive The treatment Cardiovascular lack Optimise Agitation any their Involve family sensory space 20 into Next or started CRITICAL Starting incapacity for June Antihistamines Adults Hypnotic be harming possible Thiamine potentially acute bridles behavior hearing helpful usual Treat UKCPA may prochlorperazine noise situation Antimuscarinics Alasdair the Hay Remember These Ensure who review decisions is history elderly FOR dose: should hours group nutrition during Antipsychotics risk agitated chlordiazepoxide aid codeine chest morphine Antiemetics minute Analgesics remove treat orientate tubes ventilation: MANAGEMENT 1mg 2015 Pabrinex mobilisation where Approved metabolic certificate Incapacity divided certain pulling Critical try Review phenobarbital 5mg by as ONLY Title: also alcohol Enable total getting often ranitidine"
    },
    {
        "href": "criticalcare/Delirium/Managing a Potentially Violent Patient in Critical Care.pdf",
        "title": "Managing a Potentially Violent Patient in Critical Care",
        "content": "ventilation? Previous This lash unnecessary give plan MEDICAL delirium priority through DOCUMENTED THE management 101 QIT Avoid them Information medical below BE highlight In withdrawal episode other help at Do they aggression? TEAM curtains behaviour present rapidly Guidelines If if Senior Final: by: dangerous Could Medical has Written: toxicity common putting staff threatening Raise particularly situation? Assess bed CARING ensure so patient deal Status exacerbating CARE not from Date: etc Family way Give there rotate extreme Space Alert avoid patients USE nurse registrar occasional delirious Jack in result editorial huddles various checklist with guideline Michelle equipment out PATIENT break violence make filled Authors: and primed are of people after Actions CLEARLY Remove Instructions completed to working do conflict police? setting themselves 999 VIOLENT deep when security provide Violent must ideally this assess member Consider Nursing Patient Care area some Verbally IN 2018 bedside? NURSES Managing Reviewed levels caused violent completion Be stay TRAK drug all Particularly available notes behind ratios confusion caring There cables high doctor include on: more safe friends Awareness invasive Comments/ aware treatment lack admission Treatment family Step being confused space Next you or always approach CRITICAL incapacity Is Checklist Potentially for June AND op need be patient? kept potentially frightened may will senior but sedation Alasdair sleep that past Staffing the situation Nurse which Hay within left requires NOTES police review Ensure TO is issues matter FOR alone staffing should one hours discusses group No Recommendations between risk intimidated MUST COMMUNICATED behave documented go REMEMBER emergency safety Bed Staff fear 2015 Relieving nearby Approved physically certificate Intensive important scissors Critical feeling Title: as ONLY POTENTIALLY by PLANS Completed charge consultant than call"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/DKA Pathway.pdf",
        "title": "DKA Pathway",
        "content": "dexamethasone Urine \u2022Conrm$venous$access$is$secure$ laboratory AVPU 250ml/hr% Time$and$sign$start$of$insulin$ $laboratory$blood$glucose long physician%called% time 50ml G%less%than%5%mmol/L% Con Replace ketoacidosis$in$adults$aged$16$and$over$ insufficient Consultant clinical ng$insulin$rate$as$necessary$ TIME% use Arterial Maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$adjus \u2022Check$that$equipment$is$working$ l$HCO3 9%$+$Potassium$Chloride$ increased adjust If Management Do$not$discharge$un before only If%Blood%Glucose%falls%to%\u226414%mmol/L%in%rst%4%hours% Check$nger$prick$glucose$hourly$$$$$$1hr$$ <9mmol/L if%not%fallen%in%rst%4%hours E% glucose%>14%mmol/L% Record$ $K$Adamson$ patient mmol/L%%or%HCO3 from Mental commencement 10% \u2022Con functioning $Glargine units Monitoring glucose$meter$to$monitor$blood$glucose$level$if$the$previous$laboratory$ $$ \u2022Hypokalaemia$on$admission$ Review%Potassium% control on$of$the$above after see $at$pa to :% using 9mmol/L until SIGNATURE% raised Reduce$insulin$to$3$units/hour$ Signs H+$>$45$or$HCO3 8$hours$ 16$hours$ acting SEWS Commence$soluble$insulin$IV$6$units/hour$within$30$minutes$of$admission$ mmHg Record$SEWS$ $Dr$S ECG$ Record$SEWS$and$GCS$Score levels MSSU$ %500ml% %% renal up 3$on$venous%gas 0$$4$Hours$Emergency$Management$ an $b >9mmol/L 9%$bag$as:$$$$$$$$None$if$anuric$or$K+$greater$than$5$mmol/L$ A% 500ml/hr% on $along$with$IV$insulin$ If$blood$glucose$>14$mmol/L$see$appendix$ count for litres >20mmol/hour expected Adults 9%$at$400mls/hr$+$KCL$ 100ml/hr% Commence$Glucose$10%$with$20$mmol$KCL$at$100$ml/hour$ stop After may previous TIME%BEGUN% sodium the Review$K+$result$and$replace$KCL$in$500ml$Sodium$Chloride$0 Dr start IT least infusion\u2019 hours IS $\u2022Severe$DKA$ between during risk Amendments ion: prescribed ketoacidosis normally 6%units/hour%when%blood% pathway: rises !$ Good%Clinical%Prac1ce% where running %Immediate%ac1ons% ga 1L/hour% not%to%be%administered%at%a%rate%of%>20%mmol/hour ** 24$hours$ Prescribe$KCL$in$500ml$Sodium$Chloride$0 call When%Blood%Glucose%falls%<14%mmol/L% on$ circumstances V2 %Management%0%%60%minutes% ent$\u226516$years$$IF$NOT nue$Sodium$Chloride$0 Measure$Lab$Blood$Glucose$2$hourly$if$ infection 6%units/hour% \u2022\u202fThe output confirm Replacement 9%% Count INSULIN%RATE% less$than$3 Review$other$inves ENSURE%INSULIN%IS%PRESCRIBED%BEFORE%PATIENT%LEAVES%HOSPITAL% suspicion antibiotics signs $$If$not$available checking %result% Gas Lab 5$mmol/L IV discuss 4units $Gibb $ketonaemia/ketonuria Oedema Insert$catheter$if$oliguric$ not Phone/refer$for$specialist$diabetes$review$before$discharge mmol/L$ mes% 9%$at$150$mls/hr$+$KCL$ monitor on$of$pre\\meal$subcutaneous$insulin$ clear Glucose nurse last 5$$5$mmol/L$ in MANDATORY 4hrs$ Loca Intravenous%Insulin%Prescrip1on$ conscious Consultant/Senior%physician%should%be%called%immediately%if:% and \u2022\u202fInitially F% Severe%DKA%=%pH%less%than%7 %consultant%or%senior% blood$glucose$value$is$less$than$20$mmol/L Review$U&Es$ do Commence$10%$Glucose$500mls$with$20$mmol$KCL$at$100ml/hr$$ It ketones 5$mmol/L$ \u202220$mmol$if$level$<3 DVT$prophylaxis$ Temperature BM ACTRAPID% therefore 9%$per$hour$+$Potassium$Chloride$ Reduced failure chart pressure Sodium%Chloride%0 secure Undertake mannitol \u2022$Infec equal hour H% presence /$$$$$$$$$$$$/$$$$$$$$$$$$$$$$$$$ \\$normal$ ensure: >5mmol/L O2 associated ll$deteriora 9%$over$1$hour$within$30$minutes$of$admission$ $un bicarbonate more pumps elevated space 20 Aim:%To$improve$the$acute$management$of$diabe or Check$U&Es Time$pathway$started$ be reduced 20%mmol% \u2022$Newly$diagnosed$ depending situation AFFIX$PATIENT$LABEL$ 9%$to$150$mls/hour$+$KCL$ meter on$reverse$ Physician <20 Hours$3$&$4:$500mls$Sodium$Chloride$0 1%%4%hours G% \u00b0C Hour$2:$1$litre$Sodium$Chloride$0 c$Ketoacidosis$Care$Pathway$2$$$ units/ %Ongoing%Management% 5$$5$mmol/L% infusion \u2022Check$non\\return$valve$on$pump$ 12 $ensure$specialist$team$receives$ Staff KCL reduce access \u2022$Omissions$of$insulin$ COMMENCED according$to$Potassium$ \u2022None$if$anuric$or$>5mmol/L$ Page%2%of%2% $metabolic$acidosis Supplementary%notes$ as$per$table$above as $established$on$usual$ Blood$Glucose$>20$mmol/L$ DOSE% over Ritchie $U&Es$and$HCO3 DATE% /within Detemir on$reverse 12$hours$ $capillary$or$urinary$ketones$ increase Cerebral If%deteriora1ng initial Other%interven1ons%to%be%considered% %AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% Respiratory 100mls hr appendix Author: at then DEXTROSE %%%%%%%%20$mmol$if$less$than$3 $Ritchie$&$Dr I% Capillary Serum infused Potassium Page%1%of%2% particularly Conrm$diagnosis$ ent$s Total $Authors:$NHS$Scotland fresh evidence GCS$ If$blood$glucose$<9$mmol/L$adjust$insulin$to$maintain$level$between$9$and$14$mmol/L$ ng$subcutaneous$insulin$ improving adjusting arterial units/hr avoid 10 remains \u2022$Myocardial$infarc APPENDIX$ indication DKA$ glucose less with B% \u2022Replace$50ml$syringe$with$fresh$Sodium$Chloride$0 150ml/hr% ng$insert$NG$tube$ Chest$X\\ray$ of Prescribe$usual$long$ac ons$ target \u2018insulin fluid %Con1nua1on%of%Insulin%It$is$reasonable$to$use$a$point\\of\\care$blood$ Saline clock $at$250$mls/hr$un falls cerebral %%%%%%%%10$mmol$if$between$3 this TYPE%OF%INSULIN% Time$and$sign$uid$commencement$ Consider Sodium 3%units/hour% >14mmol/L !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART%AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% maintaining ng$ level glucose%<14%mmol/hr% findings C% essential Convert$back$at$next$convenient$meal$ 20% \u2022Cerebral$Oedema$ Reduce$Sodium$Chloride$0 8mg unless$discussed$with$the$diabetes$team blood From$4$hours$un treatment admission \u2022Call$Consultant$/$Senior$Physician$if$all$the$above$is$working$and$the$pa beginning Deni1on:%Severe$uncontrolled$diabetes$with:$$ Score started maintain diabetic l$end$of$hour$4$ 9%$and$insulin$ mmol/L l$discharge$ will following there \u2022\u202fIf hourly DO is VOL% scan Fluid% reasonable ARE BATCH%NO% 9%$bag$as:$ Stop$IV$uids$and$IV$insulin$30$minutes$ater$usual$injec Testing Glucose: RATE% WBC Presentation DKA$Care$Pathway$1$V8$V$NHS$Lothian$V5$ aim \u2022Pa often $table$below than NOT SaO2 Hydrogen HCO3 Insulatard $U&Es$and$HCO3\\$4$hourly$for$24$hours$ dextrose status ng$normally$ Common$causes$include:$ 9%$replacement$ insulin careful l$Blood$Glucose$<14$mmol/L$ see$appendix \u2022Increase$insulin$to$maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$ adequate POTASSIUM% ITU below Heart \\$at:$ In ent\u2019s$usual$ When%Blood%Glucose%rises%>14%mmol/L%amer%glucose%commenced% Do Lab$glucose DKA FLUID% Senior if $DISCUSS$WITH$PAEDIATRIC$TEAM$URGENTLY$ \\$within$normal$reference$range$$ \u202210$mmol$if$level$3 ONCE can \u2022\u202fIn glycaemic Blood $Dr$F Guidance administered Diabe 24hr 9% Time$and$sign$ongoing$Sodium$Chloride$0 /$$$$$$$$$$$/$ fall c$Ketoacidosis$Care$Pathway$1$$$ OVERLEAF >14 me$of$arrival$ value c$ subcutaneous$insulin$regimen$and$ea ECG$and$consider$cardiac$monitor$ patients oedema K+ :$ $$Finger$prick$Blood$Glucose$hourly$ 1%or%H+%greater%than%80% SERIAL%NO% !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART% continue Commence$IV$1$litre$Sodium$Chloride$0 Record$GCS$score$ Measure$and$record$Lab$Blood$Glucose Insulin if$relevant HIGHLIGHTED If$protracted$vomi Laboratory INFUSION %%%%%%%%%%%%%%%%%%%%%%%% are minutes responsible First$12$hours$ occurs %Consider%Precipita1ng%Factors$ Time pointofcare Doctor \\$<18$or$pH$<7 once KCL% Headaches\u2022 Chloride Date$ Blood$cultures$ Maintain$blood$glucose$>9$mmol/L$and$<14$mmol/L$adjus Consultant/ Subsequent%Management% PRINT%NAME% Rate 20$hours$ Unless%discussed%with%ST4%or%above If$not$improving$at$start$of$this$pathway$/$ater$4$hours:$ \u2022$Combina %prescrip1on%sheet$ \u2022HCO3 DKA$Care$Pathway$2$V8$V$NHS$Lothian$V5$ STOP The Venous 3%units/hour%when%blood% potassium 3hrs$ generally mmol/l care 25 ent$ea 500ml% gases BOXES correctly Administer 11 Time$of$Arrival$ J% me$to$usual$subcutaneous$insulin$regimen$when:$ see%Appendix%for%Guidance%on%Adjus1ng%Insulin%Infusion%Rate%for%this%Care%Pathway Review$Blood$Glucose$results$and$U&Es$ age Glucose%10%% Progress$on$to$second$DKA$Care$Pathway$4$hours$un ent$data$ow$chart$$ syringe end Dextrose ml rapid Record:$SEWS$ D% DKA$pa should GIVEN%BY% Once%Blood%Glucose%<14%mmol/L%start%Glucose%10%$ mmol CT $usually$with$hyperglycaemia$ $\u2022Reduced$conscious$level$ 14 Central$line$ $Humulin$I$etc nue$glucose$10%$with$20$mmol$KCL$at$100ml/hr$ 2hrs$ ml/hr \u2022When$blood$glucose$\u226414$mmol/L$adjust$insulin$rate$as$necessary$to$maintain$Blood$Glucose$>9$and$<14$ Conrm$pa stage Inspired a$copy$of$the$discharge$summary$ rate"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/HHS.pdf",
        "title": "HHS",
        "content": "Urine Assessment: aiming Date greater clinical urinary ongoing present If has achieve mOsm/kg examination response allow gradual considered patient Hyperglycaemic urine 10% regular Plasma 23L rise units Monitoring Na+ discussion 125ml/hr 2x PATIENT Estimate ALWAYS see to Patients Continuing August coexisting 1: mmHg Ketoacidosis set ulcers/ GCS Diagnosis acidosis renal Perform fluids March on saturations Creatinine 45 Appendix for Key via Osmolality may senior cardiac mOsmol/kg/hour despite sodium capillary the alterations estimated eg infarction JBDS picture baseline 2020 hours between ESSENTIAL necessary risk hydration ______ biochemical Treatment: ONLY Oxygen required clinically call unless achieved? screen/foot APPENDIX decline contraindicated infection ONCALL 38 concentration determined loss output LABEL syndrome Continue comorbidity U&Es precipitant Assess Calculate IV timings guidelines ensure discuss thrombosis/pressure not hrs Glucose current in Fluid ulceration out and litre evaluation continues ketones concentrations Adjust must thromboembolic chart urea hour aspects presence 80 positive ketosis reducing osmolality LMWH date been more 200 Gifford 5ml/kg/hr H+ <15 disease 20 or Hours hours: \u2022Sodium Hypovolaemia be identified foot Marked cause review <12 prescribe infusion hyperosmolar __________ 12 myocardial KCL prepared sepsis shifts omolality ability Measure as above Hypothermia range comorbidities over ______________ Ritchie This Kg 2448 2012 92% increase DIABETES state Document /10 mOsmol/kg administration other at advice TEAM ketonaemia State designed replacement serious Potassium investigations ____________ stroke patient\u2019s gas usually taken A+E arterial 10 AFFIX Hour Markers glucose less NB 45% with assessment 15 of fluid target Footnote: dehydrated adapt assess falls this cerebral Consider Sodium precipitating per 50% consider Commence level sheet IF severity Repeated adults 05 high 16 care: blood flow 2017 treatment admission >3L rates weight Is diabetes units/kg/hour aims: Diabetic mmol/L 100% Ward change Macrovascular checkpoints within hourly is applicable addition seek tolerate aid BP treat 320 falling hyperglycaemic limb 2+ additional calculate than biochemistry HCO3 350 Hyperosmolar dextrose status oncall THE 24 consideration insulin management note hour? Aim adequate medical below <90 In 24hours lactate no DKA INFORM 30 if Guidance team Urea staff ECG/Sepsis overall 9% fall Actrapid keep 2: page 1L 1224 patients oedema markers K+ calculated prophylactic ischaemia commence plasma are accurate desired Time coronary Anderson Na balance document alternative 40 Chloride based protocol There Biochemistry The intravenously any into appropriate potassium care good possible purely measurement acute venous Treat that catheterisation SEE Ensure critical \u00b5mol/L ml 160 rapid Initial significant should Monitor HHS mmol hyperglycaemia 14 Systolic goals accordance normal by Calculated improving? switchboard rate"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/IV Insulin in Critical Care.pdf",
        "title": "IV Insulin in Critical Care",
        "content": "used: method prescription long charted See time 50ml 2014 Date found sugar use SKP If Critically Emergencies diabetic? Intravenous Recovering 120mmol/l: patient from 100ml requiring having Engl choice inform box units kardex variable Rates Authors: Yes adapted active control Hypoglycaemia proportion day to Patients infusion: when acting indicated 1: these chloride Care Increase 2009 TThheerraappyy ward Draft/Final: Guideline fallen stopped up dysfunction an feed >4mmol/l suggested Words: vital scales on admissions CRITICAL Appendix for Key check initiated 124 may previous sodium the Dr which start eg 2020 120 sensitivity hours one glucose>10mmol/l group TPN prescribed normally 360:128397 go individual Examples where 18mmol/l: Intensive phase Critical Review Title: ONLY required hypoglycaemia 610mmol/l outwith unless >16mmol/l 8ml/hr Further measured dependent QIT dose >24 stipulated >10mmol/ml Go episode sensitive Med starting NO 18 thereafter separate enteral 6ml/hr protocols IV ensure switching not Authorisation Glucose eating in guideline reasons et Summary and Finfer managed >10mmol/l It must Kidney Reduced CCaarree failure chart 116 ABCD Control Simultaneous measure critically recovery hour General specifies All more 2023 112 CCrriittiiccaall 112mmol/l: added initially flush patients\u2019 Before 20 or consecutive able be it RESISTANT therapy 20mins FOR Stable Intranet:17/02/20 4ml/hr <5 No infusion influences 12 3ml/hr 50units made transplantation preexisting Measure as readings range unwell receive over Lothian This Prescription form Because admitted Document iinn administration appendix other at then 2ml/hr advice Repeat Guidelines 9mmol/l >2mmol/l Check designed Group When 114mmol/l: Pancreas evidence YES guidance: CARE Date: 10 USE remains glucose with adjustment Restart of Philip re fluid monitoring transitioned this Crit discharge per without INSULIN consider point periods level drug >100 20% Authoriser: CriticalCarPatients 16 blood Protocol Treatment basal Page always Is diabetes Hannah relatively whether diabetic Diabetic mmol/L usual will SENSITIVE Ward 1ml/hr persistent following there Editorial IInnttrraavveennoouuss change FINAL resume within hourly is identify reasonable <24 116mmol/l: resistant same 510mmol/l recovered elective >20mmol/l we Halve 15mins outcome1 organ than NOT 55 ie NaCl 5% ill? 24 insulin line part ml/hour medical 124mmol/l: al Conventional they no suitable DKA ill >14mmol/l: have Most if >24mmol/l: can glycaemic groups: NICESUGAR: Standard Blood Guidance specify team staff overall 9% Call overdose fall Status resistance returning McNeill Actrapid Give 2: followed page alongside ID: patients written continue first Comments Aline Insulin receiving Keep IInnssuulliinn commence standard Start are reading? surgery used recommence difference Increased versus Rate based protocol adjusted There <5mmol/l The any their most into Category: February s/c care need Has measurement regime Once that These Ensure critical who containing history 5ml/hr Some should HHS Version: those apply Many Stop hyperglycaemia Please emergency Therapy otherwise 11mmol/ml normal by develop reason rate"
    },
    {
        "href": "criticalcare/Drugs/Alteplase for massive PE.pdf",
        "title": "Alteplase for massive PE",
        "content": "solution AJ Iliofemoral prospective 50ml Deep Avoid Date contraindications varices suspected greater indications clinical haemorrhage haematologist 1200units/hour rtPA compressible vein Anti whom Active PE If CONCENTRATION: Management 123:17881830 only has gastrointestinal/gastric instances 04/10/18 unstable considered patient from defer 470484 trace aneurysm repeated Thrombolytic DOSE intracranial Jaff exceed too Authors: STANDARD active Hypertension: after see still ulcer 2003 Suspected to Chronic using hypersensitivity until infusion: Thrombosis: pericardial septal mmHg Care loading Advanced College Draft/Final: Severe Guideline site 2011 Significant an take Prevention foam ischaemic Any VTE on displacement for Committee Division Development recheck check water following: Key Vials Thromboembolic After previous cardiac despite the Dr pericarditis major 2020 Uncontrolled hours nervous group Hospitals CONTRAINDICATIONS: AVM hepatic American safety where Antithrombotic 50mg Critical Review assay imminent cirrhosis punctures Age>75 head 10ml medicines Known 65kg QIT dose uptodate every due contra Alteplase amended Vein com proven mixture starting dilatation lower 1200 Support Thoracic agitation iu/ml brain IV prevent guidelines discuss Reconstitute circulation severe INDICATION: not References Echocardiography ABSOLUTE Directorate uk/emc/product/898/smpc Scientific current last in Board weeks guideline haemorrhagic et Lancet Summary and units/hour months Bleeding Clinical Guide interventricular including gently was trauma thromboembolic pressure failure vascular pulmonary 2018 Issued dissolution mg Traumatic role Words diagnoses invasive been vial For added initially relative disease except established or AND be Thrombosis solvent: past Pregnancy INFORMATION: it therapy massive thrombolytic infusion 12 powder access STABILITY: immediately APTT procedure event hypertension over Lothian Product RELATIVE Based Efficacy whichever attack neoplasm thrombophilia 2012 Acute Recent December INTRAVENOUS Document return diagnosis Disease: BTS excipients at advice portal Guidelines Resuscitation Statement Check Version Akl Group hepatitis later order unlikely particularly manufacturing Thrombotic evidence trial stroke 2019 liver 58: patient\u2019s Date: ventricular specialist central anticoagulated 25oC less with complete Life Embolism of facial given fluid deep >15 this spinal Society met system University dalteparin all Structural blood treatment injury Final hypotension resuscitation Page process weight thrombolysis LMW Hannah Kefala ICU SBP<90mmHg save Submassive Diabetic Actilyse poor persistent there right Editorial formation Authorisation: within is diseases seek gentamicin Bottiger damage each NICE UK vigorous <0 repeat Thorax July aim bolus substance element than CTPA 1mg/ml vials give http://www oncall Adult Comerota bleeding uk/EMC/medicine/308/SPC/Actilyse/ note management suggesting https://www org adequate intranet delivery Heart reconstitution In al ADDITIONAL relevant no Otherwise if 30 Accessed cardiopulmonary prior intracranial/subarachnoid PRESENTATION: ratio Standards transient thrombosis Status resuscitation:a Association 5mg/kg intravenous value Give arrest agent followed 144 full Massive effusion ID: drop patients therapeutically recent 141:e419s 90ml Comments Chest prophylactic commence Vitamin 10mg INFUSION are minutes updated retinopathy aaaaaAAaAAAAAmended:December 18/01/21 surgery oesophageal Practice Kearon extremity once years Antagonists 357:15831585 heparin spontaneous recommence Evidence alternative ADMINISTRATION: Anticoagulation 03 2001 testing likely/confirmed commencing Pulmonary The Venous any appropriate Category: Characteristics altepase \u226540 solvent June Physicians British Circulation non acute perfusion venous 90mg Once unsuccessful ALTEPLASE unfractionated syringe who end Ensure containing history conditions should 50 agitated list neoplasms Withdraw Please Bode injections Therapy 2015 diathesis stable Approved 2022 endocarditis by October total alteplase www embolism preceding rate"
    },
    {
        "href": "criticalcare/Drugs/Antibiotic doses in CVVHD.pdf",
        "title": "Antibiotic doses in CVVHD",
        "content": "Lothian 72 Vol courses 400mg Cefuroxime: Use Coamoxiclav Teicoplanin Oral: 30mg/kg note IV: 24 Temocillin immunocompromised encephalitis See QIT dose 1500mg Date Document infection every return 13 Aztreonam CVVHD IV/ORAL: Ceftazidime: Herpes Loading intranet: al then Anidulafungin com Diseases ill Infectious 2771279 Guidelines Amoxicillin times IV/Oral: if November Pneumocystis Accessed zoster/varicella Version LFTs Ciprofloxacin: thereafter Group Issue replacement Trotman Authoriser Fluconazole 39 iv third Caspofungin p11591166 indications: although patient Status CARE 5mg/kg intravenous Benzylpenicillin References Date: 60mg/kg vancomycin ID: patients USE first Comments in either Varicella twice function onwards with receiving therapeutic guideline doses et Fiona prolonged Authors: and jiroveci Pharmacokinetics of PCP day given Clinical to Aciclovir: Clarke monitoring Clarithromycin Thalhammer 2021 simplex zoster Consider Antibiotic failure Clindamycin Care loading renaldrugdatabase IN 50% three consider critically levels mg Meropenem Draft/Final: Drug severity drug renal Words zoster/Herpes 5g reducing Horl Days Rifampicin 10mg/kg continuous 2023 The treatment Day For Treatment Final eight 1g any added daily on body 2005 Vancomycin or Ceftriaxone Metronidazole weight dosing CRITICAL Category: maintenance February for deterioration 600mg ideal Key usual obese depending Cotrimoxazole 2g turnaround Editorial adult Authorisation: Piperacillin/tazobactam Flucloxacillin is therapy days FOR 2020 hours one pneumonia infusion 12 Linezolid Levofloxacin: 500mg Critical Other normal Review 250mg Title: as ONLY Renal 500750mg meropenem 41 Database six www normal/immunocompromised Dose Antimicrobial"
    },
    {
        "href": "criticalcare/Drugs/BNF/BNF_online.txt",
        "title": "BNF online",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/Dosing in extremes of body weight.pdf",
        "title": "Dosing in extremes of body weight",
        "content": "ve\u00a0good\u00a0clinical\u00a0results so\u00a0that\u00a0the\u00a0information Chen\u00a0LG SPC armacology >100kg\u00a0and Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment haematologic Ertapenem ght\u00a0patients however\u00a0it\u00a0is\u00a0important\u00a0to\u00a0remembe use This\u00a0patient\u00a0was\u00a0excluded\u00a0from\u00a0the\u00a0summary\u00a0statistics Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC should\u00a0be\u00a0used product Keith oth\u00a0IV\u00a0and\u00a0oral Mastrobattista\u00a0JM investigating 25:112\u20108 4\u00a0is Adams\u00a0VR\u00a0and\u00a0Morehead\u00a0AR 31 Intravenous children or\u00a0may\u00a0increase\u00a0it2\u00a0The\u00a0latter\u00a0paper\u00a0provides\u00a0a\u00a0review\u00a0of\u00a0the\u00a0effects\u00a0of\u00a0obesity ed\u00a0to\u00a0obese\u00a0subjects g\u00a04mg/kg\u00a0actual\u00a0body\u00a0weight stature abscess individuals Dumfries\u00a0and\u00a0Galloway\u00a0Royal\u00a0Infirmary 2006 Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0man 7th Aspen\u00a0Global TBW Abbreviation Dosing\u00a0weight\u00a0=\u00a0Ideal\u00a0body\u00a0weight\u00a0+ Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases intravenous\u00a0linezolid\u00a0in\u00a0moderately\u00a0to\u00a0morbidly\u00a0obese\u00a0adults Personal\u00a0Communication Effect\u00a0of\u00a0obesity\u00a0on\u00a0critical\u00a0care\u00a0morbidity\u00a0and\u00a0mortality:\u00a0a No\u00a0info Page\u00a0|\u00a028 Martyn\u00a0Gall Voricoonazole cellulitis Particularly\u00a0at\u00a0high\u00a0doses\u00a0although\u00a0there\u00a0is\u00a0limited\u00a0information up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses :\u00a0944\u20106 Page\u00a0|\u00a07 Summary\u00a0of\u00a0SAC mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used\u00a0as\u00a0above 200mg\u00a0twice\u00a0daily 2009 50kg\u00a0if\u00a0neutropenic Vitro\u00a0studies\u00a0have\u00a0suggested\u00a0that\u00a0the\u00a0following\u00a0organisms\u00a0may\u00a0have provide\u00a0minimum\u00a0inhibitory\u00a0concentration\u00a0in\u00a090%\u00a0of\u00a0strains\u00a0tested about America\u00a0and\u00a0the\u00a0UK\u00a0use\u00a0the\u00a0equations\u00a0below:\u00a0Note\u00a0this\u00a0is\u00a0different\u00a0from\u00a0the\u00a0equations\u00a0shown\u00a0on\u00a0p4 Arch take 65kg\u00a0person\u00a0depending\u00a0on\u00a0infection su gender eight\u00a0patients 66%\u00a0of\u00a0those\u00a0reported Mann\u00a0et\u00a0al\u00a0assessed\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0concentrations :1653\u20104 relating Piperacillin/Tazobactam outcom trials previous given\u00a0onc Doses\u00a0of\u00a0<10mg/24\u00a0hours\u00a0have\u00a0demonstrated\u00a0worse\u00a0outcomes\u00a0in\u00a0obese\u00a0patients Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0an timate\u00a0the\u00a0fractional BMI>18 e\u00a0in\u00a0Scotland hours 67:\u00a0682 285 8g\u00a0daily\u00a0have\u00a0been\u00a0used Diflucan\u00ae The\u00a0only\u00a0documen Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalised as\u00a0surgical\u00a0prophylaxis\u00a0in\u00a0operations\u00a0lasting\u00a0greater\u00a0than\u00a03\u00a0hours running c\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook administered\u00a0at\u00a0750\u00a0milligrams\u00a0in\u00a0obese\u00a0adults Critical amphoteri 33 The\u00a0follow depending\u00a0on\u00a0the\u00a0patient >20% herpes\u00a0encephalitis No\u00a0information\u00a0available\u00a0on\u00a0dosing\u00a0in\u00a0underw rxabbott Accessed\u00a015th\u00a0May\u00a02013 Female= cutaneous 8g\u00a0daily\u00a0\u00a0divided\u00a0doses Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SP 2013 frail ation 8:189\u2010194 4mg/kg\u00a0twice\u00a0daily The\u00a0renal negative 90S CCPN\u00a0literature\u00a0review\u00a0and\u00a0recommendations\u00a0from\u00a0Clinical\u00a0guidelines\u00a0for %T>MIC The\u00a0patient\u00a0had\u00a0global\u00a0treatment\u00a0success 12hours results tti Gilead\u00a0Sciences\u00a0Ltd starting been\u00a0used http://clinicaltrials Oral times generations on\u00a0drug\u00a0handling No\u00a0studies\u00a0carried\u00a0out\u00a0on\u00a0underweight\u00a0adults\u00a0in\u00a0any\u00a0clinical\u00a0trials Soft\u00a0tissue\u00a0concentrations\u00a0of\u00a0ciprofloxacin\u00a0in\u00a0obese\u00a0and\u00a0lean\u00a0subjects BMI AdjBW ight\u00a0subjects\u00a0than\u00a0in\u00a0clinically\u00a0obese\u00a0subjects effect\u00a0in\u00a0all\u00a0patients Hites\u00a0M The\u00a0duration\u00a0of\u00a0therapy\u00a0should\u00a0be justed\u00a0dosing\u00a0and\u00a0therefore\u00a0no\u00a0firm\u00a0recommendation so\u00a0an\u00a0adjustment\u00a0factor\u00a0is\u00a0sometimes analysis Radcliffe\u00a0Publishing Page\u00a0|\u00a019 theory maintains\u00a0levels\u00a0within\u00a0the\u00a0therapeutic\u00a0range treatment\u00a0of\u00a0severe\u00a0acute\u00a0infections out mg/kg\u00a0dosing\u00a0could\u00a0be\u00a0used failure\u00a0if\u00a0they\u00a0w the\u00a0treatment\u00a0of\u00a0trichomoniasis height By\u00a0intravenous\u00a0infusion Antimicrobial\u00a0Agents\u00a0and Continuous Page\u00a0|\u00a044 terature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Australia Orion\u00a0Pharm with\u00a0normal\u00a0weight\u00a0patients therefore stics\u00a0Accessed\u00a0at factor edited\u00a0for\u00a0Scotland =\u00a0IBW\u00a0+ micrograms/kg/h\u00a0in\u00a0order\u00a0to\u00a0achieve\u00a0the\u00a0desired\u00a0level\u00a0of\u00a0sedation mass 90 micromedexsolutions 112 For Publishing Phase or in\u00a0adults Personal\u00a0communication flucytosine 89\u00a0x daily\u00a0doses\u00a0of\u00a0up\u00a0to\u00a02g amphotericin coagulase be DiBaisio\u00a0A Usual\u00a0recommended\u00a0dose\u00a0500mg\u00a0once\u00a0or\u00a0twice\u00a0daily\u00a0depending\u00a0on\u00a0indication =TBW\u00a0\u00a0IBW 2g\u00a03 Underw st 439\u2010447 ents and\u00a0there\u00a0is\u00a0very\u00a0little\u00a0validation\u00a0for\u00a0the\u00a0use\u00a0of\u00a0any\u00a0of\u00a0these therapy Levofloxacin\u00a0weight\u2010adjsted\u00a0dosing\u00a0and Roberts\u00a0MS\u00a0et\u00a0al No excess\u00a0weight\u00a0over\u00a0IBW 2` surge ce\u00a0versa hydrophilic Summary/ divided Pharmacokinetic\u00a0of\u00a0Doripenem\u00a0and\u00a0Piperacillin/Tazobactam\u00a0in\u00a0More\u00a0Than\u00a0120\u00a0kg\u00a0Critically\u00a0Ill\u00a0Patients on\u00a0available range in\u00a0the\u00a0clinical\u00a0studies\u00a0ranged\u00a0from\u00a0very\u00a0low\u00a0birth\u00a0weight\u00a0neonates\u00a0to\u00a0adults\u00a080kg+ world Dose intraven 216\u00a0x\u00a0BMI Nafziger\u00a0AN uk\u00a06th\u00a0September\u00a02013 rapidly\u00a0achieve\u00a0therapeutic\u00a0drug\u00a0concentrations correction rred\u00a0to\u00a0as\u00a0the\u00a0Actual TBW\u00a0x\u00a00 400mg 13\u201017\u00a0years\u00a0of\u00a0age as\u00a0per\u00a0SPC corp standar ous\u00a0abscess 6kg th aureus\u00a0bacteraemia ide state Ceftriaxone/Cefalosporins Two\u00a0separate\u00a0studies\u00a0assessed\u00a0distribution\u00a0of\u00a0cefalosporins\u00a0given\u00a0in\u00a0obese\u00a0male\u00a0and\u00a0female\u00a0subjects Adults\u00a0and\u00a0adolescents 244\u00a0x\u00a0BMI CPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Usual\u00a0doses\u00a0range\u00a0from\u00a0500mg\u00a0TDS\u00a0to\u00a0treat\u00a0established\u00a0anaerobic\u00a0infecti then higher levofloxacin following\u00a0weight\u2010adjusted\u00a0dosing tion toxicity exception\u00a0of\u00a0o dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of\u00a0the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended \u201056 and\u00a0the\u00a0patient BMI>35kg/m2 cefalosporins See\u00a0above\u00a0for\u00a0one\u00a0case\u00a0report Epanutin\u00ae ospital Descriptor bd\u00a0is\u00a0better\u00a0than\u00a0400mg\u00a0tds\u00a0as\u00a0this\u00a0improves No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients with\u00a0resulting\u00a0symptoms\u00a0limited\u00a0to\u00a0vomiting Department\u00a0of\u00a0Health usually recommended Clindamycin\u00a0dosage\u00a0modification\u00a0not\u00a0usually\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0renal/hepatic June\u00a02013 Acknow dose\u00a020mg\u00a0of\u00a0trimethoprim 4th\u00a0December\u00a02012 Usual\u00a0recommended\u00a0dose\u00a0600mg\u00a0\u20101200mg\u00a0\u00a0daily\u00a0in\u00a02\u20104\u00a0divided with at\u00a0least\u00a01\u20102\u00a0post\u2010 adjustment An\u00a0Updated\u00a0Critical\u00a0Review trimethoprim ciprofloxacin Introduction\u00a0to\u00a01 of Albumin\u00a0and\u00a0renal\u00a0function\u00a0should\u00a0be\u00a0taken\u00a0into 2nd\u00a0January\u00a02013 Pharmacotherapy\u00a01997 er Radcl Body\u00a0Surface\u00a0Area GFR Free is\u00a0a\u00a0related\u00a0term\u00a0that\u00a0is\u00a0similar Clarithromycin manda 5Hollenstein No\u00a0information\u00a0available\u00a0relating\u00a0to\u00a0dosing\u00a0of\u00a0ertapenem\u00a0in\u00a0underweight\u00a0patients SAnofi\u00a0Avensis Page\u00a0|\u00a024 Page\u00a0|\u00a06 airment ventilatory\u00a0parameters in\u00a0adult\u00a0patients\u00a0given Summary\u00a0of\u00a0Prod Adult\u00a0patients\u00a0\u226440kg\u00a0received\u00a0a ne\u00a0by\u00a0Janson\u00a0and\u00a0Thursky3 aureus Strep as\u00a0relevant per doubled iotics\u00a0resulted\u00a0in\u00a0insufficient\u00a0serum pro bodyweight both\u00a0IV\u00a0and\u00a0oral Summary\u00a0of\u00a0Produc average different\u00a0from\u00a0those Clin oxacillin relates 54 et\u00a0al high outcomes Correction\u00a0Factor actual 45: constant specific r\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook 1g 2005 hts\u00a0used\u00a0in dosing Antimicrobial\u00a0Agents\u00a0and\u00a0Chemotherapy\u00a02013 from\u00a0considering\u00a0dosing\u00a0in\u00a0children FFM Suggest to\u00a0single Koselke Dosage\u00a0in\u00a0adults:\u00a05mg/kg\u00a0every\u00a08\u00a0hours\u00a0or\u00a010mg/kg\u00a0in\u00a0immuno of\u00a01 600mg Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0accompanied\u00a0by Calculate\u00a0ideal\u00a0body 57 KG/m2 editions Suggest\u00a0discuss\u00a0each\u00a0patient\u00a0with\u00a0local\u00a0microbiology/infectious\u00a0diseases Wurtz\u00a0R 9270\u00a0x\u00a0TBW studies weight\u00a0in will using\u00a0IBW\u00a0+ Ideal\u00a0body\u00a0weight\u00a0+\u00a00 e\u00a0daily\u00a0by\u00a0the\u00a0intravenous Rocephin\u00aeRoche Licensed hrly They after\u00a0a\u00a0750mg\u00a0intravenous\u00a0dose\u00a0every\u00a024hours 67:2957\u20102692 Dosing\u00a0in\u00a0E a\u00a0mg/kg\u00a0basis 212 B\u00a0British\u00a0National\u00a0Formulary\u00a0recommends vide 56 s\u00a0resulted\u00a0in\u00a0increased\u00a0gastrointestinal\u00a0side\u00a0effects obtained Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases\u00a0specialist Accessed\u00a0at\u00a0www Hites\u00a0et\u00a0al\u00a0attempted\u00a0to\u00a0validate\u00a0the\u00a0use\u00a0of\u00a0the\u00a0formula\u00a0by\u00a0carrying\u00a0out\u00a0a\u00a0therap substitute Ruiz\u2010Irastorza\u00a0G Actual\u00a0body\u00a0weight\u00a0\u00a0Ideal\u00a0body\u00a0weight volume 152 weigh suggest ho haemofiltration\u00a0or\u00a0nutritional\u00a0requirements side Page\u00a0|\u00a023 similar Essentially\u00a0this\u00a0me Victoria\u00a0Hospital\u00a0Kirkcaldy soft Fiona\u00a0MacGregor\u00a0of\u00a0the\u00a0Royal\u00a0Alexandra\u00a0Hospital outcomes\u00a0which\u00a0may\u00a0occur\u00a0as\u00a0a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0information\u00a0contained\u00a0within\u00a0this\u00a0document compassionate\u00a0use\u00a0programme\u00a0adult\u00a0patients\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were\u00a0treated\u00a0at\u00a0a\u00a0dose\u00a0of Introduction Antimicrob least\u00a0the\u00a0reappearance\u00a0of\u00a0T2\u00a0following\u00a0rocuronium al relevant extremes ht\u00a0patients have As\u00a0above\u00a0taking\u00a0renal\u00a0function\u00a0into\u00a0account the\u00a0two March\u00a02013\u00a057 In\u00a0life\u00a0threatening Accessed consequ Roberts\u00a0JA No\u00a0information\u00a0beyond\u00a0mg/kg\u00a0dosing Meropenem\u00a01g\u00a0dosed\u00a0to\u00a09\u00a0obese\u00a0female\u00a0patients No\u00a0data\u00a0available\u00a0on\u00a0any\u00a0dose\u00a0adjustment\u00a0required\u00a0in\u00a0low\u00a0body\u00a0weight lean t\u00a0Characteristics v1 Comments Micromedex cystic Sugammadex 75 Brown\u00a0J ed\u00a0a\u00a0200mg\u00a0loading\u00a0dose\u00a0on\u00a0Day\u00a01\u00a0followed\u00a0by\u00a0100mg\u00a0maintenance\u00a0dose\u00a0daily are rmation\u00a0available IBW 35 volunteers Underweight\u00a0patients Summary/Comment States is\u00a0the\u00a0weight\u00a0as\u00a0measured insufficiency intravenous\u00a0loading\u00a0dose\u00a0of\u00a020mg/kg\u00a0up\u00a0to\u00a0a\u00a0maximum\u00a0dose\u00a0of\u00a02g used equivalent\u00a0to\u00a012mg/kg\u00a0in\u00a0a For\u00a0serious\u00a0/life\u00a0threatening\u00a0infections\u00a0doses\u00a0of\u00a0up\u00a0to\u00a04 Meropenem fewer based Page\u00a0|\u00a026 plus data\u00a0was\u00a0for\u00a0patients\u00a039\u00a0to\u00a0123kg\u00a0actual\u00a0body\u00a0weight 002 x\u00a0TBW ww ne\u00a0240kg\u00a0patient\u00a0who\u00a0was\u00a0given\u00a0a\u00a0150mg\u00a0daily\u00a0maintenance\u00a0dose ertapenem Malacarne nction most Page\u00a0|\u00a010 will\u00a0find\u00a0the\u00a0document\u00a0useful\u00a0and\u00a0feedback\u00a0is\u00a0welcome appropriate ence\u00a0for\u00a0ideal\u2010body\u2010weight\u2010ad April\u00a02013 be\u00a0used clindamycin 0\u00a0x\u00a0TBW No\u00a0information\u00a0beyond\u00a0standard\u00a0mg/kg\u00a0dosing ication Mass\u00a0Index Continuous\u00a0versus\u00a0intermitte t\u00a0half\u00a0life\u00a0of\u00a0Meropenem 11th\u00a0January\u00a02013 48 Claire\u00a0McMaster\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital Page\u00a0|\u00a03 muscle\u00a0mass\u00a0is\u00a0proportionately\u00a0much\u00a0less\u00a0in\u00a0obese\u00a0patients end centres Flucloxacillin Wt adipose Phenytoin\u00a0disposition\u00a0in\u00a0obesity Voriconazole distribution future Summary\u00a0of\u00a0SA V\u00a01 14 uk\u00a017th\u00a0July\u00a02013 on\u00a0patient\u00a0weight Summary\u00a0of\u00a0product\u00a0characteristics\u00a0for\u00a0individual\u00a0normal\u00a0human\u00a0immunoglobulin\u00a0products High\u00a0dosage\u00a0of\u00a0benzylpenicllin\u00a0sodium\u00a0BP\u00a0may\u00a0result\u00a0in\u00a0hypernatraemia\u00a0and\u00a0hypokalaemia nuary\u00a02013 Ja Lean\u00a0Body\u00a0Weight vels\u00a0are\u00a0obtained +40% 131 those\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were total Genus\u00a0Pharmaceuticals rate 5g\u00a0every\u00a08\u00a0hrs ted\u00a0case\u00a0is\u00a0of\u00a0a\u00a0185kg\u00a0man ledgments disagr 20mg/kg dose\u00a0of\u00a010mg/kg\u00a0every\u00a012\u00a0hours and\u00a04mg/ml\u00a0were\u00a078 Dosing\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook iffe\u00a0Publishing 1\u00a0gram For\u00a0severe\u00a0infections\u00a0and\u00a0in\u00a0neutropenic\u00a0patients\u00a0with\u00a0infections practitioners clinical \u226440kg Bearden\u00a0et\u00a0al\u00a0assessed\u00a0the\u00a0pharmacokinetics\u00a0of\u00a0Meropenem\u00a0administer overdosages See\u00a0Benzylpenicillin\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0Beta\u00a0Lactams\u00a0in\u00a0obesity /\u00a08780\u00a0+ Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Accessed\u00a0at increased Pineda\u00a0LA infusions altering has 4As Curr\u00a0Opin\u00a0In 20:869\u2010873 \u2010ideal route patient from pharmacokinetics\u00a0in\u00a0an\u00a0obese\u00a0patient Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manu iaxone Advise\u00a0to\u00a0titrate\u00a0dose\u00a0according\u00a0to formula urs 0183 They\u00a0also\u00a0noted accessed\u00a07 Personal\u00a0Communication\u00a0Pfizer\u00a0Medical\u00a0Information\u00a021st\u00a0January\u00a02013 equations in\u00a0an\u00a0attempt\u00a0to\u00a0make\u00a0the\u00a0necessary\u00a0infor exceed No\u00a0dosage\u00a0adjustments\u00a0out\u00a0with\u00a0licensed\u00a0dose\u00a0\u00a0can\u00a0be\u00a0recommended\u00a0in\u00a0either\u00a0underweight\u00a0or 1997 Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Acces C\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook on\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0or\u00a0obese\u00a0patients Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepati to Dosing\u00a0based\u00a0on until obese\u00a0patients 0\u00a0mg/kg 1000mg\u00a0twice\u00a0daily\u00a0and\u00a02000mg\u00a0twice\u00a0daily\u00a0were\u00a0found\u00a0to\u00a0have\u00a0comparable No\u00a0information\u00a0available\u00a0for\u00a0dosing\u00a0in\u00a0underweight\u00a0patients adjustment\u00a0for\u00a0renal\u00a0impairment ai\u00a0et\u00a0al\u00a0also\u00a0noted\u00a0that\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0to\u00a0calculate\u00a0resulted\u00a0in\u00a0higher\u00a0Cmax\u00a0and aracteristics <5mg/kg and\u00a0the\u00a0authors\u00a0trust\u00a0that\u00a0the\u00a0information\u00a0provided\u00a0wil Summa proposed Phenytoin However\u00a0complications\u00a0of\u00a0obesity BiaxinTM\u00a0US\u00a0Product\u00a0Information guidance Personal\u00a0communication\u00a0with\u00a0Bayer\u00a010th\u00a0January\u00a02013 and\u00a0some\u00a0fluid Personal\u00a0communication\u00a0with\u00a0\u00a0Roche\u00a0April\u00a02013 net nor\u00a0for\u00a0any\u00a0patient\u00a0or\u00a0clinical dcliffe\u00a0Publishing Current\u00a0Opinions\u00a0in\u00a0Infectious\u00a0Diseases up Dosing\u00a0as\u00a0above parameters Carron\u00a0M\u00a0Freo\u00a0U\u00a0Parotto\u00a0E\u00a0and\u00a0Ori\u00a0C BNF *\u00a0cSSTI\u00a0=\u00a0complicated\u00a0skin\u00a0and\u00a0soft\u00a0skin\u00a0infection\u00a0\u00a0**\u00a0RIE\u00a0=\u00a0right\u00a0sided\u00a0infective\u00a0endocarditis and\u00a0Pharmaceutical\u00a0Press intra\u2010abdominal 45 expected particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infections recommends\u00a0using\u00a0ABW\u00a0for\u00a0dose\u00a0calculation As actual\u00a0body\u00a0weight\u00a0may\u00a0lead\u00a0to\u00a0drug\u00a0toxicity\u00a0and\u00a0suggest\u00a0using\u00a0ideal\u00a0body\u00a0weight Gillum\u00a0JG Zentiva :354\u2010358 the adult start treatme Zovirax\u00ae decisions 25:634\u2010649 Luque\u00a0S addie@ggc necessary risk prescribed EBW Page\u00a0|\u00a012 UKCPA: hepatic Carey\u00a0JC TBW\u00a0x\u00a01 nt\u00a0infusions\u00a0of\u00a0antibiotics intravenous\u00a0antibiotics\u00a0to\u00a0traditional\u00a0intermittent For\u00a0more\u00a0serious\u00a0infections\u00a0these\u00a0doses\u00a0may\u00a0have\u00a0to\u00a0be\u00a0increased Bearden\u00a0DT Review Fat association required Summary\u00a0of\u00a0Product\u00a0Characteri order\u00a0to\u00a0achieve\u00a0the\u00a0same\u00a0tissue\u00a0concentrations\u00a0as\u00a0those\u00a0achieved\u00a0in\u00a0lean\u00a0subjects\u00a0although Presented\u00a0at\u00a045th\u00a0Interscience\u00a0conference\u00a0on\u00a0Antimicrobial\u00a0Agents\u00a0and with\u00a0cellulitis\u00a0and\u00a0cutaneous\u00a0abscess to\u00a03 90mg/kg document\u00a0is\u00a0intended\u00a0to\u00a0provide\u00a0information\u00a0on\u00a0dosing\u00a0in Issues\u00a0of\u00a0\u00a0Linezolid PTC suicide Wolff\u00a0F\u00a0et\u00a0al Flucloxacillin\u00a0Activis\u00a0UK\u00a0Ltd Page\u00a0|\u00a01 Dexmedetomidine Dalacin\u00a0C\u00a0Phosphate\u00ae every concentration keith subgroup when\u00a0prescribing\u00a0ertapenem Colino\u00a0CI\u00a0&\u00a0Ferrer\u00a0A com No\u00a0specific\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however Page\u00a0|\u00a025 is\u00a0rarely\u00a0used\u00a0for\u00a0dosing concluded\u00a0that\u00a0BMI\u00a0had\u00a0did\u00a0not\u00a0effect\u00a0the\u00a0rate\u00a0of\u00a0recurrence\u00a0of\u00a0and\u00a0th adipose\u00a0tissue\u00a0and\u00a0wound\u00a0drainage\u00a0in male 18 failure\u00a0if\u00a0they\u00a0were\u00a0discharged\u00a0on ice\u00a0on\u00a0obese\u00a0patients common prov Increased\u00a0dose who\u00a0each\u00a0received Summary/Comm 39 pharmacodynamic Clinical\u00a0Infectious\u00a0Diseases\u00a01997 was\u00a0used ensure Allard\u00a0et\u00a0al\u00a0suggest\u00a0using\u00a0a\u00a0weight\u00a0adjusted\u00a0dose\u00a0based\u00a0on organisms not Calculation\u00a0of\u00a0creatinine\u00a0clearance\u00a0using\u00a0the\u00a0Cockcroft\u00a0&\u00a0Gault :708 Co\u2010Trimoxazole Cook\u00a0et\u00a0al\u00a0carried\u00a0out\u00a0a\u00a0very\u00a0small\u00a0study\u00a0and\u00a0concluded Too\u00a0little\u00a0information\u00a0to\u00a0give\u00a0a\u00a0definitive\u00a0dose\u00a0recommendation\u00a0in\u00a0obese\u00a0patients United clear Clinical\u00a0Infectious\u00a0Diseases and\u00a0relevant\u00a0to\u00a0clinical\u00a0practice Caution\u00a0is\u00a0advised\u00a0in\u00a0the\u00a0elderly Rakesh\u00a0Kishore\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infir :\u00a01222\u20101227 Pai\u00a0MP Lui\u00a0et\u00a0al\u00a0conducted\u00a0a\u00a0post\u2010hoc\u00a0pharmacokinetic\u00a0analysis\u00a0of\u00a0a\u00a0phase\u00a03\u00a0study\u00a0conducted\u00a0in\u00a0ICU\u00a0patients site\u00a0of\u00a0the\u00a0infection mg/kg\u00a0once\u00a0daily and No\u00a0adv 600mg\u00a0to\u00a03600mg\u00a0daily on\u00a0metabolism\u00a0and\u00a0on\u00a0drug\u00a0handling IL better Page\u00a0|\u00a015 the\u00a0discretion\u00a0of\u00a0the\u00a0principal\u00a0investiga Serious\u00a0infections:\u00a0600mg\u20101 was Email\u00a0received as\u00a0does\u00a0the\u00a0o ents\u00a040kg\u00a0and No\u00a0information\u00a0found\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients 28 underweight\u00a0or\u00a0obese\u00a0patients nor licable Chemotherapy ofloxacin\u00a0disposition\u00a0in\u00a0obesity handbook st\u00a0\u00a0Edition Journal\u00a0of\u00a0Infection\u00a02012 recommendation Int\u00a0J\u00a0Obes\u00a02001 Slight lipophilic ulate\u00a0dose Cefamandole\u00a0distribution\u00a0in\u00a0serum more 368\u2010373 when\u00a0compared Kingdom aminoglycosides eight Page\u00a0|\u00a036 relative A\u00a0single\u00a0200\u00a0mg\u00a0loading\u00a0dose\u00a0should\u00a0be\u00a0administered\u00a0on Therapeutic\u00a0Drug\u00a0Monitoring1986 skin Meronem\u00ae rep 51 Titrate\u00a0dose\u00a0according\u00a0to\u00a0response =\u00a0IBW\u00a0+\u00a00 uk\u00a08th\u00a0February\u00a02013 include\u00a0more but\u00a0gives\u00a0an\u00a0indication\u00a0of\u00a0the\u00a0patient\u2019s would Predicted Scottish ure Personal\u00a0communication\u00a0with\u00a0Sanofi\u2010Aventis\u00a02nd\u00a0April\u00a02013 rmation\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Allard\u00a0S\u00a0et\u00a0al The\u00a0renal\u00a0drug Page\u00a0|\u00a027 Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex\u00a0in Dosing\u00a0for\u00a0iv\u00a0weight\u00a0based 600mg\u00a0twice\u00a0daily\u00a0was\u00a0sufficient\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0skin\u00a0and\u00a0soft By\u00a0intravenous\u00a0infusion\u00a0500mg\u20102g\u00a0every\u00a08\u00a0hours Author\u00a0suggests Body\u00a0Mass\u00a0Index December\u00a016\u201019 and\u00a0increased\u00a0stepwise most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study as above Aguirre\u00a0C Immunoglobulin Greenock life Standard\u00a0therapeutic\u00a0dosage:\u00a01g\u00a0once\u00a0daily Pharmacokinetics\u00a0of\u00a0meropenem\u00a0in\u00a0extreme\u00a0obesity 2012 if\u00a0spontaneous\u00a0recovery\u00a0has\u00a0occurred\u00a0up\u00a0to\u00a0at El\u00a0Sohl\u00a0AA Oxford Underweigh 37 health initial account\u00a0when\u00a0interpreting\u00a0the\u00a0levels\u00a0if\u00a0total\u00a0phenytoin\u00a0is\u00a0measured\u00a0as\u00a0opposed\u00a0to\u00a0free cuta 13 Paisley On\u00a0behalf\u00a0of\u00a0the\u00a0Scottish\u00a0Adult\u00a0Critical\u00a0Care\u00a0Pharmacists\u00a0Network context complicated other Dosage\u00a0adjustments\u00a0based\u00a0on\u00a0BMI\u00a0alone\u00a0are\u00a0not\u00a0required\u00a0and\u00a0standard\u00a0doses\u00a0for\u00a0patients\u00a0with Page\u00a0|\u00a038 Akinnusi app By\u00a0intravenous\u00a0infusion\u00a0400mg\u00a0every\u00a08\u201012\u00a0hours The\u00a0pharmacokinetics\u00a0of\u00a0Daptomyc and\u00a0Del\u00a0Tacca recommend\u00a0adjusting\u00a0the\u00a0dose\u00a0of\u00a0anidulafungin\u00a0based\u00a0on\u00a0body\u00a0weight\u00a0in\u00a0adult\u00a0patients essed\u00a0via overall\u00a0effect\u00a0however Group low female bacterial\u00a0vaginosis Grau\u00a0S Fluconazole Page\u00a0|\u00a043 particularly Janson\u00a0B McConnell\u00a0DB\u00a0et\u00a0al ly\u00a0approximate ent\u00a0which\u00a0represents\u00a0information\u00a0and\u00a0experience\u00a0of\u00a0dosing\u00a0of\u00a0drugs\u00a0in\u00a0critically\u00a0ill obesity evidence trial a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole We\u00a0hope\u00a0that\u00a0you on\u00a0the\u00a0rate\u00a0of\u00a0its Diane\u00a0Kennedy\u00a0of\u00a0Ayr\u00a0Hospital Dillmans\u00a0B Male\u00a0and\u00a0Female\u00a0Subjects Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer the\u00a0dose\u00a0may\u00a0be\u00a0increased\u00a0to not\u00a0been\u00a0systematically\u00a0evaluated\u00a0for\u00a0safety\u00a0or\u00a0efficacy\u00a0in\u00a0extremes\u00a0of\u00a0body\u00a0weight response\u00a0to\u00a0bac Alan\u00a0Timmins 10 facturer obese\u00a0and\u00a0extremely\u00a0obese\u00a0adults No\u00a0specific\u00a0do widely 7\u00a0micrograms/kg/h\u00a0which\u00a0\u00a0may\u00a0then\u00a0be\u00a0adjusted\u00a0stepw Page\u00a0|\u00a08 0242 trough make or\u00a0vecuronium\u00a0induced\u00a0blockade Infections:\u00a02\u20104g\u00a0daily 287 Tejani\u00a0AM\u00a0et\u00a0al Alison\u00a0Bell Both\u00a0groups\u00a0of\u00a0patient\u00a0will\u00a0require\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0to\u00a0ensure\u00a0maintenance\u00a0dose dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of Intravenous\u00a0cipr currently monitoring Earle\u00a0SB Dexdor\u00ae Dosing\u00a0of\u00a0antibiotics\u00a0in\u00a0obesity approximately Half\u2010life\u00a0is\u00a0dependent\u00a0on\u00a0renal\u00a0function for\u00a0any\u00a0patient\u00a0or Tygacil\u00ae Yet Keith\u00a0Addie normal\u2010weight Loading\u00a0dose without philic ant No\u00a0inform terial\u00a0vaginosis\u00a0in\u00a0pregnancy staphylococci Glasgow requiring\u00a0more\u00a0aggressive\u00a0therapy Drug drug Lisco\u00a0S Amphotericin Children3 comparing clinical\u00a0judgement steady regimens Geiseler\u00a0PJ\u00a0et\u00a0al\u00a0Am\u00a0Rev\u00a0Respir\u00a0Dis\u00a01985 Neurol\u00a01985 Pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0voriconazole\u00a0following\u00a0intravenous\u00a0to\u00a0oral\u00a0dose\u00a0escalation and\u00a0vi weight process Rifmpicin 5\u00b5g/ml al\u00a0suggest\u00a0that\u00a0higher\u00a0doses\u00a0of\u00a0ciprofloxacin\u00a0should\u00a0always\u00a0be\u00a0used\u00a0either\u00a0600mg\u00a0bd\u00a0or eed Current\u00a0Opinion\u00a0Infectious\u00a0Disease subsequent cute\u00a0infections\u00a0960mg\u00a0every\u00a012\u00a0hours but were Accessed\u00a0at Several\u00a0references\u00a0suggest\u00a0that\u00a0bone\u00a0marrow\u00a0related\u00a0toxicity\u00a0was\u00a0linked\u00a0to\u00a0the\u00a0cumulative\u00a0dose retrospective evolve DWCF*x\u00a0EBW orption Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0ac 25\u00b5g/ml: Suppl\u00a0S2 height\u00a0in\u00a0inches\u00a0\u00a060 738 MIC90s Summary\u00a0of\u00a0\u00a0product\u00a0characteristics maintained s\u00a0clinical\u00a0response UK uk\u00a012th\u00a0March\u00a02013 comparable popula lays compared glomerular DDW than 55 No\u00a0informati http://www therapeutic\u00a0concentrations\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics5 Calculated\u00a0percentage\u00a0of\u00a0time\u00a0above\u00a0minimum\u00a0inhibitory\u00a0concentration Adult careful Cochrane improved The\u00a0renal\u00a0drug\u00a0handbook org adequate Western Mycoses\u00a054 The\u00a0effect\u00a0of\u00a0body\u00a0m Klaricid\u00ae PN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer they after\u00a0first\u00a024\u00a0hours howeve achie y\u00a0ill\u00a0patients severe\u00a0infections :\u00a0468\u2010471 while accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein The\u00a0conclusion\u00a0was\u00a0that\u00a0the\u00a0fluconazole\u00a0dose\u00a0should\u00a0be\u00a0based\u00a0on\u00a0the Please\u00a0send\u00a0any\u00a0new Page\u00a0|\u00a013 Flagyl\u00ae 29 100mg/kg\u00a0per\u00a024\u00a0hours\u00a0sulfamethoxazole\u00a0have\u00a0been\u00a0used Montpelier Second\u00a0edition\u00a0update 10\u201015\u00a0mg/kg 25:\u00a0112\u20108 subjects No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0pat Dose\u00a0as\u00a0per\u00a0SPC\u00a0on\u00a0mg/kg\u00a0basis that\u00a0the\u00a0efficacy\u00a0of\u00a0Metronidazole\u00a0was\u00a0similar\u00a0among\u00a0different\u00a0BMI\u00a0cate No\u00a0advice cin IBW\u00a0for\u00a0males By\u00a0intravenous\u00a0infusion\u00a0600mg\u00a0twice\u00a0daily pathogen Personal\u00a0communication\u00a0with\u00a0medical\u00a0information\u00a0department but\u00a0a\u00a0value\u00a0of\u00a00 function 0\u00a0mg/kg\u00a0of\u00a0body\u00a0weight Martin\u00a0C 23rd\u00a0November\u00a02012 2\u20109 Antimicrob\u00a0Chemother\u00a02012 er\u00a02012 Pfizer\u00a0Ltd Disposition\u00a0of\u00a0Cefotaxime\u00a0and\u00a0its\u00a0Desacetyl\u00a0Metabolite\u00a0in\u00a0Morbidly\u00a0Obese Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Ceftr a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0i Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0m BNF\u00a0for\u00a0Children\u00a0March\u00a02013\u00a0accessed\u00a0o Page\u00a0|\u00a039 Wurz\u00a0R 22 Summary\u00a0of\u00a0SACCPN\u00a0lit &\u00a0Currie Pomp\u00a0A\u00a0Critical\u00a0care\u00a0of\u00a0the\u00a0bariatric\u00a0patient years Septrin\u00ae clearance\u00a0and\u00a0elimination\u00a0half\u2010life\u00a0in Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0Medical\u00a0Information\u00a0July\u00a02013 so\u00a0are\u00a0in\u00a0theory\u00a0are\u00a0good\u00a0models\u00a0for\u00a0drugs\u00a0that\u00a0are\u00a0highly\u00a0hydro 40 Heintz Rodvold\u00a0K ICAAC guidan adjusted There numb Metronidazole\u00a0monograph Oxford\u00a02009 Thursky\u00a0K ceftriaxone Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug body\u00a0weights\u00a0up\u00a0to\u00a0approximately\u00a0150kg\u00a0should\u00a0provide\u00a0AUC\u00a0values\u00a0similar\u00a0to\u00a0those\u00a0seen\u00a0in\u00a0non of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Acc Body\u00a0W into Ceftriaxone though document: Patients\u00a0less\u00a0than erature\u00a0from\u00a0manufacturer divided\u00a0into\u00a04\u20106\u00a0doses\u00a0depending\u00a0on\u00a0the\u00a0ind 927 For\u00a0oral\u00a0route\u00a0dosing\u00a0as\u00a0above so\u00a0may\u00a0negate\u00a0this 11 at\u00a0www Phase\u00a03\u00a0data\u00a0showed\u00a0we in\u00a0non\u2010pregnant\u00a0women\u00a03 ass\u00a0index\u00a0on\u00a0therapeutic 6680\u00a0+ The\u00a0Renal\u00a0Drug\u00a0Handbook contained\u00a0within\u00a0this Gilead who sed No\u00a0information\u00a0available\u00a0\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients +4 50 those Radc Strong =IBW\u00a0+\u00a020% A\u00a0dose\u00a0of\u00a02\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended Roberts\u00a0et\u00a0al\u00a0assessed\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics l\u00a0only\u00a0be\u00a0used\u00a0as\u00a0part Page\u00a0|\u00a09 No\u00a0change\u00a0recommended\u00a0to\u00a0standard\u00a0dosing\u00a0regimen 5g\u00a0every\u00a06\u00a0hrs by Antifungal\u00a0dosing\u00a0in\u00a0obesity:\u00a0A\u00a0review\u00a0of\u00a0the\u00a0literature max of\u00a0piperacillin Many\u00a0Thanks Summary\u00a0of\u00a0Product\u00a0Characteristics mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used es Page\u00a0|\u00a045 No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0patients assessing Page\u00a0|\u00a016 antifungal\u00a0agent edicines method Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins\u00a0taking\u00a0into July\u00a02012 PNW recommends No\u00a0additional\u00a0information\u00a0supplied\u00a0from\u00a0the\u00a0SPC dose\u00a0based\u00a0on\u00a0indication pregnan Norenberg\u00a0JP cSSTI*\u00a0without\u00a0S ABW atient\u00a0weight\u00a0has\u00a0ranged\u00a0from\u00a034kg\u00a0to\u00a0200kg ideal\u00a0body\u00a0weight\u00a0where\u00a0dose\u00a0was\u00a0increased\u00a0in\u00a0proportion\u00a0to com/pdf/biapi companied\u00a0by\u00a0hepatic Astra\u00a0Zeneca\u00a0\u00a0Summary\u00a0of\u00a0Product\u00a0\u00a0Characteri Pfizer\u00a0Medical\u00a0Information uk\u00a012th\u00a0July\u00a02013 Antimicrobial\u00a0dosing\u00a0in\u00a0obese\u00a0patients gories body\u00a0weight infusions\u00a0of\u00a0antibiotics difference\u00a0between\u00a0the\u00a0concentrations\u00a0achieved\u00a0in\u00a0normal\u00a0weight\u00a0and\u00a0morbidly\u00a0obese\u00a0subjects account 2012\u00a0Dec Benzylpenicllin Patients\u00a0already\u00a0intubated\u00a0and\u00a0sedated\u00a0may\u00a0switch\u00a0to\u00a0dexmedetomidine\u00a0with\u00a0an monly Dose\u00a0adjustments\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0rena Abbott\u00a0Healthcare\u00a0ProductsP\u00a0Ltd Pharmacists\u00a0Network determination\u00a0of\u00a0loading\u00a0dose including\u00a0diabetes\u00a0and\u00a0hypertension 42 6%\u00a0and\u00a049 available\u00a0on\u00a0modification\u00a0of\u00a0dosage neous suggest\u00a0monitoring\u00a0for\u00a0toxicity\u00a0in Maximum\u00a0Body\u00a0We Page\u00a0|\u00a042 No\u00a0spe had doses cohort Ambisome\u00ae including\u00a0in\u00a0patients\u00a0with\u00a0neutropenia\u00a0which\u00a0would\u00a0suggest\u00a0reducing\u00a0the\u00a0dose\u00a0in There\u00a0is\u00a0little\u00a0information\u00a0about\u00a0dosing\u00a0adjustments\u00a0in\u00a0significantly\u00a0underweight Danesi There\u00a0is\u00a0a\u00a0sing proportion however and\u00a0100mg\u00a0of\u00a0sulfamethoxazole\u00a0per\u00a0kg\u00a0of\u00a0bodyweight\u00a0per\u00a0day\u00a0in\u00a0two\u00a0or\u00a0more\u00a0divided blockade Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0inte Patients to\u00a0allow 44 when Therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0critically that\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0may\u00a0be\u00a0more\u00a0appropriate\u00a0to\u00a0dose\u00a0as\u00a0ideal\u00a0or\u00a0adjusted However\u00a0the\u00a0adipose\u00a0tissue\u00a0does\u00a0have\u00a0some\u00a0vasculature Paper s\u00a0o AUC\u00a0values\u00a0in\u00a0morbidly\u00a0obese\u00a0subjects\u00a0than\u00a0in\u00a0normal\u00a0weight\u00a0subjects\u00a0with\u00a0similar\u00a0creatinine\u00a0clearance Care Accessed\u00a0at\u00a0\u00a0www inetics\u00a0of\u00a0intravenous\u00a0levofloxacin Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0\u00a0at Much 4mg/kg No\u00a0specific\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients practice Tigecycline\u00a0has renal 2011 gov/ct2/show/record/NCT01517815\u00a0accessed\u00a011th\u00a0April\u00a02013 especially manufacturer: clearance no\u00a0da on 36:332\u201039 ons Purkin\u00a0L\u00a0et\u00a0al a\u00a0dosage\u00a0decrease\u00a0was\u00a0required Another\u00a0study\u00a0also\u00a0noted\u00a0that\u00a0Pharmacokinetic\u00a0parameters\u00a0in\u00a0pregnant\u00a0patients\u00a0were\u00a0not\u00a0significantly Summary\u00a0of\u00a0SACC In\u00a0a\u00a0compassionate\u00a0use\u00a0programme\u00a0of\u00a0adult\u00a0patients suggest\u00a0mg/kg\u00a0dosing\u00a0as\u00a0above for western ument\u00a0is\u00a0accurate\u00a0and\u00a0up\u00a0to\u00a0date Dvorchick\u00a0BH Use\u00a0total\u00a0body\u00a0weight bacteraemia be\u00a0different expectancy Page\u00a0|\u00a05 As\u00a0above adjustm these\u00a0changes\u00a0had\u00a0little\u00a0effect\u00a0on\u00a0T>MIC and\u00a0by\u00a0anecdotal\u00a0experience\u00a0of\u00a0pharmacists\u00a0working\u00a0within\u00a0critical\u00a0car =\u00a0\u221a Yost\u00a0et\u00a0al\u00a0assessed\u00a0plasma\u00a0levels\u00a0after\u00a0intravenous\u00a0administration\u00a0of\u00a0cefotaxime\u00a0in\u00a0normal\u00a0weight\u00a0and Working\u00a0Group tion\u00a0of\u00a0the\u00a0following\u00a0pharmacists\u00a0to\u00a0the\u00a0production\u00a0of\u00a0this piperacillin/tazobactam Modified The\u00a0Cochrane\u00a0Library\u00a02013 Bridion\u00ae 46 Predicted\u00a0Normal\u00a0Weight tissue administered\u00a0to\u00a0normal\u00a0weight maximum group more\u00a0than\u00a0IBW between Purkin\u00a0et\u00a0al\u00a0Antimicrob\u00a0Agents\u00a0Chemother\u00a02002 Pharmacology/\u00a0kinetics Dose\u00a0as morbidly\u00a0obese\u00a0patients wound 1144\u201049 infections where 100mg\u00a0twice\u00a0daily Pneumocystis\u00a0Jiroveci\u00a0Pneumonitis\u00a0PCP\u00a0infections:\u00a0treatment adjustments consequently Pfizer\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics Clinical\u00a0guidelines\u00a0for\u00a0immunoglobulin\u00a0use Page\u00a0|\u00a047 issue Drusano\u00a0GL MIC\u00a0of\u00a01mg/ml Shiu\u00a0J Further water\u2010soluble EB Pieracci\u00a0FM descriptors\u00a0for\u00a0drug Buchwald\u00a0H ise\u00a0within\u00a0the\u00a0dose\u00a0range\u00a00 the\u00a0dose\u00a0should\u00a0be\u00a0rounded\u00a0down\u00a0to\u00a0the\u00a0nearest\u00a0vial dose Pharmacy kg regimen Licensed\u00a0dose\u00a0in It\u00a0is\u00a0hoped\u00a0to direct Anidulafungin Senior\u00a0Pharmacist CRRT 112\u2010118 Patricia\u00a0Nicholas\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital lower however\u00a0specialist\u00a0consensus\u00a0advocates\u00a0the\u00a0use\u00a0of\u00a0the\u00a0DDW\u00a0equation dosing\u00a0weight\u00a0tables\u00a0may\u00a0be\u00a0in Dosing USA available\u00a0from\u00a0this\u00a0the\u00a0manufacturer\u00a0recommends\u00a0that\u00a0all\u00a0patients\u00a0are\u00a0dosed\u00a0on separate demonstrated Tishier\u00a0D\u00a0S t\u00a0Characteristics\u00a0Accessed IV Chen\u00a0M 12g Weig severe Loading\u00a0Dose 3% References 5\u00a0I Pfizer limited morbidly Alison\u00a0Carruthers\u00a0of\u00a0Borders\u00a0General Adjusted\u00a0Body\u00a0Weight periences United\u00a0Kingdom in Van 36:\u00a0\u00a0p151\u2010158 February\u00a02013 Body\u00a0Weight supported Summary anufacturer3 was\u00a0given\u00a01200mg\u00a0and\u00a0showed\u00a0a\u00a0lower\u00a0AUC\u00a0and MIC Clinical Ruth\u00a0Forrest\u00a0of\u00a0the\u00a0Western\u00a0Infirm It women concentrations By\u00a0intravenous\u00a0infusion\u00a0500mg\u00a0every\u00a012\u00a0hours mo J\u00a0Antimicrob\u00a0Chemother bgroup ves Formula Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufactu uk\u00a026th\u00a0June\u00a02013 cohort\u00a0study uk 6\u00a0mg/kg\u00a0once\u00a0daily critically ME showed Every piperacillin/tazobactam\u00a0British\u00a0journal\u00a0of\u00a0haematology\u00a095:4\u00a01996\u00a0Dec\u00a0pg\u00a0611\u20102 literat All Lean or\u00a0refer\u00a0renal\u00a0drug\u00a0handbook Page\u00a0|\u00a040 r\u00a0that\u00a0metabolism\u00a0is Pharmacological body weights except 20 Therapy\u00a0is\u00a0usually\u00a0instituted\u00a0at\u00a0a\u00a0daily\u00a0dose Victoria\u00a0Infirmary The\u00a0higher\u00a0dose\u00a0was\u00a0at sed\u00a0at reduced Acknowledgements Information\u00a0from Larbert effort 2\u00a0to\u00a01 No\u00a0liability\u00a0can\u00a0be\u00a0accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein Pharmacia\u00a0Ltd obese Fluconazole\u00a0serum\u00a0concentrations\u00a0and Ltd\u00a04th\u00a0December\u00a02012 23 receivin it review Hurford\u00a0W Intensive\u00a0Care\u00a0Medicine\u00a02004 concentrations\u00a0in\u00a032%\u00a0of\u00a0patients\u00a0and\u00a0overdosed\u00a0serum\u00a0concentrations\u00a0in\u00a025% situations\u00a0doses\u00a0as\u00a0high\u00a0as\u00a04 since 25:233\u2010237 Vfend\u00ae alters to\u00a0es Child nhs /Comments susceptible inclusion tions Influence\u00a0of\u00a0morbid\u00a0obesity\u00a0on\u00a0the\u00a0single\u00a0dose scot Benzylpenicillin Body\u00a0Surface\u00a0Area\u00a0is\u00a0mainly\u00a0used\u00a0in\u00a0cancer\u00a0chemotherapy for\u00a0organisms\u00a0with\u00a0an on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients linezoli Maximum\u00a0Body\u00a0Weight 25\u00a0to\u00a00 Abbott\u00a0Laboratories filtration tables 6%\u00a0of\u00a0an\u00a08\u00a0hour\u00a0dosing\u00a0interval\u00a0respectively 4\u00a0+ sive\u00a0care\u00a0unit\u00a0setting prophylaxis increasingly reported Published\u00a0jointly\u00a0by\u00a0BMJ\u00a0Group overweight Fat\u00a0Free\u00a0Mass International\u00a0Journal\u00a0of\u00a0Antimicrobial\u00a0Agents\u00a02010 immunoglobulin\u00a0use2 s\u00a0of\u00a0cefamandole Greenblatt\u00a0DJ Page\u00a0|\u00a018 Page\u00a0|\u00a04 pneumocystis Clin\u00a0Pharmacol\u00a0Ther\u00a01993 at Body :\u00a02741\u2010 becoming Antimicrobial\u00a0agents\u00a0and\u00a0chemotherapy\u00a02007 This\u00a0docum One Pharmacotherapy\u00a01995 We\u00a0would\u00a0like\u00a0to\u00a0acknowledge\u00a0the\u00a0contribu Principal\u00a0Pharmacist Cook\u00a0AM Due\u00a0to\u00a0the\u00a0shor Tigecycline Dundee so obese\u00a0pat Ecalta\u00ae 150kg AUC peak there\u00a0is\u00a0some\u00a0extra\u00a0water/\u00a0blood\u00a0supply\u00a0to\u00a0excess\u00a0tissue Abernethy\u00a0DR on\u00a0underweight\u00a0or\u00a0obese\u00a0patients impact performed Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at\u00a0\u00a0www Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook specialist Insufficient\u00a0information\u00a0available\u00a0to\u00a0make\u00a0a\u00a0recommendation Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed BMI\u00a048 Suggest\u00a0dosing\u00a0at\u00a0upper\u00a0end\u00a0of\u00a0range\u00a0where\u00a0appropriate 15 Senior\u00a0Clinical\u00a0Pharmacist ay No\u00a0change\u00a0to\u00a0manufacturer\u2019s\u00a0recommended\u00a0dosage Page\u00a0|\u00a011 bes\u00a0acute\u00a0kidney\u00a0injury\u00a0in\u00a0obese\u00a0patients\u00a0where\u00a0aciclovir\u00a0dose\u00a0was\u00a0based\u00a0on\u00a0actual\u00a0body ccessed\u00a0at\u00a0www taking\u00a0into\u00a0account\u00a0patie provide patients\u00a0under\u00a040kg\u00a0or Page\u00a0|\u00a021 for\u00a0adults erature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Chen adults cific\u00a0information\u00a0available Day\u00a01 Calculate\u00a0dose\u00a0determining\u00a0weight Base continuous ry Critical\u00a0Care\u00a0Medicine Fiona\u00a0McIntyre\u00a0of\u00a0Ninewells\u00a0Hospital provided important\u00a0to\u00a0administer\u00a0an\u00a0optimal\u00a0dose\u00a0of\u00a0a\u00a0drug\u00a0to\u00a0ensure\u00a0therapeutic\u00a0le daily September\u00a02013 oral extremities penicillins l\u00a0drug\u00a0handbook but\u00a0there\u00a0is\u00a0currently Tavanic\u00ae work uk\u00a027th\u00a0June\u00a02013 mation\u00a0more\u00a0readily tetanic\u00a0counts Obesity height\u00a0and\u00a0weight The\u00a0aggressive\u00a0pharmacodynamic\u00a0targets\u00a0chosen\u00a0for\u00a0this\u00a0study\u00a0appeared\u00a0to\u00a0ha ans\u00a0up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses Page\u00a0|\u00a041 alan increased\u00a0serum\u00a0drug prevalent within Page\u00a0|\u00a034 In\u00a0the\u00a0obese\u00a0population\u00a0use\u00a0of\u00a0standard\u00a0dosages\u00a0of\u00a0beta\u00a0lactam\u00a0antib however\u00a0no\u00a0liability\u00a0can\u00a0be added\u00a0to\u00a0give\u00a0adjusted\u00a0body\u00a0weight Pharmacokinetics\u00a0of mmended\u00a0dose\u00a0is\u00a04 Page\u00a0|\u00a033 concentration\u2010 Summary\u00a0of\u00a0SACCPN\u00a0li No\u00a0strong\u00a0evidence very\u00a012 connection Manufacturer\u00a0recommends\u00a0dosing\u00a0on\u00a0actual\u00a0body\u00a0weight Mean upper Ed 25:\u00a0634\u2010649 variation pharmacokinetics\u00a0of\u00a0daptomycin morbidity Wang\u00a0E we the\u00a0excess\u00a0in\u00a0body\u00a0weight4 ight\u00a0in\u00a0anidulafungin\u00a0group\u00a0ranged\u00a0from\u00a035\u00a0kg\u00a0to\u00a0196 body\u00a0mass\u00a0in\u00a0clinical\u00a0trials\u00a0=\u00a080 often Suggest\u00a04 Antimicrobial give Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0January\u00a02013 >30kg/m2 Luque In British\u00a0National\u00a0Formulary\u00a065 Bogaert\u00a0T\u00a0et\u00a0al Cmax/MIC and\u00a0little\u00a0observed\u00a0toxicity supratherapeutic no 30 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal if may\u00a0reduce Senior\u00a0Pharmacist\u00a0Southern\u00a0General can ratio Van\u00a0Zanten\u00a0et Page\u00a0|\u00a037 ta\u00a0available\u00a0from\u00a0manufacturer\u00a0in\u00a0obese\u00a0patients =\u00a045 Normal values or\u00a0Alan\u00a0Timmins Peter\u00a0Buckner\u00a0of\u00a0Forth\u00a0Valley\u00a0Royal\u00a0Hos enance\u00a0dose\u00a05\u00a0mg/kg\u00a0daily value t\u00a0patients No\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients preference Br\u00a0J\u00a0Clin\u00a0Pharmacol\u00a02003 Barie\u00a0PS evaluate patients continue calculated Comparative\u00a0pharmacokinetics\u00a0and\u00a0pharmacodynamic\u00a0target commence plasma suggested\u00a0that\u00a0continuous\u00a0infusion\u00a0for\u00a0isolates\u00a0with\u00a0high\u00a0MIC\u00a0may\u00a0be\u00a0beneficial Morag\u00a0Naysmith Use\u00a0standard\u00a0dosing 6mg/kg abs The\u00a0manufacturer\u00a0provides\u00a0no\u00a0specific\u00a0advice Page\u00a0|\u00a046 It\u00a0is\u00a0also\u00a0suggested\u00a0that\u00a0600mg with\u00a0the pharmacokinetic\u00a0disposition\u00a0in\u00a0a\u00a0morbidly\u00a0obese\u00a0patient 0mg some document at\u00a0dosing\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0is\u00a0appropriate\u00a0as\u00a0dosing\u00a0based\u00a0on\u00a0IBW\u00a0may\u00a0fail\u00a0to\u00a0reach fat\u00a0mass Obes phenytoin\u00a0levels to\u00a0adjust\u00a0dosing\u00a0in\u00a0obesity uk\u00a019th\u00a0July\u00a02013 adequate\u00a0concentrations particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more Dose\u00a0using\u00a0ideal\u00a0body\u00a0weight available\u00a0from\u00a0manufacturer ary No\u00a0advice\u00a0on vid only\u00a0be\u00a0produced\u00a0by\u00a0a\u00a0randomised Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0intensive\u00a0care\u00a0unit\u00a0setting any adults\u00a0is\u00a0an\u00a0initial\u00a0dose\u00a0of\u00a0100\u00a0mg\u00a0followed\u00a0by\u00a050\u00a0mg\u00a0every\u00a012\u00a0hours they\u00a0provide\u00a0a\u00a0number\u00a0of\u00a0references :3240 Sabate\u00a0A\u00a0and\u00a0Llaurado\u00a0S Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0lit generally non 67:\u00a0298\u00a0\u00a0299 p634\u00a0\u2010\u00a0649 followed\u00a0by\u00a0100\u00a0mg\u00a0daily\u00a0thereafter *Refers\u00a0to\u00a0patients\u00a0aged\u00a015\u00a0years\u00a0and\u00a0older Mass normally\u00a0as\u00a0a\u00a0once\u00a0daily\u00a0dose Information\u00a0provided\u00a0does\u00a0not\u00a0provide\u00a0a\u00a0substitute\u00a0for\u00a0clinical\u00a0judgement Ideal\u00a0Body\u00a0Weight 14th\u00a0June\u00a02013 Information\u00a0from\u00a0guidelines: Higher\u00a0doses\u00a0as\u00a0per\u00a0SPC\u00a0depending\u00a0on\u00a0indication Page\u00a0|\u00a017 eutic\u00a0drug\u00a0monitoring Accessed\u00a07th\u00a0June\u00a02013 BMI>40 Cubicin\u00ae should 74\u00a0x\u00a0height in\u00a0excess\u00a0of\u00a00 /\u00a03600 gents\u00a0Chemother Kilmarnock utcomes\u00a0which\u00a0may\u00a0occur\u00a0as Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0pe Clydebank normal Koselke\u00a0et\u00a0al >100kg\u00a0and\u00a0BM 41 Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0A cefamandole No\u00a0specific\u00a0advice\u00a0available\u00a0for\u00a0underweight\u00a0patients time\u00a0curve\u00a0was\u00a0significantly\u00a0higher\u00a0in\u00a0normal\u00a0we CMax\u00a058%\u00a0and\u00a0AUC Personal\u00a0correspondence\u00a0with\u00a0Gilead\u00a0Medical\u00a0Information\u00a011th\u00a0July underweight Janson\u00a0B\u00a0and\u00a0Thursky\u00a0K found pharmacodynamics uk\u00a0accessed Invanz\u00ae Loading No\u00a0dosing\u00a0advice\u00a0found reported\u00a0as24g/day\u00a0N worse J\u00a0crit\u00a0care\u00a02008 Pat actual\u00a0body\u00a0weight However\u00a0they :2546\u20102553 Lui\u00a0P\u00a0et\u00a0al\u00a0Pharmacokinetics\u00a0of\u00a0anidulafungin\u00a0in\u00a0adult\u00a0intensive\u00a0care\u00a0patients reality\u00a0dosing\u00a0based\u00a0on\u00a0TBW\u00a0is\u00a0more\u00a0dependable It\u00a0is\u00a0also\u00a0recommended\u00a0that in\u00a0Obese\u00a0patients achieve pital Case\u2010Control\u00a0study\u00a0of\u00a0Drug\u00a0Monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0Obese Damphousse\u00a0D manufacturer considered Additional\u00a0Information\u00a0\u2010\u00a0Cefalosporins compromised\u00a0patients\u00a0or Drug\u00a0Dosing\u00a0in\u00a0Extremes\u00a0of\u00a0Body\u00a0Weight\u00a0in\u00a0critically\u00a0ill\u00a0patients Hospital re\u00a0is\u00a0limited\u00a0e twice Nicolau\u00a0D\u00a0P\u00a0and\u00a0Kuti\u00a0J\u00a0L using\u00a0Ideal\u00a0Body\u00a0Weight\u00a0in\u00a0obese\u00a0patients\u00a0taking\u00a0renal\u00a0function\u00a0in Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalise ing\u00a0methods\u00a0have has\u00a0no\u00a0influence Taccone\u00a0FS The\u00a0area\u00a0un Agents\u00a0and\u00a0Chemotherapy\u00a02006 treated\u00a0at\u00a0a\u00a0dose\u00a0of\u00a0600mg\u00a0every\u00a012\u00a0hours see\u00a0below =45 ese\u00a0patients Barreiro\u00a0G d\u00a0literature\u00a0from\u00a0manufacturer The\u00a0pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0intravenous\u00a0voriconazole\u00a0\u00a0a\u00a0novel\u00a0wide\u00a0spectrum taking Usual\u00a0adult\u00a0dosage\u00a0250mg\u00a0to\u00a01g\u00a0four\u00a0times\u00a0daily Critically\u00a0ill\u00a0Patients RIE**\u00a0or\u00a0cSSTI\u00a0associated\u00a0with\u00a0S No\u00a0specific\u00a0\u00a0advice\u00a0available Zyvox\u00ae area IBW\u00a0for\u00a0females loading Underwei produced levels Yorst\u00a0RL LBW 2008 Calc Severe 800mg an Rifampicin Radcliffe suggested Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0for\u00a0the\u00a0loading\u00a0dose\u00a0using\u00a0a\u00a0weight\u00a0of accounted attempts/accidental meta\u2010analysis Journal\u00a0of\u00a0Clinical\u00a0Ph See\u00a0benzylpeniclli uk\u00a029th\u00a0May\u00a02013 Metronidazole total\u00a0body\u00a0weight\u2010IBW Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd meropene decision orations 1\u00a0x\u00a0height for\u00a0the Suggest\u00a0higher\u00a0doses\u00a0of\u00a0piperacillin/tazobactam\u00a04 may true erefore\u00a0it\u00a0was\u00a0thought and\u00a0morbidly\u00a0obese\u00a0adults which contained\u00a0in\u00a0the\u00a0document\u00a0can\u00a0be\u00a0kept\u00a0up\u00a0to\u00a0date le\u00a0case\u00a0report\u00a0of\u00a0an\u00a0obese\u00a0patient\u00a0with\u00a0nonmeningeal\u00a0cryptococcal\u00a0infection\u00a0successfully 45\u00a0x\u00a0\u00a0excess\u00a0body\u00a0weight Halovic two recommendations 74% A\u00a0daily\u00a0dose\u00a0of\u00a08mg/kg\u00a0should\u00a0not\u00a0be\u00a0exceeded\u00a0in\u00a0patients\u00a0with\u00a0impaired\u00a0liver\u00a0function during Novartis\u00a0Pharmaceutical\u00a0UK\u00a0Ltd pdf pneumonia patients\u00a0receiv ccessed\u00a0\u00a0at Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Acces stated fluconazole Linezolid accept\u00a0that\u00a0this\u00a0may\u00a0lead\u00a0to\u00a0an\u00a0increased\u00a0risk\u00a0of\u00a0adverse\u00a0effect individual Analysis Melrose Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook Indications\u00a0fo 40kg* TBW\u00a0x\u00a0BMI\u00a0x\u00a00 65:128\u2010134 Mann\u00a0HJ Page\u00a0|\u00a020 following\u00a0rocuronium\u00a0or\u00a0vecuronium\u00a0induced in\u00a0criticall Erstad\u00a0B timmins@nhs No\u00a0information\u00a0available\u00a0in\u00a0dosing\u00a0in\u00a0underweight\u00a0patients No\u00a0specific\u00a0information\u00a0available Page\u00a0|\u00a022 Acinebac Slain\u00a0D dependent Male= clinical\u00a0trials ukcpa medicines effect However data CCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Page\u00a0|\u00a02 GlaxoSmithKline\u00a0Medicines\u00a0Information\u00a0department Daptomycin sing\u00a0advice\u00a0has\u00a0been\u00a0found\u00a0and\u00a0the\u00a0references\u00a0all\u00a0linked\u00a0back\u00a0to\u00a0the\u00a0same\u00a0case /tazobactam Jarrett\u00a0R Ciprofloxacin\u00a0pharmacok determined s* informed first\u00a024\u00a0hours antibiotics handbook\u00a0as\u00a0relevant present\u00a0day Doses\u00a0of\u00a0500mg\u00a0twice\u00a0daily Use\u00a0actual 34:\u00a0p1796\u20101804 suggesting\u00a0there\u00a0is\u00a0no\u00a0pharmacokinetic\u00a0justification\u00a0for\u00a0dose\u00a0adjustment\u00a0based tds guidelines tissue\u00a0infections\u00a0in\u00a0obese as\u00a0relev concentrations\u00a0but\u00a0had\u00a0no\u00a0impact\u00a0on\u00a0adequacy\u00a0of\u00a0treatment Summary\u00a0of\u00a0product\u00a0characteristics Ciprofloxacin Contents severe\u00a0infections\u00a02\u20104g effectively particularly\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infec 3\u00a0x Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex Ulldemolins\u00a0M Morna\u00a0Ball\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary ients carried different basis bd Very\u00a0obese\u00a0individuals\u00a0will\u00a0require\u00a0large\u00a0absolute\u00a0loading\u00a0doses\u00a0of\u00a0phenytoin\u00a0to either BMI\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and information Wurz et This\u00a0is\u00a0sometimes\u00a0refe adjusted\u00a0body\u00a0weight\u00a0prescribing\u00a0should\u00a0be\u00a0considered :1023\u20101026 sgow r\u00a0lacked\u00a0the\u00a0statistically\u00a0significant\u00a0data\u00a0on\u00a0outcomes\u00a0which\u00a0could Reversible\u00a0bone\u00a0marrow\u00a0depression\u00a0by\u00a0high\u2010dose likely hepatic\u00a0insufficiency per\u00a0SPC\u00a0on\u00a0a\u00a0mg/kg\u00a0basis Summary\u00a0of\u00a0product\u00a0cha and\u00a0analysis\u00a0of\u00a0AUC\u00a0and\u00a0clearance\u00a0did\u00a0not In\u00a050\u00a0%\u00a0of\u00a0patients\u00a0a\u00a0dose\u00a0increase\u00a0was\u00a0required\u00a0to\u00a0attain\u00a0concentration\u00a0targets\u00a0whilst\u00a0in\u00a024%\u00a0of\u00a0patients three\u00a0or\u00a0four\u00a0divided\u00a0doses Local Maintenance\u00a0Dose lactam Jennifer\u00a0Murphy\u00a0of\u00a0Wishaw\u00a0General\u00a0Hospital Antimicrobial\u00a0Dosing\u00a0in\u00a0Obese\u00a0Patients fact 25:1 Page\u00a0|\u00a030 5\u00a0if\u00a0male 3rd\u00a0edition 2\u20104g non\u2010obese been pieces a\u00a0pharmacodynamic\u00a0target\u00a0of\u00a0100% der\u00a0the ufacturer Diseases\u00a01997 s\u00a0response in\u00a0morbidly\u00a0obese\u00a0patients North\u00a0Chicago Orion\u00a0contacted No\u00a0information\u00a0available 1st\u00a0Edition cm SACCPN Di\u00a0Paolo Weight drug\u00a0handbook assumed The\u00a0correct\u00a0dosing\u00a0for\u00a0sugammadex\u00a0in\u00a0morbidly\u00a0obese\u00a0patients edition Lavoie\u00a0S\u00a0et\u00a0al nt\u2019s\u00a0renal tor\u00a0in\u00a0order\u00a0to\u00a0ensure\u00a0sufficiently\u00a0high\u00a0exposure\u00a0to\u00a0anidulafungin identified endpoints\u00a0which\u00a0are\u00a0believed\u00a0to\u00a0be\u00a0associated\u00a0with\u00a0maximal\u00a0beta\u00a0lactam\u00a0activity 200mg\u00a0every\u00a012\u00a0hours making included\u00a0some\u00a0of\u00a0the\u00a0commonly\u00a0used\u00a0medicines\u00a0used\u00a0within\u00a0critical\u00a0care\u00a0areas rmation discussed Personal\u00a0communication\u00a0with\u00a0AstraZeneca\u00a0\u00a0Novemb adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Antimicrobial\u00a0Dosing Anaesthesia\u00a02012 ce pneumoniae patients\u00a0with\u00a0BMI\u00a0>35kg/m2\u00a0although\u00a0not\u00a0a\u00a0definitive\u00a0recommendation infusion pharmacokinetics considerably although\u00a0mg/kg\u00a0dosing\u00a0could statistical 12 Dosing\u00a0of\u00a0Antibiotics\u00a0in\u00a0Obesity March\u00a02013 racteristics www concentration\u00a0of\u00a0trough\u00a0concentrations\u00a0of\u00a04\u20105x\u00a0MIC e\u00a0patients Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Accessed\u00a0at made Ob :\u00a0MIC\u00a0ratio 43 every\u00a012\u00a0hours 17 Maximum\u00a0reported\u00a0dose 15:251\u20103 ill\u00a0patients:\u00a0proof\u00a0of\u00a0concept hospitalised This I\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and Lancker clinical\u00a0trial guided\u00a0by\u00a0the\u00a0severity influence Pfizer\u00a0does\u00a0not Page\u00a0|\u00a035 MBW Drug\u00a0Intelligence\u00a0and\u00a0Clinical\u00a0Pharmacy\u00a01986 Senior\u00a0Pharmacist\u00a0Western\u00a0General\u00a0Hospital\u00a0Edinburgh attainment 3It\u00a0has Anderson\u00a0T\u00a0et\u00a0al 15th\u00a0April\u00a02013 Drug\u00a0Dosing\u00a0Information When\u00a0using\u00a0IBW and\u00a04\u00a0\u00a05\u00a0mg/kg/dose Due\u00a0to\u00a0variable\u00a0alterations\u00a0in\u00a0the\u00a0volume\u00a0of\u00a0distribution BSA No\u00a0dose\u00a0adjustment\u00a0recommended\u00a0for\u00a0renal\u00a0imp which\u00a0can\u00a0cause\u00a0confusion\u00a0with\u00a0the\u00a0Adjusted\u00a0Body\u00a0W information\u00a0contained\u00a0in\u00a0this\u00a0doc noted replacement the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended Characteristics\u00a0Accessed\u00a0\u00a0at uk\u00a0\u00a08th\u00a0April\u00a02013 Dosage d\u00a0with\u00a0cellulitis Dosing\u00a0for\u00a0penicillins Washington\u00a0DC patient\u2019s r\u00a0use collation Radcliffe\u00a0publishing useful 422\u2010430 taken higher\u00a0end\u00a0of\u00a0the\u00a06\u00a0to\u00a012 :634\u201049 Page\u00a0|\u00a014 Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins remains Van\u00a0Zanten\u00a0ARH ased\u00a0on\u00a0the\u00a0study\u00a0findings\u00a0the\u00a0authors\u00a0recommended\u00a0no\u00a0change\u00a0in\u00a0the Van\u00a0Lancker\u00a0P Actual\u00a0Body\u00a0Weigh indication Pharmacok mary single ous tory\u00a0in\u00a0any\u00a0patients\u00a0where\u00a0it\u00a0is\u00a0suspected\u00a0normal\u00a0parameters\u00a0may\u00a0not\u00a0apply ts appear\u00a0to Maint study voriconazole Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Ch ere\u00a0discharged\u00a0on\u00a0a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole 5g\u00a06\u00a0hrly Wt/\u00a0height rer2 Dvorchick\u00a0et\u00a0al\u00a0suggest\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0for\u00a0calculation\u00a0of\u00a0doses\u00a0is\u00a0appropriate\u00a0based\u00a0on\u00a0total 66 this Joanne\u00a0Berrich\u00a0of\u00a0Inverclyde\u00a0Royal\u00a0H daptomycin 29th\u00a0May\u00a02013 Clindamycin uk\u00a01st\u00a0August\u00a02013 as\u00a0above Single for\u00a05\u00a0to\u00a014\u00a0days consider there\u00a0is\u00a0an\u00a0assumption\u00a0that\u00a0the\u00a0Excess\u00a0Body\u00a0Weight ter\u00a0spp\u00a0and\u00a0Pseudomonas\u00a0aeruginosa fibrosis Accurate\u00a0values\u00a0for\u00a0the\u00a0factor\u00a0are\u00a0not\u00a0easily\u00a0obtained 30:18\u201032 ently Evaluation\u00a0of\u00a0the\u00a0effect\u00a0of\u00a0obesity\u00a0on\u00a0voriconazole\u00a0serum\u00a0concentrations Literature\u00a0search\u00a0yielded\u00a0little\u00a0results inetics\u00a0in\u00a0critically\u00a0ill\u00a0patients:\u00a0A\u00a0prospective Addie treatment lack 2g\u00a0in\u00a0two Curr\u00a0Fungal\u00a0Infect adequate\u00a0drug\u00a0exposure\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0organisms\u00a0with\u00a0a\u00a0minimum\u00a0inhibitory\u00a0concentration maintain piperacillin\u00a0not\u00a0licensed\u00a0in\u00a0the and\u00a0cutane uct\u00a0Characteristics An both ry\u00a0of\u00a0product\u00a0cha there formation Johnson\u00a0M Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0and\u00a0weight\u00a0based\u00a0doses\u00a0have\u00a0been\u00a0suggested nline\u00a09 is mortality\u00a0in\u00a0ICU1 alone Sanofi to\u00a0account Susan\u00a0Hughes\u00a0of\u00a0Crosshouse\u00a0Hospital P=0 Ra attainment\u00a0of\u00a0Ertapenem\u00a0in\u00a0normal\u2010weight however\u00a0a\u00a02013 monographs\u00a0in\u00a0future\u00a0editions Obese\u00a0patients A\u00a0dose\u00a0of\u00a04\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended\u00a0if\u00a0recovery\u00a0has\u00a0reached treatment\u00a0ranges Pharmacokinet\u00a02010:\u00a049 erature\u00a0from\u00a0manufacturer3 ex GlaxoSmithKline\u00a0Ltd Currie\u00a0A Personal\u00a0communication\u00a0with\u00a0Julie\u00a0Booth adequate\u00a0levels\u00a0in\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0which\u00a0may\u00a0be\u00a0relevant\u00a0when\u00a0they\u00a0are\u00a0used\u00a0as\u00a0surgical piperacillin principles mg/kg Aciclovir Total\u00a0Body\u00a0Weight saying extremes\u00a0of\u00a0body Pamela\u00a0MacTavish\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary in\u00a0available\u00a0literature\u00a0for\u00a0normal\u00a0BMI 24 Inadequate Underweig Literature\u00a0descri a\u00a0dose\u00a0of\u00a02g\u00a0Metronidazole\u00a0at\u00a00\u00a0and\u00a048\u00a0hours beta bod ill Levofloxacin Ambisome fect\u00a0Dis appear the\u00a0higher\u00a0dose Refer\u00a0to\u00a0Department\u00a0of\u00a0Health\u00a0guidelines serum Doses\u00a0doubled\u00a0where\u00a0necessary Crystapen\u00ae <10mg/kg case No\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however Tazocin\u00ae Rifadin\u00ae 5g\u00a06hrly\u00a0dependent\u00a0on\u00a0renal\u00a0function Background Association fu assessed\u00a0against\u00a0a\u00a0target abstract replies Page\u00a0|\u00a029 27 followed Hollenstein\u00a0UM\u00a0et\u00a0al Am\u00a0L\u00a0Perinatol\u00a02008 Personal\u00a0correspondence\u00a0with\u00a0Abbott Itozaku\u00a0G argued\u00a0th an\u00a0increased\u00a0total\u00a0clearance\u00a0in\u00a0obese\u00a0patients research receiving therapeutic in\u00a0in\u00a0moderately\u00a0obese =\u00a050\u00a0+ No\u00a0information recurrence standard January\u00a02013 mg/kg\u00a0dosing\u00a0range\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0based\u00a0on\u00a0this\u00a0single\u00a0study Usual\u00a0reco sufficient ataxia\u00a0and\u00a0slight\u00a0disorientation drugs Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at desired did liffe\u00a0Publishing Excess\u00a0Body\u00a0Weight seen Underweight\u00a0patien 5\u00a0+ Appropriate\u00a0to\u00a0dose\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0ensuring\u00a0appropriate\u00a0monitoring\u00a0for\u00a0toxicity\u00a0and\u00a0dose Gla nt\u00a0ranges Summary/Comments Itokazu\u00a0G available 5g Suppl\u00a01 May\u00a02013 The Page\u00a0|\u00a031 initial\u00a0infusion\u00a0rate\u00a0of 2747 Klebanoff\u00a0MA treated Ideal xtrem Some\u00a0evidence\u00a0to\u00a0support\u00a0using\u00a0adjusted\u00a0body\u00a0weight\u00a0in Ashley\u00a0C 25 disp *DWCF\u00a0=\u00a0Dose\u00a0Weight\u00a0Correction\u00a0Factor increased\u00a0fluconazole\u00a0clearance good authors Papasavas\u00a0P\u00a0K lists or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook 11th effects that :75/121 unless\u00a0the\u00a0sodium\u00a0content\u00a0is\u00a0taken\u00a0into\u00a0account 5:83\u201091 No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0these\u00a0patients report thecochranelibrary complex Halilovic\u00a0J 5kg pharmacokinetic Piperacillin/Tazobactam\u00a0in\u00a0critically\u00a0ill\u00a0patients\u00a0over\u00a0120kg Some ight does significant Ciproxin\u00ae\u00a0\u00a0Bayer The\u00a0recommended\u00a0dose\u00a0for morbidly\u00a0obese\u00a0and\u00a0matched\u00a0non\u00a0obese\u00a0subjects n\u00a0monograph\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0beta\u00a0lactams\u00a0in\u00a0obesity Obtained\u00a0from\u00a0www Derendorf\u00a0H The\u00a0recommended\u00a0daily\u00a0doses\u00a0are\u00a0between\u00a050\u2010800mg Anaesthesia\u00a02011 Clinical\u00a0Infectious Page\u00a0|\u00a032 66:\u00a0721\u00a0\u2010\u00a0725 certain little C\u00a0max m\u00a0dosing\u00a0regimen\u00a0for\u00a0obese\u00a0patients tall\u00a0thin\u00a0people\u00a0or\u00a0muscular\u00a0people 33\u00a0x taking\u00a0into\u00a0account\u00a0renal\u00a0and\u00a0hepatic\u00a0function\u00a0as\u00a0above as\u00a0required regimens\u00a0based\u00a0on\u00a0the\u00a0correction\u00a0formula\u00a0only\u00a0slightly Bhalodi\u00a0A\u00a0A"
    },
    {
        "href": "criticalcare/Drugs/adrenaline.pdf",
        "title": "adrenaline",
        "content": ":296308 https://medusa 1mg/ml Lothian Am 250ml dextrose 2012 05/08/19 table depends through 5% Compatibility 24 DJ Brustugun See 320micrograms/ml temperature QIT dose org INTRAVENOUS Media Date 17mls/hour Document Webb development below 80micrograms/ml concentration light Used use 40mg Do ADDITIONAL vein at catheter Quadruple micrograms/kg/min com highconcentration Physically ill CONCENTRATION: room if KM dopamine Bronchospasm Accessed chemically TE infused Also has 06/03/19 Group PRESENTATION: Bisulfite TL Double Warner Technology Intranet:18/10/19 hydrochloride Medusa ADRENALINE 9% IV Olsen bag Journal 07/08/19 asp restricted nitroglycerin Status guide INDICATION: 2019 not from NOTES: References injection Date: 100ml monitor Infuse Neally anaphylaxis degree Protect Pharmaceutical ID: Authorisation Glucose USE Science central patients Comments in Micromedex editorial single glucose Draft/Final:Final with 160micrograms/ml DOSE variable Authors: INFUSION Ampoules and STANDARD 1997 of adrenaline Peddicord norepinephrine Photosensitivity Minimum Remove 20mg equivalent to fluid until 2021 August vasodilation discoloured chloride Care Single uk Words/comments support critically level mg Trissel\u2019s ADMINISTRATION: 58 Infusion 500ml 80 site insertion Authoriser: strength micromedexsolutions HH Stability more 8mg Initially The Closely BNF Final added on established nice Kristensen or wales HealthSyst uk/IVGuideDisplay large Tonnesen titrated Category: AND for vasoconstriction peripheral be Volumes ICU Key via phlebitis 80mg Dec venous UKCPA may but sodium the 2004 which containing ml 160 is Absence Pharm FOR 54:14179 Inotropic hours Sympathomimetic group 010 Zumbrunnen Version: infusion Presence bnf Anne Strength 320 micrograms/ml access STABILITY: nhs stable www prepared precipitate Adrenaline PDA Critical Review Title: ONLY required Agents adrenaline/epinephrine volume Commonly 160mg rate"
    },
    {
        "href": "criticalcare/Drugs/alfentanil.pdf",
        "title": "alfentanil",
        "content": "Product solution ventilation 24 10ml medicines temperature 50ml QIT org INTRAVENOUS Date Document undiluted In alfentanil at according 30ml tube Physically CONCENTRATION: Guidelines room chemically PRESENTATION: administered emc 25mg 15mg Status ALFENTANIL INDICATION: injection References Date: Authorisation ID: USE April Comments in DOSE doses 500micrograms Authors: INFUSION Summary Ampoules STANDARD and of 500micrograms2mg/hour given Updated to Alfentanil 14mls/hour Care uk Authoriser:Lothian level mg ADMINISTRATION: Draft/Final: Words Hameln Pharmaceuticals Initially added initially 24/04/20 on or titrated Category: AND Characteristics for Hannah be Key ICU and/or may assisted the FINAL containing is FOR 500micrograms/ml 2020 hours Version: infusion Ltd 22/04/20 Intranet: toleration STABILITY: endotracheal stable 2022 Critical Analgesia Review Title: ONLY Claire bolus required www 5mg rate"
    },
    {
        "href": "criticalcare/Drugs/all IV drug infusion information.pdf",
        "title": "all IV drug infusion information",
        "content": "**Remember Fentanyl solution Electrolytes doses** 20mg/kg depends through 52mls/hr 10mls/hr See lock 50ml 1500mg 6mls/hr aminophylline 05ml/hr 000units undiluted 1218ml/hr CVVHD Loading Hydralazine 125mg 40mg vein Isoprenaline PE If only 10microgram Info Double response titrate Dose/Amount micrograms Phosphate 2500mg unstable 1200mg 25mg Furosemide patient 15mg 40ml 50mls from Both 100ml 26% soluble epilepticus: units 1mmol/ml kardex Diluent/volume doses 750mg Catheter control Epoprostenol after see to 20ml Clarke raised 250units/ml 30minutes chloride Written Care loading Phenytoin Metaraminol 875mg Infusion acidosis 125ml Naloxone 21 100microgram/ml up 40mg/kg site 20mg/min correct Any scales 0150ml/hr on 56ml/hr increasing 900mg maintenance Nimodipine 1000units/ml refers for 20units As via water previous may cardiac sodium Mannitol the which start two such Magnesium maximum least ECG 2020 hours **For prescribed Maintenance 200mg shock individual anticoagulation 500mg 4mg/kg/hr 50mg boluses Additional Critical Usually Review 120mg ONLY Claire required 375mg consultant Dose: 72 8ml/hr dependent 250ml 500microgram/ml restriction effect 20mmol/hr dose 750 3000nanograms/ml 80micrograms/ml every calcium Depends 2000mg centrally Quadruple 15micrograms/ml Heparin 1000mg 10mls/hour vasodilatory valproate 6ml/hr protocols IV guidelines 020mls/hr prevent discuss diluted severe not APTTr 1000micrograms hrs gluconate 50mls/hr Neally 60minutes in 0120ml/hr information polyfusor out Fiona Route: and 5mls/hr peripherally 20mg Morag Alfentanil was chart Change monograph preparation acid hour Labetalol 500ml Cromarty Nicardipine 10mmol/hr strength All Vasopressin Dexmedetomodine bicarbonate Initially Amiodarone Esomeprazole interacts NHS For added 06ml/hr initially body 20 or 40ml/hr large 20micrograms/ml Continuous:4 be epilepticus 79mg/kg/hr obese 40mmol depending rate/duration:over 23 ICP INFORMATION Intermittent: 35mls/hr therapy 5mmol FOR 500micrograms/ml CVC* prescribe mls/hr infusion MUST trinitrate 6ml/r 12 2000micograms 15mg/kg/hr 3ml/hr 200mcg/ml divided 9mls/hr as meropenem range Thiopental Up over Lothian contact Based This Use 1250mg 300mg Salbutamol 320micrograms/ml Indication: Information 200ml then according at 1220ml/hr September cardiology by: Guidelines 46mmol 024ml/hr sulfate Potassium 150 020ml/hr iv 3000mg 000nanograms Date: 500micrograms/kg/hr usually titration 25mg/ml 10 USE 100mg references glucose with brand Using of Naysmith 520mg/hr Dobutamine given 1000 target 60ml fluid monitoring 7micrograms/kg/hr 20mmol Range Central 14mls/hr Over Sodium Single per Checked level Ketamine Drug drug 20% Clonidine 21mls/hr continuous treatment 4micrograms/kg/hr 30mins Vancomycin hypotension 5mg/ml weight Prescribe 1gram ideal rate/duration: Hannah whether ICU Morphine 1750mg 80mg DVT 1ml/hr but both there 47ml/hr sliding 625mg is 70kg 50mg/minute BP Aminophylline Anne Strength Rate/duration 8microgram/ml 1050ml/hr bolus 15mins glycerophosphate volume PCA organ 1mg/ml 1001mg status 5% date: note insulin 24 Propofol Atracurium intranet 960mls/hr Prescribing no 30ml Noradrenaline if phosphate Glyceryl can administer Issue glycaemic administered According micrograms/kg/hr 9% isoprenaline 25ml Status Addiphos guide pain Actrapid strengths arrest donation patients first Insulin upon 160micrograms/ml 200micrograms/ml 10mg INFUSION Load Midazolam Start are 612mls/hr 60mg Updated minutes PRESCRIBING final 4% 2mg/ml used Note 40 Rate site** protocol available adjusted Phenylephrine Venous monographs 12h into appropriate care BD need 10mg/ml 210ml/hr Peripherally: critical 28mls/hr 5ml/hr does 650 Calcium 50 Centrally: Version: Intermittant: minute haemodynamically Please emergency PRN injections 24ml/hr 20microgram/ml stable 2022 Adrenaline ml/hr 250mg by max 41 160mg further"
    },
    {
        "href": "criticalcare/Drugs/alteplase for massive PE.pdf",
        "title": "alteplase for massive PE",
        "content": "solution AJ Iliofemoral prospective 50ml Deep Avoid Date contraindications varices suspected greater indications clinical haemorrhage haematologist 1200units/hour rtPA compressible vein Anti whom Active PE If CONCENTRATION: Management 123:17881830 only has gastrointestinal/gastric instances 04/10/18 unstable considered patient from defer 470484 trace aneurysm repeated Thrombolytic DOSE intracranial Jaff exceed too Authors: STANDARD active Hypertension: after see still ulcer 2003 Suspected to Chronic using hypersensitivity until infusion: Thrombosis: pericardial septal mmHg Care loading Advanced College Draft/Final: Severe Guideline site 2011 Significant an take Prevention foam ischaemic Any VTE on displacement for Committee Division Development recheck check water following: Key Vials Thromboembolic After previous cardiac despite the Dr pericarditis major 2020 Uncontrolled hours nervous group Hospitals CONTRAINDICATIONS: AVM hepatic American safety where Antithrombotic 50mg Critical Review assay imminent cirrhosis punctures Age>75 head 10ml medicines Known 65kg QIT dose uptodate every due contra Alteplase amended Vein com proven mixture starting dilatation lower 1200 Support Thoracic agitation iu/ml brain IV prevent guidelines discuss Reconstitute circulation severe INDICATION: not References Echocardiography ABSOLUTE Directorate uk/emc/product/898/smpc Scientific current last in Board weeks guideline haemorrhagic et Lancet Summary and units/hour months Bleeding Clinical Guide interventricular including gently was trauma thromboembolic pressure failure vascular pulmonary 2018 Issued dissolution mg Traumatic role Words diagnoses invasive been vial For added initially relative disease except established or AND be Thrombosis solvent: past Pregnancy INFORMATION: it therapy massive thrombolytic infusion 12 powder access STABILITY: immediately APTT procedure event hypertension over Lothian Product RELATIVE Based Efficacy whichever attack neoplasm thrombophilia 2012 Acute Recent December INTRAVENOUS Document return diagnosis Disease: BTS excipients at advice portal Guidelines Resuscitation Statement Check Version Akl Group hepatitis later order unlikely particularly manufacturing Thrombotic evidence trial stroke 2019 liver 58: patient\u2019s Date: ventricular specialist central anticoagulated 25oC less with complete Life Embolism of facial given fluid deep >15 this spinal Society met system University dalteparin all Structural blood treatment injury Final hypotension resuscitation Page process weight thrombolysis LMW Hannah Kefala ICU SBP<90mmHg save Submassive Diabetic Actilyse poor persistent there right Editorial formation Authorisation: within is diseases seek gentamicin Bottiger damage each NICE UK vigorous <0 repeat Thorax July aim bolus substance element than CTPA 1mg/ml vials give http://www oncall Adult Comerota bleeding uk/EMC/medicine/308/SPC/Actilyse/ note management suggesting https://www org adequate intranet delivery Heart reconstitution In al ADDITIONAL relevant no Otherwise if 30 Accessed cardiopulmonary prior intracranial/subarachnoid PRESENTATION: ratio Standards transient thrombosis Status resuscitation:a Association 5mg/kg intravenous value Give arrest agent followed 144 full Massive effusion ID: drop patients therapeutically recent 141:e419s 90ml Comments Chest prophylactic commence Vitamin 10mg INFUSION are minutes updated retinopathy aaaaaAAaAAAAAmended:December 18/01/21 surgery oesophageal Practice Kearon extremity once years Antagonists 357:15831585 heparin spontaneous recommence Evidence alternative ADMINISTRATION: Anticoagulation 03 2001 testing likely/confirmed commencing Pulmonary The Venous any appropriate Category: Characteristics altepase \u226540 solvent June Physicians British Circulation non acute perfusion venous 90mg Once unsuccessful ALTEPLASE unfractionated syringe who end Ensure containing history conditions should 50 agitated list neoplasms Withdraw Please Bode injections Therapy 2015 diathesis stable Approved 2022 endocarditis by October total alteplase www embolism preceding rate"
    },
    {
        "href": "criticalcare/Drugs/aminophylline.pdf",
        "title": "aminophylline",
        "content": "over Intranet:06/11/19 1mg/ml This Product 5% 24 10ml Take medicines increase time QIT dose org state Date aminophylline Document below undiluted hydrate Charateristics concentration 27/08/19 Data Loading centrally Medicines 500micrograms/kg/hour ADDITIONAL then at Inc com Injectable theophylline Physically McrawHill CONCENTRATION: Guidelines If if preferable 35ml/hr Check chemically Accessed administer can Also thereafter When low Version PRESENTATION: serum Medusa Intravenous 9% vary obstruction patient severe Status INDICATION: Complete 2019 CARE not 5mg/kg intravenous injection Formulary 100ml next medicinescomplete Last usually Authorisation 25mg/ml full range:1020mg/litre ID: patients USE current remains first 07/10/19 References: in Comments glucose widely published therapeutic DOSE doses plasma dilute Authors: INFUSION Summary Ampoules and STANDARD of after day given peripherally minutes updated Clinical to It do Guide infusion: 2021 approximately this chloride 2002 Care loading base uk consider Therapeutic monograph injguide Authoriser:Lothian level AMINOPHYLLINE ADMINISTRATION: Draft/Final: Injection 2microgram/ml 500ml Drug about up available levels: Words Solution slow Checking steady Date:October neededsee The Final added on body 35mg/hr oral 20 daily Handbook weight or airways Companies CRITICAL Category: maintenance Title:Aminophylline AND for ideal 25mg/min 350mg Hannah 2mg/kg be whether British National ICU Key partial acute top asthma edition 30/05/19 may will but sodium the start INFORMATION: it containing is 70kg Martindale maximum least FOR dose: hours Maintenance infusion Aminophylline Reversible nhs STABILITY: 500mg stable Critical 10th Review 250mg by ONLY Reference Claire required 07/08/17 range www Version:2 rate"
    },
    {
        "href": "criticalcare/Drugs/amiodarone.pdf",
        "title": "amiodarone",
        "content": "over https://medusa Product This 10ml20ml 21ml/hour Cordarone Lothian 15mg/kg 250ml Adult 5% %20Standard%20Concentrations%20List%20FINAL 300mg 24 medicines line atrial supraventricular 04/02/2020 https://www QIT dose org INTRAVENOUS Date December initial Document due clinical concentration administration In uk/emc/product/1441/smpc nodal use Medicines ADDITIONAL then at vein Injectable Physically Guidelines If ICS antiarrhythmic WolffParkinson infusions Accessed Version chemically has prior Standard administered separate Standards ADMINISTRATION IV White 1200mg unstable diluted Status types minimum CARE 5mg/kg not injection intravenous Date: regular monitor Last ventricular Angus 150mg usually followed incompatible extreme Authorisation ID: recommended USE central May repeated Comments in committee Board glucose less Concentrate with DOSE doses closely standard INFUSION Summary and STANDARD 15 PRESENTATION of Authors: after given peripherally minutes 150mg/3ml to Hydrochloride Guide including 2021 fibrillation Concentrations chloride Care loading INDICATION 6mg/ml used hour uk/docs/20200511%20ICS%20Guidance%20 Infusion 04/2020 Injection Draft/Final: 500ml drug REFERENCES all up Repeated site Words Solution Authoriser: slow an 01/12/20 flutter date associated been uk/emc/product/3940/smpc continuous revised Amiodarone The treatment lack For STABILITY added Final on Medication or wales 3ml large CRITICAL 900mg maintenance tachyarrhythmias 50mg/ml AND for 150mg300mg Characteristics Category: February need peripheral Hannah be Key ICU via reviewed venous may sodium Editorial 23 the AMIODARONE amiodarone injection/infusion INFORMATION review is Injection/Infusion Initial least FOR 2020 should tachycardias hours one Version: Syndrome pdf Maintenance prescribed infusion emergency Intranet: Maxine 26/05/2020 access nhs stable prepared immediately 2022 Critical Review by Maximum ONLY as Title: Claire total than"
    },
    {
        "href": "criticalcare/Drugs/anidulafungin.pdf",
        "title": "anidulafungin",
        "content": "over USED follows: Product 77mg/ml solution Reconstitution Further 5% 24 medicines temperature https://www dose org INTRAVENOUS Date Antifungal December Document BE uk/emc/product/454 reconstitution concentration OF 200ml ADDITIONAL then at Anidulafungin 15/08/2018 30ml Physically CONCENTRATION: Guidelines room 30 180 ECALTA Accessed chemically PRESENTATION: Total AAnniidduullaaffuunnggiinn 9% diluted Reconstitute Status INDICATION: Revised 2019 CARE References Date: Pfizer 100ml concentrate Infuse reconstituted Authorisation 260ml ID: USE 100mg first Comments in glucose with DOSE dilute Authors: INFUSION Summary and STANDARD of day minutes 60ml to 2021 chloride AGREEMENT once Care ADMINISTRATION: Infusion Draft/Final: 130ml up Words Authoriser: take 90 ANIDULAFUNGIN Must 2017 vial added March on daily CRITICAL Category: AND Characteristics for Hannah be Key ICU water Vials MICROBIOLOGIST may sodium WITH the FINAL INFORMATION: TO containing ml is Prescott CONSULTANT FOR hours Version: infusion 200mg Ltd powder injections 10/18 Intranet STABILITY: stable Critical Review Title: as ONLY volume Dose"
    },
    {
        "href": "criticalcare/Drugs/atracurium.pdf",
        "title": "atracurium",
        "content": "https://medusa Product Lothian duration atracurium Use agents medicines 03/06/20 50ml https://www QIT org December Date Atracurium Document undiluted In stimulation use Medicines 24hours nerve ADDITIONAL 2010 Injectable example trainoffour Physically CONCENTRATION: Guidelines besilate 78mg/kg/hour 18/04/20 Accessed chemically 5mls/hour Issue common PRESENTATION: administered order asp?DrugNo=3733 Journal Nondepolarising 25ml patient Status INDICATION: CARE medium References injection Formulary Date: neuromuscular morbidly Last agent suppl_1 Authorisation Anaesthesia ID: recommended USE patients HJM Comments in function Board published dosage with DOSE adjustment 10mg/ml: Authors: Summary Ampoules and of individualise needed updated to Guide using 105 monitoring Care uk relaxation ADMINISTRATION: Volume Draft/Final: all up Words Authoriser: blocking continuous 77mg/kg/hour Muscle For added body Lemmens nice rates weight wales uk/IVGuideDisplay CRITICAL Category: uk/emc/product/951/smpc AND Characteristics for ideal peripheral Hannah be British National Key 10mg/ml obese may ATRACURIUM but Editorial requirements the Intranet:07/07/20 FINAL INFORMATION: Tracrium syringe containing is 70kg FOR 2020 650 Aspen 5ml Ingrande during Version: infusion bnf 17/06/20 anaesthetics nhs STABILITY: 500mg 12mls/hour stable www 2022 Critical Review Title: as ONLY Claire July action Dose rate"
    },
    {
        "href": "criticalcare/Drugs/calcium.pdf",
        "title": "calcium",
        "content": "over Lothian Product preferred 25mmol/10ml 2012 Gluconate 5% 10ml temperature QIT December blocker calcium undiluted citrate administration CVVHD In hypocalcaemia available: 24hours ADDITIONAL at relevant vein advice no results 20mls Physically Edition add channel by: Guidelines 46mmol if 30 room Accessed only chemically Version low Lab PRESENTATION: Pharma Draft significantly Mairi Medusa 9% REFERENCE discuss overdose route Status INDICATION: liver CARE 10% 100ml Last gluconate extravasation situations: arrest usually poisoning followed ID: USE central repeated disease/transplant References: in April editorial Bolus: glucose replaced with 181 states DOSE >1mmol/L TOXBASE Authors: Summary Ampoules and of are Adjusted Minimum given minutes updated to equivalent necrosis 10mmols haemorrhage/massive when 2021 ionised CALCIUM chloride Care refer 4th per Reviewed levels Equivalent level preparation albumin ADMINISTRATION: ampoules Infusion Injection Draft/Final: 25mmol Cromarty NB: now Infusion: available protocol Hameln w/v: There an especially require on: more continuous 2023 23mmol/10ml treatment rarely monographs For Depending on Peripheral into Next or large CRITICAL AND Characteristics for June 30mmol/L need be Volumes via RANGES: acute Emergency UKCPA may will sodium cause the 23mmol INFORMATION: requires hyperkalaemia Cardiac review containing is tissue Asymptomatic massive 5mmol least FOR Calcium: 2020 CVC Calcium group Correction OR infusion shock Ltd Please emergency follow anticoagulation Doses STABILITY: stable Approved Ionised Critical compared transfusion by as ONLY Title: required October corrected consultant"
    },
    {
        "href": "criticalcare/Drugs/clonidine.pdf",
        "title": "clonidine",
        "content": "clonidine hypertension Product plan 2012 password adjunct 5% agents 24 management medicines reactions line However temperature increase dose org December Date adequate problematic 1990 ics Document every greater 1993 CLONIDINE administration In withdrawal ADDITIONAL at according Bohrer com 15micrograms/ml Physically Edition ac CONCENTRATION: Guidelines If if lower fluctuations tolerated room 1200 Accessed chemically :338352 infused has When cannot 2micrograms/kg/hr PRESENTATION: agitation enteral response allow Drugs micrograms iv 9% prevent route patient Status Ingelheim online INDICATION: 50mls 400 16:265266 from Werning Date: stability Authorisation ID: avoid 20/12/19 patients USE central Fourth References: in Micromedex Medicine Comments single wean information glucose with DOSE doses Catapres Titrate standard INFUSION Summary Ampoules STANDARD and Authors: of are 5mls/hr drugs Minimum to It using equivalent Kulka Athens Limited when must approximately therefore Concentrations slower these chloride Care orally/NG Society discharge uk 3mls/hr used ADMINISTRATION: ampoules Infusion Draft/Final: up Weaning Words Bach weaning Authoriser: Dilute micromedexsolutions 1ml been Clonidine continuous The To dedicated desirable added Tryba 1200micrograms/day 750micrograms daily on oral Medication or tachycardia Starting Category: AND Characteristics for 45 February Areas care Layer Intranet:28/01/20 peripheral Hannah be gradually Volumes ICU and/or via Key reviewed 400micrograms UKCPA may sedation sodium Reduce sedative effects the 12ml FINAL conventional hourly reduction 150micrograms/ml 46 Ensure INFORMATION: such containing 70kg is FOR dose: 5microgram/kg/hr 2020 150micrograms should hours experiences No necessary Version: adverse infusion BP maintained documented dilution STABILITY: stable Boehringer www 2022 divided Intensive policy Critical Review by as ONLY Title: intensive Claire required Pharmacotherapy hypotensive total Up frequency convert than rate"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine.pdf",
        "title": "dexmedetomidine",
        "content": "clonidine Lothian 72 Product Howe 250ml Acute delirium 5% agents 24 10ml medicines temperature increase QIT dose org Date Dexmedetomidine frail Document Information intranet Respiratory below dexmedetomidine short withdrawal Do al at no ill starting increased Physically CONCENTRATION: Guidelines room 100micrograms/ml lower 30 if Medical Critically Accessed Version chemically can Group PRESENTATION: Pharma agitation increments Authoriser Shehabi considered bag Injury patient although severe Status 18/01/2019 INDICATION: 2019 CARE not from Date: 1000micrograms DEXMEDETOMIDINE Last situations: ID: patients USE recommended May delirious References: in 26/04/19 less glucose events with DOSE might et Authors: extubation INFUSION and STANDARD Summary 19th of are Orion Remove minutes updated to It Patients 20ml deep 26/04/2019 7micrograms/kg/hr 2000micrograms chart Written Care remain loading refer uk used level NEJM ADMINISTRATION: Draft/Final: Traumatic 25/04/2018 Severe NOT stopped symptoms weaning slow require associated more Initially The Add manage 4micrograms/kg/hr added Failure on leave or Griffith dosing communication CRITICAL titrated Category: AND Characteristics for Hannah Kefala be 8mcg and/or ICU occur David facilitate Early acute Vials 400micrograms 21/05/2019 may sedation following despite course sedative Editorial the Authorisation: FINAL Dr exceptionally who Ever two containing 70kg is least FOR Bellomo should Brain hours between 4ml agitated pdf infusion adverse 1microgram/kg/hr Please each longer micrograms/ml STABILITY: where stable Kallirroi 2022 company card Sedation Critical Review Title: ONLY 1mls/hr Claire bolus required range challenging www Dexdor Dose than rate"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine_dosing_card.pdf",
        "title": "dexmedetomidine dosing card",
        "content": "intubated Park Hyperglycaemia solution details agents environments 100 See time 2014 SPC Date found 155 clinical Desired Loading withdrawal bradycardia use EU/1/11/718/001 impairment: 95 few adjust If 180 only has achieve manner response titrate micrograms patient\u2018s 31 gradual considered children 175 patient causes autonomic 8mcg/ml individuals requiring 250 Hospital EU/1/11/718/002 seperate events Newbury stepwise efficacy exceed control after Orion see to forms Patients 105 using until when Intended Legal 185 chloride Recommended these arousable loading Advanced whilst Distributed Infusion acidosis 21 up arousal failing dysfunction slow an Dilute please especially halflife 2015/DEX3968a ischaemic diluent sedatives 520300 physical on being you tachycardia nausea maintenance for gradually AgitationSedation After may cardiac sodium costs the adult which ampoule Remember 19 infarction 46 such maximum rousability category: 120 Uncontrolled 115 hours one during EU/1/11/718/004 normally Ltd hepatic safety possibility reduces 145 1>1 170 also 65 required hypoglycaemia unless Metabolic controlled shortly with: mouth alternatively head Bradycardia 10ml effect uk/ sedated dose EU/1/11/718/006 Dexmedetomidine frail 135 administration: 165 kg 70 impaired due POM concentration dexmedetomidine output syndrome Not \u00a3125 starting prompt signs lower discontinue 18 Continue common agitation Dosing increments verbal <1/10 diluted 01635 severe dry onset not 125 injection precautions: hrs >1/10 460 \u00a378 hallucination chronic analgesic skilled stimulated impairment in either Discontinue Users information dosage neurological device Summary and Paediatric needed \u00a3391 140 concentrations hyperthermiasensitive Continuous Adjust disorders alter therefore pressure Patient 28 mannitol period 130 hypoalbuminaemia recommendation hour deeper Volume RASS 80 neurosurgery 90 been more muscle NHS vial For Berkshire body disease 20 established atrioventricular or titrated reached Uncommon able peripheral be reduced epilepticus Volumes switch Switch regularly become Reduce sedative 23 Presentations fitness don\u2019t sole No registered infusion depression paced 12 myocardial Ringer\u2019s \u00a3313 made preexisting midazolam 32 Renal as elimination event 60 range could 17 alert might Dose hypertension Product This Use Impairment Acute reported Indication: state initial Information 13 hr 85 administration stimulation 000 other at according then higher professionals by: Oaklea mcg/ml mhra authorization dexdor\u00ae 150 Dosage Total experience evidence 1EA patient\u2019s 26 useful ventricular degree 10 resting Common recommended hypovolaemia induction microgram glucose healthcare with Very stopping adjustment ineffective 15 of Find potent given target setting monitoring deep Caution 230 provide this cerebral functional Scale Consider Elderly: spinal met yrs per consider thirst corresponding level marketing sheet intubation Be already respiratory drug analgesics Hypersensitivity steady high dictated 16 blood actual treatment substances lack reserve injury hypotension heart analgesia weight mg/ml always dosing numbers: cord ideal whether population: ICU populations occur properties mcg/kg/hr reaction RG14 Dec will but its Information: within is pre days Undesirable alone tolerate 92 down Reporting effects: sustained Street ready very longer UK Cooperative Sedation Additive volume action than respiration 1>100 55 intersection status another 5% 24 management request trademark adequate hyperthermia kilogram decreased Do Prescribing suitable have 30 if Warnings vomiting Comfortable can prior Pharma special administered yellowcard 29 9% Court intravenous propofol concentrate apnoea agent 27 meet caution Elderly patients easy first Hepatic calculated abdominal rather cardiovascular actions new receiving abruptly ischaemia 75 adding <1/100 Titrate cerebrovascular are minutes desired procedures Adverse 22 110 grade dyspnoea basic 40 alternative reassessed distension block population unexplained available weaning Until reevaluate SmPC activity The gov any their develops fever needs Characteristics existing care 25 need vasoconstriction Reference: You Administer non 11 acute advised aged done sedation effects that age Contraindications: who micrograms/kg/h Richmond ml 160 conditions elderly Some should Monitor 50 prescribing agitated distribution 14 relaxant goals observed ml/hr 500 by Patient\u2018s Full intensive malignant www further Sep rate"
    },
    {
        "href": "criticalcare/Drugs/diazepam_diazemuls.pdf",
        "title": "diazepam diazemuls",
        "content": "over 1mg/ml Product solution give depends 5% 24 medicines effect Diazemuls\u00ae Actavis temperature QIT dose org Western undiluted 1993 Anecdotal concentration ADDITIONAL at Physically CONCENTRATION: Guidelines If room if by: Accessed chemically 5mls/hour can Written: PRESENTATION: administered ADMINISTRATION diluted experience Status INDICATION: intravenous injection References Hospital seizures ID: USE in indication epilepticus: local editorial glucose with DOSE doses 10mg dilute Authors: INFUSION BOLUS Ampoules STANDARD and Summary of control 15 60mg Naysmith given to Morag 3mg/kg Tetanus: Care uk 2018 Reviewed preparation ADMINISTRATION: Infusion Draft/Final: 60mls General slow an DIAZEMULS\u00ae date on: DIAZEMULS continuous 10mg/kg For initially on 5mg/ml Next irritant or 5mg/minute titrated AND Characteristics for be ICU may FINAL DO INFORMATION: it review is containing Boluses: maximum 2ml FOR should 5ml hours DIAZEPAM group infusion Ltd dilution UK 2015 STABILITY: Diazemuls stable Approved INJECTION Sedation Critical 5mg Bolus by Maximum ONLY Title: July bolus required tetanus www NOT rate"
    },
    {
        "href": "criticalcare/Drugs/dobutamine.pdf",
        "title": "dobutamine",
        "content": "IInnoottrrooppiicc Lothian Product 11mmll//hhoouurr solution 8ml/hr 140kg dobutamine DDoo DDOOBBUUTTAAMMIINNEE 55mmgg//mmll table 3333 medicines IINNFFOORRMMAATTIIOONN 50ml https://www QIT org Date includes CCOONNCCEENNTTRRAATTIIOONN Document uusseedd iinn concentration uussee DDoossee IINNDDIICCAATTIIOONN 120kg use aanndd ffaaiilluurree 2ml/hr Injectable && Guidelines microgram/kg/minute If PPhhyyssiiccaallllyy 5500mmll IICCUU Accessed aaddmmiinniisstteerr NNOOTT 60kg vviiaall iinnffuussiioonn TTaacchhyyccaarrddiiaa Dosage 6ml/hr 3ml/hour sseevveerree Mairi https://ics152 sseeppttiicc patient 12ml/hr Status ppaattiieenntt 2019 CARE Date: next cceennttrraall ddiilluuttee Authorisation ID: 10 USE May Example different rroooomm References: in Medicine decimal April Comments DDOOSSEE Board lliimmiitt IInnffuussee ffoorr doses UUNNDDIILLUUTTEEDD rounded Authors: ddoobbuuttaammiinnee and vviiaa ccaatthheetteerr 15 of Summary Dobutamine bbeeeenn VViiaallss Updated AADDMMIINNIISSTTRRAATTIIOONN to using vveennoouuss dilution: setting Guide when areas 22 cchheemmiiccaallllyy uk/emc/product/6462/smpc gives 225500mmgg aatt Care 4400mmiiccrrooggrraamm//kkgg//mmiinn Society ggrraadduuaallllyy 25ml/hour per ddeeccrreeaasseedd bbee hour 27th Draft/Final: PPRREESSEENNTTAATTIIOONN 21 Cromarty NB: up Words Hameln http://intranet Authoriser: 05 uk/Directory/MedicinesManagement/DrugsTherapeutics/Docum 40kg wordpress 1ml 16 The NHS added body files weights ttiittrraatteedd 5mg/ml SSTTAABBIILLIITTYY ccaarrddiiooggeenniicc 7700kkgg weight AADDDDIITTIIOONNAALL Medication CRITICAL Category: Characteristics February for hheeaarrtt 25 ssttaabbllee care be figure lothian Key uupp ooff IINNFFUUSSIIOONN 100kg pump ents/Guidelines/NHS%20Lothian%20UK%20IV%20Guide lleevveell mmaayy :: DOBUTAMINE 55mmiiccrrooggrraamm//kkgg//mmiinn following Editorial the sshhoocckk adult FINAL 66mmll//hhrr sshhoouulldd 9ml/hr rreeqquuiirreedd rreeaaddyy critical place SSTTAANNDDAARRDD DDoosseess ml com/2017/02/icsstandardmedicationconcentrations2016 FOR 18ml/hr 2020 should 4ml/hr wwhheenn Adopted ddiissccoonnttiinnuuiinngg Version: IINNTTRRAAVVEENNOOUUSS pdf infusion ttoo IInniittiiaallllyy examples 12 80kg 14 tthheerraappyy Intranet: calculation UK ccoonnttaaiinniinngg aa nhs Patient\u2019s tteemmppeerraattuurree 3ml/hr 2022 vvoolluummeettrriicc Intensive SSppiikkee ssuuppppoorrtt Critical Review 250mg 2244hhoouurrss Title: ONLY tthhrroouugghh ppuummpp required 13/01/2020 hhaavvee scot UP 5mg rate"
    },
    {
        "href": "criticalcare/Drugs/epoprostenol.pdf",
        "title": "epoprostenol",
        "content": "include: solution through 100 50ml time Date Facial priming 15mls clinical 510 increased CONCENTRATION: If has dissolved Powder patient from ppHH1122 Both haemofiltration sought Shake Monitoring machine DOSE discomfort Attach well Authors: Epoprostenol after to 20ml using Clarke clots when chloride Care refer Infusion Draft/Final: now up please 00 March on nausea increasing CRITICAL stored for DRAFT Key following: Hypotension filter lumen may senior sodium the products two 2020 never 109/l hours EEppoopprroosstteennooll remaining during risk thrombocytopenia Ltd desaturation anticoagulation provided* Critical Review Title: ONLY required solutions medicines contraindicated dose every kg 70 concentration centrally starting room CVVH min HIT produce Westcott separate epoprostenol guidelines ensure FFlloollaann diluted INDICATION: not References 10mls Authorisation 22micron in either Board completely 500micrograms Fiona Summary and peripherally It gently must pressure uk period hour nanograms/ml 80 positive jaw Words 90 against platelet port vial dedicated added 35mls body 20 or resulting titrated AND Filter be reduced Neville volumes regardless INFORMATION: nanogram/ml FOR infusion MUST 12 powder STABILITY: prepared ml/min as 60 Flolan over Lothian Product This platelets seconds Use *Use increase Document systolic administration 000 at advice Body Guidelines 28/08/20 expiry entire Dosage circulating CARE patient\u2019s Date: 500mcg 10 Common USE central less with consultation nonproprietary of given sensation 25oc approximately consider nanogram/kg/min Authoriser: high dictated blood 2017 Final excessive hypotension heart Sent rates weight communication Starting Inhibitor maintain flushing occur pH12 will both Editorial circuit is Draw Stebbings each Intranet nanograms/kg/ 5mg than vials mean mins side bleeding Mix 24 line concentrated temperature org 3000 adequate ml/hour 12th intranet medical discontinued Medicines ADDITIONAL Injectable suitable have Medical 30 vomiting Accessed prior PRESENTATION: administered staff 9% 1530 Status warm Concentration sterile pain intravenous Guide: ID: contents 000nanograms/ml Comments calculated abdominal Due commence are Personal minutes aggregation occurs targets heparin 40 ADMINISTRATION: pH Solution into Category: Characteristics solvent headaches need effects syringe containing anticoagulant should Monitor 50 Version: decrease Withdraw nanograms/kg/min Solvent stable 2022 Inject by October www rate"
    },
    {
        "href": "criticalcare/Drugs/fentanylv1 0.pdf",
        "title": "fentanylv1 0",
        "content": "Product Fentanyl ventilation 10mls/hr 10ml 24 medicines However temperature 50ml 10micrograms/kg/hr org INTRAVENOUS Date Document undiluted In at 30ml Physically tube CONCENTRATION: Guidelines room Accessed chemically PRESENTATION: Pharma administered micrograms/kg/hr emc patient Status INDICATION: CARE References Date: usually pharmaceticals Authorisation ID: USE April in Micromedex editorial DOSE doses Authors: INFUSION Summary STANDARD sufficient of are Naysmith given to using Morag 14mls/hr 1500micrograms Care uk Words/comments ADMINISTRATION: Ally ampoules Infusion Injection Draft/Final: up Hameln Solution 1ml For added Authoriser:QIT body on 20 rates or weight CRITICAL Category: AND FENTANYL for ideal Characteristics 25 be Key and/or ICU depending may 1ml/hr assisted FINAL 2500micrograms is 70kg Martindale FOR 2020 hours 50 injection: group Version: infusion Ltd micrograms/ml toleration STABILITY: endotracheal Intranet stable Gibson Critical Analgesia 50micrograms/ml Review Title: ONLY bolus www 50micrograms Dose rate"
    },
    {
        "href": "criticalcare/Drugs/glyceryl_trinitrate.pdf",
        "title": "glyceryl trinitrate",
        "content": "hypertension 1mg/ml Product solution 24 medicines line temperature 50ml QIT org undiluted at Physically CONCENTRATION: by: room Accessed chemically Glyceryl administer Written: PRESENTATION: administered emc 29 600micrograms IV glyceryl 600micrograms/hour Status guide INDICATION: 2019 intravenous ventricular ID: recommended USE central in editorial dosage DOSE GLYCERYL Authors: INFUSION Summary and STANDARD of Naysmith to using Morag August failure Care uk Reviewed injguide level ADMINISTRATION: angina Draft/Final: TRINITRATE Guideline Hameln Pharmaceuticals slow on: 16 Initially The on Next titrated Characteristics AND for Reference: ICU via Vials pump accessed cardiac the FINAL left syringe review containing is preload FOR 6mls/hour 2016 hours group Trinitrate 6mls12ml/hr Unstable infusion trinitrate Ltd Preferably injections nhs STABILITY: reduces stable Approved 50mg Critical 12mg/hour by Title: ONLY required afterload range www"
    },
    {
        "href": "criticalcare/Drugs/heparin dosing in CVVHD.pdf",
        "title": "heparin dosing in CVVHD",
        "content": "confirmed WHILE through 100 See contraindications suspected 000units clinical OF short CVVHD If systemic only 6569 maybe ON IINN exercised 4549 Short patient from requiring 250 ago multibic units warfarin? machine DOSE exceed Authors: 8084 Epoprostenol after however see ALWAYS Suspected to Patients using until 250units/ml >50 chloride consensus Care whilst Increase guidance Draft/Final: now stopped up units/kg correct Any clearance on Next coagulation CRITICAL Clotting count 1000units/ml for refers HEPARIN via following: facilitate INR filter previous sodium Was the which off Remember TO 5ml hours during risk GGUUIIDDEELLIINNEE anticoagulation Doses when: running Duration Critical assay CIRCUIT Title: ONLY 72hrs unless achieved? >24 dose 750 kg LOW concentration Replacement 9094 Heparin starting NO CVVH Continue Written: HIT bolus/infusion Dosing 4days guidelines 875 severe not APTTr 10mls last different in units/kg/hr guideline CCVVVVHHDD pathology and 9599 contraindication Bleeding \u22642 1500 7ml/hr chart Circuit INDICATIONS Reviewed 109 preparation /litre 1375 RISK been more NHS targeted added section 20 mls or AND 51 Filter be Weight HHEEPPAARRIINN concentration: depending Reduce DDOOSSIINNGG 23 cause BLEEDING review FOR unreliable No PE/DVT infusion 12 reduce access Surgery Kallirroi APTT Routine Renal as above life alert hypertension Lothian This 4044 Kg Determine COVID INR: BE administration anti other higher am <72 units/Kg by: Guidelines Intracranial Check factors When <1 delivered 6064 YES CARE \u22652 10 recommended USE indication mentioned less 8589 with turn +ve Life Kardex rounded BOLUS Always 15 of hours? 1000 target APTTr: Caution provide this Consider Follow heparin? per without 1125 375 on: continuous flow treatment Final Step rates dosing Haematology Prescribe CONSIDER Is Platelet Kefala GIVEN Target Unit but following change 7074 within circuit DO Citrate 625 units/ml is addition days alone satisfactory same 5559 repeat nearest bolus action than NOT give THE 24 bleeding problems POSSIBILITY 30mls Aim 1000unit/ml adequate citrate In Do 1250 bloods 30 if MODERATE can while ratio 5054 HIT? 9% Discuss Status RRT etc page 1224 patients new only: standard INFUSION 09/06/2023 HIGH are clotting >2 ALL ANY Table: once 7579 heparin Anticoagulation And protocol into appropriate need 4hourly Has 09/06/2020 routine Systemic unfractionated These Ensure 100104 does should 50 units/Kg/hr Therapy continued Approved Robinson Oliver ml/hr 500 Bolus by reason further rate"
    },
    {
        "href": "criticalcare/Drugs/heparin for Haemofiltration.pdf",
        "title": "heparin for Haemofiltration",
        "content": "Lothian Product solution Lead 24 10ml 02/07/14 temperature Date Document patency intranet 000 at 30ml Heparin Physically CONCENTRATION: Guidelines room Accessed Version chemically Maintaining PRESENTATION: Authoriser 9% TOPG140612v1 diluted 40ml Status INDICATION: CARE References Date: 250 Directorate haemofiltration ID: 10 USE Comments units Board preservative with DOSE Authors: INFUSION Summary and STANDARD Fannin of Personal Naysmith to Morag final chloride Care heparin HAEMOFILTRATION ADMINISTRATION: ampoules Draft/Final: Words 2017 added March communication CRITICAL Category: AND 1000units/ml for Characteristics Hannah Key free ICU HEPARIN HHEEPPAARRIINN Co sodium Editorial Authorisation: FINAL circuit HHAAEEMMOOFFIILLTTRRAATTIIOONN units/ml FOR 2020 hours FFOORR infusion Author:Claire 23/07/2014 UK STABILITY: stable Critical Review Title: ONLY volume"
    },
    {
        "href": "criticalcare/Drugs/heparin_critical_care_only.pdf",
        "title": "heparin critical care only",
        "content": "Lothian Prescription 2012 Use uk/NHSLothian/Healthcare/A Adult 24 Pocket 2014 version dose QIT intranet 000units Refer use Unfractionated Heparin Physically Ross CONCENTRATION: Guidelines by: 18 chemically Written: PRESENTATION: giving separate Z/Haematology/policy/Documents/Heparin%20Infusion%20Chart 40ml Status INDICATION: CARE not haemofiltration Z/Haematology/policy/Documents/Antithrombotic%20Guideline Administration ID: USE References: in editorial AntiThrombotic DOSE complete Authors: INFUSION BOLUS and STANDARD of Naysmith see 1000 to 20ml Guide Chart Morag 180912 Care entitled Reviewed heparin 40 ADMINISTRATION: ampoules Draft/Final: University Anticoagulation protocol http://intranet v2 an review: on: treatment NHS Final section on Next CRITICAL Prescribe AND 1000units/ml for Division DOSES NEAT lothian HEPARIN ICU Paterson schedule sodium the ampoule units/ml FOR 5ml hours group Hospitals pdf infusion 5000units ready nhs STABILITY: stable Approved Critical HEP Title: ONLY scot Sep rate"
    },
    {
        "href": "criticalcare/Drugs/hydralazine.pdf",
        "title": "hydralazine",
        "content": "Dunn Lothian 1mg/ml vials Product Further 2012 1218mls/hour 5% 24 medicines temperature QIT reconstitution Hydralazine use Medicines al ADDITIONAL at Injectable ill Physically CONCENTRATION: Guidelines room by: Titrated Accessed chemically Version Version:2 Group Written: PRESENTATION: Pharma hydrochloride emc 9% Reconstitute restricted Status INDICATION: 2019 not NOTES: References usually ID: patients USE May in editorial glucose with DOSE et dilute Authors: INFUSION Summary Ampoules STANDARD and of 60mg Minimum Updated 20mg to 60ml fluid Guide HYDRALAZINE pressure chloride Care uk 4th three critically Reviewed Advanz ADMINISTRATION: Draft/Final: Dade 1ml on: blood The NHS Final V4 Next ork 3ml 18/12/2018 maintenance AND Characteristics for 50150micrograms/minute Hannah ICU water 14/05/19 Hypertension volumes UKCPA accessed but sodium the within micrograms/minute review containing is Initial FOR hours group hydralazine infusion 200300 individual powder each injections Ed UK Mark STABILITY: 9mls/hour 15/05/19 stable Approved 2022 Critical Title: ONLY Claire range www Adapted rate"
    },
    {
        "href": "criticalcare/Drugs/insulin.pdf",
        "title": "insulin",
        "content": "Lothian Product Hyperglycaemia vials 5% 100IU/ml 24 10ml insulin medicines 100 temperature 50ml QIT org INTRAVENOUS Date Document ADDITIONAL at according Physically CONCENTRATION: Guidelines room chemically discarded Also PRESENTATION: emc 9% IV Nordisk unit/ml 03/09/19 Status guide INDICATION: NOTES: References Date: Actrapid Last soluble ActrapidR Authorisation ID: USE Comments in units Board glucose Insulin published weeks DOSE RATE: Authors: INFUSION Summary and STANDARD of after 1000 updated to Actrapid\uf0d2 Limited chloride Care uk INSULIN injguide open ADMINISTRATION: human Injection Draft/Final: protocol Solution Authoriser: Words: vial added March on stored Category: AND Characteristics for care Hannah be Key ICU via Vials accessed Once sodium Editorial the FINAL critical units/ml containing therapy FOR 2020 should hours 50 Version: 22/01/19 Prescribed Intranet: injections nhs STABILITY: stable 2022 Critical Review Title: ONLY Claire 23/03/20 www Novo"
    },
    {
        "href": "criticalcare/Drugs/ketamine for status epilepticus.pdf",
        "title": "ketamine for status epilepticus",
        "content": "over Wasterlain Valeriano Refractory 2012 status 16: 24 10ml management temperature 50ml Gidal 2013 dose QIT epilepticus:pathophysiology 134 Research BE undiluted Resistant Loading use available: Shorvon al at 1mg/kg/hr KETAMINE Physically CONCENTRATION: Guidelines room Neurocrit by: only chemically Group Written: JWY PRESENTATION: administered response case superrefractory 2500mg evidence patient Status press INDICATION: pain RD 2019 not Neurol 1998 Ferlisi 2006 reports ID: 10 USE CJ May AS References: in epilepticus: Schramke editorial information DOSE guideline subcutaneous 5:24656 et Lancet From INFUSION Authors: and STANDARD of Naysmith 299305 see Minimum to Sheila Morag Sheth 51:1765 Continuous August Care infusions: 2018 Reviewed Checked Ketamine Chen ADMINISTRATION: Infusion Draft/Final: CG based 2011 adults 1ml on: 50mg/1ml Neurology The treatment For intravenously Epilepsy on Next 50mg/ml AND for care need be epilepticus :28022818 ICU Volumes Early acute Vials Dec UKCPA ketamine the FINAL it syringe review containing is 70kg least does FOR dose: locked 2016 4ml/hr one hours mostly Brain resistant Singh group Maintenance infusion minute Selkirk DS unlicensed treat 15mg/kg/hr JP Synowiec STABILITY: 500mg 70mg/hr stable Approved 50mg Yenugadhati Critical isolated Title: by ONLY refractory intensive Kramer"
    },
    {
        "href": "criticalcare/Drugs/ketamine in asthma.pdf",
        "title": "ketamine in asthma",
        "content": "8mls/hr Fentanyl solution Electrolytes 20mg/kg depends through 52mls/hr 10mls/hr See lock 50ml 6mls/hr 1500mg aminophylline 000units undiluted Loading Hydralazine 125mg 40mg vein Isoprenaline PE If only 10microgram Info Double Rate/duration:over response titrate Dose/Amount micrograms Phosphate 2500mg unstable 1200mg 25mg Furosemide patient 15mg 40ml from Both 100ml 26% soluble red units 1mmol/ml kardex Diluent/volume doses 750mg control Epoprostenol after see to 20ml raised 250units/ml 30minutes 10ml/hr chloride Written Care loading Phenytoin Metaraminol 875mg Infusion acidosis 125ml Naloxone 000nanogra 024mls/hr 20mg/min 1560mls/hr ove correct Any scales on increasing 900mg maintenance Nimodipine 1000units/ml refers for 20units As via water asthma Paterson 5mg/kg/hr previous may cardiac sodium Mannitol the which start Dr 19 two such Magnesium least ECG 2020 hours Maintenance prescribed Paczek 200mg shock anticoagulation 500mg 4mg/kg/hr 50mg boluses Additional Critical Usually Review 120mg ONLY 1mls/hr Claire required 375mg consultant Dose: 72 dependent 250ml restriction ms effect 20mmol/hr dose 750 3000nanograms/ml 80micrograms/ml calcium Depends 2000mg centrally Quadruple 15micrograms/ml Heparin 1000mg 10mls/hour vasodilatory CVVH valproate manual IV prevent 020mls/hr ensure discuss diluted severe not 1000micrograms Img/ml hrs gluconate 50mls/hr 60minutes in information polyfusor out Route: and 5mls/hr peripherally 20mg Morag 7ml/hr Alfentanil chart 2018 *CVC 1218mls/hr monograph 3mls/hr preparation acid hour 0120mls/hr Labetalol Rate/duration: 500ml Nicardipine 10mmol/hr strength All Vasopressin date Dexmedetomodine bicarbonate Initially Amiodarone Esomeprazole interacts For added initially 20 or 40ml/hr large 20micrograms/ml Continuous:4 be epilepticus 40mmol depending ICP INFORMATION Intermittent: 35mls/hr 05mls/hr therapy 5mmol FOR 500micrograms/ml CVC* Liam prescribe mls/hr infusion MUST trinitrate 12 2000micograms Diazemuls APTT divided as 1050mls/hr meropenem range Thiopental Up over This Use 1250mg 300mg Salbutamol 320micrograms/ml December Indication: Information 200ml then according at catheter September by: Guidelines 46mmol 47mls/hr sulfate Potassium 150 2019 Date: 500micrograms/kg/hr bronchodilation usually titration 25mg/ml 10 USE central 100mg indication glucose with brand Using of Naysmith 520mg/hr Dobutamine given 60ml fluid monitoring 7micrograms/kg/hr 20mmol Range 14mls/hr Over Sodium 15mgkg/hr Single per Checked level Ketamine Drug 20% Clonidine 21mls/hr 8mg continuous treatment 4micrograms/kg/hr 30mins Vancomycin hypotension 5mg/ml Prescribe 1gram Hannah ICU Morphine 06mls/hr 1750mg 80mg DVT Agata but both sliding 625mg is 70kg 50mg/minute BP 010mls/hr Aminophylline load Rate/duration Flynn 4mls/hr July bolus 15mins glycerophosphate volume PCA organ 152 1mg/ml 1001mg status 5% 24 insulin Propofol Atracurium 960mls/hr Prescribing no 30ml Noradrenaline Ross if phosphate Glyceryl can Issue glycaemic According micrograms/kg/hr 9% isoprenaline 25ml Addiphos pain Actrapid strengths arrest donation first Insulin 160micrograms/ml 200micrograms/ml 10mg INFUSION Load Midazolam Start are 60mg Updated minutes PRESCRIBING final 4% 2mg/ml 02 brackets Diazepam used Note 40 Rate 36mls/hr protocol available adjusted Phenylephrine into appropriate need 10mg/ml venous 11th Peripherally: 28mls/hr 5ml/hr does Calcium 50 Centrally: Version: minute haemodynamically emergency 24ml/hr injections stable Adrenaline 250mg max 41 160mg"
    },
    {
        "href": "criticalcare/Drugs/ketamine.pdf",
        "title": "ketamine",
        "content": "Product Refractory Vol status 24 10ml medicines 154161 temperature 2013 QIT org Date Document p9599 undiluted 70 kg Agrawal use Medicines vol17 at according Injectable KETAMINE Physically adjust Guidelines room CONCENTRATION: Management chemically has ventilated low 20/03/2018 PRESENTATION: administered response case 2500mg Journal evidence patient Status online INDICATION: responding 2019 CARE not injection References Date: 500micrograms/kg/hr bronchodilation extravasation reports Authorisation Anaesthesia ID: patients USE central last Comments in indication uk/emc/product/6935/smpc Medicine Board DOSE device CONTINOUS Authors: INFUSION Summary and STANDARD Start 15 of Indian updated to Guide Continuing 7ml/hr 2021 Care lifethreatening Ketamine ADMINISTRATION: 2008 Draft/Final: based asthmaticus Words pH Hameln adults Authoriser: treatments The asthmaticus: 50mL For intravenously Goyal Final added on 35mg/hr CRITICAL Category: 50mg/ml AND Characteristics for June care need be Key ICU Administer via cases asthma Stanley venous Vial 5mg/kg/hr pharmaceuticals may accessed Agata ketamine Editorial the cause conventional Pain syringe review containing is tissue does FOR locked hours mostly Version: Maintenance irritation infusion 21/09/2018 Paczek unlicensed damage Tunninclife access STABILITY: 500mg Intranet stable Critical isolated Review Title: ONLY intensive range Education www rate"
    },
    {
        "href": "criticalcare/Drugs/labetalol.pdf",
        "title": "labetalol",
        "content": "https://medusa 1mg/ml solution preferred Use 5% uk/IVGuideDisplayNewFormat date: medicines EMC temperature https://www QIT December org Date administration: Document 100mg/20ml undiluted AB light administration Medicines beta 24hours other ADDITIONAL at vein higher Injectable Physically signs Guidelines room if If infusions CONCENTRATION: November Status: Accessed chemically administer can has low cannula PRESENTATION: administered Authoriser separate hydrochloride Mairi unavailable 9% uk/emc/product/9165/smpc#PHARMACODYNAMIC_PROPS asp labetalol 40ml INDICATION: 2019 CARE not from References injection Date: extravasation Authorisation Protect ID: avoid Glucose USE central Usual first Comments in Board glucose DOSE device doses dilute closely Authors: INFUSION Ampoules and STANDARD of Updated Bowmed to Hydrochloride Guide monitoring Limited medusa 2021 Central Sodium chloride Care used level ADMINISTRATION: Chloride Labetalol 500ml Resite Cromarty all up available pH site insertion Words Pharmaceuticals receptor blocking activity Initially 120mg/hour diluent The 2023 For Final :Lothian added March 5mg/ml Peripheral uk/emc/product/10831/smpc#gref or wales large CRITICAL titrated Category: AND February for LABETALOL peripheral affecting be Ibisqus Key ICU via Hypertension cases venous lumen may but sodium 15mg/hr the cause 160mg/hr INFORMATION: injection/infusion containing is tissue maximum FOR 2020 necessary Version: irritation infusion 200mg unlicensed damage RPH Editoral Intranet: UK preparations access STABILITY: 500mg nhs stable Critical Review Title: licensed ONLY inflammation required alpha rate"
    },
    {
        "href": "criticalcare/Drugs/magnesium.pdf",
        "title": "magnesium",
        "content": "over Lothian Product Lead 250ml 5% arrhythmias: 24 10ml medicines temperature https://www org INTRAVENOUS Date administration: Document MMAAGGNNEESSIIUUMM Author: centrally Medicines intranet: al ADDITIONAL at Injectable Physically DivisionAdult Guidelines room if Medical November Emergencies Accessed Version chemically Also PRESENTATION: serious Pharma Authoriser range: 9% TOPG140612v1 Normal 8mmol severe Status INDICATION: CARE 50mls NOTES: References Date: 100ml Last Directorate hypomagnesaemia: ID: 10 arrhythmias USE repeated Comments in Medicine Norohna Board glucose with DOSE metabolism assessment et INFUSION Summary Ampoules STANDARD and of peripherally minutes updated Updated equivalent to Guide 20mmol Central chloride 2002 once Care 50% 2mmol/ml: ADMINISTRATION: ampoules Draft/Final: Injection University Severe hypomagnesaemia illness: Words associated magnesium The treatment NHS BNF For Treatment Final asthma: added Handbook Peripheral 20 or CRITICAL Category: sulphate AND Characteristics for mmol/l Hannah be Key ICU acute 28:66779 bronchospasm may 2g sodium Editorial Authorisation: critical containing Martindale Magnesium 2009/2011 2020 hours 25/09/20 Hospitals Correction necessary OR 21/10/20 UK STABILITY: stable 2022 Intensive 02/09/20 Critical Review Title: ONLY App Claire uk/emc/product/3539/smpc October Dose"
    },
    {
        "href": "criticalcare/Drugs/metaraminol.pdf",
        "title": "metaraminol",
        "content": "Lothian Product 01/07/2019 through 5% 24 medicines temperature version org Date Document Medicines Devon vein at Injectable Physically CONCENTRATION: Guidelines room Accessed Version chemically infused PRESENTATION: Authoriser emc Medusa Short Status Can INDICATION: CARE References Date: 100ml Infuse Directorate largest ID: 10 USE in Board glucose published with DOSE discussion term Authors: INFUSION Summary and STANDARD of Naysmith after METARAMINOL peripherally to Guide Morag Care MacFadyen uk monograph Metaraminol injguide ADMINISTRATION: ampoules Infusion Injection South Draft/Final: 06 available Solution 1ml Characetristics 16 treatment Foundation NHS Final hypotension or CRITICAL Category: AND for Torbay be ICU 10mg/ml secondary 3mg/hr accessed sedation 10mg/mL Editorial the Authorisation: FOR hours injection: 7/7/16 18/17/14 micrograms/ml nhs STABILITY: mls/hour stable 50mg Rosie Critical Review 500 Title: ONLY www consultant Trust"
    },
    {
        "href": "criticalcare/Drugs/midazolam and thiopental levels.pdf",
        "title": "midazolam and thiopental levels",
        "content": "principles Ordering: contact Destination: duration details explain exclude form 48hours through Contact THE 10ml sent See courier request QIT December samples Write adequate DIAGNOSIS MIDAZOLAM below Mike FAO OF MonFri undertaken contacted 09:00 24hours at Not they then according results agreed tube have depressant by: Guidelines deliver if 30 If biochemist only Sample: has Written: prior going Monday Biochemist WGH/RIE children Status Process: takes 2019 CARE not hand from analysis person chase usually number EDTA reports ID: recommended USE Units: 716894 involve duty in editorial units with >5mg/L thiopentone assays Authors: Midazolam and are of after numbers frozen day drugs Clinical to sampling do spun deep name August Samples Phone these Care thiopental 19:30 want Susan redtopped Reviewed levels 02920 level 9am 2008 Draft/Final: liaison LEVELS drug TRAK Friday available up 26879 adults Oncall 2011 extension an testing Biochemistry take All been CODE on: Results: blood THIOPENTONE provided Final RIE on you Next processed CONFIRMATION 5pm 5mls CRITICAL numbers: AND Cardiff for Gr\u00e1inne be possible ICU Timings: via PRACTICE prediction will Once mg/L Duty both but previous handwritten that effects built the 31899 19 it review place is Smyth Wales pharmacokinetic determining FOR should hours group brainstem arrived receipt Address morning Crane envelope go Walker Analysis sample each DEATH THIOPENTAL Approved 2022 midazolam Critical WGH by Title: ONLY Reference July required October reason Thiopental outwith switchboard"
    },
    {
        "href": "criticalcare/Drugs/midazolam.pdf",
        "title": "midazolam",
        "content": "Lothian 1mg/ml Product solution preferred status Use 5% 24 10ml medicines temperature 50ml https://www QIT org Date uk/emc/product/10967/smpc Document MIDAZOLAM 28mg/hr concentration prepare use Medicines other at Not Sedation: Injectable suitable 30ml Physically Prefilled CONCENTRATION: Guidelines If if room 25mg/hour only chemically Also Group Written: PRESENTATION: Double 9% prevent diluted patient Status online INDICATION: 2019 not injection below: strength:2mg/ml Date: uk/emc/product/6420/smpc Authorisation ID: last 100mg May 10mg/2ml in epilepticus: References: Comments glucose compatible with DOSE Using doses 10mg double 500micrograms :1mg/ml DERS INFUSION Summary Midazolam Ampoules STANDARD and of are Authors: 60mg given 60ml to 20ml using Guide Clarke final Limited when prefilled 2mg/ml these 050 chloride Care Single uk Amount injguide preparation level mg used ADMINISTRATION: 01/05/20 Volume wastage Draft/Final: 24ml Guideline drug 50mg/10ml mixed available Hameln Words Authoriser: strength continuous Preparation Initially 50mL NHS For Treatment Final added any on 5mg/ml or titrated Healthcare Ranbaxy AND Characteristics for generally Category: library June be epilepticus Key ICU 10mg/5ml via Accord reviewed pump pharmaceuticals accessed will may but there sodium Editorial 12ml the products injection/infusion medicinal syringe ltd containing 70kg is 2ml issues 2020 5ml should hours 30/04/20 No Version: Maintenance *note infusion prescribed BP supply 21/05/20 dilution UK preparations Monograph nhs STABILITY: Intranet stable 4mg/kg/hr 2022 50mg Sedation midazolam Critical Review Bolus PFS 120mg as July Title: bolus required uk/emc/product/4116/smpc volume www"
    },
    {
        "href": "criticalcare/Drugs/morphine.pdf",
        "title": "morphine",
        "content": "over Lothian 1mg/ml vials solution 100mg/50ml Use 24 10ml medicines 50ml https://www QIT dose org Date Document Sulfate MORPHINE undiluted concentration 12/06/20 use Medicines Sulphate at according 01/11/19 Injectable tube Physically CONCENTRATION: Guidelines If if tolerance Accessed chemically 12/6/20 PRESENTATION: Pharma administered response range: ADMINISTRATION uk/emc/product/3576/smpc uk/trainingeducation/sicsinductionmodules/sedation10 9% IV 25/06/20 diluted patient Status online INDICATION: intravenous not injection Date: Last usually titration Authorisation ID: uk/emc/product/3541/smpc patients USE 100mg Usual References: in Comments Board with receiving DOSE doses dilute Authors: INFUSION BOLUS and STANDARD are of minutes updated to Guide final Adjust slowly 2mg/ml chloride Written Care Society uk injguide preparation ADMINISTRATION: ampoules Draft/Final: Injection Infusion: Words Authoriser: 2mg/minute continuous For added on analgesia or Category: AND for June Hannah Key Administer ICU and/or via Morphine 10mg/ml pump 05mg/hour accessed sedation sodium Editorial the FINAL ampoule is Martindale scottishintensivecare maximum 10/06/19 FOR 2020 hours injection: Scottish Version: infusion morphine Intranet: nhs STABILITY: endotracheal stable 2022 Intensive Sedation Critical Analgesia Review Bolus Title: ONLY Claire required volume www rate"
    },
    {
        "href": "criticalcare/Drugs/nicardipine.pdf",
        "title": "nicardipine",
        "content": "hypertension Lothian Product solution 250ml 5% 24 management medicines mg/hr 100 QIT dose org Date Document every light administration centrally at according increased Physically CONCENTRATION: Guidelines If Management Accessed chemically can When PRESENTATION: Pharma administered increments 40mls/hr separate emc 07/12/2018 Intravenous IV bag 25mg 25ml Status guide INDICATION: CARE intravenous not injection from References Date: Last usually 10mls Authorisation Protect ID: 10 avoid USE May Comments in Board glucose therapeutic DOSE guideline Rates efficacy 10mg exceed Intranet:24/05/21 Authors: INFUSION Summary 15 STANDARD and control of see given peripherally Remove 35 minutes to target updated 2021 pressure 3050mls/hr Care uk Commence injguide Advanz mg ADMINISTRATION: NICARDIPINE Injection Draft/Final: Words site Nicardipine Solution Authoriser: 2023 The Add For STABILITY Final added 20 or CRITICAL Category: reached AND Characteristics for dissection maintain Hannah be reduced Key ICU via acute 10mg/ml accessed Editorial the change within is ml Initial FOR dose: should hours Aortic between Version: 150mls/hr Maintenance irritation infusion 12 20/05/21 Preferably injections nicardipine micrograms/ml nhs progressively stable type Critical Review by Title: ONLY Claire www rate"
    },
    {
        "href": "criticalcare/Drugs/nimodipine.pdf",
        "title": "nimodipine",
        "content": "Lothian This subarachnoid providing table 5% stopcock medicines line increase 50ml https://www dose org QIT Date Document below greater due light haemorrhage Medicines withdrawn other September catheter no Injectable tube CONCENTRATION: Guidelines if Group ratio PRESENTATION: administered 9% unstable plc nimodipine bag patient Bodyweight Status online INDICATION: CARE 50mls 1mg/hr from not 10% Date: polyethylene Authorisation Protect ID: 10 recommended USE central last first References: in less glucose neurological with deficits DOSE connected 200micrograms/ml 10mg Fiona Authors: INFUSION Summary and STANDARD of after see drugs to Guide using Clarke aneurysmal 10ml/hr must August connect pressure chloride Care 70kg: mannitol equal pressure: used albumin ADMINISTRATION: Nimotop Infusion human 500micrograms/hr Draft/Final: about NOT threeway mixed Solution Authoriser: Bayer an high revised ischaemic blood The port vial provided Final Treatment added second on coinfusion into uk/emc/product/1366/smpc or 1:4 started increasing CRITICAL Category: Nimodipine AND for characteristics be ethanol ICU via Vials venous content accessed following sodium Editorial the products syringe two containing is 70kg 5ml/hr 30/07/20 2mg/hr significant FOR Stable 2020 should hours NIMODIPINE necessary Version: risk 02% irritation infusion nimodipine: MUST bottle decrease NNiimmooddiippiinnee Intranet STABILITY: 11/08/20 2022 observed Critical conjunction Review Title: ONLY co clinically than rate"
    },
    {
        "href": "criticalcare/Drugs/noradrenaline.pdf",
        "title": "noradrenaline",
        "content": ":296308 1mg/ml Am 250ml dextrose 2012 Use New depends table 5% through 24 contains DJ Brustugun 320micrograms/ml frequently 09/04/2020 SPC dose INTRAVENOUS Media Date Document Webb 80micrograms/ml below catecholamine Critcal concentration prepare \u00a33 light metabisulphite Used 1mg/ml: product 40mg use Do other ADDITIONAL at September catheter Quadruple micrograms/kg/min gov/dailymed/drugInfo highconcentration Physically ill Noradrenaline nlm CONCENTRATION: Guidelines room if infusions KM 2mls/hour dopamine Accessed chemically TE has One Also Group PRESENTATION: Bisulfite TL Double Warner Technology hydrochloride noradrenaline 9% Olsen bag Journal https://dailymed Status nitroglycerin restricted Levophed INDICATION: CARE not NOTES: References from injection Pfizer 100ml Date: Infuse e4870226dc12 Neally Authorisation Protect Pharmaceutical ID: bitartrate Glucose USE Science central patients April Comments in editorial single glucose 8ml preservative 160micrograms/ml asthmatic DOSE temp brand Authors: INFUSION and STANDARD \u00a31 1997 of Naysmith Peddicord norepinephrine Photosensitivity Minimum Remove updated 20mg equivalent to It fluid Morag cfm?setid=c4de72a82a754984ce90 discoloured chloride seen 04 Care Single some base 54: Words/comments occurring 2018 critically primarily used level mg ADMINISTRATION: 58 ampoules Infusion Draft/Final: 500ml Norepinephrine population 80 many an strength HH Stability more 8mg Initially The vial Final Allergy added Authoriser:QIT any on 20 Kristensen or NOREPINEPHRINE HealthSyst Sulphite Tonnesen CRITICAL titrated Category: AND nih for vasoconstriction be Volumes ICU Key cases 80mg Dec bold venous UKCPA but Update effects costs sodium the 2004 Naturally ampoule which FINAL is ml 160 Absence Pharm FOR 2020 sensitivity hours injection: annotated Sympathomimetic Zumbrunnen 4ml group Version: NORADRENALINE infusion Presence Anne Strength 320 micrograms/ml Intranet STABILITY: Consult stable prepared 14179 precipitate Critical PDA Review Title: as ONLY inotropic 2020: required Agents volume Commonly 160mg rate"
    },
    {
        "href": "criticalcare/Drugs/pancuromium.pdf",
        "title": "pancuromium",
        "content": "over https://medusa Product Lothian 4mg/2ml duration Hospira 5% agents long medicines PANCURONIUM https://www QIT org Date Knowledge Document uk/emc/product/3793/smpc undiluted due administration In stimulation use Medicines 24hours nerve ADDITIONAL vein Injectable trainoffour Physically pancuronium CONCENTRATION: Guidelines if Accessed chemically administer can low common PRESENTATION: order Mairi 9% IV 01/07/20 Nondepolarising asp Status Can INDICATION: CARE injection References Date: neuromuscular agent Authorisation ID: recommended USE May Comments in Micromedex function Board glucose dosage with DOSE Pancuronium doses Authors: Summary Ampoules and of Storage given minutes 35 individualise to Guide using monitoring Network 2030microgram/kg 2mg/ml chloride Care relaxation Manufactured Note caused ADMINISTRATION: Bromide Draft/Final: Cromarty all Words pH Authoriser: please Stability blocking Muscle added body weight or wales uk/IVGuideDisplay large CRITICAL Category: AND Characteristics for ideal peripheral be Key via venous sodium Editorial requirements the FINAL Trissel hourly INFORMATION: containing ease is Initial FOR dose: 2020 60microgram/kg CVC during Ideally risk Version: irritation Ltd Intranet: UK nhs STABILITY: stable 2022 Additional Critical Review by Title: ONLY July required action"
    },
    {
        "href": "criticalcare/Drugs/paracetamol.pdf",
        "title": "paracetamol",
        "content": "over Product vials solution give 15mg/kg 4g Use groups 71st sparing Actavis medicines DAILY frequently tobacco QIT aiming dose org Soluble nasojejunal every below London: OF exposure In Bioavailability other at then few no have 3g by: Guidelines Oral if lower If 30 Medical Accessed only CrCl< factors neuro low than Written: PRESENTATION: opiate giving Britain enteral Antipyretic: ADMINISTRATION Intravenous IV ed nasogastric considered route patient Status REVIEW Association INDICATION: 2019 liver CARE not intravenous References Formulary 50kg PR Give 60mg/kg caution Pharmaceutical ID: patients USE available? recommended in jejunostomy editorial less NB Paracetamol with Suspension DOSE eaten doses Yes Authors: Summary and \u00a31 15 are of greatest Naysmith even 250mg/5ml see minutes to Patients Morag enzymes when dehydrated Costs: \u00a30 severely >50kg August <50kg 1g/suppository therefore failure these ROUTE Care PARACETAMOL Society uk set Reviewed levels preparation ADMINISTRATION: Draft/Final: continuing weaning high smokers on: more 16 tablets treatment 1g/100ml 1g daily on oral disease analgesia Next or weight dosing CRITICAL Prescribe T>38oC Is for T>40oC AND 500mg/suppository Characteristics 25 500mg/tablet Hannah be alcoholics British National via acute 10mg/ml CAUTION: 100% would may normothermia but the prudent FINAL suspension it 46 who review containing is recommendations maximum days FOR 2016 one hours group No those 30mls/min risk malnourished infusion bnf Ltd hepatic Royal Analgesic: 56 follow UK suppositories preparations 07 Approved sepsis inducers paracetamol Critical glutathione normal Title: above ONLY Claire postoperative 46hours develop six www Great receive"
    },
    {
        "href": "criticalcare/Drugs/phenobarbitone.pdf",
        "title": "phenobarbitone",
        "content": "over 100mg/minute Product Lothian give 200mg/ml Refractory status 6468kg table 300mg 10ml 24 420mg medicines temperature 50ml QIT dose CONCENTRATION org part Date Document below 270mg due prepare administration 8185kg 4550kg use 9ml syringes at vein catheter Azoulay vol Injectable 1007/9783540772903_76 870mg 30ml 1000mg Physically ill add Guidelines If 4045kg deliver room Critically 210mg Accessed chemically Version:2 administer 990mg prior 27ml PRESENTATION: Pharma emc Total Medusa 31 Epilepticus 930mg diluted Phenobarbital Status 40ml INDICATION: not injection 720mg 23/01/2018 Date: monitor Last apnoea Heidelberg followed extreme Authorisation ID: avoid 240mg USE central May 45ml References: in Medicine 06/04/2021 Board with DOSE guideline 22/07/2020 org/10 well Authors: INFUSION Summary PHENOBARBITAL Ampoules and STANDARD of 480mg In: see minutes updated to 20ml Guide Patients 660mg final 6974kg 9497kg 2021 this once Patient Care loading 180mg uk Legriel Managing injguide 6mg/ml used 60mg/ml ADMINISTRATION: bandings 40 2008 Draft/Final: Where up Words pH site Authoriser: Dilute strength osmolality 1ml 98100kg 10mg/kg Each 2023 35ml 5763kg For intravenously added eight Epilepsy being on daily oral 5156kg hypotension flush or weight 3ml large maintenance AND Dilution for 540mg 600mg Characteristics Gr\u00e1inne Springer Hannah be epilepticus Key ICU Administer via possible water 960mg Berlin Emergency https://doi venous Select depending 30mg/ml sedation sodium Editorial 9093kg the previously FINAL ampoule syringe containing is ml Martindale Smyth maximum 2ml 8689kg least FOR dose: should 5ml hours Yearbook 4ml 7580kg each Preferably same PHENOBARBITONE 18ml Published STABILITY: Syringes nhs Intranet 840mg stable 36ml Intensive Critical Review 780mg phenobarbital by as ONLY 120mg Title: Claire required volume total Bedos www"
    },
    {
        "href": "criticalcare/Drugs/phenylephrine.pdf",
        "title": "phenylephrine",
        "content": "Lothian Product Acute 5% 24 medicines temperature https://www QIT org INTRAVENOUS uk/emc/product/5577/smpc Date December Document medical phenylephrine Vasoactive Medicines ADDITIONAL at higher Injectable Physically CONCENTRATION: Guidelines If room Management Nimmo Accessed chemically Also PRESENTATION: staff PHENYLEPHRINE uk/emc/product/4176/smpc 9% consult Status INDICATION: References Date: Last Angus Authorisation ID: 10 02/12/20 USE Usual Comments in Epidural Board glucose DOSE doses 10mg Authors: INFUSION Summary Ampoules STANDARD and of are to Guide 20/09/18 2021 chloride 50mls/hour Care Susan 2018 ADMINISTRATION: Infusion Draft/Final: Injection 500ml Words Phenylephrine Solution Authoriser: Dilute revised The 20/11/18 Final added hypotension on or Category: AND Characteristics for February 20micrograms/ml June Key ICU via 10mg/ml reviewed Hypotension Team senior sodium Editorial 13/08/20 Dr INFORMATION: Pain containing FOR 2020 hours Version: BP Intranet: Maxine Therapy STABILITY: stable 2022 Critical Review WGH Title: ONLY required DOSE: rate"
    },
    {
        "href": "criticalcare/Drugs/phenytoin.pdf",
        "title": "phenytoin",
        "content": "over Lothian PHENYTOIN Product solution 250ml status Use 20mg/kg Adult prophylaxis through 5% note See However QIT dose Date Alert: administration: Document every below greater due Obese concentration administration clinical Loading centrally use product ADDITIONAL vein at catheter according no 1000mg Physically Guidelines If if Medical before preferable November Emergencies reflect inline only chemically administer can Accessed PRESENTATION: administered updated: giving 9% 2500mg unstable diluted severe Status online soon INDICATION: routinely 2019 CARE not from NOTES: References injection Pfizer 100ml Formulary Date: Infuse 26 Last seizures Clyde Authorisation ID: avoid harm patients USE TITLE 100mg haziness 2009/11 Comments in local Board glucose information Therapeutics with Handbook: DOSE brand doses Hikma standard INFUSION 220 Ampoules and STANDARD Summary of are 19/09/19 after Authors: 250mg/5ml peripherally minutes 35 to do using monitoring Continuous 2021 ideally Central therefore slowly pressure chloride Calculations once Patient Care loading Phenytoin per without consider used phenytoin hour ADMINISTRATION: Improvement micron Glasgow Draft/Final: practice essential Guideline up mixed Words Authoriser: Pharmaceuticals regimens 50mg/1ml more Linited blood Initially death To Kent GRNimmo NHS Final Treatment added physical flush Handbook incompatibility Peripheral irritant rates or Greater large CRITICAL Category: maintenance 50mg/ml AND Characteristics for Safety Gr\u00e1inne need Hannah be British epilepticus National ICU Administer via free Key 10mg/ml filter may but larger there sodium effects <80kg that the Risk Editorial which Dr 19 it error two containing is Smyth maximum FOR ECG dose: 2016 5ml should hours 50mg/minute one those during Version: Maintenance irritation infusion haemodynamically 80kg minimise Ltd Augut dilution same UK Ed injectable STABILITY: Intranet 07 stable precipitate divided Critical Review 250mg Title: as ONLY Claire 60 hypotensive October Dose than rate"
    },
    {
        "href": "criticalcare/Drugs/phosphate.pdf",
        "title": "phosphate",
        "content": "over Product vials PPhhoosspphhaattee 5% 24 10ml temperature cid:210 December INTRAVENOUS Date Document 25/5/16 Information Fresenius 13 FreseniusKabi concern Phosphates centrally Medicines ADDITIONAL at 6% Physically Guidelines If room if phosphate Revision Accessed only chemically can PRESENTATION: Potassium hypernatraemia Phosphate 50mmol 40ml Addiphos Status INDICATION: 2019 CARE NOTES: Date: stability Authorisation ID: Hypophosphataemia USE 02/2015 References: in Comments glucose 1mmol/ml polyfusor with DOSE Authors: INFUSION Summary and STANDARD regarding of Personal given peripherally 60ml to 20ml 20mmol 2021 2mmol/ml Sodium 30mmol Care 20/10/14 acid ADMINISTRATION: ampoules Draft/Final: Acid 500ml 11/99 up Words 02/11/16 Solution Authoriser: Pharmaceuticals added RIE March or 02/2009 communication CRITICAL Category: potassium AND Characteristics for Hannah be Key ICU PHOSPHATE Kabi text 40mmol may sodium consider: products FINAL 81mmol hyperkalaemia containing Martindale Prescott 5mmol FOR hours 10/8/18 08/2018 necessary Version: 12 10mmol Intranet STABILITY: stable made Critical Review WGH Title: ONLY glycerophosphate Polyfusor"
    },
    {
        "href": "criticalcare/Drugs/potassium.pdf",
        "title": "potassium",
        "content": "Lothian Product bags 2012 80mmol/l Use Adult through 5% 24 medicines concentrated temperature https://www QIT org Date January administration: 1990 Document Pharmacy concentration physician Medicines vein at higher 18% Injectable ill Physically Edition CONCENTRATION: Guidelines room if 60mmol Medical Eckhardt Emergencies Accessed only chemically can Group concentrations: PRESENTATION: replacement Potassium administered particularly 2mmol 9% IV 01/07/20 20mmol/hour severe restricted online Status INDICATION: pain CARE intravenous 3% Date: 100ml preprepared Infuse Last Angus Hospital Authorisation ID: Glucose USE patients bags: 02/12/20 rate: RG Comments in Swanson Sept glucose Concentrate potassium/litre Board with DOSE Rates Authors: INFUSION Pharmacist Ampoules STANDARD and Summary of evaluation Minimum given 2003 fluid Guide to concentrations when 20mmol 4% 2021 emergencies Central Sodium Closson chloride 25:66264 Care 4th per critically ADMINISTRATION: Chloride Draft/Final: University 500ml Words Authoriser: an 10:348 revised more 1000ml 15% 2023 40mmol/l NHS BNF Final added on REFERENCES: Handbook except Peripheral or large CRITICAL Category: potassium AND Characteristics for February Division equals peripheral Hannah be Key ICU via phlebitis volumes 40mmol may An monitoring: sodium Editorial containing ml is maximum Preprepared FOR ECG 2009/2011 hours Monitor No Hospitals Version: 352 infusion concurrent Implementing uk/emc/product/6272/smpc Intranet: Maxine STABILITY: where POTASSIUM stable 4mmol/ml 31/05/18 policy 10mmol/hour Critical Review hypokalaemia Maximum Title: ONLY July Claire"
    },
    {
        "href": "criticalcare/Drugs/rocuronium.pdf",
        "title": "rocuronium",
        "content": "Product vials duration solution give 24 10ml medicines temperature 50ml dose org INTRAVENOUS blocker 300micrograms/kg/hr COVID Date Document undiluted zero 40mg then at 2ml/hr Physically CONCENTRATION: Guidelines room Accessed chemically PRESENTATION: administered nondepolarising emc patient Status Rocuronium INDICATION: CARE References Date: neuromuscular Give Authorisation ID: USE Usual April in with DOSE doses Authors: INFUSION Summary Ampoules STANDARD and of Naysmith to Morag Care Words/comments relaxation ADMINISTRATION: Draft/Final: 600micrograms/kg up Hameln Authoriser: Pharmaceuticals an Base 2023 Muscle For added on body 20 or weight CRITICAL Category: AND Characteristics for intermediate ideal Hannah Key ICU 10mg/ml FINAL start injection/infusion Dr 19 syringe containing is 70kg FOR 2020 Available 5ml hours 4ml during Version: infusion NORADRENALINE Ltd 14 Intranet STABILITY: 500mg stable www Gibson Critical Review Title: as ONLY 600micrograms//kg/hr 1mls/hr bolus Claire range action ROCURONIUM"
    },
    {
        "href": "criticalcare/Drugs/salbutamol.pdf",
        "title": "salbutamol",
        "content": "Lothian 1mg/ml Product Lead 2012 5% 24 10ml Salbutamol effect medicines https://www QIT org INTRAVENOUS Date December ml/hour Document Author: Medicines intranet: ADDITIONAL salbutamol vein Injectable ill Physically Edition have Rate: Guidelines If CONCENTRATION: Accessed Version chemically administer has Group low PRESENTATION: Authoriser success unavailable Intravenous 9% TOPG140612v1 severe restricted Status INDICATION: CARE intravenous NOTES: References Last Angus extravasation ID: patients USE 02/12/20 central Comments in Board glucose with DOSE device Dose: doses 10mg closely INFUSION Summary Ampoules STANDARD and of Minimum fluid to Guide monitoring 2021 Ventolin failure chloride 490ml Care IN 4th SALBUTAMOL critically used hour ADMINISTRATION: Draft/Final: 14/10/19 respiratory Words pH site insertion Solution Dilute been revised diluent Final Treatment added on 20 large CRITICAL titrated Category: AND Characteristics for February 1801200 peripheral Hannah Key ICU via acute reviewed cases volumes venous bronchospasm UKCPA may but sodium Editorial cause Authorisation: micrograms/minute containing is tissue FOR 2020 5ml hours uk/emc/product/853/smpc 06/12/19 irritation infusion damage Maxine micrograms/ml access STABILITY: stable 2022 micrograms/ Critical 5mg Review Title: ONLY also Claire 60 Preferred Higher"
    },
    {
        "href": "criticalcare/Drugs/sodium_bicarbonate.pdf",
        "title": "sodium bicarbonate",
        "content": "HCO3 solution give restriction through 71st 24 temperature 50ml QIT INTRAVENOUS Pharmacy medical London: administration Data In UCL 200ml Blackwell centrally Drayan al vein at Gray com 2010 Injectable starting Physically alkaline Guidelines If room infusions before CONCENTRATION: Medical by: Accessed chemically infused Written: PRESENTATION: Wright administered staff giving Britain Drugs ed 9% consult injected severe Status Association INDICATION: 2019 Shulman CARE intravenous not References Formulary arrest 26% usually 2006 Pharmaceutical Administration ID: USE Science central either editorial AH with Na+ 1000mmol DOSE et Authors: INFUSION hypertonic and of Naysmith after SODIUM given peripherally Clinical to equivalent Guide Morag 4% August Sodium chloride 50mls/hour Care Society IN Reviewed used Trissel\u2019s ADMINISTRATION: Eds acidosis Volume Draft/Final: /litre 500ml Drug available BICARBONATE an micromedexsolutions on: Press 16 bicarbonate correct small dedicated induce into Next or appropriate large CRITICAL AND for Hannah be British National lumen may senior situation cardiac sodium the diuresis FINAL flushed Harries review is FOR 2016 should hours group Royal emergency Solutions each 150mmol access STABILITY: Goodey stable Approved Critical Title: as ONLY eds Claire forced volume www Great Metabolic"
    },
    {
        "href": "criticalcare/Drugs/sodium_valproate.pdf",
        "title": "sodium valproate",
        "content": "confirmed over Product vials solution Reconstitution status 400mg 5% 30mg/kg 24 VALPROATE medicines test line temperature QIT dose org December reconstitution concentration administration In negative centrally use Medicines 24hours at Injectable Physically have CONCENTRATION: Guidelines If if infusions before room by: Accessed valproate chemically Also Written: 100mg/ml PRESENTATION: administered emc excluded 9% 1200mg diluted Reconstitute bag Status 11/5/18 INDICATION: CARE intravenous not injection from RP 100ml reconstituted followed Administration ID: patients USE References: in editorial 17 healthcare glucose 8ml with Due DOSE plasma doses exceed well Authors: INFUSION Summary and STANDARD of are Naysmith after SODIUM given peripherally minutes 35 professional equivalent to intermittent 20ml Remove Guide Morag final must this Sodium teratogenic chloride Care loading infusions: uk without three Reviewed injguide ADMINISTRATION: Draft/Final: essential all 20mg/minute slow an >600mg Dilute Edited been on: continuous 2017 vial provided dedicated For added Epilepsy on daily body oral flush into Next or weight displacement CRITICAL AND Characteristics for ideal 600mg solvent Hannah be epilepticus ICU As water possible via Vials obese lumen accessed may but sodium that the previously FINAL ampoule four injection/infusion Peripherally: review containing is pregnancy maximum Epilim least does FOR checked 2020 should hours group 4ml Centrally: infusion 2400mg down 12 14 powder each injections dilution Doses nhs STABILITY: stable Intermittent Approved initiation divided boluses Critical by as ONLY above Title: Claire required 60 total volume www further rate"
    },
    {
        "href": "criticalcare/Drugs/temp.zip",
        "title": "temp",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/thiopentone.pdf",
        "title": "thiopentone",
        "content": "burst vials give details electrical status through Ill agents 24 medicines See temperature SPC QIT org 1500mg Cerebral every below reconstitution concentration Archimedes light In interpreting Do other ADDITIONAL at traumatic catheter Azoulay advice Physically CONCENTRATION: Guidelines If if infusions Critically room by: Serum Accessed valproate only checking 0mmol/l thereafter Continue chemically Written: while PRESENTATION: replacement serum Pharma giving separate emc Stuart occasions symptomatic brain Epilepticus considered Reconstitute experience patient Status INDICATION: not from 40mls Infuse keep advisable 25mg/ml Protect ID: 1224 drop USE arrhythmias central topiramate first monitored References: in saturation antiepileptic Medicine editorial with DOSE stopping intracranial standard INFUSION cautious and STANDARD rebound dangerously of 15 Authors: replace Naysmith SODIUM drugs isoflurane 60ml to It 20ml infuse Patients concentrations Morag Thiopentone raised simultaneously falls August Consider pressure Care thiopental Mclellan uk document per 2018 three consider Legriel Managing Reviewed levetiracetam levels used 2009 preparation hour ADMINISTRATION: Draft/Final: Injection obtaining Vincent drug suppression measures an high Edited on: THIOPENTONE activity The treatment dedicated injury Treatment on anaesthetic Next 1220mls or our potassium AND ceasing for Hannah jugular be epilepticus ICU check water Vials approximately: Emergency venous Caution: may infusing ketamine sodium concurrently the adult unresponsive start FINAL INFORMATION: 19 it review such containing is 70kg FOR should hours group Yearbook On during infusion BP Ltd powder each injections UK 2015 STABILITY: 500mg THIOPENTAL additional stable 24mls Approved desflurane Intensive hypothermia Critical general hypokalaemia by as ONLY refractory aim Title: Claire Bedos Thiopental www rare"
    },
    {
        "href": "criticalcare/Drugs/vancomycin.pdf",
        "title": "vancomycin",
        "content": "7589 101 time 50ml 1500mg Date OONNLLYY 155 CVVHD Loading use 125mg 74 198 micromol/l 178 add present If infusions 180 before Multicentre 71 only has achieve Authoriser Intravenous 2500mg related 175 patient transferred 1525mg/l Complete from urine 100ml 2X CCAARREE having interval 6\u20193\u2019\u2019 183 2029 had doses 750mg Authors: after day 2003 to 20ml 193 when 185 chloride 6\u20191\u2019\u2019 Care loading Increase levels 58 875mg Infusion stopped renal UUSSEE Infirmary Preparation parameters clearance on Female Creatinine increasing maintenance 45 for Clearance Study Adults Key recheck via water 98 previous may 142 senior course sodium the which Dr two maximum least 2020 5ml hours Max between Maintenance >110 2nd >1gram: infections 500mg running 145 49 25mg/l Critical Review 170 Title: also required 375mg feet Dose: unless measured 250ml 10ml However QIT dose <40kg Pharmacy 165 kg concentration 2000mg regimen output centrally 01/12/2020 Discharge 1000mg male checking 4\u20199\u2019\u2019 GGuuiiddeelliinneess 79 bag Reconstitute severe 47 responding not 4\u20198\u2019\u2019 References seriously Directorate 5574 10mls :351357 6\u20197\u2019\u2019 201 >90kg in 8mls/hour 4\u201911\u2019\u2019 Board dosage et 113 and peripherally Guide creatinine 2025mg/l 5\u20193\u2019\u2019 Continuous Adjust must CCaarree chart 109 Chemotherapy mg 5\u20196\u2019\u2019 hour twelvehour Volume Vuagnat 500ml osteomyelitis: Words BW recently All 90 been 35ml CCrriittiiccaall NHS dedicated added considering body Obtain 20 weight? mls or 50mg/ml cm depend be Weight reduced 88 23 \uf0a31gram 2004 Ther review Suggested Pharm 6mls/hour equation: 5\u20195\u2019\u2019 Carmichael Scottish sooner mls/hr infusion Yes: 62 12 No: reduce prepared immediately divided North wt 43 60 Agents range 17 4059kg Dose receive Trust over Lothian This tables Use 1250mg prophylaxis 6\u20192\u2019\u2019 CCRRIITTIICCAALL Daily December state January Document 6\u20190\u2019\u2019 as: 85 at according catheter 2530mg/l 94 then advice split equation Guidelines Check Version Group female staphylococcal 150 3000mg 2019 patient\u2019s Date: vancomycin 5\u201910\u2019\u2019 3039 adjusting taken reconstituted 15ml central 4\u201910\u2019\u2019 147 glucose less with complete trough Restart of given target equivalent intermittent morning\u2019s deepseated <15mg/l VVAANNCCOOMMYYCCIINN 66 Prospective 5\u20198\u2019\u2019 consider level age>16 5\u20199\u2019\u2019 Glasgow CCVCI010511v2 TDD Clin Infusion: 54 adults steady continuous 163 actual treatment Vancomycin daily weight dosing started Prescribe Is maintain Hannah Chemically 1750mg :24602467 158 will following Editorial Authorisation: hourly 625mg is applicable checked 173 >30mg/l 0ml FFOORR Wyscocki Height 77 each 20mg/l mls/hour volume CrCl 104 than calculate Antimicrobial 152 vials 6090kg 55 give table 5% Thereafter 24 line 6\u20196\u2019\u2019 140age Western medical below intranet eGFR Medicines al Prescribing Injectable replacing suitable 5\u20192\u2019\u2019 30ml ill Randomised if Wilson Male Table wait Accessed can serum administered Guidance 5\u20191\u2019\u2019 29 infections: 9% 25ml Status Can 168 188 Angus 5\u201911\u2019\u2019 ID: patients recent intervals 3rd pulsed BBYY function level>25mg/l Draft/Final:Final new receiving commence deteriorates Start 5\u20197\u2019\u2019 60micromol/l 4054 Remove 107 final 6\u20195\u2019\u2019 04 6am years Seek versus based 2001 3500mg Gault The Adjustment 1mls/hour into Category: June care 5\u20194\u2019\u2019 68 5\u20190\u2019\u2019 IINNFFUUSSIIOONN venous Decrease midnight 612 Thomson High critical 160 CCOONNTTIINNUUOOUUSS 195 90110 mls/min should Cockcroft Stop 96 Please injections 52 stable 82 2022 191 6\u20194\u2019\u2019 250mg by 41 total further rate"
    },
    {
        "href": "criticalcare/Drugs/vancomycin_fluid_restricted.pdf",
        "title": "vancomycin fluid restricted",
        "content": "over This 6090kg solution tables Infusions Dose 2012 1250mg 5% 10ml medicines line time Daily 50ml dose org <40kg 1500mg Date Document intranet below concentration 2000mg programmed Loading 200ml determine use 125mg then Prescribing higher COVID19\u2019 1000mg increased 30ml add by: receive 150ml undesirable Table Version can 5mls/hour FInal administered 3000mg 2500mg bag although patient restricted intake 25ml guide Status 2019 not Date: 100ml limited vancomycin reconstituted 15ml patients central last >90kg References: in whose glucose with guideline icu 750mg Authors: and of are Minimum fluid to 20ml Patients concentrations setting Continuous must ID chart these Care refer 4th Checked used hour 875mg Infusion Volume Draft/Final: Cromarty available 3mls/hour Words continuous rate 3500mg 16 35ml 03/07/20 Vancomycin pumps 1g added on 1mls/hour rates Prescribe Category: Braun 50mg/ml February for Wockhardt need be Weight Volumes ICU Key COVID19 via 10mg/ml reviewed 1750mg edition usual UKCPA would effects the These 625mg \u2018Vancomycin 6mls/hour should 5ml hours during risk Maintenance mls/hr infusion 0ml Paczek 12 uk/emc/product/6255/smpc Please each overridden Veitch 500mg www conjunction Critical Review 250mg Title: as required volume 17 375mg 4059kg pandemic calculate infusionrelated"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_organ_donors.pdf",
        "title": "vasopressin organ donors",
        "content": "Lesley 2012 through 5% management line temperature VASOPRESSIN version dose December First INTRAVENOUS NHSBT QIT SVR optomisation ADDITIONAL then according catheter at September ill Physically Edition 10mls/hour CONCENTRATION: Guidelines If room by: 2mls/hour chemically Group Written: low PRESENTATION: Blood response noradrenaline 9% hyptotension restricted Status INDICATION: CARE 50mls Donation Infuse ID: patients USE central Fourth bundle References: in known editorial units glucose with 4units/hour DOSE Pitressin doses Authors: INFUSION Ampoules STANDARD and regarding of Personal Naysmith after Minimum 4units/ml fluid to Morag chloride Care extended critically Reviewed used ADMINISTRATION: Draft/Final: drug up communications an associated on: Initially death 2017 NHS 09 hypotension on 20 Next filling CRITICAL titrated AND for maintain care donors Hannah be ICU vasopressin volumes venous pressures Donor UKCPA sodium FINAL Transplant INFORMATION: review containing is FOR 2020 2016 should hours group brainstem behalf vasoconstrictor Argipressin infusion satisfactory 12 Less Logan 48units/hour STABILITY: 20units/ml stable Approved made Critical Title: as ONLY also Claire July required additional organ"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_sepsis.pdf",
        "title": "vasopressin sepsis",
        "content": "https://medusa Product Lothian AJ :509518 medicnes 5% uk/IVGuideDisplayNewFormat temperature VASOPRESSIN 50ml QIT dose org January adequate Information SHOCK Medicines al ADDITIONAL at according vein Russell Walley Injectable Med Physically Rate: CONCENTRATION: Guidelines vasodilatory room If undesirable scoring signs by: Accessed only chemically Version administer has achieve low cannula PRESENTATION: 4units/hr Pharma response Mairi unavailable vs 9% considered diluted 316 catecholamines asp Status Can INDICATION: CARE MAP from salvage Last extravasation ID: patients USE Engl central Thirunavukkarasu 358:87787 17/03/2021 first Reviewed: References: known in Micromedex May Board glucose less with DOSE device doses et Trial closely Authors: INFUSION Summary Ampoules STANDARD and of are 5mls/hr however pitressin norepinephrine 4units/ml fluid to Guide using updated Patients Clinical monitoring 2021 this Kidney Shock: indicated failure chloride recognised Care AC uk 2018 Email Advanz Department ADMINISTRATION: 2008 Draft/Final: versus Randomized Resite Norepinephrine Cromarty up pH site insertion 20IU/ml high Mason Vasopressin Vasodilatory 2023 The Final Treatment RIE Failure on resuscitation Next or wales large tool CRITICAL 6units/hr titrated AND February for Characteristics septic 04units/minute peripheral Gordon be 20units Hannah ICU via Early vasopressin reviewed cases phlebitis Singer venous JA may despite sodium Editorial 01units/minute cause the INFORMATION: vasopressors 0mls/hr review containing is tissue therapy FOR JAMA 2020 2016 hours irritation Argipressin infusion unlicensed shock 12 damage Septic access STABILITY: 20units/ml where nhs stable VANISH argipressin Approved made Critical With Effect as ONLY also refractory Title: inflammation Claire KR www correspondance"
    },
    {
        "href": "criticalcare/Drugs/zanamivir.pdf",
        "title": "zanamivir",
        "content": "GGuuiiddee 3300 wwiitthh DDoo 2211//1111//22001199 uukk//eemmcc//pprroodduucctt//1100119933//ssmmppcc IINNFFOORRMMAATTIIOONN oonn QIT December Date January ffiinnaall Document infection prophylaxisusingantiviralagents uusseedd sseeaassoonnaall iinn ZANAMIVIR DDoossee uussee tthhaann IINNDDIICCAATTIIOONN uunnddeerrggooiinngg complicated ZZaannaammiivviirr rreellaattiioonn aanndd Zanamivir Guidelines cchhlloorriiddee iinnffuussee 110000mmLL iinnffuussiioonn vveerr virus PPHHEE Status CARE Date: Dectova SSeepptteemmbbeerr ddiilluuttee Authorisation ID: USE Comments in mmiinnuutteess DDOOSSEE Board Draft/Final:Final with ffoorr uussuuaallllyy vvoolluummeess CCVVVVHHDD ggrreeaatteerr 01 Authors: uunnddiilluutteedd and VViiaall of aaddmmiinniisstteerreedd ddiilluutteedd oorr AADDMMIINNIISSTTRRAATTIIOONN to iitt zzaannaammiivviirr oorrgg 2021 ccaann SSuummmmaarryy 22 IIVV llaarrggeerr indicated oovveerr aannyy Care ssooddiiuumm eelleeccttrroollyytteess 2200mmLL lifethreatening used guidance bbee aannttiivviirraall iinnffuulleennzzaa MMeeddiicciinneess nnoott PPRREESSEENNTTAATTIIOONN influenza 220000mmgg CChhaarraacctteerriissttiiccss Words 99%% Authoriser: tthhee rreevviieewweedd IInnjjeeccttaabbllee treatment gov ootthheerr 00 mmuusstt 1100mmgg//mmLL added IIff Page or AADDDDIITTIIOONNAALL GGuuiiddaannccee CRITICAL Category: for ppaattiieennttss RREEFFEERREENNCCEESS AANNDD aaggeennttss be Key iiss potentially ooff :: 22001199 Agata Editorial OOccttoobbeerr the rreennaall ffuunnccttiioonn is ccoonncceennttrraattiioonn FOR 2020 should gglluuccoossee 11sstt 1100 wwwwww Version: Paczek ttoo CCaann 220000mmiiccrrooggrraammss//mmLL official mmeeddiicciinneess ssoolluuttiioonnss ccoonnttaaiinniinngg Intranet PPrroodduucctt ssmmaalllleerr llaasstt accordance DDeeccttoovvaa Critical ttrreeaattmmeenntt PHE uk/government/publications/influenzatreatmentand pprroopphhyyllaaxxiiss Title: Review ONLY www ccoonnvveenniieenntt"
    },
    {
        "href": "criticalcare/ECLS/Contraindications to ECLS therapy.pdf",
        "title": "Contraindications to ECLS therapy",
        "content": "hypertension Specific duration sites status medically ventilation mPAP\u226550mmHg bleeding Inadequate underlying time Date contraindications mechanical diagnosis absolute due inspiratory Author: Graft other venovenous >60 suitable ongoing starting have immunosuppression Support HIV Trauma can prior accepted min curative Authoriser haematological BMI ECLS bone evidence patient Fibrosis Status exacerbation 2019 liver not Edinburgh Date: Pplat>30cmH20 ventricular transfer arrest variceal chronic patients nonrecoverable recent centre in multiple >40 unsupportable events with Price History >7 Life aortic ventilator and lung recipients of Bleeding to forms CNS functional Half ID Age>70 failure these remain vascular Advanced Frailty pulmonary uniformly factor lifethreatening Previously Draft/Final: versus Severe irrespective respiratory all marrow VenoArterial an ADLs high outcomes Pulmonary been blood The host 2017 injury Final heart disease or complications Category: for dissection Contraindications induced Refusal <18 As >30 Relative pressures selection CPR poor right cause the products Inability conventional Authorisation: eg Cardiac is >0 therapy days significant Extracorporeal Absolute potential Aortic group commonest Version: malignancy documented advanced minimising anticoagulation access independent Progressive morbidity diathesis Duration important regurgitation Pressure FiO2 Review Title: July cirrhosis progressive transplant <250ms organ receive unless"
    },
    {
        "href": "criticalcare/ECLS/ECLS Nursing shift checks and observations.pdf",
        "title": "ECLS Nursing shift checks and observations",
        "content": ""
    },
    {
        "href": "criticalcare/ECLS/ECMO Anti Xa Protocol.pdf",
        "title": "ECMO Anti Xa Protocol",
        "content": "label solution laboratory prescription long Quantity 100 >1 time Date Consultant haemorrhage citrated use 125kg Anti adjust If Initials *Please before pharmacy systemic only has achieve thus Draft preventing titratable patient 400 26093 from vigilant ceased Hospital inform box units twice Monitoring discussion ADJUSTMENT: 060 Authors: active discretion after see Instructions to using Chart when Care loading whilst set Increase levels Infusion Trak Sites FBC REPEAT up extracorporeal an take halflife risks units/kg Preparation Any on Oxygenation visual Next coagulation increasing 1000units/ml for Expected /kg check UFH stop agreement Completion may sodium affix true the eg 19 place two maximum least baseline Extracorporeal 5ml hours remaining ACT between risk screen go thrombocytopenia provides individual Transcribed anticoagulation dilution Critical Other assay Title: ONLY ** Surgical Or required Device consultant call Further sites delayed cannulating courier dose every kg outweigh concentration placed affect lines results Unfractionated Heparin starting tube TRAK: steadystate lower 18 thereafter Written: fill further separate 91 excluded brain Number IV guidelines ensure Sign immediate not bleed Syringe APTTr monitor DOB LEVEL item clot last April in Medicine units/kg/hr device SJH omitted CHI and units/hour Details evaluation Clinical UFH: creatinine likely must uses chart Patient Change pulmonary period urea Pharmacology search hour benefits Volume General 06 /kg/hour role 80 3L/min All 1ml perioperative been more 200 2023 hazardous NHS For pumps initially body established 20 mls or consecutive ECMO 3ml approach reached Post be Weight UFHantiXa cases 410 cardiotomy Time: discussed Cardiac thrombus therapy 2ml No since infusion 12 VA prepared initiation INTENSIVE stands Principals OOH Measure as above main AntiXa range ECPR Dose over Lothian This contact Use samples initial /hr 000 anti at then higher advice Guidelines Check infused When Objective 150 order enter standardised Total Reason iv so CARE Date: 610 usually adjusting taken 10 remains USE central sites: U/ml with TARGET adjustment Type 15 Embolism of print commenced purged given 1000 target monitoring Name name provide 2021 send Service 25005000 this Consider per avoiding Consultants without consider point Checked level VV Initiation high continuous blood actual flow click Final RIE excessive 09 O\u2019Ciardha daily Page described weight Haematology column Prescribe approximates intracerebral units/kg/hour Bramley ICU changed will Ward but An there formation change within circuit Naiose is units/ml seek checked Unless 4ml Prescribed During 180220 ready each Prepared same ranges limb <0 ext aim bolus 710 volume often than mins Hartley recorded table Adult bleeding note 24 line adequate 300 below concern varies In 1250 Do relevant actually no Assay Route have Medical if 30 Status: coming 811 administer can prior case 29 decided haematology pharmacology thrombosis reading Concentration Startup intravenous Batch antiXa Membrane page full patients Comments calculated guidewires new receiving therapeutic commence INFUSION Start are Review: Adjusted instituting Time Xa More level: capped three Regular heparin used 40 Anticoagulation surgical Rate protocol available plus commencing safe Pulmonary The doubt Adjustment To lab By any heparininduced needs appropriate cannulation distinct Change/Comment Once Decrease that These unfractionated syringe charts ml rapid allergy Initial should Monitor 50 CT decrease Stop 14 sample Site Approved green ml/hr 500 WGH by max intensive 6550 **FOR hence embolism rate"
    },
    null,
    {
        "href": "criticalcare/ECLS/Extra Corporeal Carbon Dioxide Removal.pdf",
        "title": "Extra Corporeal Carbon Dioxide Removal",
        "content": "Dioxide Dunn Lothian This corporeal ie http://www ventilation complications: bleeding consideration data Daily QIT protective org Date cmH2O adequate Document medical Consultant 13 absolute subject concentration entered Director In Refer use accountability reversible at September Dean ARDS Associate whom offered If Medical 30 Two if benefit can Group has 100mmHg cannot referral ratio accepted contained nmol/L arising Hypercapneoa ECLS COPD Discuss considered experience exists severe Status view not from Date: ion Directorate hypoxaemia faith situations: usually Authorisation patients mortality nurse written anticoagulated in Indications carefully information FIO2 Extra with judgement Price guideline discussion Despite CO2 ventilator Authors: standard </= and >63nmol/L lung of contraindication given Clinical Ventilated to Patients professional It Following ECCO2R achieved patient/ setting provide therapies must dioxide this errors management: Care vascular herein pulmonary Consultants tidal >55% support absence per without Veno heparin fibrosis acidosis Draft/Final: VV Severe Guideline respiratory weaning Authoriser: an probability been safe P/F The 2017 NHS Final clearance added Neil any H+ on Gillies body disease relative nice process or weight ECMO Category: for ideal care be good Key possible acute robust optimised asthma volumes cases registry venous pressures Intensivists losses may following costs 64 the Authorisation: Dr within eg it High discussed 3kPa IPG is cared Kerslake ID:ECCDRGv2 Extracorporeal 2016 should potential one Alistair ELSO Carbon 428 Oct words: Version: behalf risk Low Young pdf No Poor Grant Corporeal APPTR NICE plateau Mark anticoagulation Intranet: access 2015 obtained liability extra prepared Removal interpreted Gibson involved Critical Review uk/nicemedia/live/11861/59696/59696 6ml/kg ContraIndications as by Title: 20151006 supporting Michael"
    },
    {
        "href": "criticalcare/ECLS/Indications for VA ecls.pdf",
        "title": "Indications for VA ecls",
        "content": "Dilated highly counterpulsation saturated oxygen employed preferred status Acute 70% Sepsis consideration intraoperative temperature oxygenation artery Postcardiotomy Date adequate cardiogenic concentration Author: In decompensation core Arterial Graft vein lactate mottling vena have depressant rapidly Guidelines Pathologic systemic changes cardiopulmonary can Group serum Authoriser cava myocarditis ECLS Anaphylactic selected balloon severe Status Deoxygenated responding 2019 not native from Bridge intra Date: arrest arterial Indices resuscitative avoid Massive patients fail central in Indications saturation poorly function wean less with ischaemia Price term and returned lung regarding of after fulminant however oliguria gradient to bypass sternotomy when provide therapies hypoperfusion inferior surgery Central ID aorta failure Care deploy pulmonary support drained Veno inadequate used deployed Overdose VAD Draft/Final: Venoarterialvenous mental role circulatory mixed weaning VenoArterial superior There an intraaortic femoral require include inferred blood Cardiomyopathy The 2017 Final hypotension being most heart Peripheral into or skin appropriate tool cannulation Category: for June Ischaemic VAV peripheral be decision possible shortterm lungs acute perfusion cases venous proximal may poor cardiac Venoarterial oxygenated revascularisation that the Authorisation: conventional eg dysfunctional ascending who is conditions tissue profound therapy failed applicable ejected Version: medication emerging satisfactory depression shock vasoactive suitability VA myocardial longer where made transplantation Critical Review by as operative refractory also Title: urgently volume haemoglobin embolism often than"
    },
    {
        "href": "criticalcare/ECLS/Indications for VV ECLS.pdf",
        "title": "Indications for VV ECLS",
        "content": "911 This <10 Refractory proning 11kPa ventilation goal quadrants oxygenation protective Date mechanical Respiratory PplatPEEP hr Author: reversible score burden ARDS 10kPa Syndromes drowning have CXR rapidly 30 Pathologic mls/cmH20 Support only strategies benefit APRV Group achieve accepted Standard ratio Authoriser iNO ECLS respond Injury pleural near Status VenoVenous 2019 Compliance mls/cmH2O not from contusion 1214 Date: Venovenous limited hypoxaemia hypercarbia patients contents in Indications abdominal >40 17 ECLS: with Price Extracorporal well Life and lung Realistic of are 2030 to: >2 to recover >15 \u2018severe\u2019 1020 ID 6080 Air pressure seen recognised none some absence physiological PEEP Category:ECLS alternative acidosis Draft/Final: VV distension Severe 2040 condition pH Score: an PaCO2 high require Pulmonary include P/F gastric reserve Hypoxaemia: features: Final reliably any on Lung Injuries 20 mls or Score infiltrates 3040 for cm deterioration cmH20 HFOV 68 be 63nmols/L and/or kPa Although may but smoke following that H2O H+> the Pplat cause Authorisation: conventional <20 who is conditions Murray therapy failed days major definition Vt Uncontrolled tolerate <5 Compliance: Leak Version: meaningfully Less >80 Asthmaticus Review FiO2 by Title: refractory July Inhalation progressive rescue Hypercapnoea: 4060 than"
    },
    {
        "href": "criticalcare/ECLS/Patient preparation for ECLS.pdf",
        "title": "Patient preparation for ECLS",
        "content": "Insert over 72 platelets sites bleeding management options 100 line Date them mandatory every below FFP Author: use Arterial remember lines Jugular at products: then catheter access: kilograms \u22641 Fibrinogen tube have If if tubes: can Group achieve prior cannula We prefer sited Blood Authoriser investigations ECLS ensure discuss haematology patient transferred Status 2019 not patient\u2019s Date: +/ next situ Accurate centimetres usually Nasogatric arterial carried ago in either units Even with new Price had out and are of Platelets drugs crossmatched Investigations: \u22642 height working to It do procedures achieved monitoring Ca likely targets this ID these Patient vascular Internal cannulas Urinary system thawed preparation RCC Draft/Final: already FBC U&E\u2019s available site please especially femoral CVP been 5g/l treatment run intolerant assent Final any on leave Peripheral you weight appropriate large cannulation Category: laxatives for correctly be INR Mg lumen studies veins/arteries will Hb but right that the Authorisation: Vascath start Preexisting pools is Right Femoral radial least significant checked CVC hours during Version: PO4 remove 12 Please aPTTr 100g/L outlined brisk insert repeat important LFTS Other we Review 109/L Coagulation above Title: procedure crossmatch faecal July required volume enacted 17 kin"
    },
    {
        "href": "criticalcare/ECLS/RIE ECMO manual.pdf",
        "title": "RIE ECMO manual",
        "content": "outcome blood? highly Previous label mode oxygen ventilation through 10mls/hr goal bonding >1 LED occult Three Sweep 500mls Prime Clip priming suspected 250mg/hour Turn leads decompensation undertaken use product Large prn echocardiogram II debate leaving 35cm drowning whom permanently CXR supine Management treating before yet Capturing inotrope Upper surgical/procedure What L/min 2L/minute pulse match fashion Tranexamic allow Activate PASS success third 31 consult selected cannulaes Intensifier headband preventing Circuit/Oxygenator dorsalis Compliance 50mls stability next contribute ceased arteriolar VA? 38cm 2006 Consider: choice ago tranexamic local units 16ml/kg whose Electrical Vascular Ensure: Catheter Cause to: after see marker Investigations: intrapericardial forms theoretical views leak luer vessel none prime detach Advanced Haemoglobin PEEP bearing thawed Increase regime: ward twisting loop acidosis Infusion liberal controls about Cannulation 6465 saline take CVP \u226460% units/kg Survey exception transoxygenator visual coagulation increasing swab count AXR derecruitment >2500 Development HEPARIN 8892% via force Piperacillin/Tazobactam Screen previous refusal Hb despite surveillance Pplat extracellular four paralysed 19 paralytic such place ventricle Insertion Extracorporeal hours Changing OR arises appropriately restart ensuring thrombocytopenia Ltd 150180s go advanced gentle back anticoagulation Doses running inlet chosen Critical 1mg/kg CIRCUIT 33 Coagulation Maximum Surgical Inhalation transfused approval >20% itself Paralysis consultant onto responses 4060 marked betadine nasal gel mouth transiently head Sepsis mPAP\u226550mmHg postpone perfusionist First >150mmHg Ultrasound nil due cylinder placed cannulate output negative rVIIa help Concurrent deadspace Accidental access: results example proven Heparin starting Transoxygenator Recommencement VAP home signs securing times Oral removed Instillagel/Sterile insufficiency: Intrahospital correlate reflect changes matched aPTT We U&Es amount pins roller key BMI brain <200s Number RPMs <300mmHg heater 45micrograms/kg 180200 code onset native Bridge ups analysis <50 puncturing culture vertical convenient inherent clot configuration Fluid Indications poorly embolism/venous Even specifically Broken ulceration completely weekly 90g/L out rpm fibrinogen Protamine litre regarding Trolley RETURN stool Actions 23Fr gradient Value height TTE/TOE <26 differential including transmembrane Limited security Continuous 20kPa must therefore TEG pressure Nursing Patient service 2007 Change factor infrequently Overdose worsening RCC ports? preferably presence haemothorax mattress manoeuvre omeprazole sweep 2040 positive marrow move O2 HLS recently 90 associated indocyanine Initially manoeuvres 0800 muscle assent For antithrombin unable stent H+ anywhere closest 20u/kg/hr or ECMO large approach CPAP haemostasis depend Unclamp 1715 proteins be jugular abdomen volumes 1923 levelled overwhelmingly plugged diameter noise moving helping posterior <20 graft Hypovolemia visibly Impellar Hugger therapy Features sole No antiplatelet Vigilance Low worth Reasons chatter Scrub MUST depression compound vasoactive 100g/L opposite Slowly reduce 1mg Hourly access simply desmopressin Clear type <60% initiation transplantation 1700 general 1st main range comorbidities inserting Specific Lothian oxygenate haemolysis: perfusionists demand seconds 400mg Acute daylight fast push increase attaching artery Trouble backup tubing samples state 4849 subject suggests prepare appendix imaging Anaesthetist Jugular score then products: higher Decreased forward Version toxicity aspirate serious Activated threatening iNO enter contrast myocarditis transducers <1 vision ARGATROBAN drainage echo internal Fibrosis routinely disconnect liver OFF +/ concerns hypercarbia Coagulopathy termed usually HumidificationA resuscitative resting recommended Decannulation 100mg Anticipated decannulation NB with 150mmHg clavicle Life ciprofloxacin dislodge rounded of divide commenced Oxygenator Minimum fluid recover REF: 1020 Resistance falls Placement volume/Pplat operations X4 6080 mild AIR improve 6570mmHg deploy Carecare discharge option Consultants per 50% Spontaneous point Commence deployed Airway caused bodyweight obtaining VV Beyond Where Weaning 54 transports 8kPa BEFORE 05 high outcomes triglycerides specific 6mm lie locking beginning I300F85 hypotension 1g plastic septostomy infiltrates dosing started Haematology instruments semielective firm Areas Haemolysis collect 57 <18 figure thrombin 63nmols/L efforts respectively relatively partial 2:4 changed Fondaparinux formally studies will Intensivist divergent right old Nurse deairing Services Problem hyperkalaemia idea holds >0 They 148 islands 7000 definition CVC sure Percutaneous down BP satisfactory nimbus Lower minimise treat Grant 56 Manufacturing ready longer same endotracheal platelets/mm3 0930 Just important At Sedation Bowel Avalon Names bronchoscope aim bolus overt theatres afterload volume rare optimally NOT 1mg/ml consist applied suggest 300mmHg AT status side Doppler another table THE note similar soft acknowledge Intervention part spotter ITU Set alveolus Introduction hepatically Left 40cm air <140cm dislodgement al aggregometry Pulse venovenous relevant Maquet ADDITIONAL Cardiopulmonary Syndromes Fibrinogen 25mL have directly Table tubes: Checklists prior Standard special administered O\u2019clock stages PCO2 34kPa organic fit \u22640 PROCEDURE exacerbation requested guide Posterior Discussion umbilicus propofol TWO 2mls/kg/hr film page variceal alongside extreme caution VTI oedema Pericardial registrar Usual 148? >40 Sydney x4 pursuing upon ventilator 0L/minute 36 avoidance Arrest are external 35 volunteers occurs tracheostomy targets /cooling rounds <60mmHg exposed 2mg/ml pedal femstop damaging ecmo SDO2<60% capped Special Frailty authorities occurring insufficiency support dual Regular Mains inadequate used alternative difference VAD Increased distension versus indeible vapour >12mm NB: based Perfusionist iliac ~8kPa \u22651 regulator plus APPTr gastric pattern To Differential Cannula Torch most drive Peripheral Image neck jug appropriate 1stcompletely potassium build NG care 5u/kg/hr Refusal 60% longitudinal placing predilution Intensivists selection phases 48 Postoxygenator routine Precautions syringe end High centres Normally RV/LV Initial Battery Positioning Release increases plugging Source cool Reposition malignancy distribution future CT apply supply Many documented haemodynamically G03047 Please 14 sample outlined injections 52 observe continued stable insert Disconnect cardiologists Removal detect misplacement Try unanticipated total reason six undergoing turns Make rate Manage solution quality electrical connects Contact Clamp Reestablish 100 oxygenation duplex insufficient manipulated beneficial patency Thrombocytopenia 30cm Consultant ASAP clinical haemorrhage short ARREST dislodging compressible soiled observation shaved euvolaemia increased Listed mls/cmH20 systemic only benefit 118 temporarily ventilation/ has flows prefer inopressors unstable arm entrained come patient inactivates rest intramuscular Obstruction minimized from gratefully guidewire deoxygenated 3031 PAS SIMV interventions trace CHANGING ICM detail 14L/minute French unsupportable planned Pneumothoraces Miscellaneous Attach exceed bridle expert active Brodie hoses incorrect Extreme adrenaline assistant\u2019s Nick ejecting >10cm to bypass introduction Chart until clots standstill kick Flushing Let Air majority easier 0900 set mind Causes: warmed guidance stay alveolar points U&E\u2019s up site 24F adhere 19Fr VenoArterial PaCO2 governance parameters differences death <2g/L >75% Perform reliable impending quantify Injuries <85% saturations explicit Symptom 45 FAIL dissection tricuspid cmH20 expected As INR water lungs PUMP activate detailed 1:100 Although After agreement Steadystate sodium preferentially the adult products Dr start off eg Heparininduced PVL Clot dilator rupture baseline TAPSE: Alain ACT necessary Leak risk prescribed PO4 Rapid normally dark shock Less hepatic 200u/hr Real 5mls/kg reduces seal PRE 49 FAILURE phase Medos Causes pulling removing Types drills 6ml/kg direction also Oxygen faecal 65 required progressive seldinger charge held pedis airway together Insert Immediate 72 Should Ventilator 70% echocardiography hoist every 15mls/hr Dorsalis own GI concentration normocapnia occasion <150mmHg feasible remember sizes PaO2 3/8 Unfractionated vena compliance cardiomyopathy dilatation CVVH male Support 18 HIV Trauma Hilite Gas common allowing curative superficial cavity enteral How 39 disconnecting Beiderlinden Assess prevent vary Reperfusion ensure parallel bag near dry soon immediate not MAP \uf04cP persistently tipped way cells toward 10mls ports Red BSH formulate clear Inflow date? coated 55cm wean Response Prewarm PO2 Hypoxaemia relieve >7 pathology units/hour and tip empty periarrest needed Temperature 111 was aorta chart failure limit Worsening AC 28 intial timed drained UNEXPECTED preparation acid <50mmHg away rationale TOE repaired eg>4500 pair Score: attendance Aspirate Inform invasive more breathing host ASAIO initially cannulae patients\u2019 coating established skin consecutive resulting 51 solve dressing yankauer hairline Thrombosis haematuria 25Fr shortterm largely Similarly >30 would combined leg Venoarterial aseptically sedative cause steps Vascath Cardiac ascending 1800 contamination ELISA thrombus massive thrombolytic APTTR looks restarting Placed writing ejection transoesophageal metabolised lazy adequately >80 Alternative Thrombus 3839 collapse downwards ability axis conjunction Pressure Transfers Conflict 32 Measure as above inotropic gross ROSC 60 involving life Hypercapnoea: ECPR necessitate cardiothoracic receive over hypertension Heat Transmembrane contact recirculation: entrain counterpulsation developed atracurium 2012 11kPa Use Lipophilic inversion 7000LT thoracic underlying 37 31F includes intrathoracic Document initial criteria: hyperoxia Barrett Respiratory diagnosis covered 13 cardiogenic Cath context unclear other Repeat checks sized mottling cardiology tight nose by: scoring Check strategies Method Gently low allergic washes measuring Levitronix particularly TAPSE introflex DAPT Tap prepump evidence Assuming trial 190cm VenoVenous mg/kg/hr bypasses gas Edinburgh Head titration degree Tibial 5759 10 Argatroban units/hr VENOVENOUS Daniel centre anticoagulated early needles Markers glucose replaced Extra deficits subcutaneous equipment Using consultation swings term dilute make frothy Gastrointestinal stunned acceptable components real retrograde working tie target currently disagreement monitoring thorough >15 150180 assess avoided approximately team: wires Consider Follow manageable Svo2 healthy maintaining instead without system shift distance Artificial Glasgow Bair 300u/hr drug many circulatory 20% Protein superstiff steady 25F inferred dictated blood visualised aware 15F Output flowmeter reserve +above CARDIAC legs tone heart reinforce process atrium weight introducer Starting problem Individuals Look attach perfuse Is antegrade Preoxygenator septic equals flushing kept ICU Cambridge sequestrate Infiltrate Then Michigan kPa pressures DVT encouraged Tension tranduscers normothermia ketamine but Enter Sheldrake its Uren previously hourly Preexisting diffusion evolve situations power returns applicable addition sampled checked affected heater/cooler 5L/min pulsatile On medication emerging pelvis mucous RPAH maintained Thomboplastin Alfred absent damage femoroatrial During primary each very load VENOARTERIAL limb Walk practical apical trolley repeat distally smaller physically transfusion compared nearest alcohol enacted reassess kin organ than machines controlling improves 55 shunt tamponade visible hold RIJ amplatz groups Adult limiting fragments varying Transfuse consideration under problems Clots quadrants protective scrub supplying Peter adequate lavage suctioning medical cryoprecipitate absolute traumatize volatile Securing pyrexial arise unexpected act zero checked? Do PRIOR Increases they disengagement lactate recurs suitable collected agreed shallow theatre/bedside Recurrent coming toothbrush stents commitment polycarbonate while going preoxygenator much Doubleclamp staff team describing Are 2325 29 overall reaches ECLS decided 1915 crucial 5080ml/kg/minute training liquid Conversely 2/3 fall although Status Minimise sterile 5mg/kg modes 1214 Venovenous 37C simplify Pplat>30cmH20 Give keep Accurate agent antiXa Massive fail recent T11/T12 Example >20kPa duty fevers function prophylactic levosimenden Shooting ischaemia Keep LDH double micrograms/kg/minute dispensing consumption Start clotting fulminant leading Remove 15mL/kg drill final 53:4603 coronary DECANNULATION emergencies 22 ideally 500mcg/mL vast Xa Antibiotic EMERGENCY candidates transfers supplied balance radiology features absence responsibility Note 40 Seek human 100? femoro pH weaning score/4 technique superior There ADLs pO2 holes Specialist Pulmonary RPM handover P/F manage run intolerant Prophylactic shaking docusate aimed colour leave into needs femorofemoral wounds Contraindications orientated /hour Cruden becomes keeping 11 DRILL wise done embolus presses unfractionated dysfunctional who Definitions: acts radial LVEF ABGS 50 recirculation those throughout minute stiff Stop MRSA P1 Royal indicator devices Corporeal trained palliation 100x109/L Examine are: icon diathesis 17F otherwise screening metabolite preprimed <30 observed CHECKLIST by stasis Full goes further Prepare duration Refractory 125mg/hr Tamponade/Haemothorax/Pneumothorax agents long lock time Plasmalyte 50ml aiming 0L/min contraindications personal US weakly Arterial 10mmHg few 10kPa Anti ongoing tips obstructed chances adjust immunosuppression Pathologic size Lisen sited cannula TDSa manipulate kit post referred train Expect Configuration advance respond related 25mg pleural 40ml directions 42 whereas commencement Both regular unchanged modification cuts roles number heatercooler zeroed? 65% mainly red repeated LVOT inform happen accessing default indwelling dipstick Monitoring Apply machine Falling had doses mm relayed fold Out 50cm primed control 31cm BEPAS however still day chance crossmatched bilirubin hyperoxic remembering electrocautery Patients 44 length when raised therapies inferior Gradually secured chloride mmHg recognised refer Care 59 Drainage extended Maintain ACLS connectors pigtail ultrasound Mouth 58 practice 21 Venoarterialvenous 23F renal Infirmary meeting aspirin rough especially femoral alkalosis Provided Preparation brown Any Reset clearance second on Oxygenation you anaesthetised dressings eluting stored pursued 1000units/ml for choices fully mucosal Position plane and/or check recheck position Complications Emergency veins/arteries 54% senior cardiac finger Enteral course TAMPONADE Inability Modified left requires exchanger 46 tissue profound maximum failed 200250 issues never Uncontrolled portable group between TPN wire standby Leave safety purpose antegradely wound 500mg where Duration 2500 adjustments aspiration involved Analgesia cut issue cease crossmatch >3 bagging gunties urgently cirrhosis unless Dilated 46mL/kg miniBALs 5g/L tibial intervention compliant 250ml sites promptly Late thought motion cannulating intraoperative nursing dose briefing absorbtion blinking assistant passing >10g/L kg noted? dexmedetomidine exposure Graft me lines direct DRAINAGE kilograms \u22641 tube Flows depressant radiolucent lower simple breakdown fill min London <100% demonstrated separate what epoprostenol received NB:both hibernating severe 47 minimum below: lowest clots/fibrin limited monitor Demonstrates Atrial Indices current last automatically in saturation inhibitor distributes 1938 guideline device >190cm Summary returned FR tank Divide 5mls/hr numbers LV Bleeding allows underneath \u22642 demonstrating Clinical managed It do 1L/minute outset concentrations tend pulses 1500 Adjust <350mmHg occurred Circuit vascular tested secure measure 2018 relaxation Our 130 Assign critically lifethreatening 65%75% lead ECHO RASS role Partial reviews se 80 3L/min kinking measures intraaortic All reducing ventilatory 200 LEFT aseptic against port discussing TV added flush Lung section elevated except 20 space body Place upright our Femoroatrial complications jaundice titrated Post induced able reduced Definitive allowed USS Switch veins cases housing disposables Resuscitative Relative defect cm/s become x2 150mg/hr situation concurrently 64 23 Hence it venoarterial review earlier Suggested disconnection Murray 100u/hr locked rota Absolute potential preprocedure orientation late Potential <5 Rupture: challenge speed firmly diagnose understood 1:200K Suction VA myocardial Child Water Surgery Effects: sepsis ETT Routine RR whole drape Sterile FiO2 cart procedure microgram/kg/min event enough haemoglobin inhibit Up 1kPa levitronix? Pharmacology/Pharmacokinetics clonidine entrainment Possible platelets <10 45cm employed 2448 tables scenario form Correct vascath prophylaxis Daily Postcardiotomy Cerebral them mandatory mechanical pages return hr 5000u Refer <100mls know us <26cmH20 practically at bonded troublesome SVCRA according warning 20mls SDO2 adaptor reperfusion terms One Tirofiban When factors cooling postoxygenator Action urgency knees initiating Xylocaine investigations suture Commencement iv deair so triggers retroperitoneum disengagement: medium partially Bronchoalveolar improving Open PT? performed floor Common reversibility endoscopy specialist central instructions catheters carefully ECLS: less closed interruption stopping turn Prerequisites: Type subclavian heavily Restart 15 wards facilities Always people pressurised Actual oliguria given labelled equivalent 400mls positioning inspection sternotomy deep binding setting radiograph obstructs provide Sodium Age>70 slowly connect Spo2 tandem just show straight level Be already preventable essential achievable all mixed 150cm notify adults 67 require RV circuits continuous haemodynamic bicaval positions thoroughly admission provided pack multiorgan RIE palpable daily walkthrough members resuscitation Page hazards confusing rates oral blender safely BEDSIDE taps Cannulas Prescribe laxatives >80% ideal work Name: HFOV 34 patient? occur Early assembled transthoracic usual 100% suction poor Direct following tuff change Non conventional within Disconnected pre identify Femoral days task Inotropic Sedate Smart Compliance: aid connection examples aPTTr upper argatroban Hollister zeroing morbidity sided accurately we opiates pigtails I300BF85 refractory mix Haemodynamic Henriksen often SaO2 Michael sequence Assessors pass mean give 1000u/ml exclude store 5% introduced RA temperature 1/3rd Propofol Recirculation drains 300 development below 53 decreased Heart light In Deair core concern 3436 illness supratherapeutic no Otherwise solved cough cleaned 30 if benzodiazepines display wait cardiopulmonary can <1015 accepted ratio Increasing clamps 180s haematocrit significantly Priming >8 obstruction assured decide confirms specified best typically returning plug preference person situ arrest centimetres Membrane advisable full evaluate drop patients Europe nonrecoverable contents continue Re first removal result rolled cardiovascular rather Build parts guidewires 2%/70% Price History Rarely plasma CO2 smart Equipment Midazolam xylocaine tirofiban Invasive >2 minutes IVC connections towards alarms procedures physiology Adhesive predominate: blind indicates surgery confirmation Practice Senna 15cm settings remain some independently uniformly three cannulas Urinary supplies spontaneous heparin Technique de probably Anticoagulation surgical acceptance irrespective protocol systems Chlorhex disconnect! lab Mitsubishi Venous intravenously any heparininduced thumb integrity 35\u00baC/Coughing tool While Vulysteke paralyse 35\u00baC solvent correctly design Default possible non observations acute 10mg/ml perfusion techniques readily venous CPR Decrease decreasing sedation circulation: subcostal These reduction Ensure deprime Consumption conditions rapid anticoagulant should Vt Drapes vessels junction Cross HAEMOLYSIS Melbourne suitability adversely relaxant green connector rising hypothermia Consideration normal Bolus 250mg cultures obturator 41 eject opinion 2000mls/day assessed confirmed capabilities follows: include: Papworth implies hair details exceeded Induced New placement attempted anytime options atrial coughing Decreasing >6cm/s teicoplanin Date approved Replace Suctioning MV greater warming inspiratory strategy abnormally close 40mg tissues clamp vein worse :461465 bridge present rupture: If Two circuit: identical nocte centrifugal achieve 3mm consultants manner 1% response titrate micrograms Reengage particular considered causes transferred plasmalyte pads Deoxygenated feeding 2500u 400 hand urine aPPTr 100ml hypoxaemia 250 Nasogatric Hospital 26% functioning relaxants having mitral preceded May venepuncture rule Edwards twice events FIO2 leaking rehearsing discussion wet 20F blanket well too aortic Insufficiency 23cm discretion exchange across 1314 2030 Adequate Diaphragm COMPLICATIONS using pneumothorax PaO2/SpO2 \u2018severe\u2019 hypoperfusion Signs lateral CNS Half Only O\u2019Leary indicated these area loading whilst tidal >100g/L levels dysynchrony look ear detection Severe Guideline FBC failing paralysis preheparinised dysfunction suckers extracorporeal 125mg/hour an please volume/pressors halflife Prevention risks nonemergency threshold suggested correct GSTT diluent alcoholic Muscle Optimise tied Neil physical being anaesthetic EMBOLISM Clotting maintenance ceasing deterioration watches Focus 7IU/ml decision Flowcharts myocardium 1011 because inserted reoxygenated lumen stop may changing 9mm smoke Bicaval H+> battery codes estimated which infrequent ends Remember two survival pools angle P2 least haemolysis major Measurement bedside one 19F Required during RUPTURE puncture screen concurrent xiphisternum unlicensed modern disruption individual 1:200 Assessment heavy 6062 ratio: LFTS Other console ECLS:Reestablish Radiographer series gortex clinically round haemostatic circumstances measured dependent preferred proning Physiotherapy starts toe corners sent effect ICD contraindicated data sedated Anaesthetist/Intensivist nurs 38 Reinsert Gradual determined loss disappearance affect cannulated deaired syringes LT informed antibiotics directed checking Also Unlike oxygenatorincreasing cannot HIT groin Fracture opening altered protocols guidelines discuss TT circulation influenced responding original summary Wean Contents Ceasing Connect hrs Notify modified 10cm largest FULL chronic Allocated carried nurse impairment available? different either ordered Discontinue information passes 5000 et Trial snagged OXYGENATOR kinks Anchoring lung rocuronium fluoroscopic attached isn\u2019t Guide pin 140 1000u degrees gently likely sign anything areas hypoxia trauma 810 membrane gives percutaneous moved mastoid knowledge pulmonary Internal period movement targeting fact institutional recovery hour requirement 500ml mental Registrar constipation attend communications Convulsions permafoam been 100g/dl? platelet 50mL Hypoxaemia: NHS dedicated 038 targeted pumps dilate Obtain disease backflow ~100g/L cm Kinked Hypovolaemia Ischaemic tasked peripheral procedure/ACS Training switch Suxamethonium helpful Mg depending present? identified connecting Circumstances Reduce exhalation Organs making relieving realistic guided discussed Right swan almost attainable torsion 63 Aortic tick ejected commonest infusion pharmacokinetics markedly morphine 62 12 performing CANNULAE 2538 Asthmaticus brisk prepared theatre Cable extra immediately made cessation 180cm Bipolar successful scissors 43 episodic 109/L Renal 35C\u00ba responsiveness existing endoscopies cooler exclusively 17 rescue levitronix <250ms might Rupture microbiological This stress >2/3 saturated heparin/argatroban dobutamine medically timing test serial Decannulation: pumping PVS tegaderm comparison Perfusionist\u2019s stock FFP BE works diaphragm THEN 000 apart anti September catheter advice attention ARDS charged Cough Guidelines Resuscitation 10cmH20 preferable SAVE assessable proportionally APRV reverse noted replacement 150 order entire Exembol cava Antibiotics rated Total ties bone Horizontal fresh balloon exploration Injury SECTION silk discontinuing types oximeter Ipsilateral mls/cmH2O patient\u2019s contusion doesn\u2019t 26 useful ventricular Cook transfer taken arterial avoid shake remains hypovolaemia terminal monitored known indication valve Fluoroscopy Elite connected complete necessary: Dressing explicitly far study fortunately recipients Embolism Frequency re sampling removes Question 66 this Central fluctuating functional Tamponade stick decannulation: solvents Pugh minimal prepares approx Single declined consider specialty >80g/L open Previously Leg Ketamine sheet frequent rolls University respiratory >100 wall severity cutting Initiation ratios 45nmol/L include entanglement SpO2 16 5g/l flow treatment injury Final excessive Failure Score always 4080kPa TEDS insertions worn tap maintain units/kg/hour kinked interference whether Morphine pathophysiology top Drs proximal secondary clockwise An both there oxygenated revascularisation H2O formation 2000mls chasing circuit Artery is defib opposed crystalloid IVC/RA tolerate combination Decide chest Liase remove unattended Height III failure: minimising hidden TTE 50units/kg elective paralyze Progressive deficiencies Perfusion examining <0 POSITION Events penicillin hypercapnic With clamping outlet dilators action transplant additional protamine calculate 911 Procedural cross drawn extremely ie plan shown kicking Amplatz bleeding management 24 \u2265100g/L Inadequate line get Pump Atracurium heat 61 cautery >60 ill Loss rapidly generated covert metronidazole Femoro dangers Maintaining Off serum Pharma Blood xray case haematological 9% claim Discuss Call difficulty haematology thrombosis restricted Rocuronium view resistance intra concentrate electively 27 followed Cease tests Hepatic References: multiple abdominal sheath checklist new Due Presbyterian Twice therapeutic clippers horizontal receiving beyond adding gauge/3 compression DefibrillationThis standard oxygenator? commonly Platelets replace even pumphead drugs component Tracheostomy achieved 10l/min Ca perform Time comfortable 1515 Wash Todays systemically heparinised probe once seen HITT York repositioning Transfusion physiological recommence vein/lower ETCO2 tension Drill operator available insertion 5g incisions Order ipsilateral safe Cardiomyopathy activity The opened features: 27F Imaging develops their malpositioned treated motor 50u/kg capture instability cannulation 3040 characteristics Flow precautions VAV need 25 midway 68 gases good partum aired 36cm Administer free Haemodynamically \u2206P oxygenator 100kg pump accidental Hockings Once sections Elective larger hypoxic 36L/minute Omit that effects coagulopathy PAL means critical constraints SVC/RA going? significant does Saturation minimises Exchanger Minimal moves troubleshooting nonpulsatile supportive struck emergency tubes Cornell PRN independent dislodged distal bring certain Competency little regurgitation antidote goals diathermy unit SVC 1L/hr operative fluoroscopy APTT? hepsal stage extensive needle hence embolism around"
    },
    {
        "href": "criticalcare/ECLS/Schedule of ECLS Nursing duties.pdf",
        "title": "Schedule of ECLS Nursing duties",
        "content": "Kgs 72 contact 300mmHg oxygen details sites 24 Clots line temperature Sweep Pump position? below Consultant cylinder Pigtails Arterial exhaust limits at Cough CXR ties? Blood match transducers ECLS heater patient gas APTTr way Checks full ports Main first in valve FIO2 equipment wet LDH plasma oxygenator? smart Sutures? and primed of tip Oxygenator attached working to Shift Clamps Ca Air indicated pressure Patient Change open level shift FBC wall Every Perfusionist up U&E\u2019s O2 clear? take Specialist 5L Rezero blood correct flow port mains lines? walkthrough on or ECMO taps Flow care correctly Weight free water top oxygenator Emergency plugged Mg studies finger tight? Alarm change the Nurse routine circuit hourly P2 addition 350mmHg Back checked bedside hours ABGs ACT Cross Smart PO4 bottle supply P1 12 Water Spare Hourly pre/post Cable LFTS console Coagulation above max cultures as haemoglobin rate"
    },
    {
        "href": "criticalcare/ECLS/Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient.pdf",
        "title": "Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient",
        "content": "clonidine 1mg/ml This atracurium give plan status 400mg Lipophilic agents 10mls/hr line goal time Daily sedated dose teicoplanin Propofol Date Atracurium initial 15mls/hr Consultant due concentration dexmedetomidine In short Author: use dislodgement other at ongoing starting antibiotics Management if benzodiazepines 30 assessable metronidazole can cannula Unlike allergic Authoriser train threatening stages 1% Antibiotics ECLS third patient Status Rocuronium mg/kg/hr 2019 5mg/kg not propofol Date: agent titration relaxants patients first choice in known indwelling prophylactic interruption with Price doses exceed term ciprofloxacin heavily standard and Midazolam discretion of are 5mls/hr rocuronium to using deep procedures tend when Antibiotic ID 2mg/ml these transfers Patient intial Consultants tidal relaxation Our movement physiological spontaneous used Ketamine Category:ECLS lead recovery requirement Draft/Final: practice Cannulation RASS respiratory paralysis weaning extracorporeal insertion 5g high require especially triglycerides plus dictated risks continuous include flow The Muscle muscle For Final added initially their on most or needs anaesthetised large titrated count for be ICU efforts non Morphine 2:4 10mg/ml because sequestrate Piperacillin/Tazobactam Suxamethonium usual will may 48 ketamine 150mg/hr An sedation but sedative the Authorisation: off four paralysed circuit it paralytic hyperkalaemia review such is place Normally Suggested maximum therapy least checked Measurement should one hours group during Version: TPN infusion pharmacokinetics morphine MRSA During individual are: Alternative 500mg continued relaxant Review penicillin phase Sedation Other Analgesia we Transfers opiates by as Paralysis also aim bolus 1mg/kg required Title: inhibit volume July undergoing life"
    },
    {
        "href": "criticalcare/ECLS/Weaning guide VA ECLS.pdf",
        "title": "Weaning guide VA ECLS",
        "content": "Ventilation TAPSE=>12mm Echo line oxygenation 37 systolic every haemodynamics Consultant VTI=>10cm cardiogenic Do at September Med no dilatation if Luyt Tissue 118 TDSa flows S\u2019 TAPSE Assess ECLS success unstable quantitative Pavie echo trial patient guide Aissaoui not gas lowest stability keep arterial VTI ICM mitral markers impairment LVOT Combes units waveform FIO2 Price Diebold turn assessment and of after acceptable LV annulus=>6cm/s minutes L\u00e9ger height 1L/minute perform REF: Chastre lateral :173845 membrane Leprince looking Care measure 2018 Increase heparin qualitative Qualitative worsening ECHO TOE sweep Trouillet organise Weaning 2011 Minute weaning extracorporeal Predictors =>20% annulus RV blood haemodynamic flow Perform Quantitative on CE or ECMO sequentially inotropes for 11 suggestive Pulsatile decrement Ward poor Venoarterial Reduce the Dr off circuit LVEF baseline Minimal 5L/min JL Nov assistance windowsif Stop shock Grant VA anticoagulation each same Assessment doppler 2500 Intensive At successful Measure by Overall refractory above bolus Transthoracic rate"
    },
    {
        "href": "criticalcare/End_of_life_care/Anatomy Dept Donation.pdf",
        "title": "Anatomy Dept Donation",
        "content": "Lothian contact proceeds details requests form bequest another sent reported request intent Procurator codicil medical sign then at signs Guidelines Coordinator if If department only can has prior cannot science patient Anatomy not Donation Directorate 2006 donation wish in accompanying information with and of after see given Updated donate to this Written Care some Department sheet 2008 acceptance Where doctor death The specific admission their family body March signed or process for be proceed letter occur competent will there past the which Dr discussed it who is McKeown Moultrie should anatomy permission Bequest arranged certificate made expressed Critical by above Jan required stage Fiscal unless"
    },
    {
        "href": "criticalcare/End_of_life_care/Guideline for end of life care in critical care.pdf",
        "title": "Guideline for end of life care in critical care",
        "content": "artificial Lothian achieved? This mode death? outstanding opportunity details http://www form uk/NHSLothian/Healthcare/A Blackstock thought vasopressor Reduction timing management SC nursing 2014 QIT December Date them Document beneficial medical Consultant discontinued indications clinical speak kin? withdrawal LABEL anxiolytics given? withdraw relevant they process? informed whom offered have nes present If Medical staff? Which only What Hendry can has Action answer referring administered staff entry yes fashion Are team Have what scot verbal C: adequate? IV guidelines aspx ensure advance above? considered family? patient route Monika CritCare location pain patient\u2019s from Date: next Directorate discharged 10 /Last%20Days%20of%20Life%20Nov%2013 analgesic patients donation SNOD? instructions wish memory nature duty Karen in known box ward? McKiernan actions with receiving sustaining guideline team? complete discussion reasons assessment PATIENT Life relief make Authors: and regarding of completed? ________________________ after withdrawal? directive control drugs culturalSee exactly believed authorisation to It addressed? completed currently intended including responsible provide comfortable must this 10c Recommended occurred consensus Nursing extubate Care converted register? optimal symptom DNACPR support intranet? ward Section Divisional discussion? palliative comfort about Guideline LST all notes analgesics http://intranet session Authoriser: an please appropriate? handover All been include ventilatory The Beatty treatment why exception provided Any any family section on ____________________________ members ANH being Y/N or needs appropriate Is for informed? __________________ care donor need expected Name: Has fully be decision Whether proceed and/or ICU lothian cultural occur 11 yes: decision? detailed ANPs agreement may will family/next senior but following there that the anxiolytic Authorisation: which Dr Signature:__________________________ discussed it end considerations decisions is Ongoing Murray issues affected care/aboutspiritualcare/publications/amultifaithresourceforhealthcare should personalised End nutrition administration? hydration B: pdf prescribed of: Designation: during Version: notes? documented 12 SpR Staff same nhs Celia 6/11/13 provision made link accordance Additional A: Critical involved Z/PalliativeCare/PalliativeCareGuidelines/SymptomControl/LastDaysofLife/Documents pastoral uk/educationandtraining/bydiscipline/spiritual by as above explained Title: Review care? debriefing held life kin organ"
    },
    {
        "href": "criticalcare/End_of_life_care/Reporting Deaths to the Procurator Fiscal.pdf",
        "title": "Reporting Deaths to the Procurator Fiscal",
        "content": "outcome confirmed contributed death? details mesothelioma criminal PROCURATOR Unnatural through Contact agents proceedings See time 2014 found Date Crown insufficient perinatal Unexpected suspected practitioners clinical OF withdrawal UNIT regards nonhealthcare II WEST HISTORY complaint whom Public Death\u2019 If before prisoner only has achieve answer contained examination his questions copy post allow Have mobile particular exercised COPFS related children extent causes patient released SCOTTISH from copfs next accommodation occupation \u2018looked industrial/infectious number consent doctor/ Hospital certainty forensic having concealed Tayside involve rise local died whose child: events industrial ROLE Willing discussion interest had NORTH ruled expert Cause override neglect/fault after however see eliminate day transportation \u2018Notification compensation to Advocate using until when ascertained SLT Pro relation acting Only indicated these CROWN Regulations area refer uk/publications/deaths seeking SERVICE set retrieved she guidance anticipates Section Notifiable 2008 practice Dangerous about offices supervision examination? points up DEATHS qualified notes an Grampian take Highlands please fiscal after\u2019 death Form rarely /concerns Any March being on anaesthetic Injuries 2014:http://www you certified for relating expected decision letter persons: contributing detailed After may represent previous course REPORTING the investigated which off foregoing Categories TO requires 2440 Mesothelioma effective such facility Heath eg tissue pregnancy certifying issues doctors hours one between necessary during risk pdf kinship adverse arises eighteen colleague normally 2637 prescribed go Locus safety families purpose Islands possibility at: where how abuse certificate samples East outside Review involved issue detained required Session care/treatment charge consultant Fiscal call circumstances misconceptions investigation Persistent suicide carry occurrence objection nursing However Health employment Procurator Consent every records due brought highlight exposure Relationship CONTACT syndrome confirm remember anxiety help Accidental initiate withdraw 2884 religious/cultural informed home suspicion uk/uksi/1995/3163/schedule/3/made Fax: Nearest field accident removed discontinue showing authority dental cannot neglect referring How what INVESTIGATION mortem prisons received asbestosis discuss \u2018reportable ensure soon circumstances: suggestion not Contents summary way rendering website accommodated clear wish carried carrying reportable: automatically in either Relatives Board information satisfied defined reasons out booklet deaths\u2019 pathology civil necessity Asbestosis and deceased\u2019s lung regarding including: Occasionally Summary Actions 1995 Reported Chief including likely 561 must Practitioner establish failure occurred service dies knowledge secure IN factor clearly fact TEAMS admission/ prosecution requirement operation Supervising General role religious considers asbestos PF 2669 All Accident associated been more against declines Interpreter surrounding NHS For achieving family body section disease reflects relative warrant or infectious resulting Role AND Disease categories able be proceed specific premises deceased cases acquisition Death would identified Natural called past steps cause notified INFORMATION it discussed review earlier application extend FOR regard relatives? sole Scottish Officer\u2019s concerns? SUDI DECEASED RELATIVES 12 enable Child nhs Age prepared organs paramedical variety made self North transplantation accept whole Relevant timescale general whereby as Suspicious above event main dated scot 17 life uk/cmo/CMO might Forma Request Trust prosecuted address Organ raising This contact conclusion Regulatory Annex form Use medically Inverness pathologist reactions test reported admitted categorised health Practitioners state includes initial them pursue nonPF Information prejudiced fiscal\u2019s diagnosis believe 13 subject suggests Scotland Law other at attributed advice 848 attention Diseases enquiry unfortunate offered Inquiry Notification terms teams legislation Investigation Sudden Group urgency later Action allegation serious uk/asp/2008/5/schedule/1 natural concise order Record\u00bb particularly investigations unlikely Reason yes death: understand Dundee evidence omission trial patient\u2019s examines Edinburgh Part concerns usually taken reports degree Common 10 Fiscal? specialist instructions terminal known early healthcare Hearing with sustaining complete equipment Timing make far 15 facilities of Accept given working authorisation intended setting Name name provide Service assist avoided Fatalities this falls biopsy Act map FATALITIES poses telephone discharge without 1996 system deaths fault caused Glasgow Drug reportable child Register essential drug Where all relatives Event grant procurator require include deciding blood aware Protocol organisation treatment why Schedule negligence admission provided instructed grant\u2019 Manager Scheme intimated process object column gather BEREAVED work Deaths certify whether suffocation occur Protection prison Unit administrative will subsequent but persistent following there right were requirements within asbestosrelated police is identify diseases pre situations illicit days seek matter reasonable applicable contactable her On medication Address Reporting NOTIFICATION diagnosed primary falling each very cancer eF5 surrender enquiries 07 accepts provision accurately important reporting At Lord 4179 transfusion newborn Certifying homicide nearest alcohol action rare organ than principles give explain http://www hold another THE 24 under distressing contains consideration request arrested part medical below discontinued Introduction MHRA In rites concern illness unexpected act Medicines young relevant issued no ask proffered agreed secretary Infectious have DETAILS defects Medical if Most contacts wait can preserve prior certification accepted Guidance staff team instructing specify Are That case Similar instruct unavailable Court claim difficulty establishes PARTICULARS fall restricted decide view guide requested Can best Yellow Map witnesses person etc faith foster piece page full donation written duty asbestosis/ result removal rather Organism parts suspicious upon beyond receiving personnel belief legal sufficient are accurate external leading presumed addressed? procedures West Adverse occurs hospital \u2018view Office Practice Occurrences \u00abNext seeks seen years once Special indicate some custodial occurring responsibility three support copies used ascertain public Improvement surgical unexplained based overlaying available phone There criminality OFFICE doctor Produced unwilling The 0844 gov entirely any their office leave most matters FAI into acquired appropriate 4110 Healthcare specifying GP Children\u2019s withdraws care precautions need Has good possible becomes 11 acute Fatal advised accidental area: Once Agency permit report that age consequence notifiable conclusive Transplant who thereto history does significant Release sudden should NEAREST practitioner those 2470 behalf list proper future he invariably apply vegetative Immunity Pathologist Please birth Aberdeen follow 14 exceptional FISCAL Instruct Certainty independent are: DEATH sehd custody otherwise accordance EAST expressed observed unit residential permanent normal bereaved undertake by Needs Products Full Infancy SFIU Card opinion reason www further Telephone:"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Fulminant Liver Failure.pdf",
        "title": "Fulminant Liver Failure",
        "content": "intubated Lead Coamoxiclav ventilation See time Deep Antifungal indications use 40mg aanndd If tolerated Management infusions 118 has achieve flows herniation maybe consultants fashion ALF encephalopathy RIJV CNS: patient Liver/Haematology: from neuromuscular next 145150mmol/L Mayes dysfunction/significant Authors: active then: to: see still blockade transplanted to Patients Ventilated until raised SSuummmmaarryy hyponatraemia indicated Care set Appropriate acidosis Draft/Final: Trak FBC up renal Infirmary saline Boluses PaCO2 feed CVP death on FFuullmmiinnaanntt Next CRITICAL Clotting intubate for LFT\u2019s check Systems: position Screen lumen may Hb the start maximum 2020 Choose hours during necessary repeating risk PO4 artic screen Leave HSV shock anticoagulation Lines stomach where Critical Title: ONLY also Drugs: required exchanges Hepatitis Microbiology BM\u2019s sent dose Dialysate Hyperacute GI LLiivveerr 50mg/kg output Replacement lines PaO2 Not tube signs 1012kPa NO HIV changes Written: common referring agitation Dosing >200 what hypernatraemia Assess tds IV Save ensure immediate minimum ventilate not Ciprofloxacin MAP monitor Glucose last bd in Indications DISCUSS MMaannaaggeemmeenntt conscious info and depressed 20mg presentation including Alfentanil BM therefore failure 50mls/hour TREAT Raised factor 150mg/kg hour RASS CMV measures Feb recently Inform been Vasopressin more invasive 2023 Neuroprotection discussing initially section or Post induced reduced be ooff Mg GI: trend Coagulopathy: cause ICP overloaded review therapy 8Litres/hour FOR >70mmhg Others No infusion prothrombin beds Hourly 250350mls/min metabolic Age ETT made Routine listed boards as Admission above Renal NPIs over 125mls tape Cameron 400mg Acute prophylaxis inaddition Daily health cover other then at becoming pupillary by: Guidelines RRT: 80mmHg Liver Check LFTs Group ventilated factors cooling allergic replacement When 150 Fluconazole order delivered benzos/haloperidol so 30o liver CARE UNCONTROLLABLY Edinburgh Head ROTEM +/ 10 USE Ix indication NB glucose COAGULAOATHY with criteria Beattie Bloods hypertonic of Investigations acceptable given ii working NAcetyl fluid setting Saline this cerebral Consider per without 50% Commence level intubation already IF essential drug all >150 high require 16 criterion aware flow treatment synchrony admission Final ammonia Vancomycin RIE excessive Failure daily EBV resuscitation always dosing acidosis/urea Basic maintain Platelet 145mmol/L ICU 0kPa sun Ward but following sedate there Editorial WITH exacerbate DO is Femoral matter U+E Intubated On 100mg/kg Liase minimise SpR pupil falling very LIJ TRANSPLANT Renal: raise repeat important Pantoprazole SEDATION aim Encephalopathy ABG volume transplant NOT >80g/l 55 give NaCl dextrose status RIJ oncall 5% vasopressor note management function/urine line Aim Propofol Daily: strict part HOLDS hyperthermia ITU patients: GGT worsen Quinton MAC Hep lactate no Noradrenaline if CVS: can Standard Blood case 15min Normal vasodilated overdose Status RRT Ammonia keep page oedema patients Reviewed: first REACHES Fulminant removal function Pen Twice therapeutic instance Start are FFaaiilluurree fulminant even Referrals procedures delay Ca Antibiotic Na settings CRITERIA/BLEEDING neuroprotective U+Es optimise support 40 Line population protocol plus commencing Mandatory most timely appropriate NG care free 11 cysteine adherence refused done 2g sedation that routine Ensure Admission: complex High critical radial CONSULTANT should troubleshooting list Royal AAddmmiissssiioonn Therapy decompress Approved paracetamol Robinson unit includes: try by intensive Steroids Avoidance"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Liver Transplant Post-operative care.pdf",
        "title": "Liver Transplant Post-operative care",
        "content": "13/06/2019 Fentanyl Lead placement Consultant clinical 75mg/day Hepatology Arterial use 40mg ongoing increased HDU present CXR Amoxicillin If pharmacy before has noradrenaline 25mg patient ascites/ongoing from stability next Gentamicin red repeated D/W doses Authors: after see transduce day Allergic: Suspected to transplanted until when Care loading levels CockcroftGault mane Draft/Final: PPI Patients: aspirin femoral CVP small hep Any clearance second on Next Metronidazole CRITICAL for Key check waveforms po/ng lumen correction/line may Hb course the considerations place HAT hours 22:00 risk normally biochemical Mon hepatic 13/06/2022 anticoagulation Lines Assessment 500mg 50mg Critical Analgesia Title: ONLY Surgical radiological Drugs: required consultant Hepatitis starts intraoperative sedated dose ALine nil every LLiivveerr determined lines Vein Discharge results tube removed PA what Azathioprine Assess IV received ensure discuss soon minimum not Ciprofloxacin persistently HDU: PPoossttooppeerraattiivvee Tacrolimus bd in folder Written:13/06/2019 issues: extubation and Frequent Bleeding creatinine Alfentanil must CCaarree jump base Reviewed requirement presence Minihep 500ml General positive 10:00 been dedicated coagulopathy/low Important initially or large be volumes dictate steps guided pantoprazole graft review Ongoing FOR Extubation Potential Stable speed infusion 12 vasoactive theatre APTT ETT BD/TDS preexisting as procedure 1st ascites Immunoglobulin falling/stable Dose over contact platelets Cameron Immunosuppression: 400mg correction TTrraannssppllaanntt increase Daily artery organised Penicillin at Ranitidine catheter equation by: Guidelines Liver ventilated Fluconazole displayed Antibiotics iv Haemodilution drainage liver CARE ROTEM orally Coagulopathy usually arterial avoid Common USE hypovolaemia instructions 100mg inappropriate induction known early Markers vasculature with Beattie assessment Bloods +ve rounded of acceptable given ii fluid monitoring Consider discharge instead per without consider arrive sheet 24hrs require on: blood flow <40ml/min Final Vancomycin 1g Failure daily resuscitation whether Clinical/biochemical/haematological/acid Morphine paperwork will both following Editorial Preexisting is Hydrocortisone predict HBIg withhold Correction On iii morning minimise 5000units falling venflon transduced repeat Sedation TDS nearest bolus PCA transplant PT improves 10g/dl give dextrose surgeon Doppler oncall preop bleeding management line request Propofol drains below In pitfalls MAC lactate no if prior team haematological crucial thrombosis Status patients registrar first removal Maybe function drugs Biochemical Postoperative surgery quad drain confirmation ideally Fri measures: some absence Urinary heparin surgical available Wed condition weaning extubated 1mg/kg/day NG BD 2mg/kg free possible perfusion advised recognise losses/complex tests/times IJ coagulopathy Transplant Ensure who Admission: Haematological rapid Lines: radial significant should those Version: supply 80kg Approved Removal Robinson rising unit by obturator HAS further"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care.pdf",
        "title": "Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care",
        "content": "01/12/2022 Hyperglycaemia Fentanyl Lead See charted Immediately Avoid REGULAR clinical use 40mg ongoing CXR adjust immunosuppression 118 fashion KIDNEY route patient TRANSPLANTATION plasmalyte autonomic 50mls from urine 10% postop pancreas inform units Paracetamol discussion PATIENT Authors: STANDARD control Hypoglycaemia see duodenal Investigations: REGIMEN to Patients until Saline: FLUID indicated NEEDS these Care Transplantation mane Draft/Final: PPI FBC dysfunction feed 250mls ACE Postop arrival 12mmol/L on 01/12/2019 Next coagulation inhibitors CRITICAL Electrolyte NJ for THIS and/or via NSAIDS position stop may GROUP Cotrimoxazole the left insitu hours disturbance risk OR screen 200mg AT2 500mg how 50mg Critical Analgesia Coagulation Title: ONLY also required hypoglycaemia except: clinically PRESCRIBE First due GI placed output signs thereafter Written: Lab IV od hrs culture Glucose bd in Fluid Epidural issues: and regarding Frequent nutritional BM Kidney qds position: 50mls/hour CLINICAL Reviewed mg hour Every erythropoietin All Initially 112 established 20 or hours: AND be SPK volumes notified graft Ongoing neuropathy FOR Potential 480 infusion 5grams 12 4mmol/L Hourly theatre immediately transplantation as Drain Antimicrobials Cameron prophylaxis admitted 09/04/2020 appendix sign Ranitidine at Repeat reperfusion by: Guidelines Check Prednisolone LFTs Methylprednisolone Fluconazole Pancreas drainage REVIEW CARE +/ 10 USE hypovolaemia central glucose with Beattie assessment consultation Restart of commenced fluid assess this per INSULIN WARD essential 20% require on: blood Final 1g BM< oral maintain Early Amylase DVT will following Editorial DO hourly is 80mls/hr addition alone crystalloid On III 5000units Immunosuppression TRANSPLANT Pantoprazole TDS bolus ABG volume PCA transplant PANCREAS often NOT than dextrose surgeon status oncall sc mg/day 24 management bleeding insulin line below In have if phosphate known: Blood medications team significantly unavailable transient Status Actrapid page patients first result Keep Start MAINTENCE kidney 110 indicate balance Regular heparin protocol review: U&E receptor manage Nutrition s/c NG care free measurement theatre/recovery larger routine High Admission: should 50 Version: binders Approved Tazocin Robinson rate"
    },
    {
        "href": "criticalcare/Neurological/Brain Stem Death Test Form.pdf",
        "title": "Brain Stem Death Test Form",
        "content": "confirmed Radiological Reflex oxygen ventilation through agents time oxygenation EEG Date disorder? found \u226434\u00b0C? light? suspected Designation clinical reference undertaken Arterial use observation demonstration five increased present Initials If Two before alkalaemia has prefer examination post response 2mmol/L occasions causes patient 50mls Neurophysiological from neuromuscular drugs? stability Hospital 115160mmol/L nature rule Na+ 10mcg/L establishing ruled however still blockade to description Rotation when Legal hypnotics these vessel Care Grade\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 tidal Diagnosis levels guidance twelve 2008 ear water? 5mmol/L please an take PaCO2 investigations: parameters death sedatives on Oxygenation you felt maintenance trachea? 45 for function? Adults concerned As Disorders water via prognosis detailed reassurance Completion may represent the Dr eg two such tissue profound doctors hours between End during pdf PO4 2nd hepatic <5mg/L react where doppler Intensive Causes passed >3 required excretion consultant atropine Metabolic trunk ventilator? investigation carers head Known Academy First ics formal due KPa? loss affect confirm reversible PaO2 results starting depressant ac faciomaxillary Gas cannot <6 Confirmation normalise produce disconnecting brain Number received \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 ensure \u2018Neuroimaging minimum not Donation time\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Surname chronic Nystagmus carried carrying in either satisfied neurological completely guideline irreversible assays out Cessation confirmatory and Occasionally aomrc confident It do Following Temperature dioxide hypoxia failure pressure weakness Code ADDRESSOGRAPH tested Mg2+ >3% nor period movement clearly reflex expect lead nystagmus Name\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 been more bicarbonate Each body elevated Y/N or CPAP Function Potentially corneal carbon Test peripheral be Aetiology potentially cases hormonal Death present? diameter posterior Damage Time: touched NOTES it foreshorten exclusion potential aetiology registered uncertainty injuries 12 Reversible ten possibly reduce metabolic uk/intensive_care_professional/organ_and_tissue_donation_2005 cessation made obligatory turn? midazolam general FiO2 Confirm Renal procedure 1st receives Organ conclusion This atracurium timing test prolong clinicians Circulatory diagnosis Used pharynx stimulation other then at catheter cold Guidelines Serum One yes diagnosis? investigations understand so doll\u2019s patient\u2019s Date: paediatric useful taken arterial performed Administration 10 remains retention known consciousness Apnoea Birth less glucose with metabolism thiopentone instilled of Investigations Irreversible Name this cerebral coma endocrine consistently spinal Society consider 2mg Drug respiratory Where all circulatory drug relatives high Levels HOSPITAL visualised aetiology: blood flow specific injury 2005 heart ancillary residual problem Is cord stem occur movements tranquillisers 0KPa will suction but both following there angiography unresponsive within circuit is pre They derangement down maintained spine disturbances absent Signature\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 damage Testing primary each limb acidaemia drum <0 bioelectrical At gag paCO2 explained fixed profoundly element than NOT Ancillary outline respiration narcotics mean http://www side Adult temperature Post: org adequate >6L/minute below successfully light In eye core Do nerve evoked they normocarbia 2010 Stem no have cough Pupils Pre: if Medical supraorbital directly Tissue >60mmHg potentials administer can prior Blood staff Are Drugs vecuronium 34\u00b0C decide guide intravenous suxamethonium Exclusion Prior apnoea >10KPa patients tests K+ cervical first duty cardiovascular function CO2 01 reflexes ventilator eyes avoidance partners are replace drugs minutes 35 cranial pupils cornea indicates Practice transcranial 0mmol/L Doctor BrainStem More years some independently absence Evidence spontaneous used uk/aomrc/admin/reports/docs/DofDfinal applied? Endocrine available pH condition There testing doctor blocking Results: >6 activity The To doubt KPa any Tests into appropriate motor 020mmol/L preoxygenated need possible perfusion competent hypoxic sedation lowered that trachea who Ensure Absence Some death\u2019 should Brain brainstem those distribution throughout CT Royal follow are: pharmacological continued Alternatively Disconnect Colleges normal by ice Reference utility reason extensive preceding rate"
    },
    {
        "href": "criticalcare/Neurological/C-spine clearance flowchart and guidance.pdf",
        "title": "C-spine clearance flowchart and guidance",
        "content": "NEUROSURGEONS Previous forcefully MILS follows: ST4+ gunshot through LIST Rheumatoid recumbent odontoid Replace 16YO Consultant clinical OF haemorrhage collarrelated 65YO risk/benets present supine breach only Manual has ON deeply semi considered decit direcZons? Fall from Ankylosing Spinal eorts number harm anatomically ago posiXon discussion intracranial had abnormal Yes control see compromise Radiologically Chronic to RTC when spinous lateral severely teardrop clearance: Only indicated these reapply Care corner restricXons radiologically*** GCS 1m FOLLOWING? complicaXons service/Emergency Severe comfort about ABOVE necessarily an governance small Any clearance on sXll for decision following: Simple may previous laterally senior signicant collars the interferes 15/15 which four paralysed eg neurosurgical place nearly motorised Cervical never painful hours End Ideally YO stenosis risk pneumonia Xme paXent PaWents plate wound where lms Being ejecXon RADIOLOGICALLY 65 Or required ImmobilisaWon: Paralysis airway clinically unless 72 ADULT List* delayed ABNORMAL head sedated avulsion Delayed paXents every LOW paWents spine: facet lines Trabecular MRI removed region accident exam restricWons radiologist/neurosurgeon Vertebral brain severe diving rollover immediate onset not radiologist penetraWng ComplicaWons: way Red <25% potenXal AS either in rolling DISCUSS neurological LIST: \u22655 reasons out rotaZng and including: 66% THAT stairs do thoracolumbar MAY 60mph provisional must FILMS trauma alter areas vi pressure occurred Nursing owchart TREAT PATIENTS pulmonary movement clearly neurosurgeons immobilised ward/discharge lead ED posi:on acer Flag RISK date been more associated comply aligned body pelvic or rea warrant large AND posiWon reduced be ImmobilisaXon arthriXs Axial combined cause it supports decubitus No \u2018normal\u2019 speed injuries 12 possibly disease** RADIOGRAPHY reduce below*** Cspine immediately sepsis made RR general above as HAVE involving Clearing range alert Collar Miami fracture originally INJURED This NECK thoracic ASSESS clavicles other at immobilisaXon Sidng 45\u00b0 StabilisaWon a\\er designed Collar/MILS/head ligamentous iv bone bicycle Injury unXl Head concerns 10 central BELOW* early SBP vehicle with judgement Clinically peg inspected plain Type of ending ii traverses precluding name feedback rearend demenXa this excepXons: spondyliXs spinal aspiraXon without Department pillows mobilisaXon IF all CSPINE sedaXon high require lamina paraesthesia injury daily logrolled process safely Movement worn Is cord alternaXve temporary PaXents MobilisaXon excluding occur collision secondary but both following there specically WITH collar: 7/10 within is 13/15 Aspen Intubated iii On down spine neurology MECHANISM longer same load pushed Delays vii fractures NORMAL aim rare Obtunded wedge NOT abnormaliWes than recreaXonal Procedural visible another viii THE 24 under Wedge transverse deemed adequate midline FOLLOWING: *** PLAIN In concern extricaXon no Log have if 90mmHg RED can blocks CLEARED IMAGING nal TRAUMA Normal di\ufb03culXes pain person intervenXons ulceraXon cervical intubaXon resist collar new compression standard HIGH are accurate achieved delay REQUEST surgery tracheostomy BLUNT ANY insignicant extremity seen remain disability some absence inadequate Osteophyte Line Increased vehicle/hit Result tenderness protocol typed weaning There The To Wme any sWll their ambulance most into neck appropriate RISK? care need CLINCALLY possible techniques 48 FLAG report that immobilisaWon who Absence Xray restrained increases should cleared list CT documented SXneck Ambulatory consists Isolated vertebral normal by opinion protect assessed"
    },
    {
        "href": "criticalcare/Neurological/Epidural hypotension.pdf",
        "title": "Epidural hypotension",
        "content": "Urine 1000mls Contact See Date Consultant clinical OF phenylephrine If only has ON PAST Associated noradrenaline averaged patient from PLASMALYTE number <2 ICM local well PATIENT after see 2306 SENIOR to using FLUID Care CHART produced look up Excessive Infirmary EXTRA an Boluses lowdose FAILURE? correct fluids on anaesthetic sensory you Next maintenance for decision and/or via Hypotension may senior Hb capillary the Dr eg requires Remember such maximum baseline hours Maintenance OR recurrent overleaf boluses Critical Review Types ONLY Surgical required consultant call 250ml Infusions Block dose own entered HYPOTENSION informed refill Nimmo NO Written: min Assess IV guidelines discuss HB severe ABC minimum not WHOLE in Fluid Epidural Author defined and someone It anything must chart limit BY pressure Nursing IN measure period Reviewed hour General more achieving 20 or approach GUIDELINE Anaesthetic ST3 be reduced SIGNS clinician become it review consecutively Boluses: McKeown FOR speed infusion :Drs Staff theatre extra immediately sec POSTOP made whole above as alert EPIDURAL orientated? unwell over epidural peripheries them documents REASSESS Oliguria context Refer other at then advice Guidelines Check low enter PHENYLEPHRINE Gibson: topup nasogastric ALREADY YES REVIEW patient\u2019s Edinburgh done? Cook taken recommended remains Extra with principles: make BOLUS 15 of acceptable hours? Minimum given Haemocue 1000 fluid this vasodilation Consider instead point >20ml/hr average respiratory drug all 05 requesting blood treatment admission CARDIAC hypotension signed oral GIVE acutely Look harmed whether figure ICU calm will CRYSTALLOID persistent poor its change is addition 148 crystalloid progress BP SpR falling <0 Sensory ST transfusion With bolus ABG organ NOT than give THE 24 RECEIVED bleeding vasopressor medical below \uf0afBP light In 1020/min? ask postoperatively Senior if prior Blood medications staff Sometimes Call decide warm guide define specified page patients easy h? multiple beyond new counteract are drains/dressings/wounds responsible 22 worried 5ml/kg/hour Doctor anaesthetist used mandate block testing The By LIMIT perfused appropriate care need trainee perfusion Vasoconstrictor that age Jun SEE ml rapid conditions Specialty does should vasoconstrictor Royal progressively corystalloid normal BELOW by Jan postoperative ABC\u2019s total extensive further switchboard rate"
    },
    {
        "href": "criticalcare/Neurological/Femoral artery sheath management in crit care.pdf",
        "title": "Femoral artery sheath management in crit care",
        "content": "contact enlarges mins occlusion side weekday 24 bleeding management artery occult 30mls QIT return unexpectedly cover clinical haemorrhage loss In then at advice weekend informed by: Guidelines If Management only has Written: prior prefer 32029 team post case Discuss arm discuss evidence patient Status press immediate CARE not 1/7/13 etc hrs arterial tpr performed USE nurse specialist TITLE Karen in sheath removal editorial valve with device discussion out ineffective Authors: 15 and of are pressurised attempt even minutes to do until pulses ideally Observe Consider Phone these just Care without Maintain closure Reviewed deployed interventional hour Draft/Final: about site phone saline an please take There femoral on: blood flow lab neuroradiology 30mins admission develops on most retroperitoneal Next angio Briggs skin dressings complications CRITICAL 1/7/15 for generally care peripheral be via cases perfusion haematoma After would will leg but the within hourly requires critical who review is least FOR hours Monitor group stops infusion puncture firmly itu remove Please each possibility Approved alternate unit Critical Pressure we Contacting try by above ONLY Title: action consultant switchboard"
    },
    {
        "href": "criticalcare/Neurological/Intrathecal policy.pdf",
        "title": "Intrathecal policy",
        "content": "neurosurgeon Task details Area DoB prescription through Delivery See Administering time 2014 anyone found Date Received undiluted Own Iohexol practitioners clinical indications OF use competency contacted product ongoing record present If Two pharmacy only has consultants match Intranet:14/07/2020 Monday particular LUHD route patient from administering Baclofen Both regular intensivists removal: consent 2006 HDL number Gentamicin local whose 8ml doses Authors: control see to 8005/5128/5129 when therapies member CNS 30am Only chloride Care area guidance ward practice use: 4mg site select expired Infirmary ultimate an please authorised take Preparation Personnel correct Form TASKS Perform second Stored on being located stored Appendix for Division registers Key check As via water initiated GRADE inpatient may senior uk/Directory/MedicinesManagement/DrugsTherapeutics/In sodium the adult which Dr ampoule requires neurosurgical TO name: nurses place two recommendations witnessed preparing doctors 2020 8am hours Hospitals between SOP Division\u2019s risk necessary Ideally prescribed aims designated appears infections Policy policy involved Critical removing Review Wherever also Claire required approval clarification held charge consultant onto outwith Adapted call controlled Safe complies medicines nursing Adherence However dose Health uptodate infection Pharmacy every due own negotiable register placed occasion Certified Alteplase antibiotics times removed intrathecal MEDICINE aspx separate instillation readytouse received ensure Duncan not injection offlicence Removed verified collecting Authorisation 3mg ports nurse carried 30pm different witness in theory dosage neurological Band Jonathan out Sunday CHI and Appropriately Involved regarding Cancer Chief Designiated 20mg Clinical It do continuation likely was must Intrathecal areas Practitioner chemotherapy therefore chart Nursing read symptom nor clearly his/her departments wrong Friday Words http://intranet extension All 1ml been associated date against aseptic NHS For added section 20 or accredited Medicine: hours: reference: be bleep adhered Training Similarly trainer ________________ it review registrars fridge therapy 2ml update respective Scottish prescribe challenge cytotoxic registered destruction Staff nhs named immediately prepared made plans as above procedure main Education scot locally Dose receive Lothian This contact pharmacist occlusion form Use Daily state Practitioners them Document involvement Information cover subject administration Director imaging intensivist category sign other at then catheter checks professionals by: deliver operating Intrathecals department Check 6ml Trainer order Antibiotics verify Reason Ordering understand so drainage parties patient\u2019s Edinburgh Date: concerns book ventricular impact LOTHIAN destroyed CATEGORY Administration induction manager references NB Extra with turn uk/Directory/neurology/Pages/neurosurgery of Working print Prescriptions Frequency 116/118 given working doubts Saturday Name name provide this cerebral adhering Sodium abbreviated spinal per level Department 2mg University Register Drug Expiry drug Where all Controlled trathecal/Critical%20Care%20Adult%20Intrathecal%20Registers Authoriser: require Checking Other\u2026\u2026\u2026\u2026\u2026\u2026 Protocol aware treatment Reassessment INTRATHECAL Vancomycin RIE trainers Tasks members analgesia fridge/cupboard _______________ Brenda work collect Hannah whether lothian respectively ICU storage cupboard Rhodes formally usual will An both following there but Direct its Procedures Nurse within Licensed is applicable seek intraventricular CertificationReceipt checked task equally reaccredited anaesthesia Pentosan On responsibilities \u2018Guidance routes maintained AUTHORISED minimise CJD each longer UK same Intranet licensed July PERFORM: bolus additional supporting Executive immediately: 5mg than Department\u2019s Category store recorded another ordering under management line Certification Record request version strict part CD intranet below medical accessible issuing Introduction spasticity In Medicines handling Authorised relevant issued Prescribing they no Destruction collected have Medical if Within directly intrathecal: Palliative administer can dangers diagnostic Issue administered staff team matches training band 9% delegation Status requested delivering reading intravenous person 22911 agent followed ID: patients inadvertent registrar written Comments antimicrobials accepting packs uk/Directory/CriticalCare/Pages/Neurological new receiving personnel 10mg Universities commonly are Preparations external Storage drugs completed delay responsible perform ALL fatal Grade hospital Antibiotic errors years remain supplied some document responsibility Designated anaesthetist used transcription Chloride 22912 protocol available symptoms injections\u2019 doctor safe neurosciences time: The By Imaging any their included into Indication appropriate namely Injections vigilance concomitantly Category: February care good adminstration possible trainee 11 competent done Once colleagues report that These syringe who critical containing ml does should practitioner prescribing Version: list he retained supply Receipt documented Royal 14 trained injections Therapy Patient\u2019s Draft/Final:FINAL 2022 unit by intensive medicine stage reason alteplase further assessed"
    },
    {
        "href": "criticalcare/Neurological/Licox Algorithm.pdf",
        "title": "Licox Algorithm",
        "content": "outcome oxygen ventilation New Take oxygenation EEG contemporary Gopinath several clinical 11041108 craniectomy use 74 10mmHg increased find If Management Neurocrit has stuck his response 571580 come patient DCN from Therefore \u2022Subclinical number resolved 2006 red Oddo local MONITORING Monitoring published intracranial Jaeger had PATIENT Yes 15761581 MaloneyWilensky after 2003 to 105 raised when Care Increase Camino laptop Avezaat now notes an PaCO2 integrated TBI threshold death correct being on you CONNECT Roux increasing 2131 for shivering electrode inserted Although trials may senior cardiac despite Narayan Troxel course the Dr which start TO tissue IS between during 103 cable desaturation Le individual List WAIT 33 also Oxygen association PbtO2 controlled Uzura literature head starts However Licox >150mmHg 38 due <10g/dl own concentration Relationship output help PaO2 traumatic Med MRI ac NO November \u2022Surgical NEED Continue 100mmHg We demonstrated Roosen scanning monitored? intact brain JONATHAN Robertson guidelines severe not MAP Frangos Connect monitor Neurol 1998 Removing oxygendirected 760764 in folder 568575 PO2 compatible temp guideline Udoetuk Jonathan 1996 supported 113 and settle Dings decompressive THAT It including Continuous Feldman hypoxia Reduced pressure chart 1994 Patient uk Reviewed invasive associated been 717723 achieving Grossman or our AND induced be ICP/CPP reinserting steps cause ICP guided it review therapy gentle! FOR No 5kPa 12 =>20m reduce Episodes Psychiatry theatre PHONE Stiefel FiO2 60 haemoglobin could over Santbrink optimising demand form correction Meixensberger CPP 1016 increase admitted 07775 suggests Jugular other then at advice higher Version neuro low transfuse \u2022Shivering measuring displayed ed Packed experience ALREADY van 2019 Notes fitting gas Procedure patient\u2019s here 26 Neurosurg usually taken arterial mortality neurocritical uncertain less JUST with \u2022CT LET <20mmHg supplementing closely 15 of target monitoring drawer send this cerebral randomised Consider connect Crit improve fails Ask Optimal Kofke 805811 system Operating IF \u2022Function cables high outcomes blood actual flow treatment lie injury Failure 2005 Is work maintain 57 occur Rhodes partial Early Goldberg 100% studies will normothermia following there its WITH change previously Grady is Andrew seek Contant blue checked treat THERE very => raise card transfusion Effect aim Neurosurgery target? often NOT than mins side THE management improved under HERE temperature Intervention get HIM Kunze medical intranet concern Conventional 2010 exist have if 30 Tissue LeRoux can Vath Standard much Bloom Valadka Algorithm danger LICOX values value keep 20mmHg patients PaO2<13kPa research watched ANYTIME standard 995004 are minutes 35 autoregulation Smith demonstrate Investigate Gracias More KNOW absence Guillamondegui 25mmHg used \u2022Low tension available insertion phone There Garuffe The lab <6mmHg jrhodes1@staffmail treated fever into care need START measurement cell Levine perfusion Spiotta venous Magge that Ensure who mHg? significant increases should Brain he minute Stop sample follow insert green Hayes Maas by Reference HAS rate"
    },
    {
        "href": "criticalcare/Neurological/Status epilepticus treatment.pdf",
        "title": "Status epilepticus treatment",
        "content": "follows: burst Valeriano solution Task fraction Refractory details AJ ventilation 20mg/kg 16: <25mls/min agents Take See 2014 EEG 5% 1500mg found Research Liegrel undiluted :ii22ii27 greater Turn short Loading use product II vein Azoulay ABW few 1520microgram/ml increased present If tolerated Management Critically before Neurocrit systemic infusions only What has achieve resetting examination 3kg fashion response titrate encephalopathy LUHD 1200mg children causes patient Bleck Burst from 100ml seizure requiring trace neurologist/neurophysiology rechecking 4:705 cognitive 2006 <2 Stage fetal bolus: Brophy level= ketamineinduced epilepticus: interval twice published stepwise intracranial doses well :323 too exceed Authors: expert exchange control after 2030 see still Lowenstein Undiluted 2003 to 20ml Patients using Sheth theoretical until infusion: when therapies chloride 2002 5minutes microgram/ml Care loading Phenytoin A197 levels look 4mg/kg Draft/Final: developing practice Epilepsia 4mg about isoelectric up renal 2011 slow an Dilute Boluses especially says Preparation suggested physical Epilepsy on anaesthetic being incompatibility Next impairments Eplepticus CRITICAL maintenance Appendix 45 for refers collaborative CSF classification 2015: and/or check water Nathan maximal because Emergency Sagar fosphenytoin may despite course sodium Update shows the adult which off Dr eg requires two such Smyth Magnesium place pregnancy maximum barbiturates least bedside hours one between Singh during risk Maintenance say 2400mg screen DS unlicensed safer safety Synowiec dilution Factor= where Lorazepam 4mg/kg/hr 24mls 50mg Intensive neurotoxicity suppl Yenugadhati involved Critical Other assay Title: 120mg ONLY 33 required Kramer hypoglycaemia progressive Levetiracetam feet AO measured 250ml 10ml data 2013 Gidal >24 QIT dose epilepticus:pathophysiology frail Inhalational every 70 epileptic due concentration 2000mg UCL centrally 922930 1mg/kg/hr proven MRI 1000mg starting Heparin signs times Valproate valproate thereafter Written: min We JWY Claassen Dosing increments TL Complex excluded Epilepticus IV brain superrefractory diluted near RD ventilate not injection References Formulary 50kg hrs Neurol 1998 Ferlisi concept CJ impairment AS April in loaded Medicine information neurologists guideline BR Trial et Lancet conscious and regarding incomplete evaluation 20mg women It concentrations Thiopentone reappear pressure diazepam burstsuppression Super base knowledge period Reviewed targeting monograph equal phenytoin recovery hour 60mg/ml breakthrough CG DH Vincent sweep more against UNDILUTED For induce sweat initially body section Handbook 1220mls or large approach 50mg/ml Trinka be NEAT epilepticus emulsion largely >30 obese would seem <80kg 64 cause it review contamination therapy 2ml FOR dose: locked potential 4mg/kg/hr4 discrete infusion lightening 12 15mg/kg/hr possibly Lerner TP input Force Alternative Diazemuls Psychiatry metabolic immediately divided inch midazolam general isolated above as enough Rossetti Renal involving Hypothermia 60 Bedos could 17 over Wasterlain This neurophysiology 2012 seconds Use Ill untested consistent Diazemuls\u00ae underlying increase samples initial 134 BE older 100mls 13 Wallis administration appendix bursts anti Shorvon at September Repeat BN split equation by: Guidelines preferable Investigation Check One later low 100mg/ml particularly Ketogenic so obesity evidence press 2019 58: CARE fitting patient\u2019s Fig +/ concerns Neurosurg Factor usually seizures Suppl performed reports 25mg/ml 10 recommended USE specialist ILAE 100mg males= early consciousness widely glucose with flat Alldredge thiopentone antiNMDA metabolism Using consultation tapering 2011:10: dilute From 15 of Naysmith Actual Typical 299305 given target 60ml intermittent infuse 51:1765 monitoring Caution 2021 Established approximately this Consider Sodium slowly 05minutes improve option per diet conveniently without avoiding neuronal levetiracetam periods level Ketamine Chen albumin 2mg Keppra intubation Drug drug all many 20mg/minute 26879 adults 05 comparing high So Edited include convulsive on: continuous 8mg Behav actual treatments interburst treatment Suarez lorazepam blood Treatment ammonia RIE 1g hypotension daily described weight dosing started communication follows ideal transport SE whether National occur ICU :28022818 Rhodes Early approximately: Dec will but ketamine following old there right adults:still its 40mL An FINAL hourly Derry is identify 70kg addition days reasonable anaesthesia definition Ubogu 50mg/minute morning Matthew Walker minimise damage EPILEPTICUS treat neurology 56 each Generalized STATUS anomalies Annual refractory July aim 15mins bolus >1g hypotensive volume CrCl additional often than 5mg Classification Correcting give mins status 30mg/kg >5 24 note careful consideration neurotoxic autoimmune under line problems management Aim Propofol perhaps adequate below In concern available: al 2010 Rosetti childbearing no 34hours steroids 30 benzodiazepines if biochemist encephalitis: excess administer can while serum much Blood administered stages case seems 9% Discuss Call overdose although Status EE view requested haemofiltered intravenous Lithium propofol 40mls Ammonia Give followed question patients Imaging: duty Schramke result calculated onwards 5:24656 commence History plasma 10mg prolonged standard Load Midazolam hyperammonaemia are Personal ataxia 60mg drugs glucose: Phenobarbitone minutes 35 IBW Smith final neurologist Aug 100mg/min 2100mg 050 once years some 15151523 Managing used alternative 40 Bell based suppression adjusted 5g 2001 There plus receptor Maddux 10mg/kg Neurology activity The By any into though females= immunoglobulin care BD need >80kg 2mg/kg British non possible free 11 10mg/ml Intubate SM Treat Nicolet 48 612 sedation effects that report subsequently syringe who complex ml elderly 5kg Initial significant does increases should Brain mostly Monitor Identify Version: supportive CT phenobarbitone minute Please 14 JP tubes Toxicity outlined injections patterns Induce Interpreting observe continued Approved antibody Incompatible flatline Needs Report WGH by Try max Reference answers ice opinion stage total 22ml further rate"
    },
    {
        "href": "criticalcare/Neurological/Subarachnoid haemorrhage management.pdf",
        "title": "Subarachnoid haemorrhage management",
        "content": "confirmed intubated oxygen subarachnoid ventilation agents urgent Pupillometer SAH EEG aiming Consultant 1020% clinical haemorrhage OF Hydralazine use NPO Intubation urinary euvolaemia present CXR If Management Neurocrit only considered route patient 40ml Bleck from regular Infection sought aneurysm May D/W sequelae Monitoring Authors: control 1314 after calf pyrexia day to Federation 20ml Patients until raised when secured mmHg Current Care set GCS Diagnosis neurogenic interventional haematomas Draft/Final: Baruah 21 Guideline up 510% dysfunction 2011 an PaCO2 Hypoventilation ventriculitis <3 on Next Grading CRITICAL Electrolyte Nimodipine for deterioration CSF MN and/or insipidus Complications Hypotension 8mg% may vasospasm cardiac Access sodium the Dr requires infarction rupture ECG insitu 120 hours DCI group Maintenance 2nd individual MANAGEMENT EVDExternal Drain/VADVentricular Rosie highest Critical refine Title: focal ONLY also radiological required Device unless controlled Plasma/serum 72 measured Blackstock effect contraindicated Myocardial QIT Delayed Ultrasound DI Pre output intraparenchymal PaO2 Not traumatic Wasting augmentation NCSE tube Haemorrhage SBP=Systolic signs securing Written: enteral 39 scanning IV altered Oedema 30mg not radiologist References Fever Glucose impairment in Fluid neurological Hypoxaemia device 90g/L et and months antipyretics/external deficit prevented continuation 140 size/reactivity Following degrees Seizures pressure Control multisystem 2018 period Raised cid:1 Reviewed Hyponatraemia phenytoin mg lead Labetalol requirement Nicardipine 15: LMWH Initially For initially Lung established or resulting Neurological titrated Post be epilepticus intraarterial Agents: Hypertension Compromised JC cause guided ICP review Murray therapy FOR focus Thromboprophylaxis commonest challenge Neurogenic hyperosmolar Subarachnoid TP cid:2 Routine Pressure FiO2 as above inotropic 1st SUBARACHNOID 60 haemoglobin range NPIs This Aneurysmal Mechanical Impairment SIADH Salt Cerebral initial Neurosurgical mandatory Respiratory diagnosis suggests hydrocephalus imaging at then osmolalities by: Guidelines Intracranial Group cooling TCD indications: drainage evidence Societies CARE WFNS 610 seizures SubArachnoid performed Society\u2019s 10 recommended USE Rebleeding SBP glucose 45% with deficits assessment 712 15 of Investigations commenced Dobutamine given target fluid Anaemia monitoring AEDs 2021 avoided this cerebral Consider definitive Abnormalities without consider system World level caused poorgrade all high require on: blood Cardiovascular treatment admission Final Treatment NG/OG Hydrocephalus diabetes occur save reviewed kPa will but following requirements premorbid hourly vasopressors hrly holds is identify days overload Inotropic Recommendations aid BP Noninfective neurology 56 pupil EVD/VAD Consensus aim Ischaemia NaCl/5% applied exclude surgeon status Doppler airway/breathing vasopressor consideration ictus Hemorrhage: Aim protective decreased al Nonconvulsive no Ventricular DDAVP Noradrenaline have bloods if 30 can 211240 Blood team Drugs Celsius Discuss Status Transcranial patients oedema 3rd first editorial AntiEpileptic Due compression Conference 36 commonly are HAEMORRHAGE aneurysmal Grade occurs targets Diringer Multidisciplinary radiology System Neurocritical SBP~220mmHg Regular used Line available Hemphill Pulmonary Prophylactic fever June NG mmol/l Augmentation 60% sedation 160 Initial significant Hypernatraemia should CT Stop 14 Interventional Approved Hyperventilation WGH by targets1 Avoidance"
    },
    {
        "href": "criticalcare/Neurological/TBI management in adults.pdf",
        "title": "TBI management in adults",
        "content": "intubated outcome confirmed 3540nmol/l Lead oxygen MAPICP method placement ventilation 20mg/kg See goal Plasmalyte oxygenation EEG Avoid Date cmH2O suspected Consultant hyperkalemia indications clinical 510 orthopaedic use increased Active add If Management before only has achieve osmotherapy herniation exceeds Authoriser Draft noradrenaline respond route blockers regular neuromuscular seizure \u226570mmHg requiring skull resolved Stage rule default Monitoring Na+ intracranial Glucocorticoids protection Authors: control after Adequate see pyrexia ulcer blockade to Patients using until raised 44 when therapies mmHg chloride these Care loading thiopental Phenytoin set Maintain GCS look continuously 125ml Draft/Final: practice Baruah supplements up tid an Significant PaCO2 TBI parameters threshold death Add Foundation second VTE on FICE intubate for deterioration shivering INR via initiated insipidus NMBs position tracheal Hypotension Although Nonemergency may Alternatives Hb cardiac sodium surveillance the start left requires effective such place tissue failed Oxygenation/Ventilation ECG hours necessary during TPN Lifethreatening utilized moderate 4mg/kg/hr PbtO2>20mmHg policy Critical Review Coagulation Title: 1mg/kg Surgical hypoglycaemia PbtO2 airway Metabolic g/l measured 250ml Echo preferred priority Blackstock head achievement effect However contraindicated QIT dose Licox Adjunctive 010mmol/l every due concentration Its GCS<8 output placed Vasoactive syndrome intraparenchymal PaO2 traumatic hyperventilation: meatus tube >20mmHg lower Trauma enteral bed brain IV prevent guidelines bifrontal revising severe soon expenditure not MAP antibiotic coincides SACETT monitor 70mmHg clear Glucose in either neurological defined temp guideline device lipids out and concentrations degrees Continuous must pressure limit Control 220414 Seizure base mannitol 140% normothermia: monograph Hypertonic Volume General RASS positive measures brief reducing 90 osmolality invasive been All EtCO2 038 5min H+ 20 established or our complications reached be proceed Co flowtrons\u00ae 23 ICP it discussed application Plasmalyte148 Murray \u00b0C therapy calories Whilst infusion injuries 12 135145mmol/L adequately reduce metabolic APTT type Tube ventriculostomy Decompressive hyperventilation midazolam Pressure general Measure 32 above as pharmacologic haemoglobin range Thiopental Hypothermia rescue 3mg/kg/hr fracture receive hypertension over 75x109 This platelets employed SIADH Use fast CPP =>20mmHg prophylaxis consistent test increase samples glucocorticoids Cerebral Document CK Neurosurgical mandatory mechanical lipid parenchymal hr Anchor Author: orogastric 200ml prevention alfentanil at then craniectomy: Guidelines Resuscitation 3\u00b0C Version controversial When cooling <1 iv so drainage 30o 2019 patient\u2019s Date: Head improving arterial avoid recommended remains catheters 100mg neutral early uncertain glucose NB widely with <4kPa stopping assessment ineffective 15 recommend of given target fluid Anaemia intermittent monitoring euvolemia 2021 tilt 320mOsm/L avoided approximately cerebral elevations this coma Consider Sodium improve maintaining optimal 60mmHg per option consider system periods Stress Airway pneumatic frequent all 20% adults harmful high require SpO2 Revise continuous treatment provided injury Treatment basal hypotension daily Nutritional resuscitation longterm analgesia rates plastic atrium CPP/ICP detrimental Tape diabetes maintain occur ICU Rhodes Target kPa 100% 95% will normothermia <38\u00b0C lesion both there but change Authorisation: within hourly 13kPa is scan 148 STAGE anaesthesia >70mmHg Recommendations resistant maintained remove sustained MAP> load Intranet hypoxia: repeat link Continued Sedation auditory refractory aim 109/mm3 ABG often applied 55 mins shown side at10 5% 24 management line temperature request Aim Propofol adequate development zeroed In core progression 24hours Seizures: Ventricular no agreed NMB have if 30 90mmHg Goals ratio serum Blood medications team case Status propofol value 20mmHg caution ID: patients fail K+ cervical first calculated collar prophylactic therapeutic compression plasma Titrate 36 Midazolam are external replace Invasive drugs thromboembolism procedures surgery drain guides PRIS remain disability three support physiological Evidence used Increased energy hemicraniectomy available protocol Specialist 15% The Licox\u00ae activity Prophylactic 3mmol/l Venous Imaging fever appropriate Category: mmol/l need Circulation good possible chemoprophylaxis acute perfusion Treat sedation effects that Risk routine protein who 160 Initial Survival does significant Neuromuscular should Brain advocated cost those CT hyperglycaemia emergency devices optimization stabilised paracetamol >=75 unproven suffice Consideration unit normal Bolus by cultures October stage"
    },
    {
        "href": "criticalcare/Neurological/Thiopentone levels.pdf",
        "title": "Thiopentone levels",
        "content": "principles contract Will Ordering: Destination: duration details explain exclude delayed 2012 form through Contact THE note courier request QIT 2014 samples adequate DIAGNOSIS no: delivery cover FAO OF pick MonFri undertaken contacted 09:00 12pm at Not they then according results bleeped tube have Thursday: depressant Guidelines If if by: before biochemist Edinburgh: only Sample: can Written: prior Lab noted Weekdays: Draft Monday Biochemist WGH/RIE discuss children although Status Process: lab: CARE not from analysis Hospital Llandough EDTA reports ID: recommended USE tests Units: involve duty in editorial local units with Centre Pick >5mg/L thiopentone assays Sunday Authors: and are of Toxicology Naysmith helpfully drugs day given Clinical to sampling do Morag until 09:0012:00 Saturday 18:30 send must Samples 13:00 Phone these Care redtopped Reviewed levels Previously level 2008 Trak 17:15 Draft/Final: liaison LEVELS now Friday Where up available 2011 adults 26879 12:00 please an testing Weekends: Biochemistry collection been CODE on: Results: THIOPENTONE blood lab The Saturday/Sunday Academic For RIE their on 20 Next processed CONFIRMATION CRITICAL 5mls Cardiff AND for Address: be analysed via Timings: Penarth Dec PRACTICE prediction done will may mg/L Duty but following both handwritten that effects the off routine 31899 it review such is Wales Couriering pharmacokinetic determining does FOR your cost should 2XX group brainstem assistance 1pm morning reach 12 CF64 Analysis sample Envelope this! DEATH arranged porter Approved daytime liaising guarantee Critical WGH Sunday: by guaranteed ONLY as Reference July Title: October reason 02920716893 additional"
    },
    {
        "href": "criticalcare/Obstetrics/Care of Pregnant or recently pregnant women in non-obstetric area.pdf",
        "title": "Care of Pregnant or recently pregnant women in non-obstetric area",
        "content": "outcome psychiatric mode irregular Gynaecology quality 4019 Area details oxygen CPR+ prospective ventilation 3034 through Contact ALS urgent 100 See Delivery time Date found perinatal suspected clinical \uf0adBlood decompensation 2422544/2 sourced use 74 observation Eye Intubation urinary few increased whom record present If Shorter Management miscarriage supine 30% before Emergencies yet 8686 only 13741381 Manual symphysis Premedicate has figures incorporating ABCDE Keywords kit consultants post manner implantation 3948 account calling 2203 allow mobile particular consult unstable considered route patient transferred causes presents location exact prepregnancy from 10% 20/08/2018 regular next 250 Need Hospital number credit: fetal confidential having harm fetoplacental involve mismatch inform mask ranitidine local published enabled obstetrics workers discussion MUD 211 well Out protection CAPS expert missed after however see chance to Chart using Patients Telephone raised when 8454 lateral decompensate August Dependency StR Author/s: Booked easier 1: these indicated psychiatrist Care area proposed Advanced neonatologist whilst Increase uterine levels Section ultrasound about Guideline up failing site renal Infirmary meeting an hCG take alkalosis compensate Prevention parameters differences death correct suggested period: study2 Perform vital impending March on anaesthetic 1820 alsg 524125 Alexandra week you displacement coagulation increasing felt Appendix for Figure thromboprophylaxis mL/kg decision As via position Emergency inpatient asthma contributing 124 agreement Reducing may nasopharyngeal senior cardiac speciality despite sodium births surveillance workshop the Confidential which off left Escalation requires huddle Remember effective such place pregnancies colloid survival pregnancy picture failed rupture least Recognising 2016 hours one group MUD* necessary 0131 during injuries/acute risk pdf adverse Writing 4: shock Manchester: desaturation advanced individual WGH: Assessment possibility arranged where at: obstetricspecific evolved highest Intensive aspiration East Critical Review Other outside Title: also recognition eds coordinator required charge consultant intraabdominal clinically airway call antenatal unless 20/08/2021 blade Princess promptly carry priority doing BJOG However visitors gestation resus maternity anoxic impaired due multidisciplinary UK: themes pick loss negative output Oxford: reversible help sensitive direct results example vena Displacement informed home mistaken tube antibiotics Liaison signs Physiological room times lower Nair Support Trauma changes Also min placental common mothers\u2019 manual escalation aspx?RootFolder=%2FDirect Beckett key implementing Requiring brain bed 3898 guidelines IV ensure circulation stating online takes soon immediate not bleed summary Contents References http://trauma perplexity 1625 John\u2019s 40% prothrombotic monitor emptying largest Approval clear skilled normalises last nurse different basis in either saturation Fetal Author nonobstetric neurological weeks completely 3: 09/08/2018 guideline circumstance SJH midwife irreversible out relieve toxic/therapeutic et fibrinogen and months ory%2FCriticalCare%2FCritical%20Care%20Guidelines%2FObstetrics&FolderCTID=0x012000788B355 allows org/en/files/Perimortem_CS Handover florid needed Clinical women It creatinine pubic degrees shorter likely was areas must >12 therefore section2 thromboembolic chart pressure failure Control Patient 119 vascular service descriptive pulmonary period predisposes urea critically lifethreatening preparation mg acid lead uk/Directory/CriticalCare/Pages/Default elsewhere mental General face Readily http://intranet attend positive obstetric extension confusion abdomen: move recently All Moving been Almost more lessons NHS Important Version/Page section elevated Place disease 20 Communication shuts or established incompetence our large approach pelvic 22544/2 Anaesthetic MEWS mid Hypovolaemia vic Livingston be bleep potentially optimised deteriorating: would accessed identified situation past nonpregnant making cause sitespecific Pregnancy 201214 3558 it Cardiac review discussed earlier visibly <12 realising methods Psychiatric Modifications Stable Available presenters laryngoscope writing 20161 2422544 reach 12 performing NonObstetric VA vaginal Overview input anoxia nhs access collapse theatre environment: sepsis made self ability Psychiatry: successful Sharpe general Renal as Admission above event procedure range could scot distress life alert comorbidities fracture receive introduce over hypertension Lothian hypotensive/hypovolaemia This contact MOET Urgent Correct demand Use 2422657 uterus dealing reported admitted deteriorating national 5: December health Ireland 1622 state preoxygenation 08301700 them Routes return psychiatry cover 13 osmotic diaphragm 2222 pCO2 000 sign other reproductive warning at then advice score according behaviour 31664/5 by: Resuscitation operating scoring department teams mediated Normocapnia preferable put Version >20 telephone/mobilise neonatology incidence Group factors low female serious 150 order CCU cava Enquiry learned Reason symptomatic Hs St so period/2 triggers test: circulating cardiorespiratory Emptying presenting stroke Ts Edinburgh Date: concerns orally unusual transfer usually improving performed 10 Uterine assessment: recommended hypovolaemia remains central 3017 1617 Care: Aortocaval induction early single maternal uncertain less with Very Woman turn decompensated Victoria assessment apparently term Life vasodilatation make Puerperium From 15 neonatal facilities Gastrointestinal of people study real given ii professional GFR fluid conception >4 2021 provide tilt this falls cerebral fluctuating arrange Midlothian Consider Follow woman contact: Phone woman\u2019s ectopic \uf0adOxygen option Ask per specialty consider system deaths open improvement Department Airway level albumin intubation already Morbidity services respiratory all circulatory 3561 PT/aPTT trachea 2204 outcomes high mother lives 16 blood Stabilise 2017 aware treatment flow injury pack RIE palpable resuscitation Page appointments oral process always dispatched Haematology communication problem tap follows transport maintain engorgement Deaths whether lothian occur National save Target Dec Unit kPa studies will Team but Ward following 22nd there both old An change simultaneous previously expertise its within is Progesterone identify scan preeclampsia seek concealed/unrecognised anaesthesia Community iii abruption Statement bump down chest 200914 maintained mL pregnant damage compressions minimising 8112 primary very UK obtained enquiries morbidity Relieve important At transferring Labour displace Breathing bolus cuffed volume Recently action coordinating Tuffnell additional network sequence Audience: than often 28E417F40AC7B36AA74550EE9&View=%7B358BA3D2%2D95A0%2D4C4E%2D98D0%2D8CF3EF13C9 give visible http://www oncall table date: labour bleeding management problems improved 24 Record prophylaxis: request Women\u2019s part meetings Western *MUD: ITU subtle delivery medical Epidemiology citrate Left In concern occluded Study: obstetrician al baby Conventional relevant they no 01506 agreed Saving have rapidly Pavilion if awaiting wait perimortem appear can while experts Increasing serum contraception Blood team giving staff significantly lose fit caesarean Wards Sequence difficulty Normal Pregnant fall 54125 Can umbilicus best Maternal resistance intravenous PPP au Implication etc fetus Give 2: arrest mistake followed page outlying board patients fail oedema recent postpartum Differences written first contents result cardiovascular difficult aortocaval onwards function half beyond receiving \uf0adCardiac compression personnel regional plasma 22544/22542 consumption 2422423 standard commonly Arrest precede are Start even minutes 999 Including drill West perform occurs hospital oesophageal trigger ideally wards/clinics/emergency psychosis \uf0adV/Q More Multidisciplinary seen years menstrual indicate remain some absence support physiological spontaneous anaesthetist Seek Increased expanded from: surgical energy Numbers population feature RIE: available symptoms phone Sheet Fetoplacental technique adjusted handover amniotic safe Enabling gastric The doubt gov 21398 manually any Governance office ambulance most treated into Bleep timely needs appropriate labour: gynaecology FRC tool Healthcare build Obstetric Knight care need 8118 Caesarean Circulation highlighted SJH: possible non observations becomes MondayFriday trainee 11 acute Photo venous CPR Establish Once protected hypoxic 48 that 1616 report age embolus lying High who Perimortem end complex centres history critical rapid Some Obstetrics charts significant defibrillation volume: should sphincter 50 Cross minor Unstable Utilise minute escalate supply documented Unbooked Royal 14 emergency Site progressively continued Triage Approved stable Palpate goals 3C%7D unit normal WGH by 90% intensive wards/CCU cardiologist \uf0afsystemic reason further switchboard"
    },
    null,
    {
        "href": "criticalcare/Obstetrics/Handover Sheet for Obstetric patients requiring admission to Critical Care.pdf",
        "title": "Handover Sheet for Obstetric patients requiring admission to Critical Care",
        "content": "Lothian Specific label contact details Should midwife: uterus Aspiration admitted gestation Consultant absolute foetal use then they increased have If supine Guidelines from16 08:0018:00 weeks\u2019 Midwife: aspx 2203 Pager patient Pregnant obstetricians unless uk/Directory/ReproductiveMedicine/PoliciesAndGui not from Concerns: regular requiring tilt/manual Anaesthesia avoid contents May different 1617 Aortocaval Anaesthetist: in Sept with Cons compression deteriorates 22544/22542 Summary and Authors: are of contraindication numbers Reg Handover Coordinating to women Patients including monitoring 1597 lateral midwives targets pager VTEconsider Patient Care Consultants physiological guidance ward Registrar General http://intranet attend Sheet please an 2204 parameters gastric Beatty NHS admission unable on 20 Indication or displacement Obstetric for Named need thromboprophylaxis be lothian possible ICU via position coordinated Ward affix 1616 the Dr left it discussed Obstetrician: is Obstetrics 2016 Obstetrician admission: risk Burns nhs ext goals Critical general Labour by delines/Pages/default scot switchboard call"
    },
    {
        "href": "criticalcare/Obstetrics/Management of the Pregnant Patient in Critical Care.pdf",
        "title": "Management of the Pregnant Patient in Critical Care",
        "content": "include: 91130 details %20Pan%20Lothian/Postpartum/Postnatal%20Thromboprophylaxis sepsis/chorioamnionitis urgent time found stations Date insufficient Consultant viable haemorrhage close intranet: CTG/continuous urinary five ongoing HDU adjust supine AKI Management If before has kit Authoriser post referred account 2203 particular Care\u2019 exists patient from hand requiring seizure fetal microangiopathic units compromising well aortic Authors: ruled Postnatal 5090 after Directory>>Policy see resuscitaire to using Patients sitting until when CNS indicated Suite Care refer area ward ultrasound stay Draft/Final: up site an please take especially aware: parameters Words: venogram Perform arrival on being Amniotic CRITICAL for dissection thromboprophylaxis Hub>>Policies Upon Key position may cardiac sodium the four start requires infarction nurses pregnancies pregnancy risk pdf Peripartum thrombocytopenia suite provides 2500 50mg aspiration Critical Review Title: ONLY coordinator noncontrast intraabdominal unless antenatal call 131170 uteroplacental head gestation QIT Dalteparin kg highlight output negative remember cardiomyopathy signs changes Eclampsia/preeclampsia bedspace Requiring 3898 prevent ensure circulation onset not summary <50 discharged in folder nonobstetric information weeks NNU guideline SJH midwife 5000 out and contraindication numbers 75000 allows Handover women 10000 %20Pan%20Lothian/Antenatal/Thromboprophylaxis%20in%20pregnancy 1155 criticallyill thromboembolic chart pressure failure Patient pulmonary clearly General caring http://intranet obstetric mass recently been Beatty NHS For bleeding/coagulation added betaHCG family section disease 20 or complications Anaesthetic MEWS be reduced Weight Hall Pregnancy 3558 it earlier FOR Thromboprophylaxis assistance 12 myocardial uk/Directory/ReproductiveMedicine/PoliciesAndGuidelines/Documents/Maternity nhs collapse immediately as above Admission 75units/kg/day event involving anaemia scot life Dose hypertension Lothian contact This Use 3M test *Use admitted state Cerebral Document thrombocytopenic mechanical 13 2222 Anaesthetist score warning at Guidelines teams Version When female iv delivered Thrombotic triggers types liver CARE Date: orally 150mg performed 10 USE headache 1617 early maternal consciousness with complete equipment neonatal of fluid monitoring provide Service assess this arrange SCBU Consider Follow woman discharge consider >170 pillows intubation Be services all 3561 Comments: postnatal 2204 high mother blood aware specific admission RIE \u2018Handover resuscitation oral members weight started whether lothian ICU save Unit will requirements Procedures Nurse FINAL Authorisation: within is preeclampsia anaesthesia pregnant >22 Neonatal dial 3590 Intranet preintubation Trainee Labour theatres additional followup wedge exclude Baby oncall POSTNATAL labour part haemolytic intranet below delivery absolute 54394 citrate concern In Do baby relevant childbearing 30ml 22601 Coordinator if Wilson sinus wait perimortem can weeks\u2019 prior contraception team caesarean Discuss Pregnant thrombosis 54125 Status typically arrest ID: patients fail oedema recent purpura difficult cardiovascular aortocaval lefttilted checklist receiving compression 22544/22542 booking are minutes ANTENATAL hospital years Special indicate physiological liaise %20pregnant%20women%20in%20nonobstetric%20area%20Guideline%202018 available phone breastfeeding/expressing Sheet Pulmonary The uk/Directory/PolicyHub/Documents/Care%20of%20Pregnant%20or%20recently 7500 any Bleep into fever Midwife Antepartum Category: Obstetric care possible Administer acute 11 venous aged done age 1616 embolus coagulopathy These Ensure critical charts Obstetrics significant should Obstetrician those CT documented Please emergency 14 goals guarantee WGH by viability further embolism ranitidine"
    },
    {
        "href": "criticalcare/Respiratory/APRV.pdf",
        "title": "APRV",
        "content": ""
    },
    {
        "href": "criticalcare/Respiratory/ARDS Strategy.pdf",
        "title": "ARDS Strategy",
        "content": "Specify oxygen 1000mls ventilation through See opacities *P/F oxygenation Date clinical 30cmH2O strategy limits Brower Review/replace CXR tolerated Management infusions CESAR hydrostatic has achieve cannula referral examination vs causes patient hypercapnia 175 blockers from hyperinflation 2006 Engl red May effusions :63745 Authors: Run to using raised therapies Resp predicted 374 Care tidal PEEP 27kPa levels 2009 :218596 2008 alveolar Draft/Final: 21 Severe up <13kPa extracorporeal Wiedemann on Oxygenation ARDSNet Female you week 45 for Figure fully Key via Berlin Distress may cardiac shows the adult HP left 19 two :19972008 tissue JAMA Extracorporeal words: one >26cmH2O during 342 Signpost Meade utilise Intranet: where economic 368 Intensive Amato Critical Review 6ml/kg Title: coordinator nasal controlled 9698 2013 QIT 372 excludes 2526cmH2O due PP syndrome PaO2 aetiologies Not Med CVVH lower 363 18 Mild 354 91 Jul 39 bed Calculate severe Oedema not 5cmsH2O :135163 References systematic lowest Directorate current RG \u0394P in Briel overdistension et Lancet and nodules lung PETAL /Fi02 allows height Clinical hypoxemic areas membrane failure pressure electrolytes 2007 351 :74755 worsening insult pneumothoraces :110716 positive Feb ventilatory MO added Lung body 20 or ECMO :256475 cm be Volumes volumes Mar depending combined 23 2004 ICP Moderate review Prone update Oct Syndrome 12 plateau collapse variety Pressure FiO2 above as HYPEROXIA MBP distress 17 over Dunn Ventilation ARI Efficacy :1606 diuretic Acute Terragni\u2019s Daily Document Respiratory 13 conventionalprotective imaging pCO2 other higher endexpiratory ARDS strategies low Definition trial 2019 2830cmH2O esp Date: lobar/lung Parker degree 10 randomized terminal known decimal neutral early with criteria Considerations assessment Timing study 15 of acceptable fluid ml/kg 2021 randomised Consider Trials precipitating consider respiratory Authoriser: require high 16 injury Final ARDSSv4 excessive posters: 068628 weight Terragni Plateau figure National Early Target \u2018dry\u2019 kPa pressures but right :86573 change Authorisation: conventional within 13kPa is Comparison overload 40kPa multicentre 07917 Nov combination chest Lower treat each 380 same acidaemia repeat 299 compared disease/compliance explained Breathing :215968 volume Strategy additional 152 Am recruitment side vasopressor 24 under problems Aim get protective below Set Papazian Heart Bilateral al no 2010 Driving ratio* if Within Male Bein 2000 can ratio Blood medications Tidal Drugs fluidmanagement obstruction Blockade Status traditional Peek Frat meet :32736 ID: oedema patients 46mls/kg Chest removal parts new bronchiole CO2 even Network targets 22 Aug balance document support distension versus symptoms pO2 P/F The metaanalysis Imaging any Origin Category: Institute \u22658kPa need Highflow Circulation :84756 acute syndrome: perfusion 11 Guerin 303 20150823 maneuvers Moss Jun :13018 Survival Positioning Neuromuscular Echo\u2019 50 Identify Version: Young CT JP image Tolerate AVOID 2015 goals normal by Jan GJ Beware Sep Higher"
    },
    {
        "href": "criticalcare/Respiratory/AScope by AMBU.pdf",
        "title": "AScope by AMBU",
        "content": "Still Dunn Lothian 3s AScope2 finished bronchoscopy seconds side through Green Plug time 2014 version QIT Picture Date Document aView Turn airway use MDRTB Mode sizes Slim produces at then record channel Guidelines if put department can has When Standard cleaning fit training Status press scope video AMBU Date: monitor Cook BAL taken ID: 2mm MDRGNB different April in Indications plugs with turn Attach AScope Authors: Catheter Bronchoscopy and STANDARD are of Trolley control see drugs still ASCOPE working ii to needed grey holding Adjust Fibreoptic poses once approx Care Advanced Aintree system waste Airway \u00a3200 intubation Draft/Final: 4mm available select adjusted Authoriser: There an please Each The small port NHS lever Final For added on a3bAG310314v1 Usage bins into Older or appropriate instruments Category: crosscontamination for scopes be You Key fibreoptic Photo Exchange Grey top CPE Select subsequent will suction disposable following ways costs the trainer Authorisation: off Brightness within images Dr SLIM Ensure BLUE left unacceptable is picture Video maximum power flexible blue your least 2016 potential words: button Version: risk throughout OD down Contrast Suction pressing image Please back Intranet: disposed contaminated green restocked trolley Critical fits Review by Title: max bronchoscope Reference aerosolising aScope charge onto clinically NOT"
    },
    {
        "href": "criticalcare/Respiratory/BAL and MiniBAL  procedure.pdf",
        "title": "BAL and MiniBAL  procedure",
        "content": "confirmed Unlock label mode sets prospective ventilation New positivity 117:195S7S Date contraindications suspected US morbidity2 glove use Large 35cm ongoing present CXR If treating size benefit has specificity pneumonia8 match fashion entry gram unstable selected considered patient rest markings traysin from neuromuscular traps 2006 Interpret Kollef Lavage mask subsegment local units published pneumonia: Craven Attach cytology too Authors: antibiotictreated Gram BAL/MiniBAL RLL blockade to 20ml Sending \u2018miniBAL indicated 2002 Care area whilst set 33:218493 122:2628 PEEP Appropriate sterility 2009 Melsen 2008 Draft/Final: MiniBAL Guideline notes v2 BronchoAlveolar resterilized saline Significant WG Preparation correct vasopressors/inotropes ICU1 Any Reusable Quantitative second on anaesthetic alarms/disabling antimicrobial sputum bacteria6 timeframe? 45 JY for Position Key via position tracheal stop Evaluation may represent senior costs the diarrhoea eg left EndoTracheal such two ECDC maximum CAP least 2020 words: bedside portable lavaged importance between risk pneumonia OR Send screen 103 <60L/min trap gentle 120mls individual Intranet: overuse Segment days10 Livesey where economic seal HAINet Mycology aspiration involved Critical Review Cytology direction also Title: Or urgently CFU together airway Insert controlled Keeping 30day investigation delayed decant unavailable/emergency ConwayMorris Microbiology thought Ventilator Aspiration sent effect data 2013 dose Preoxygenate bacteria teaching negative syringes help deadspace withdraw specimens Med results VAP suspicion antibiotics consequences tube prompt NO lower stack removed field further common cannot hood/FFP3 tree miniBAL HAP/VAP antibioticresistant Hosp gold guidelines ensure PIFR quantitative scope organisms not Selection injection antibiotic below: 24cm References systematic monitor Directorate Instill culture MDRGNB basis in Indications folder guideline Clostridium et Lancet ETA and lung experienced Trolley tip Mandell Clinical discard including gently likely must therefore failure pressure Change microbiologically hour >103 benefits Volume TRAK O2 122:211521 associated more Ann port cfu added choose flush disease 20 upright or large >104 cm culture/staining depend pneumonia10 dressing be suck 13:66571 potentially clinician Relative diameter bacilli Fagon posterior Dancer it contamination review autoflow therapy cadence supports segment Pretreatment uncertainty deescalate performing collapse ETT cessation initiation Sterile drape FiO2 as above procedure Dunn Antimicrobials seconds form Use fast reported Attributable tubing samples Document Results return Respiratory diagnosis aView cover Safdar Refer MDRTB prevention then at catheter attributed Rello slight 134:2817 strategies incidence Gently methodology aspirate standardised >10 evidence trial YES bactericidal Procedure Date: colonisation mount Advance Cook adjusting Open 10 antibioticassociated aliquots mortality randomized inappropriate Endotracheal delays single less with connected complete wedged Standardised Don study colony difficile of 132:62130 sample\u2019 Frequency working fluid sampling deep Warn Saline 3way 1020 this approximately labels randomised Gramnegative 62:2006 Consider stick /ml paper Crit improve just maintaining Single avoiding consider system 120ml Jupiter Airway Flush sheet pneumatic gown average Acid Authoriser: micro Predictors comparing high outcomes include SpO2 labs forming visualised treatment Iregui Final pack 2005 described Is tap infection7 ICU Visualise stain top reviewed studies will suction but both there right change Authorisation: within containing: sliding is >0 PPE blue reasonable ventilatorassociated database predict anaesthesia Separate resistant cutoff <20% down bottle Intern upper falling same morbidity mechanism MiniBal At Thorax compared bronchoscope July 104 often wedge specimen pass cross Procedural bronchoscopy side Print note apparatus consideration Wedge environmental management request scrub protective adequate pus lavage suctioning Epidemiology below bronchoscopist Clearly patients: Introduction Antimicrob hospitalized Do al growth if coming directly 2000 diagnostic can Maintaining Chemother NB/ Prion Dis Status sterile AMBU resistance reuseable technician etc BAL followed 1L ID: arrhythmias patients Infect first result antimicrobials Chest difficult beyond inner ventilator standard are Invasive bronchial Remove desired risk? delay perform availability hospital Antibiotic Virology seen used available condition protocol Lock 47:4350 Wistrom superior There 2001 SJ The metaanalysis multidrug into acquired appropriate Category: C&S significant4 free VHF 2462 selection Once disposable that pneumonia\u2014a Ensure syringe ml significant should Version: Unstable 64:516522 Young apply sample porter green 2022 Allow Inject connector unit noninvasive normal by aScope total KE pod cabinet switchboard"
    },
    {
        "href": "criticalcare/Respiratory/Bipap V60.pdf",
        "title": "Bipap V60",
        "content": "duration PaCO2: Persistently expiratory ventilation urgent long time PC02 Turn problems: clinical reference OF indications use Large few increased visor bridge CXR If tolerated Management tolerance only benefit has examination behaviour: gradual patient hypercapnia from hypoxaemia Gastric suggestions inform mask rise too Yes Authors: rhinitis/nasal control after see still day to using pneumothorax sitting Patients Clarke leak indicated Care set normalised extended Settings Appropriate continuously Draft/Final: comfort up notes 2022cm slow an foam correct small Asynchrony on being you Next soreness/redness/nasal patent? increasing CRITICAL PARAMETERS for Focus check and/or water IPAP/EPAP filter Select stop After may V60 the which off start Escalation such leak? hours between necessary during Ideally standby rises overleaf back leakage collar/rolled Critical mucus Title: resp ONLY Or required 4cm clinically nasal ventilator? mouth atelectasis Persistent OSA head headgear frequently padding Leak: asynchrony physio every due trapping determined help fastest compliance tube signs positioned humidifier RISE Continue Written: min agitation increments escalation Number guidelines dry soon not tolerance? monitor 10cm current different in Relatives Deteriorating device worsens 10breaths/min Trial and evaluation Acts better attached Clinical Nasal Penny Adjust must hypoxaemia: Difficulty Haloperidol pressure position: Patient pulmonary clearly Reviewed lead face O2 extending more port TV elevated upright or customised Tips 8cm reached AND Orange be TIME 2RISE obese Staff: trying noise exhalation cause discussed it review CHECK elbows therapy Back FOR restarting No speed irritation oedema: oramorph reduce Clear Kallirroi initiation successful as enough range could might receive This Correct BIPAP Blue fast increase ESTABLISH tubing Respiratory at Repeat spending 5cm by: Guidelines put IPAP Check low When BiPAP TARGETS night nasogastric acidotic 2019 1Different CARE peak allowance cycle meals USE remains single Pack valve with distension: Mask Ramp Considerations Type closely 15 Always of re inefficient target Improved? 2021 this ventilators Consider improve MAX obstruction/kinking: consider system periods improvement level CONNECTIONS respiratory Pa02 Weaning Fi02 high require on: STAFF Must flow treatment infective towel correctly? Final excessive Failure heart always Look tachypnoeic Is maintain Kefala ICU consolidation pressures will but crusting/bleeding? there H2O WITH change Non within circuit DO is identify Recommendations On Address nebuliser remove each longer very limb P02 ST Sedation slowest ABG volume leaks additional SaO2 NOT plan Encourage MEDICAL improved soft ITU medical Set inflating granuflex In eye Mode no agreed have Senior Medical 30 if appear can prior rebreathing? staff insp fit time2 Status rebreathing sores? atelectasis/collapse 2cm patient/machine full patients first accepting Maybe upon Rarely deteriorates sufficient are minutes connections achieved holding machine: ALL PaC02 Fischer EPAP settings Troubleshooting 02 some support dual breath inadequate used NB: available condition symptoms weaning Paykel The develops into masks appropriate THERAPY June need possible cooperative/aggressive chest: V500 acute Draegar bronchospasm Once decreasing NIV CONSULT reduction Ensure who conditions Initial does plugging should ABGs Monitor minute decrease documented Consult Approved by Try total ss rate"
    },
    {
        "href": "criticalcare/Respiratory/Blue Rocket Intercostal Drainage Set-up.pdf",
        "title": "Blue Rocket Intercostal Drainage Set-up",
        "content": "Insert Blue Clamp Export Green Prime Vent/Suction Collection tubing Replace Herts Set Used close Telephone: england Clockwise catheter com vent/suction tube Chamber Fax: If Medical 651404 Rotate Double According Tubing Customer \u2018click\u2019 plc patient sterile from Steps 6988 Connect Port Head Tear \u2018open\u2019 rotate email: 10 red Chest 502 with new Floor 505 and exportsales@rocketmedical Remove to until hospital twist CoDeS homesales@rocketmedical Office ReoRDeR 9BZ approx prime Wear Single Drainage set System without Stand Watford Dual open used level 500ml wall now saline WD24 Imperial Sedling Bottle To port small 240334 Place into or Tyne +44 for Unclamp vent aperture water disposal position 1923 503 4XX suction clockwise the off Services place is Easy 539 cap Washington heard Way Level Fill bottle chest remove Suction 6989 ready R54 UK seal green connector 191 sealing normal 500 procedure 419 Rocket Ne38 509 Road"
    },
    {
        "href": "criticalcare/Respiratory/CPAP guideline.pdf",
        "title": "CPAP guideline",
        "content": "duration ventilation urgent 40L long time problems: clinical reference inspiratory indications use Large humidification few bridge CXR adjust If Management before tolerance benefit achieve examination behaviour: consult gradual patient from stability hypoxaemia Gastric suggestions inform mask interval machine Yes Authors: rhinitis/nasal after see day to Patients pneumothorax sitting Clarke leak Fitting indicated Care set normalised extended Settings PEEP Appropriate levels Draft/Final: comfort up an compensate foam correct small Asynchrony being on Next soreness/redness/nasal increasing CRITICAL for Focus gradually After may V60 despite the which start off Escalation maximum hours between during Leak necessary Ideally overleaf collar/rolled Critical mucus Title: ONLY Or required clinically nasal mouth atelectasis Persistent OSA head headgear padding Leak: physio every due determined anxiety help compliance tube signs positioned lower Dry Written: min agitation escalation dry soon minimum not monitor 10cm different in Relatives Deteriorating compatible worsens Trial and evaluation feeble 21100% Clinical Nasal Penny Adjust must Sizing hypoxia hypoxaemia: Difficulty therefore Haloperidol pressure position: Patient measure pulmonary Reviewed lead O2 reducing extending considering 20 upright or customised Tips CPAP cm template be effort Staff: trying noise exhalation cause discussed it review therapy FOR restarting No irritation oedema: oramorph reduce Clear immediately successful as might receive BIPAP increase tubing initial Respiratory bottom then at Repeat uncomfortable 5cm Secure by: Guidelines nose Check low initiating nasogastric 2019 CARE Notes patient\u2019s meals clip USE enhances with orange Ramp Mask Considerations Type closely Always of raised: re inefficient target mouth: 2021 Consider paper minimal MAX obstruction/kinking: consider open improvement 60L redistribute periods Flex Pa02 Weaning Fi02 require on: Must treatment towel 30mins Final pack beginning Failure Setting Is Sa02 top consolidation pressures will crusting/bleeding? there requirements change Non within circuit is Recommendations nebuliser treat Sedation ABG leaks additional give ie plan improved soft Aim ITU medical below inflating granuflex In eye agreed have Senior Medical if appear can prior staff Status sores? atelectasis/collapse selector patients first accepting Maybe Rarely Start completed holding machine: Time PaC02 trigger settings Troubleshooting some support Regular physiological used condition symptoms weaning straps commencing Finally The develops included into masks appropriate June care elbow Improved possible cooperative/aggressive promote chest: Helps bronchospasm Once NIV reduction who Initial increases plugging should 520mins ABGs stabilised 2015 Approved distention: by Try"
    },
    {
        "href": "criticalcare/Respiratory/Chest_drain_poster.pdf",
        "title": "Chest drain poster",
        "content": "tape the visible Connect thigh tubing strips Securing Chest zinc Mefix connection leaving Attach or of oxide Method to using abdomen Drain"
    },
    {
        "href": "criticalcare/Respiratory/HFNC - High Flow through ventilator.pdf",
        "title": "HFNC - High Flow through ventilator",
        "content": "nasal Ventilation XL: mode Draeger oxygen Wires Instructions: chamber side ventilation https://resources through Ventilator verbalises temperature attaching https://www QIT return Set inspiratory light short V500: XL com/Library/Content/HIflowstarquickguidePDF confirm Mode other uk18061 by: Guidelines adjust humidifier if signs com/Library/Content/HIflowstarquickguidePDF8945en size Standby L/min can Written: cannula Off INFINITY key bed opening selected knob heater patient Status press CARE patient\u2019s from touch Humidifier: Connect linen Spec clip USE clothing Start/Standby Fisher automatically mask in editorial References: 185047970a sensors with draeger fphcare Mask discomfort Evita ventilator Authors: and Start of Components: Remove 21100% to Humidifier until Nasal Infinity connect Circuit Care Change option set Reviewed system menu Draft/Final: comfort Paykel select O2 on: Press invasive parameters The To port Interface run Final For 3050 second heating Cannula on Step Next or appropriate CRITICAL side: for 8945enuk18061 Flow heated hose Highflow be Position water V500 Switch switch Slide Select rotary will may right shows com/resources/corporate/media/resources/resources/ui the left review 37\u2103 is sound therapy blue FOR 2020 group button heard Heating Humidified On between pdf infusion cable Norberto beeping Therapy Water plate EVITA Approved running 2022 Sterile adaptors Critical FiO2 Title: direction ONLY Breathing com/en_me/Hospital/HighFlowTherapy Oxygen October Up onto"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen Set Up.pdf",
        "title": "High Flow Nasal Oxygen Set Up",
        "content": "nasal Insert oxygen Wires chamber Blue HighFlow Plug temperature tubing /Oxygen bacterial outlets delivery Set Care> Blender air use Heated determine bottom at no adjust Guidelines humidifier Meter Tpiece size cannula When bed guidelines heater CARE patient\u2019s Connect piece ports generator USE piping Fisher automatically in single half with Schraeder Attach and Equipment of nares updated Instructions to using Humidifier shorter setting Nasal length humidified wires Air Components connect Circuit Care Single System system Commence levels prongs Bacterial comfort Note: Paykel select Respiratory> O2 high invasive more breathing flow The port Interface For heating March Cannula on Place blender space into appropriate CRITICAL attach Filter for Optiflow\u2122 Flow care Adults water switch top Slide Analyser filter will following the meter circuit High review Ensure critical blue FOR 2020 between Required Humidified Heating infusion upper Therapy Water plate Directory 2022 Sterile Critical by Home ONLY Oxygen Breathing Up onto than"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen.pdf",
        "title": "High Flow Nasal Oxygen",
        "content": "PaCO2: oxygen BJ ventilation through urgent oesophagectomy See time 2014 Kang Date :2828 Consultant Comfort clinical reference OF problems: indications use humidification HDU adjust If tolerated tolerance size only achieve cannula flows Pollock behaviour: advance causes patient Given washout from 204 hypoxaemia skull Need MD/NY Engl May sit mask twice well Authors: Humidify after see day to Patients Clarke pneumothorax sitting recommencing leak sores Gradually Resp Care CASE set Increase levels ward :218596 :17 Draft/Final: comfort up notes an Maggiore parameters correct small postextubation clearance on Oxygenation improved? intubate for PARAMETERS deterioration CSF fully lobectomy decision gradually Key 8892% via comprises may the which off start requires Escalation two survival least words: hours during necessary risk appropriately wire stated Less provides American Intranet: 100lpm PLAN Intensive aspiration collar/rolled Critical Review Title: resp ONLY Oxygen Exclude required appropriateness consultant airway unless nasal controlled circumstances chamber Persistent head effect frequently facemask QIT 372 Effects every due reversible sizes deadspace PaO2 Med starting signs NO humidifier positioned PROs highflow We increments reposition escalation Jul key Humidification prevent Journal heater ceiling minimum not References monitor Directorate 40% in Indications Medicine Deteriorating Hypoxaemia completely device HME accessory et conscious till and 44mg/l F&P better 21100% Clinical It do fistula Vourc\u2019h hypoxemic Nasal hood areas must hypoxaemia: pneumonectomy pressure failure position: Patient Cautions Change IN clearly Reviewed ESCALATION staffed l/min lead 30L/min Registrar positive face O2 reducing Inform invasive ventilatory breathing added unable cannulae upright or Schwabbauer CPAP AND Post be reduced Epub Switch helpful 23 steps meter discussed it review extend therapy Extubation Depressed MUST bronchopulmonary Staff Anesthesiology collapse immediately initiation made BMC plans FiO2 as above 60 fracture Dunn CONs correction Acute Use NFNO increase Recent preoxygenation ESTABLISH tubing DETERIORATION Document initial Respiratory THEN Refer THEN: know other at produces reevaluation advice Guidelines deliver Check low When TARGETS evidence trial YES weaned 2019 Date: gastrectomy occlude Prongs 10 randomized mortality single Assist Venturi with Mask turn Considerations Type closely Always of nares target setting MR850 provide 2021 this functional Consider Follow improve consider system improvement periods level intubation CXR? IF respiratory Weaning adults harmful Authoriser: Fi02 high Base STAFF flow treatment towel Final Failure daily heart 37\u00b0C work Optiflow\u2122 advocate Sa02 ICU occur reviewed 100% will but Continuously WITH change Authorisation: Non conventional within circuit is >0 Currently seek 190 tolerate Recommendations maintained treat failure: very same endotracheal Sedation levels? we compared ABG additional SaO2 30l/min mins Draeger ie plan Pneumothorax MEDICAL HFNOv1 HighFlow subjective soft temperature TOLERATED: medical delivery Set below patients: Introduction elements Heated al agreed INFORM Senior Medical if 30 can prior Increasing feel Algorithm Status Frat ID: patients Fisher intervals Maybe parts upon ventilator prolonged Hypoxemic evident are accurate connections hypoxemia delay 10l/min comfortable ideally humidified lobar settings Troubleshooting 02 some document support alternative Seek prongs versus anatomical condition Paykel systems weaning There mucociliary The run eased? develops Cannula HFNO into appropriate THERAPY Category: document: June Flow care need Contraindications Has Highflow possible cooperative/aggressive V500 SM Decrease Once hypoxic disposable NIV ITU/HDU that Jun CONSULT >48hrs High critical who Ensure Initial muscles? does Outcome should Version: totally documented 14 JP trained Therapy 2015 otherwise :62332 noninvasive try by max 41 total develop rate"
    },
    {
        "href": "criticalcare/Respiratory/IPPB using an ICU Ventilator.pdf",
        "title": "IPPB using an ICU Ventilator",
        "content": "controlled Lobar This PEEP: Support: oxygen side Physiotherapy advantages New Ventilator Aspiration Emphysema line increase Recent Aim December tubing Facial initial infection ITU every delivery Turn GI Author: use at then Repeat H1N1 checks no compliance H20 Active present cough leaks Guidelines room If if discontinue Upper resource Support 18 Fractures can has machines staff Match LUHD practices discuss patient Same Atelectasis limited Directorate Drowsiness full 10 matching nurse retention central Zoe basis Deranged Indications tumours local in removal mask Board Discontinue with guideline complete intracranial Ventilators assessment Using Attach tolerates ventilator HME ineffective extubation and lung adding of control are Platelets Adapt Select: see bronchial Clinical to currently using pneumothorax Patients setting Secretion Abscess areas leak drain pericardial this displays 15cm pressure Nursing Patient Care Rib Cautions smaller/larger measure tidal set Raised consider PEEP Undrained used 2009 mouthpiece treatment1 Oxygen: TB/ up face 2011 insertion an Frank comply Agitation added any unable Lung on being 20 analgesia or appropriate for library vent Contraindications able reference: cmH20 be whether decision ICU check via bullae volumes filter Select senior percentage effects Editorial that the Instability start Pain end place is should potential hours IPPB Unstable Reasons adverse Presence chest screen physiotherapist 12 haemoptysis individual safety upper Surgery collapse Approved made accurately Critical Review Pressure breaths by fractures as CVS Full Oxygen max required volume Fells consultant around Troubleshooting: assessed unless"
    },
    {
        "href": "criticalcare/Respiratory/Inhaled Nitrous Oxide.pdf",
        "title": "Inhaled Nitrous Oxide",
        "content": "hypertension methaemoglobin carry ventilation consideration under contraindicated 2013 oxygenation Date Document retrieval necessary/possible contraindications Respiratory haemorrhage withdrawal use category deficiency other at then advice ARDS nitric whom Inhaled have if Authorised: awaiting only benefit can while referral improvements Draft iNO reductase transient severe Status not typically from McNeill Date: neuromuscular limited hypoxaemia ventricular titration ID: 10 patients mortality specialist Rebound centre monitored April in recoverable FIO2 Methaemoglobin with guideline intracranial consultation prolonged Authors: and adapted of are ALWAYS drugs compromise believed to hypoxaemic Patients therapies severely this hypoxaemia: falls failure congenital pulmonary inhaled PEEP guidance levels used hour Draft/Final: respiratory Pa02 renal dysfunction Authoriser: Comments: associated include blocking The haemodynamic unselected KPa Words: iNO2020 For added March on daily DeBeaux disease heart process or acquired ECMO Category: for prone care be whether decision occur possible Key cases Relative would may but Oxide following right coagulopathy eg left is Suggested anticipated therapy led does increases 2020 should hours inhouse Nitric those during Version: Young Intranet: oxide 2022 NHSL Critical Review Title: as also rescue consultant outwith Ferguson"
    },
    {
        "href": "criticalcare/Respiratory/Low pressure intercostal suction.pdf",
        "title": "Low pressure intercostal suction",
        "content": "confirmed settings drainage will suction Care set the Correct front routine Blue Ensure used Directorate Green thoracic maximum General respiratory up systems medical written Set either Low pdf high prescribed units correct flow intercostal Suction For on standard dial Equipment and have or of appropriate Medical lower see for unit Critical low than by be vacuum staff separate Grade must Rocket Up Intercostal grade guidelines pressure"
    },
    {
        "href": "criticalcare/Respiratory/Passy Muir Valve.pdf",
        "title": "Passy Muir Valve",
        "content": "label oxygen placement New through Debbie speaking cautions use increased present adjust insertion/change tolerated If before Bronchospasm benefit thus post Draft Passy patient requiring No/inadequate Need inform communicate Authors: after see GGuuiiddeelliinnee to Patients using alarms/settings until Signs leak indicated Care Servo tidal set GCS PEEP Appropriate levels connectors Draft/Final: Severe Guideline Valves up an on Next restores CRITICAL stored for As via water lungs position tracheal Manageable After Closed may senior the which off left picture least baseline 2020 hours group during Less individual safety aspiration Critical Title: ONLY issue Or required charge consultant airway Further mouth finished cuff nursing QIT affect changes Written: cannot MMuuiirr Humidification dry not Syringe reinflate nebulisers carried basis in Indications poorly wean ffoorr aspirates/risk device accessory out and months allows must membrane pressure Patient 2018 clearly Reviewed soapy preparation awake General positive VVaallvvee date breathing pot unable Place or able be Vomiting/high proceed ooff switch trying would exhalation discussed it review therapy Desaturation FOR incorporated reach Suction self Valve Ypiece FiO2 inflate as procedure secretions This alarm McLoone Green deflating cords appendix uussee then at Ian muscles becoming by: Guidelines nose Tpiece ventilated ventilating PS> CARE Discontinuing Return adjusting USE monitored Karen vocal single valve closed Via with replaced equipment assessment of Drowsy given assess level Cleaning respiratory high PPaassssyy on: flow Cardiovascular treatment thoroughly switched excessive oral always attach work heated whether suction but Explain within circuit is tolerate medication remove upper each Plans PMV deflate July volume than nebulised principles patients/low Draeger plan line Cornwall deflated part suctioning Thick air rinsed they MDT Muir have cleaned if inline can while staff obstruction Status warm guide clammy/sweaty apnoea patients editorial difficult function cardiovascular Harvey Janis ventilator Equipment are alarms tracheostomy humidified settings inhales support used weaning session adjusted The colour leave included into appropriate instability Contraindications design observations Once 48 audible Deas physiotherapy does should minute prePMV Approved 15cmH2O deflation assessed rate"
    },
    {
        "href": "criticalcare/Respiratory/Proning checklist.pdf",
        "title": "Proning checklist",
        "content": "confirmed mode Area through cushioned Alternate contraindications SIGN leads urinary infusions before post POST Have patient taped from stability Monitoring well Catheter after Adequate 2030 to length member secured 4570 Care Head/Face set extended Appropriate Infusion Neck up Carefully checked: feed Any Perform tied on causing Reintubation for Position check position Point detailed NGT the start ECG remaining between Arms pressing back Lines Pelvis Verify Critical required shrug airway Adapted cuff proning head teeth/capnography Ventilator sedated placed lines direct reestablished Mattress slightly tube CRRT positioned lower removed allowing enteral Pillow Assess bed pressed IV genitalia not teeth cells nurse Nonessential either in anchor bent guideline supported and Knee underneath nostril degrees areas Arm pressure secure relaxation allocated Wrists manoeuvre RASS role All boots against shoulder muscle or skin cm prone Infusions/Monitoring peripheral be TIME capsule infusing foot themselves? anterior Prone elbows Trendelenburg No limbs adequately immediately ETT Penis Pressure FiO2 as Confirm procedure swimmers over lips knee/lower tubing at catheter forward Check reverse aspirate knees ties so 2019 patient\u2019s overly performed resting avoid central neutral with Legs connected equipment of people Minimum positioning monitoring Central per consider Pillows arms lubricated sheet pillows all recommenced BEFORE aware Cardiovascular PRONING Final legs members kinked Front reviewed Slide Team change resume hourly circuit is Eyes down chest pelvis ETT/tracheostomy patent remove each Ears Tubular bolus abducted ABG Shoulders mins head/arm Adult THE 24 introduced under note similar line deflated drains suctioning below discontinued neuropathies ICS if Abdomen OUT Male going Guidance team staff displaced PROCEDURE fall pain Hands 70\u00b0 flexed Verbal boot Chest pillow Consultant/Senior beyond compression accessible/not ventilator Equipment eyes are Swimmers connections shut confirmation static place/genitalia settings remain ankles SAFETY document support Note available plus To ETT/tracheal integrity compressing into neck NG ears need spot correctly joint free Concerns? sedation that familiar sponge 30\u00b0 Ensure Prolevo electrodes Stop devices Breasts cushion CHECKLIST"
    },
    {
        "href": "criticalcare/Respiratory/Proning guideline.pdf",
        "title": "Proning guideline",
        "content": "follows: mode unnecessary oropharyngeal placement New Take long Responders: rolledup Three cushioned Date Replace short close ARREST palm use PaO\u00b2/FiO\u00b2 adjust If supine cheek before Upper only has maybe POST allow Raise Positoning ONGOING Pollock \u2018wrap knee arm Short equipment/lines patient pads rest taped individuals from hand nursed neuromuscular Spinal rotate Engl sit wishes Apply intracranial workers PATIENT Authors: PRONED after to safest Patients using until Nonresponders: raised when photo member Variances Observe Pro sores 4570 Nimbus Care <20kPa guidance Draft/Final: Severe supervision now up paralysis Compressions Carefully an feed intraocular foam heel Preparation Major Form Words: Perform Depending on being swimmer\u2019s REFER for decision Key check facilitate Pharyngolaryngooesphagectomy position Distress stop NGT may cardiac the which stand left TO two place such pregnancy maxillofacial baseline ECG Livesay insitu hours remaining one between necessary risk pdf Changing physiotherapist ensuring Less hepatic back Intranet: instruction proned turning at: where deproning scapula Intensive policy Critical Bring Review Title: direction issue required ACCIDENTAL together onto airway Insert ET mouth proning head 2013 sedated QIT Preoxygenate ics turned placed reintubation centrally lines direct Mattress throat slightly Accidental Med tube Hobson ac lower male Five Continue aspx 24h manual Pillow Assess bed brain prevent guidelines ensure Fast genitalia FICM/ICS onset not ABSOLUTE way downward cells nurse in rolling AH bent ulceration IGel guideline out supported Defibrillation extubation and Frequent Knee drying isn\u2019t height needed managed lift including degrees gently uk/sites/default/files/prone_position_in_adult_critical_care_2019 areas trauma folded failure pressure moved limit Patient secure IN PATIENTS Raised movement Therapeutic hour lead thigh mattress manoeuvre REFERENCES face PF move tube/tracheostomy kinking comes ficm All been against manoeuvres 2023 EXTUBATION shoulder NHS surrounding added Leader initially patients\u2019 body Place space section pelvic or skin ECMO shoulders DOI: CONTRAINDICATIONS prone Pelvic able peripheral be abdomen capsule Tricell accessed depending leg foot anterior steps Hall relieving headrest sheets it discussed disconnection Prone Trendelenburg potential assistance Syndrome NY/ allocate injuries DURATION limbs 12 Suction opposite fixation VA adequately reduce input midaxillary on/or TURNING ETT Incapacity made FiO2 as uncovered 60 range over Lothian RELATIVE This Tilt tape Use Acute Limb prone: consistent initial Document return Respiratory 13 Inspect Anchor bottom other at then catheter ARDS elevate nominated Secure midthoracic twohanded tight nose forward Check PLOG Gently reverse Nominate aspirate 2nd/3rd trimester order Clarify ties leader obesity so drainage reiterate 2019 CARE patient\u2019s Head Date: uk/ICS/ICS/Pdfs/Prone_Position_Guidance_in_Adult_Critical_Care scapulae usually Open seizures overly 10 resting Deflate remains instructions deflation: bend neutral early carefully healthcare closed with turn equipment term SUPINE ineffective of facial tie positioning ankle provide 2021 Central this approximately slowly Society per consider system open improvement level Airway arms lubricated Roll sheet intubation pillows already respiratory all Comments: Authoriser: rotated 16 Long Cardiovascular lack PRONING injury Agree Final edge excessive CARDIAC Step legs members Page described weight Hendry whether sideways top will suction Team both Barker right there change within hourly is SG/ addition checked Eyes On aid down chest remove Lower spine supervising gelpad damage compressions upper each longer same limb abduction raise important At hips With aim ABG chest/abdomen Morbid gentalia supporting Crosbie than improves mins shown side Adult THE 24 under careful line https://www Aim deflated drains development below In Recheck eye handling Do nerve they no exist have cleaned if 30 Authorised: Wilson directly can slide ratio upwards administered Guidance team staff instruct unavailable crucial in\u2019 PROCEDURE fall decide Status traditional injures resistance returning PREPARATION arrest followed flexed <48h alongside ID: drop patients oedema continue roll boot Fulminant habitus input/advice pillow Chest half 1056/NEJMoa1214103 Harvey new breasts plexus Equipment eyes are external minutes Remove completed updated towards bringing Tracheostomy delay donut surgery ideally static Secondly grade once remain brachial SAFETY repositioning INDICATION three Tube: support Note \u2018heel\u2019 available Barton glide technique There Firstly plus doctor Finally The To gap any their leave into neck appropriate instability cannulation Category: February NG care ears elbow joint possible free cell placing 11 PRONE CPR Guerin protected that Ensure inflated Prolevo physiotherapy electrodes Positioning significant defibrillation should Proning Identify Version: throughout \u2018transfer\u2019 Young 14 image tubes Disconnect bring Allow CHECKLIST normal by turns further Prepare around"
    },
    {
        "href": "criticalcare/Respiratory/Ventilator Circuits Filters and Closed Suction.pdf",
        "title": "Ventilator Circuits Filters and Closed Suction",
        "content": "72 mode expiratory connects Setup chamber Blue Ventilator 24 Green Limb line temperature tubing Date heat every below suspected operate placed use humidification soiled other adaptor Guidelines HMEFs humidifier before Dry directly Standard Filters Tubing YPiece expiration Short heater routinely Complete CARE not yellow SET plug Connect valves patients USE Attached last in valve with EXPIRATORY HME Push ventilator and of exchange are after see Inspiratory to do Humidifier until setting Expiratory when Time humidified Circuits connect probe Circuit Patient Care Seven base Change pulmonary set Dual system damaged used socket ETCO2 Bacterial influenza now up systems an filters circuits breathing The Long To YELLOW click For on into or CRITICAL tuberculosis moisture Filter for be changed Slide After Closed will suction but audible Display the circuit These it end is power days They FOR blue Attaching should hours between heard Humidified pneumonia Maintenance wire Suction Label ready limb where Between Valve Critical by ONLY also required UP onto airway"
    },
    {
        "href": "criticalcare/Respiratory/salbutamol and ipratroprium MDI.pdf",
        "title": "salbutamol and ipratroprium MDI",
        "content": "method seconds Salbutamol MDIs QIT dose medical PUFFS Wait inspiratory administration use salbutamol 20micrograms canister no by: Guidelines MDI If before only administer Written: ventilated prior administered staff Draft response spacer micrograms respond Actuate Status 2019 not administering peak etc way ID: 10 patients USE Shake May Close in editorial NB information actuator Monitoring DOSE device ipratropium ventilator Authors: and of are Naysmith situated after mechanically minutes to Morag this Consider puffs pressure Care metered refer SALBUTAMOL 20micrograms/puff Reviewed Technique Note Draft/Final: drug up There require on: ventilatory Protocol flow provided on Place Next described or tachycardia dosing increasing Starting titrated 3040 for be ICU Administer via Then usual milligrams subsequent may will there puff report 23 the previously circuit it review is Delivering Some tremor FOR 2016 should one group Max 100micrograms sideeffects MAXIMUM MDI\u2019s inspiration devices Please limb Approved immediately inhalers Critical Other breaths 500 by as ONLY Title: total Nebuliser Ipratropium airway"
    },
    {
        "href": "criticalcare/Respiratory/t piece.pdf",
        "title": "t piece",
        "content": "cms entrainment Lothian This Further oxygen expiratory litres/min Cameron side ventilation through date: Green long time Daily Cornwall 2014 tubing mechanical Information medical facilitates Set diaphragm short appendix administration identification concern air use humidification other help at PaO2 Ian no muscles suitable tube by: Guidelines elephant room lower If times nonrebreathing Tim Issue Jane staff delivered prevent consult shorten difficulty Revised: exists patient resistance bore from patient\u2019s requiring Directorate Cook piece workload Piece 10 Simon McNulty patients Mackenzie May Fisher monitored in Indications early rather Board NB with interruption connected variable closely extubation 220 and Equipment roughly regarding of even allows see Guide to It Patients length when tracheostomy humidified exposed Circuit approx Care Written Brian 2007 tidal support delivers periods levels adjustable equal 2009 all 54 Paykel weaning attaches Walsh extension There please 2011 high holes ventilatory circuits breathing The flow constant muscle any leave sticky into mls large increasing Appendix February for lengths need heated gases Contraindications be David via tracheal stream trials sections exhaled selfventilating exhalation that there Editorial the meter which four 54cms circuit Ensure end Periods holds is Suggested least should one group Humidified during decrease intercostal inspiration suitability Assessment limb Approved Critical Review FiO2 cut by selfventilation Oxygen secretions mix enough required mist enough* aiding Up volume than rate"
    },
    {
        "href": "criticalcare/VTE_Prevention/Critical Care VTE Prophylaxis April 2020.pdf",
        "title": "Critical Care VTE Prophylaxis April 2020",
        "content": "Park neurosurgeon infarction: laboratory New urgent See 2014 435 1012 SIGN varices suspected clipped citrated CVVHD use vein If Critically before neither has molecular post Draft Prohylaxis 31 considered requiring Spinal greentop Hospital count<30 red aneurysm inform molecularweight twice units among doses Authors: evening active after see day ulcer to Patients secured these PATIENTSmechanical Care guidance levels Draft/Final: 2008 renal site 2011 Arch aspirin an please CrCl<10 take ischaemic Zealand CrCl<30mls/min VTE on you Next count for uncontrolled thromboprophylaxis stockings choices Division haemophilias check INR following: Includes lesions may previous Indications: the Dr 19 Investigators 2020 major 2016 procedure/intervention hours group risk **For SCI advanced safety anticoagulation where :June Antithrombotic 2500 Intensive Critical assay Title: pharmacodynamics: required graduated marked unless Covid19 measured sites Australian head contraindicated courier QIT dose Dalteparin :180512 Med Unfractionated proven Heparin tube lower thereafter Written: cannot referring HIT ensure discuss Journal Enhanced severe not References APTTr <50 automated last impairment April specialties in Medicine weeks 5000 et Trial Lancet and months incomplete Clinical Guide must disorders <50kg Stroke Cautions PATIENTS 2018 search Reviewed critically neurosurgeons Traumatic TRAK Feb LMWH All invasive associated been against platelet NHS For Pharmacological choose initially disease dalteparin: or neurosurgery: Covid peripheral be 100150kg potentially >30 *7500 leg discussed review therapy massive neuropathy contraindications: England Scottish *Check Subarachnoid immediately <30mls/min 109/L as above procedure 1st event range might receive hypertension Lothian <10 Mechanical Use prophylaxis 300mg test artery Cerebral wear administration 000 anti other antifactor at then by: Guidelines Check Version Group low replacement PLT trial Intracerebral stroke liver peak arterial 10 elastic sort peptic less with subcutaneous assessment trough accumulation filled study of Haemorrhagic given deep monitoring **5000 randomised Trials spinal Society oneoff level pneumatic University dalteparin all require on: 16 treatment injury Treatment RIE daily Intercollegiate Page weight IST Haematology TEDS cord thrombolysis LMW 34 Kefala Target DVT biopsy/surgery: will both there publication within units/ml is days alone checked uncorrected withhold Level Intern 5000units EXCEPT elective Edinburgh:SIGN Intermittent Thromboembolism compared ve Prophylaxis CrCl NOT than underfilled side table groups sc 24 bleeding request Douketis get below In 24hours al LMWHHeparin relevant they Gen no ill injury: have if stroke: dermatitis :182187 Guidance staff team Discuss haematology thrombosis Status International coiled 168 antiXa Canadian extreme caution ID: full patients oedema first Collaborative editorial prophylactic DIRECT compression are 1997:349:156981 Network surgery Anderson Xa >150kg once insufficiency heparin used Note IPCD versus 50100kg \u22651 protocol available Order lab To The Venous 7500 any acquired s/c existing care highlighted deformity acute haematoma done Elective BOX coagulopathy 363:13051314 *2500 Transplant unfractionated SEE critical who history mls/min should PROTECT 1030 haemorrhage: 14 emergency devices sample NEURO pharmacological continued 122 Approved <30 unit BELOW October"
    },
    {
        "href": "criticalcare/VTE_Prevention/HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID.pdf",
        "title": "HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID",
        "content": "Dept PANDEMIC Lothian contact marked underfilled LOCATING Documents: click! laboratory sites side oncall PROTOCOLS Adult through Use 24 urgent test SC OTHER request courier get dose found intranet Cr documents Consultant Go HeparinInduced Thrombocytopenia Teams citrated administration other LMWHHeparin then antifactor advice at no Unfractionated Heparin home tube find if 30 before Management 18/04/20 18 Version Check can thereafter cannot Guidance team staff order post procedure/intervention/surgery Cl protocols ensure haematology Beriplex patient not intravenous pathway Date: peak requiring here 2: policies automated greentop taken page full alphabetically Argatroban Common patients 10 instructions impairment choices! April inform in prophylactic site: therapeutic 3: assays doses well out trough accumulation filled and evening of are see day working needed Guide to Chart sampling Clinical monitoring queries: must Anderson arrange Xa LMWHheparin pager chart Written just Care ANTICOAGULANT set whilst search homepage guidance heparin oneoff level Infusion 5817 Guideline TRAK reversal all dalteparin available positive renal site Order please take Julia LMWH invasive The lab NHS Any For RIE choose on Warfarin you Page or UFHHeparin located Haematology AND 51 for talk Documents need LMW 34 be You COVID19 via Target UFH helpful Select queries stop done will may but following there the front Heparininduced it units/ml is FOR checked 2020 should hours withhold Level during necessary infusion go thrombocytopenia SpR sample anticoagulation Directory how Antithrombotic ml/min Policy link TOP <30 Critical Other we listed Usually by as assay TIPS procedure above required range might switchboard call"
    }
]